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I declare that this thesis was composed and written entirely
by myself, and has not been submitted in candidature for any
other degree, diploma or professional qualification.
I further declare that although the work reported in this
teams in two hospitals,I have made a substantial contribution to
this experience. At Westminster Children's Hospital, I was
responsible for the day to day care of the transplanted
children and the commissioning and organisation of all aspects
of the Vickers-Trexler isolators. At the Royal Marsden Hospital,
I was a paediatric member of the team caring for patients
undergoing allografting and also worked in the microbiology
department at the laboratory/clinician interface with special
responsibility for trials of antimicrobial prophylaxis.
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During a bone marrow transplant there is a major risk of infection
either due to the specific disease or as a result of the required
preconditioning. Severely neutropenic patients benefit from receiving
prophylactic antimicrobial agents within a protected environment and the
thesis opens with a discussion of and a comparison between the different
ways of achieving this protection and an assessment of the contribution
of each component.
In the second part there is description and discussion of the
practical aspects of establishing and managing isolator tents for infants
and children undergoing bone marrow transplantation in the middle of an
open ward in a Children's Hospital built 70 years ago. The isolators were
found to be effective, practical and highly acceptable to almost all
children, their relatives and the attending staff. A pathogen—free food
service complementary to the degree of isolation was established and is
described. Three different regimens of prophylactic antimicrobial agents
were evaluated in the patients undergoing marrow transplantation and
the newer regimen using co—trimoxazole found to be superior in preventing
infection but to have several disadvantages. Extensive surface and
orifice decontamination measures were not found to be worthwhile.
The third section discusses the practical aspects of caring for
infants and children undergoing bone marrow transplantation. The
management and progress of 10 infants with severe combined immune
deficiency, and 10 children with severe aplastic anaemia is described in
detail with particular emphasis on the immune reconstitution of the
survivors. The outcome of eleven children with acute myeloid leukaemia
who underwent allogeneic transplantation is described and compared with
that of children who did not receive a marrow graft. Measures used to
attempt germfree deliveries without caesarian section are described,
evaluated and found wanting.
Viral infections after grafting remain a problem and experience
with cytomegalovirus and papovavirus is discussed. Infections with
herpes simplex and varicella-zoster virus after grafting are discussed
with particular reference to 19 marrow transplant recipients treated with
acycloguanosine which was probably effective though only in the short term.
The thesis concludes with a discussion of the requirement for marrow
grafting facilities in the United Kingdom and finds that six separate
centres, each with five designated beds will be the minimum required
For matched sibling alloqrafts given the present indications and this
service will cost not less than £1.6 million per annum.
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MARROW GRAFTING IN CHILDHOGD - THE NEED FOR FACILITIES
BONE riARR Oil) TRANSPLANTATION IN INFANCY ANO CHILDHOOD
Introduction
The first reported marrow transplant was in 1939 (Osgood
et al 1939) and by 1970 (Bortin 1970) at least 203 human allografts
had been reported with proven evidence of allogeneic engraftment
in eleven of whom three were surviving. The early sixties had
been a time of great activity in marrow transplantation with
more than 133 transplants reported between 1960 and 1963. The
degree of success achieved was reflected by the waning of this
early enthusiasm to the extent that only twelve grafts were
reported between 1966 and 1968... Almost all the reported successes
were patients who had received syngeneic marrow on account of
acquired aplastic anaemia.
It had been clearly appreciated by the early workers that
transplants could be rejected and also that the new bone marrow
could attack the recipient giving rise to fatal graft-versus-
host disease (GV/HD). A further problem lay in supporting the
patient and keeping infection under control until competent
engraftment occurred. Such patients as survived the transplant
procedure frequently died due to the return of their original
malignant disease because methods of eradicating this before
transplantation were ineffective.
Bortin (1970) was uncertain when he reviewed the reports
of 203 bone marrow transplants whether the annual number of
transplants reported would dwindle to.zero or climb rapidly
in the next few years. However successful transplantation in
severe combined immune deficiency reported by de Konig et al
(1969) and Meuwissen et al (1969) gave great encouragement to
those who believed that bone marrow transplantation could be
effective. Now ten years after Sortin's review, over 2000
bone marrow allografts have been reported. Although definition
of cure is clear only in the non—malignant disorders, the
patient receiving a matched sibling allograft has an overall
chance of 30-65^ of being cured and in certain circumstances
85^ of patients may expect to be cured.
No single advance led to this increase in the number of
successful bone marrow grafts. Through the years donor
selection has become more sophisticated but even so, about 20%
of patients died of acute GVHD until recently. Improved
preconditioning regimens have reduced both the incidence of
graft rejection in patients with severe aplasia and the incidence
of recurrent disease in the patients transplanted on account of
acute leukaemia. Pari passu with these important developments,
great strides have been made in the ability to support patients
with specific blood products until encraftment occurs. Isolation,
prophylactic antimicrobial agents and systemic antibiotics have
helped to prevent and treat infections during this same critical
period before engraftment. In particular, confidence in the
techniques grew and increasing numbers of successes have led to
patients in better initial condition- being subjected to grafting
and this in turn has both improved the overall results and
substantially reduced the morbidity of the procedure.
One centre, Seattle, has performed over 700 marrow grafts
to date and by mid-1980, the International Bone narrow Transplant
Registry at the National Institutes of Health, Bethesda, had
received notification from an additional sixty-four transplant
teams of 251 patients who received allogeneic transplants for
acute leukaemia, 275 patients who received a transplant because
of severe aplastic anaemia, and 141 children who were trans¬
planted on account of immune deficiency. (iBFiTR Newsletter
9/80).
In Europe at least 160 patients with severe aplasia,
including 48 children, have received marrow transplants
(Gluckmann et al 1980) and 104 children are known to have
received allogeneic bone marrow to treat immune deficiency
( EBFIT 19 80).
In the United Kingdom about 250 allogeneic marrow grafts
have been carried out, 102 at the Royal Mars den Hospital and
about 45 each at the Westminster Hospitals and the Hammersmith
Hospital. The Royal Free Hospital has performed 18 such
transplants and a number of other hospitals around the country
have each performed less than five. About ninety children have
received allogeneic marrow in the United Kingdom, 23 at the
Royal Marsden Hospital, 36 at Westminster Children's Hospital
and 17 at the Hammersmith Hospital. Although this total is
spread over nine years, the incidence of childhood marrow
grafts has risen rapidly with at least 40 having been performed
in the past two years. I have now been fully involved throughout
the whole transplantation procedure in 34 infants and children.
The increasing success of marrow grafting in childhood
disease is shown in the results. Using a fully compatible
allogeneic sibling donor, cure rates in combined immune deficiency
now approach 60%, and 35-80/b of children transplanted on account
of severe aplasia should be cured depending on how many
transfusions they have received and whether or not they are
infected. Seventy per cent of children with acute leukaemia
grafted in first remission if a myeloid leukaemia and second or
subsequent remission if a lymphoblastic leukaemia remain
completely well and disease free a mean of fifteen months after
grafting, but whether or not this represents long term cure
is at present uncertain. What has become increasingly apparent
over the past two years is that children accept the whole
transplant procedure much better than adults as far as morbidity
and survival are concerned.
It is also now well recognised that a marrow transplant can
supply more than just circulating red cells, white cells and
platelets. The graft can replace all cell lines derived from
haemopoietic seem cells and thus monocytes, macrophages,
Kuppfer cells and osteoclasts became- those of the donor.
Consequently the range of conditions theoretically treatable by
marrow grafting includes not only 'diseases of the blood' but
also some of the inborn errors of metabolism. Engraftment of
cell lines bearing competent enzymes has already been shown to
correct the abnormal metabolic climate resulting from certain
enzyme deficiencies. These and similar diseases- resulting from
single gene defects are the new fields where marrow grafting
must be attempted, at least until better treatments are developed.
Certain problems remain common to all bone marrow transplants
whether allogeneic or syngeneic. One of these is infection, most
likely to be a problem during the neutropenia before engraftment.
Whilst isolation techniques reduce the likelihood of the child
acquiring exogenous infection during this period of neutropenia,
they will not prevent infection arising from an endogenous source.
Prophylactic antimicrobial agents may reduce this danger. In
addition there is some evidence of the role of micro—organisms
in triggering HVHD. Prevention of both clinical infection and
the acquisition of new organisms is therefore important in
children undergoing marrow grafting and both protective
isolation and antimicrobial decontamination play a significant
part in this.
ISOLATION AND DECONTAMINATION FOR SEVERELY
NEUTROPENIC PATIENTS
Introduction
Infection is the most common cause of death in patients
with haematological malignancy or severe immunodeficiency.
Infection contributed to 67% of deaths from acute leukaemia at
the National Cancer Institute between 1954 and 1963 (Hersh et
al 1965) and caused death in 69% of leukaemia patients between
1965 and 1971. (Levine et al 1974). Although the majority of
those patients had terminal leukaemia, 25% of patients died of
infection before anti—leukaemic chemotherapy could have been
expected to induce remission.
A major predisposing factor to infection is prolonged
granulocytopenia (Hersh et al 1965; Bodey et al 1966). Patients
with aplastic anaemia}whether transplanted or not^and those
leukaemia patients who fail to engraft have prolonged granulo¬
cytopenia. Although granulocytopenia is not a feature of
severe combined immune deficiency (SCID) the nature of the
disease and the much longer time requir°d for competent
engraftment makes these patients markedly prone to infection.
80% of infants with SCID reported to the International Gone
Marrow Transplant Registry were infected at the time of
transplantation and half were infected with more than one
organism. (Bortin and Rimm 1977). Most of those who were
uninfected had been born in a sterile manner and maintained
in isolation. 85% of infants with SCID who died after trans¬
plantation died of infection. Nine of the first 100 leukaemia
patients transplanted in Seattle died of infection before
graft—take. (Thomas et al 1977). Infection was the most
common mode of death following transplantation for aplastic
anaemia (storb et al 1978). In addition, graft-versus-host
disease (GVHD) which affects a considerable number of
transplant recipients delays immune recovery (Noel et al 1978)
and predisposes to infection.
Since aplastic anaemia and SCID are uncommon diseases,
and marrow grafting even less common, data derived during
remission induction of acute non-lymphoblastic leukaemia (ANLL)
must be used to consider ways of preventing infection in the
patient with prolonged neutropenia.
Schimpff et al (1972), studying 48 A NLL patients over more
than two years found that half «the microbiologically documented
infections were caused by organisms acquired in hospital. 18%
of patients harboured pseudomonas aeruginosa on admission, but
a further 48% became colonised in hospital. Dameson et al
(1971) reported one acquisition of staph, aureus per 20 patient
weeks in hospital which would suggest that at least one in three
elective transplant patients would acquire this organism during
the course of their admission. Shooter et al (1963) and the
PHLS report of 1965 suggest an acquisition rate double that of
Oameson et al (1971). A protective environment should prevent
these acquisitions.
If half the documented infections arise from organisms
acquired in hospital then half arise from organisms harboured
by the patient at admission (Schimpff et al 1971). No
protected environment will prevent these but some form of
decontamination may be effective. Removal of recently acquired
microorganisms from the skin is relatively easy whereas
decontamination of mucosal surfaces is much more difficult.
Organisms harboured in the nasopharynx, mouth or bowels are
likely to be implicated in infective processes as mucosal breaks
in these sites commonly occur as sequaelae of chemotherapy or
neutropenia. A number of different prophylactic antimicrobial
regimens have been used often in con vion with procedures to
decontaminate the skin and mucosal surfaces.
Isolation and decontamination compared with ward care
There pt*p numerous trials involving neutropenic patients
and different combinations of a protected environment and
prophylactic antimicrobial agents. Many have only small
numbers, are poorly controlled, involve historical controls or
are not randomised. There are no reports of a protected
environment being microbiologically harmful except for the
Baltimore experience of aspergillus in the asbestos fire
proofing (Young and Roody 1977). Prophylactic antibiotics for
decontamination may have some disadvantages.
Six randomised prospective controlled trials involving a
total of 441 patients have compared ward care with care in a
protected environment ..(PE ) plus prophylactic antimicrobial
agents (PA). Five involve predominantly ANLL patients under¬
going remission induction and one concerns bone marrow trans¬
plant patients. Only one of the remission induction reports
(Dietrich et al 1977) includes children who form 18% of their
93 patients.
All patients in the series reported by Yates and Holland
(1973) had active ANLL and half had previously received
unsuccessful chemotherapy. They reported the lowest remission
rate (30%) and therefore their patients were at greatest risk
of infection due to prolonged neutropenia. One quarter were
infected on admission, whereas Levine et al (1973) and Oleijfer
et al (1980) had an incidence of infection of 12% at randomis¬
ation, while infection at that time led to exclusion from the
series of Schimpff et al (1975). In the multicentre study of
Dietrich et al (1977), 45% of patients were infected at
randomisation, 30% of whom were dead by 50 days, compared with
15% of those who were not infected at randomisation. Buckner
et al (1978) reported on marrow graft recipients, one quarter
of whom were infected at randomisation.
Results
Tabie 1 shows some results from these trials.
The two remission induction series with 25% or more patients
infected at randomisation show least benefit in PEPA. The
studies by Levine et al (1973), Schimpff et al (1975) and
Sleijfer et al (1980) where infection at randomisation was either
12% or absent.show benefit from PEPA with a marked reduction
in the number of infections and bacteraemias per patient and
in the number of deaths from infection compared with the patients
on the open ward (Table 1). Schimpff et al (1975) also found
those undergoing PEPA to have a higher remission rate, a
finding not generally confirmed.
The period of severe neutropenia is usually shorter in
transplant patients than in those undergoing remission induction.
Buckner et al (1978) reported a randomised trial of PEPA from
the Seattle transplant unit. Their patients experiencing PEPA
had one—third the incidence of infection and half the incidence
of bacteraemia compared to their control group. 11% of the PEPA
Table 1
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* severe infections only
1 excludes interstitial pneumonia
PEPA (protected environment, prophylactic antibiotics)
patients required therapeutic granulocytes compared to 50^ of
the unprotected patients. However, there was no difference
between the groups in the numbe^r of deaths from infection, nor
any improvement in the overall results of transplantation.
These data show that infections are less common, less
often fatal and the measures required to treat infection are less
complicated uhen patients are nursed in a protected environment
with prophylactic antimicrobial agents. This is particularly
true for patients who are uninfected at the time of commencing
PEPA and although the' benefit may be less marked for patients
undergoing bone marrow transplantation there is still a benefit
not only for the patients but also for the staff. Other data
suggest that graft-versus-host disease (GVHD) is less common in
the decontaminated patient (Vossen 1980). For these reasons
the combination of isolation and decontamination must be
recommended for neutropenic patients, and although the final
benefits are less well documented such a policy seems wise for
patients undergoing bone marrow transplantation. However, it is
worth examining the two components, isolation and antimicrobial
decontamination, separately to see what each contributes to the
protection of the patient.
THE PROTECTED-' E IMUIR ONNE l\IT-
The use of a protected environment in,bone marrow trans¬
plantation was regarded as speculative in 1975 (Thomas et al
1975) and there is still no proof that isolation and decon¬
tamination improves the overall survival of these patients but
benefits referred to above have been clearly demonstrated
(Buckner et al 1978). The aim of a protected environment is to
prevent the child acquiring exogenous organisms from either the
environment or their attendants. The basic requirements of a
protected environment are that the physical structure be
initially gnotobiotic and can be easily so maintained; suitably
treated supplies can be introduced in an aseptic manner;
adequate patient care is feasible and the environment
acceptable to both the patients and attending staff who must not
require excessive training. In addition, the protected environ¬
ment must be able to function within the limitations of the
staff available and the hospital in which it is being used.
Different methods of achieving such an environment are available
and each has advantages and disadvantages but each system is
only as good as its weakest aspect.
Sources of exogenous infection
Although sources of exogenous infection for the hospital¬
ised child include such communal ward equipment as baths (Alder
and Clee 1966) and toilets (Neusom 1972), stethoscopes (Gerken
et al 1972), respiratory apparatus (Lowbury et al 1970), ward food
(Shooter et al 1971), drugs and disinfectant solutions -<
l*" 196C)), without doubt the major sources of cross-
infection lie in the attending staff, other patients and to a
lesser extent, visitors. A quarter of the normal population
carry pseudomonas spp., 5-20% carry strep, pyogenes and up to
40% carry staph, aureus (Bagshawe et al 1978). The hands of
attendants are frequently contaminated in intensive care units
(Lowbury et al 1970) and one—third of hospital staff may carry
staph, aureus or gram negative bacilli on their hands (Schimpff
et al 1972). In Birmingham, 12% of nurses carried staph, aureus
on their fingers (Ayliffe et al 1979) and the spread of this
organism is particularly likely if the carrier is also a skin
disperser (Hare and Thomas 1956), a situation more common in
males (Bethune et al 1965). Nurses uniforms are frequently
contaminated (Spears 1969) as is bedding with which they have
just dealt'(Lidwell et al 1974). Common respiratory tract
pathogens are also readily transferred from staff to patients
(Hall et al 1976).
Staff procedures to prevent cross-infection
Methods to prevent cross—infection from the staff are
required in all protected environments where there is direct
physical contact between the patient and the attendants. The
most important is hand—washing which will quickly remove recently
acquired organisms but for this to be performed properly is
unusual (Bagshawe et al 1978). Hibiscrub (4% chlorhexidine in
detergent) is a useful skin antiseptic (Lowbury and Lilly 1973)
which leaves some residual antiseptic activity on the hands but
the ward containers may become a reservoir for pseudomonads if
not frequently replaced. Hibisol (0.5% chlorhexidine in isopropyl
alcohol) is also effective and may have a less drying effect on
the hands. Iodinated compounds, e.g. Betadine are also anti¬
viral in action. The skin of s,ome people is sensitive to these
preparations so a choice may be necessary.
Protective clothing is required to prevent contact
transmission. This may vary from a complete change of clothing
before each entry into the protected area to putting a protective
cover over the attendant's normal clothes on each occasion.
Disposable plastic aprons cover only at the front but are
impervious to fluids and are become much less contaminated with
staph, aureus than the fabric of nurses' uniforms (Lidwell and
Towers 1972). Gowns cover the shoulders and arms but do not
cover below the knees which boiler suits will do. Cotton or
fibre protective clothing is not normally of the close-weave
pattern which will reduce staphylococcal dispersal by susceptible
people. Although special non-woven material (Fabric 440,
Oohnson and Johnson) may be used (Hill et al 1974) a member of
staff who disperses staphylococci is better excluded from the
clinical team. Linen gowns are more durable than those made of
woven fibre (Fabric 450, Johnson and Johnson) and are only
slightly more expensive. Providing a fresh gown is used on
each occasion, it is unnecessary for these to be sterile. If
sterile gowns are required, those made of fibre will survive
three trips through an autoclave but cannot be washed in the
hospital laundry.
Protective clothing traditionally includes masks, gloves,
hats and overshoes. Thin paper masks become very poor barriers
after several minutes but they have a value in limiting droplet
spread duriny speech. Industrial masks are more durable and
also more comfortable. Thin polythene disposagloves rapidly
disintegrate, are awkward for venepuncture and make bathing or
applying lotions to a child difficult.i If gloves are required
for any length of time, surgical gloves are preferable. The use
of gloves must not lead staff to omit hand washing and there is
no evidence that gloves are superior to properly washed hands
in preventing cross-infection. Paper hats are of limited
effectiveness but since hair is so readily colonised it is reason
able to cover all hair including beards (Lidwell 1977).
Disposable plastic overshoes have a value only in promoting
general cleanliness.
Washing the hands and putting on a gown and gloves takes
1 minute 3D seconds (Tyrrell et al 1977). If a cubicle is
entered three times an hourj7.5^ of a nurse's time will be
taken up with these procedures. To wash the hands and forearms
for 5 minutes is impractical. If the materials used are
disposable, the material cost of each entry into the cubicle
will be about 75 pence. Compliance with these procedures is a
further problem. Tyrrell et al (1977) reported from their
purpose-built isolation unit that half the hand washes before
donning protective clothing were omitted which is unsatisfactory
as hand contact is so effective in cross-infection.
The structure of the isolation facility
The physical structure of the isolation facility is
important. Surfaces should be smooth, impervious and easily
cleaned. "Self—sterilising" surfaces are not effective. Toilets
should not Create aerosols on flushing especially if positive
pressure air is being used as these aerosols will be dispersed
downwind to non-isolated patients. Taps on the sinks should be
elbow operated and the stream of water not cause spray by
directly hitting the plug-hole. Sinks must be deep enough to
allow washing to the elbows without splashing nearby walls which
will cause plaster and grouting to be continually damp. Sinks
should not have an overflow, a site which encourages the growth
of pseudomonads although the significance of this site has been
debated. (|_v al 19 J8). Water traps in the sink bend are
also a site for pseudomcnads but the absence of a trap may lead
to odours arising from the drains. Electric boiling systems for
water traps have not been generally adopted.
Doors leading into the protected area must fit well.
Swinging doors take up space but sliding doors are less air tight
and the runners are difficult to keep clean. While swinging
doors may be pushed open, sliding doors will contaminate clean
hands. Mechanical or photoelectric methods of opening are
possible, but doors should close automatically.
Suitable supplies should enter the protected area without
a large door having to be opened each time. In isolation
systems dependent on air curtains to maintain their integrity,
this is not a problem but in solid structures, e.g. cubicles,
through-hatches with safety locks to prevent both hatch doors
being open at once are frequently used. They are more effect¬
ive in preventing air-borne contamination if part of an
independent negative pressure gradient draining elsewhere
(Bagshawe et al 1978) but this becomes both expensive and
complicated. Ultra-violet light in a closed hatch will reduce
air—borne contamination, but areas in shadow will not be steril¬
ised and the effects are greatly reduced by humidity.
Positive pressure filtered air
These systems have the benefit of increasing the control
over the patient's environment and when available in each
isolated area, airborne cross —in feet ion between isolated patients
will not occur. Positive pressure air allows air conditioning
and has a dilutional effect on such airborne organisms as are in
the patient's environment. pressure differences at different
sites within and without the protected environment will allow
air flow to be in the required direction. While filters may
be adequate, HEPA filters (0. ZfA.) are more effective. They trap
bacteria and viruses adherent to dust particles. Individual
cubicle terminal air filtration is preferable but more expensive
than a single filter bank. Easy maintenance is of prime
importance, and as much servicing access as possible should be
outside the protected area. Diffusers fitted where positive
pressure air enters the cubicle are necessary to avoid local
turbulence and draughts. - They collect dust and debris so should
be easily cleaned. Special designs have reduced flow noise
considerably.
There are however other considerations with positive pressure
filtered air. A single air-conditioning source serving a number
of cubicles gives particularly fickle variations in pressure
and temperature within different cubicles (Hambreus et al 1972).
Contaminated air passing from a cubicle to a common corridor
may constitute a hazard to non-isolated patients (NcKendrick and
Emond 1976), but arranging for each cubicle to have an extract¬
ion system that balances the air input is technically complicated.
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An open door will double the air flow required to maintain the
slight positive pressure existing in a room which has seven air
changes per hour, but the provision of an anteroom "air-lock"
»
will maintain the differential providing the outer door remains
closed. Because of convection currents a difference of 1c° across
an open door will by itself double the flow required to maintain
a positive pressure. Few air flow systems have built-in
compensators for these circumstances.
Methods of isolation
Mask isolation with hand washing is the simplest form of
protective isolation. All methods except laminar air flow
require visible barriers and due psychological note must be
taken of this. Patients feel a sense of abandonment if totally
isolated, especially if all visitors are excluded and their
disease serious. Wherever possible, certain visitors should be
allowed and there is little justification for totally isolating
the child from both parents.
Cubicles
Unless purpose-built, hospital cubicles have fittings
making them difficult to keep clean although initial substantial
sterility may be possible using formaldehyde vapour. They rarely
have an anteroom in which staff may wash and gown-up. Integral
toilets are unusual and the plumbing is difficult to keep clean.
Glass windows make for poor sound transmission and taking x-rays
usually involves breaking isolation. Filtered air would be
difficult to install and there is rarely space for the power plant
required. It is difficult to derive a properly protected environ¬
ment from a normal hospital cubicle but considerable protection
can be derived by careful hand washing, protective clothing and
the use of a cooked food diet.
Laminar Air Flow Units
Laminar air flow (LAF) units with HEPA filters are commonly
used to provide a protected environment. The theory is to
provide an undirectional non-turbulent flow of sterile air.
The units are mobile and can be used in a cubicle or an open ward
or else a cubicle can be constructed with one whole wall as the
LAF source — a so called LAF room. Some systems have two feet
of curtaining around the edge of the LAF source and depending on
the size of the unit a variable number of beds may be placed in
the sterile air flow.
Designs include vertical downflow to a whole floor extract,
horizontal flow to either the open ward, a single floor extract
or a full wall extract.
Laminar air flow is achieved with all these designs except
the one with a single floor extract where the direction of flow
varies. However when furniture, including the bed, or
attendants are in the air flow, the laminar nature is lost
because of downstream turbulence and the convection effects of
human body heat. If an attendant is 'upwind' of the patient,
the efficacy of the unit is lost as when the power fails or
the filters clog. LAF units depend entirely on air flow for
their integrity.
The usual horizontal air velocity is 30-50 feet/minute
but this may be increased to 90 feet/min. Tne volume of air
required for a single bed unit (about 2000 cubic feet/minute)
gives a considerable diluting effect or; any airborne organisms.
A two bed unit requires a flow of 35 feet/min to prevent
contamination between beds six feet apart (Lidwell and Towers
1969). Laminar downflow requires about two—thirds the horizontal
flow rates for satisfactory operation.
With ho physical barrier there is great ease of access
and communication. This ease of access is almost a disadvantage
and requires ..discipline as the invisible curtain of air must not
be breached. Active children, careless visitors and insects can
easily penetrate the barrier. Full protective clothing must be
worn when entering the protected area. To avoid the necessity
for this, one design incorporates a moveable wall with gloves
and sleeves (Penland and Perry 1970). Certain procedures can
be performed via these sleeves avoiding the necessity of
entering the protected area.
PVC isolator tents
Plastic iolators with positive pressure HEPA filtered air
have been used for animals since 1957 and for humans since 1964.
(Schwartz and Perry 1966). These early models "Life—Islands"
were made of heavy PUC which had poor translucency. They had
heavy insensitive gloves, poor access and viewing of the patient
and with the early designs staff had to wear protective clothing
when caring for the patients. Isolators completely enclosing the
patient, the bed and the furniture and requiring the attending
staff to use whole body PUC suits attached to the walls of the
isolator were not greeted with enthusiasm by Robertson et al
(1968) who in particular felt that children aged nine or less
would prove too untidy and messy for nursing in isolators.
Those designs and the paediatric isolator reported by Barnes et
al (1968) had complicated hatches for entering sterile supplies.
The isolators developed in 1972 (Trexler et al 1975) overcame a
number of the difficulties. The shape was altered to give
better visibility and the bed and furniture left outside the
isolator but projecting into it via reflections of PUC, so
there fore, usable by the patient. The gloves and PUC were made
less heavy and the supply entry system made very simple. Other
designs (Dietrich et al 1975) have included a concertina system
of the walls so to allow greater space for the patient therein
confined.
The protected area is essentially a closed PUC bag which is
only opened to introduce supplies. Apart from the sterilisation
of these, no effort is required to maintain the integrity of the
protected environment. The system depends on KEPA filtered
positive pressure air with a physical barrier which 'also gives
protection in the event of a power failure. Small leaks or
puncture holes do not result in loss of protection partly
because of the pressure differential but also because the
electrostatic charge developed when air passes through a small
hole causes particles to adhere to the PUC. Further details of
the design and use of isolators follow page S"0 .
Microbiological surveillance of the isolation system
An appropriate programme is necessary for any isolation
system, but must be chosen to give the required information.
Initial cultures will show the sterility of the system prior to
entry of the patient but the intention of isolation is to prevent
exogenous contamination of the patient with micro-organisms
from the staff or environment.
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Routine cultures.from various sites on the patient
with antibiotic sensitivity testing of any likely pathogens
occasionally modifies the immediate treatment if presumed
infection occurs. This is particularly true of a patient
with previous hospital admissions uho may harbour antibiotic
resistant organisms. A more immediate use of routine patient
cultures is that phage typing of staphylococci and pseudomonads
and biotyping of enterobacteriaceae will identify cross-
colonisation and a breakdown in the protected environment.
Patient screening is more effective than the routine
monitoring of the flora on the attendants and does not raise
the difficult questions of how often should staff be studied
and what should be done with the results. Since 30% of staff
carry nasal staph, aureus intermittently and 25% have pseudomonads
in the stool are these staff to be transferred to another ward?
Admittedly patient monitoring only identifies post-hoc cross-
infection but these microbiological studies are only a way of
documenting that the staff are maintaining the standards to which
they were trained. This need for training applies equally to all
staff, medical, nursing and ancillary, who are in contact with
the patients. Should cross—infection occur, then a specific
carrier search can be undertaken.
Environmental monitoring using settle plates or air
sampling gives some indication of airborne-organisms. Settle
plates are cheap, easy to use and their presence is psychologic¬
ally useful. By the duration of exposure, settle plates record
both busy and quiet periods of time and can be placed strategic¬
ally throughout tha protected environment. Culturing from
surfaces is' of little value 3S these are usually kept clean.
Accumulations of dust are microbiologically hazardous but their
very presence indicates a breakdown in house—keeping which needs to be.
remedied.
The value of protective measures
Each aspect of a protected environment contributes some
protection but in the absence of certain basic measures,
sophisticated techniques add nothing. Lidwell and Towers (1972)
used a LAF unit for patients recovering from thoracic surgery.
Normal nursing techniques were used and the acquisition of
of staphylococci and gram negative bacilli compared between this
unit and their ordinary ward. Twenty per cent of the ward beds
became contaminated with staphylococci compared to 10% of those
in LAF. There were 13 acquisitions of staphylococci in the ward
patients and 9.3 in the LAF patients per 100 patient days and
8 acquisitions of gram negative bacilli in ward patients compared
to 7.5 by the LAF patients in a similar period of time. Thus the
protective effect of sterile air without any change in nursing
techniques is minimal.
A simple physical barrier (a hospital cubicle) will reduce
the acquisition of staphylococci (Parker et al 1965) but only
if the doors remain closed. The imposition of a physical barrier
was effective in the burns unit reported by Lowbury et al (1971)
who found that 65% of patients in the open ward acquired
pseudomonads compared to 10^ of those who were in an isolator.
This difference was maintained whether or not the isolator had
filters attached, i.e. the use of sterile air gave no additional
benefit in excluding pseudomonads. They also reported that the.
isolator protected to a degree against the acquisition of
multiple antibiotic resistant staphylococci but did not affect
the acquisition of proteus spp. and some other coliform bacilli.
They were not using a sterile diet and it is likely that this
contributed to the new acquisitions.
The use of a specially prepared diet is important as shown
when yossen et al (1972) compared their ultra-clean rooms
(HFPA filtered) with their hospital cubicles. Food and drug
supplies were not decontaminated but full protective clothing
was used in both systems. |\lo cultures from the cubicles were
sterile and 40c/ of surface cultures in the ultra—clean rooms
grew organisms. Eight per cent of food samples contained very
high bacterial counts. The protective effect of the HEPA
filtered air in maintaining the cleanliness of the rooms was
rapidly lost owing to these contaminated supplies.
It is therefore difficult to separate out the benefits
contributed by each part of a protected environment and it is
impossible to separate the effects of a highly trained nursing
team when results from an occupied protected environment are
quoted. However it is clear that
a) a physical barrier protects
b) sterile air is useless in the presence of contact transmission
c) food and drug supplies unless specially prepared will negate
the benefits of preventing contact and airborne transmission.
To decide the value of a protected environment by itself it
is necessary to review results obtained when this was the only
variable. Six randomised studies on patients with severe neutro¬
penia are available as are several other studies relating to
more general medical circumstances.
Results — colonisation
Dameson et al (1971) reported a reduction in staphylococcal
acquisition and many fewer patients acquiring pseudomonads in
their air-filtered cubicles and isolators but found no
difference between these two forms of isolation. (Table 2 ).
Dietrich et al (1977) reported a multicentre trial with the
protected group receiving sterile food and supplies. These
patients had proven contamination and colonisation reduced by a
third. Bchimpff et al (1975; 1978) movsd from a normally
ventilated hospital to one where the hospital air conditioning
was HEPA filtered without recirculation. The reduction in
colonisation by potential pathogens was similar in both their
additionally protected environments compered with the open ward
but the difference resulting from the HEPA filtration of the
ordinary air in their new hospital was convincing in its own
right and further HEPA filtration did not significantly reduce
the rate of colonisation. The Hammersmith group (Trexler et al
1976) knew of no organism gaining entrance to their isolators
over 770 days, and the Westminster group over 242 days (Watson
et al 1977) also identified no exogenous organisms in their
isolators.
— acquired infection
Evidence for the beneficial effects of a protected
environment (PE) on the incidence of or death from infection
is clear in only some studies and particularly those in which
prophylactic antimicrobial agents were also given and there was
a low incidence of infection at entry to the study (Table 3).
The studies of Levine et al (1973) and Schimpff et al (1975
and 1978) show considerable benefit but that of Klastersky et
T able
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al (1974) who excluded patients infected at randomisation,
showed no benefit related to isolation per se in their 16
isolated patients. However most studies show that a protected
environment is useful for patients who are in good condition
when they commence their treatment. The study of Yates and
Holland (1973) included many patients who had already received
unsuccessful remission induction therapy for acute myeloid
leukaemia and the patients reported by Dietrich et al (1977)
had an infection incidence of 45% at randomisation.
Respiratory infections are less common in isolated patients
(Yates and Holland 1973; Schimpff et al 1975; Dietrich et al
1977) as are pseudomonas infections (Yates and Holland 1973;
Levine et al 1973)but LAF within a HEPA filtered hospital did
not decrease respiratory infections further, although it did
increase the proportion of patients who never had an infection
(Schimpff et al 1978).
Schimpff et al (1975) found their isolated group took a
mean of 20 days to develop their first infection compared with
the control group mean of 15 days but Levine et al (1973) and
Schimpff et al (1978) found no such difference. No real
difference in the number of days with a fever greater than
38°C has been reported (Priesler et al 1970; Dietrich et al 1977).
Priesler et al (1970) found their isolated group spent 10% of
their days on therapeutic antibiotics compared with 25% of
their control group.
S ummary
From these data, the balance is in favour of providing a
protected environment for the severely neutropenic patient
although the use of prophylactic antimicrobial agents would
seem to add considerably to the benefits achieved. The type
of isolation facility to be used will depend on many local
factors but simple hospital cubicles have many disadvantages
and therefore a specially constructed facility is preferable.
PROPHYLACTIC ft NTIMICROB IflL REGIMENS
There are considerable differences in the content of the
oral prophylactic antimicrobial regimens used in different
centres. The use of nalidixic acid and more recently co-
trimoxazole, absorbable antibacterial agents^has given fresh
impetus to the concept of systemic antibacterial prophylaxis
as an alternative to non-absorbable antimicrobial agents which
were given solely to reduce the bacterial content of the gastro¬
intestinal tract. The majority of patients who have received
these antimicrobial prophylactic agents are adults undergoing
remission induction of acute myeloid leukaemia (AT1L) but data
relating to bone marrow transplant recipients are slowly
accumulating. Some randomised trials involving prophylactic
antimicrobial agents in AP1L patients have had a protected
environment common to both those who received and did not receive
prophylactic antimicrobial agents and therefore only limited
comparison between different decontamination regimens is possible.
Sterility of the stools
Before 1975 there was interest in the percentages of sterile
stool cultures with papers recounting long lists of the microbes
eliminated. Recently, there has been much less interest in the
elimination of all micro-organisms, although this may be
relevant to the prevention of graft-versus—host disease in
marrow graft recipients. Stool cultures from decontaminated
patients may not show organisms despite their presence on gram
staining of the stool. Culture may be rewarded if the anti¬
microbials are eluted from the stool. When decontamination is
discontinued, many organisms reappear which were present before
decontamination commenced, but were suppressed for the duration.
In addition, '.the. results of culture may depend on how the
specimen was obtained and transported, which culture media were
used and under what conditions.
The early rotating antibiotic regimen of Schwartz and
Perry (1955) became replaced in North America by gentamicin,
vancomycin and nystatin (GUN), first reported by Bodey et al
(1958). The efficacy of GUN was confirmed by Bodey and Rosenbaum
(1974), albeit using historical controls (table 4). Priesler
et al (1970) combined the results of 20 patients, some in a
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PPVF 2/19 14/19 74/
GVN 12/46 42/46 91/
Rotating regimen (Schwartz and Perry 1966)
Nystatin 2 x 10^ units daily
plus
Bacitracin 100,000 units daily
Neomycin 3.5 gms daily
Sulfathalidine 5 gms daily
Bacitracin 100,000 units daily
Neomycin 3.5 gms daily
Polymixin B .85 gms daily
Paromomycin 1.5 gms daily
Kanamycin 3.5 gms daily
Paromomycin 3 gms daily
Polymixin B 420 mg daily









Gentamicin 800 mg daily 1200 mg daily
Vancomycin 2 gms daily 1.5 gms daily
Nystatin 4-12 x 106 units daily 21 x 10 units
2.S
protected environment and some receiving a pathogen-free diet
which may explain why so few achieved consistently sterile
stools compared with the results of Bodey and Rosenbaum (1974)
(table 4 ). Flore patients receiving GUN had stool pathogens
eliminated that those receiving rotating antibiotics or PPUF.
Bodey and Rosenbaum (1974) did not report differences between
their groups as regards the suppression of particular flora but
fungi were often present in the stools. Bodey and Rosenbaum
(1974) found nystatin in their doses to be slightly more effect¬
ive than candicidin. Although amphotericin was also an option
in the PPUF regimen the results are not reported.
Three other series using oral GUN in a protected environment
have been reported with details of the constancy and complete¬
ness of microbial suppression in the stools. (Table 5). Schimpff
et al (1975) found consistent complete suppression of all stool
flora in all of 24 patients. Levi et al (1973) reported
consistent bacterial suppression in 7 of 21 patients but a further
11 of the 21 had fungi consistently present in the stools.
Levine et al (1973) showed no bacteria in 94% of the stools
cultured from their 22 patients but make no mention of consistent
complete microbial suppression in any one patient. One stool in
five contained fungi on culture. Clearly the GUN regimen, which
has also been given to infants (Park et al 1973) can give
considerable suppression of stool bacteria,but in the hands of
most authors, this considerable bacterial suppression is
associated with the isolation of fungi on many occasions.
Elimination of pathogens from the stools
Since 1975 interest has moved from total stool microbial
suppression to interest in the elimination of pathogens. Lacto¬
bacilli , strep, faecalis, bacteroides and diphtheroids are the
organisms commonly considered acceptable in the stool. It is
the elimination of the enterobacteriaciae, pseudomonads and fungi
that is particularly useful, and it is worth remembering that
although infections with exotic organisms do occur, the vast
majority of infections are due to common well-recognised pathogens.
Table 5a compares the efficacy of various antimicrobial
regimens in eliminating pathogens from the stools. Although the
reported results range from 0% to 100% success in elimination
Table 5a
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Multiple^ no 58 16 (26%)
Bone marrow transplant patients PE — protected
environment
NE - not evaluable
Bacitracin 160,000 units/day
Neomycin 3 gms/day
Nystatin 6 x 106 units per day
Polymyxin B 200 mg/day
2FRAC0N+A
Framycetin 2 gms/day
Colistin 6 x 106 units/day




Colistin 3 x 10^ urrits/day
Nystatin 1.2 x 10^ units/day
Amphotericin 800 mg/day
4 /
Neomycin or Kanamycin 1 gm/day
Polymyxin B or Colistin 400 mg/day
Nalidixic acid 4 gms/day
Amphotericin or Miconazole 1-2 gms/day
^
Choice from the following:
Nalidixic acid 8 gms/day
Co-trimoxazole (480 mg Trimethoprim/2400
sulphamethoxazole/day)
Polymixin E 800 mg/day




of pathogens some of the differences may be interpretative rather
than real. Schimpff et al (1975) using twice as much vancomycin
as in other regimens report excellent results but they admit to
this only being when the patients tolerated the regimen.
Similarly the data of Buckner et al (1978) only records the 12
patients who took and tolerated all their GUN. Only 20^ of their
46 patients receiving GUN achieved consistent suppression of stool
pathogens, results not dissimilar to those of Levi et al (1973)
and Bodey and Rosenbaum •(1974).
However, effective as the Schimpff et al (1975) version of
GUN was, there is little difference between it and the FRACON
or NE0C0N regimens reported by Storring et al ( 1977) and LJatson
and Dameson (1979). There is little to recommend the BNNP
regimens, those of Guiot and Uan Furth ( 1977) or Guiot ( 1980) ^
should the object be the consistent elimination of pathogens
from the stool. The regimen of Slaijfer et al (1980) was chosen
from three antimicrobial agents on the basis of an antibiogram.
This regimen included co—trimoxazole and when given without a
protected environment achieved consistent elimination of pathogens
from the stool in 28% of patients.
Other regimens have been reported but"not with stool
culture results. Keating and Penington (1973) used framycetin
750 mg twice daily without isolation, and co-trimoxazole has been
used as a sole agent (Gurwith et al 1978) and in combination with
FRACON (Enn'o et al 1978). Rodriguez et al ( 1978) reported 145
patients, some receiving oral absorbable plus non-absorbable
antimicrobial agents and some receiving similar systemic agents.
Days with fever or receiving therapeutic antibiotics
All comparisons with each control group except that of
Dietrich et al (1973) showed a benefit to those receiving
prophylactic antimicrobial agents. (Table 6 ). All authors
defined a fever day as a day when the patient's temperature
was greater than 38°C for more than either four or six hours,
except Buckner et al (1978) who used 38.3°C and Dankert et al
(1978) who used 39°C. The duration and degree of neutropenia
where stated were broadly similar in all the reports with the
exceptions of Gurwith et al (1978) whose patients each had
less than eight days of severe neutropenia, Keating and
Table 6
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NE0C0N + 14 14% 36%
PE — protected environment ND — no data
*
marrow transplant patients
Penington (1973) whose group receiving framycetin had twice as
much severe neutropenia as their historical controls and Dankert
et al (197B) whose treated group had half as much severe
neutropenia as the control group. GUN is not represented in
the non-transplant patients in table 6 . However regimens using
framycetin or neomycin seem to give similar results to those
employing co—trimoxazole. In view of the degree of fever
required by Dankert et al (1978) and the distribution of their
patients' neutropenic daySjOnly Dietrich et al (1977) indicate
any real value in BNNP but without appropriate controls.
There are two marrow transplant series reported, neither
of which have entirely appropriate controls. Buckner el al
(1978) used GUN with an average in-patient stay of 45 days
compared to Watson and Dameson (1979) who used NEOCON during
an average in-patient stay of 32 days. Buckner et al used a
slightly higher fever threshold yet had twice as many fever
days and 50% more antibiotic days than the Royal Harsden acute
leukaemia transplant series. One-third of the Seattle transplant
patients suffered aplastic anaemia but these had disproportion¬
ately few infection although their number of fever days and
days on antibiotics is not specially quoted.
All the regimens where each patient had more than 10 days
g
with a polymorph count of less than 0.1 x 10 /I gave results of
fever on about 20% of days and therapeutic'antibiotics required
on about 40% of days.
Infections per patient
Eleven reports in which prophylactic antibiotics were the
only variable are summarised in Table 7. Of seven studies
during remission induction of AML showing prophylactic anti¬
biotics to be useful, four included protective isolation. In
not one of the three studies showing no^. benefit to result from
prophylactic antimicrobial agents was protective isolation used.
The two best results with GUN were very similar to FRAC0N in a
protected environment, to the remarkable complex regimens of
Rodriguez et al (1978) and to the simple use of co-trimoxazole
by Rosenberg—Arska et al (1980) who did not use a protected
environment. Unfortunately the degree of neutropenia is not


































































44 1 .39 GUN plus 45 .44
+
severe infections only * both groups in protective isolation
^marrow transplant patients
1 2
PA , SA see overleaf
PA1
Paromomycin 1.5 gms/day
Polymixin B 200 mgs/day
Vancomycin 750 mg/day
Nystatin 10 x 10® units/day
5FC 1•5 gms/day
Cephalexin 1.5 gms/day for 5 days
Chloramphenicol 1.0 gms/day for 5 days
Ampicillin 3 gms/day for 5 days










8 gms/day for 5 days
200 mg/m2 for 3 days
2 gms/day for 5 days
10 mg/day for 2 days
2 gms/day for 5 days
:30 mg/m2/day for 6 days
1.2 gms/day for 6 days
10 mg/day for 2 days
For other regimens see tables 4 and 5b
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The one study of marrow transplant patients (Buckner et al
1978) showed that leukaemia patients transplanted in relapse
suffered 50/ more infections than those transplanted in remission.
Bacteraemias
Table 8 shows the number of bacteraemias per patient with
different antimicrobial prophylaxis regimens. The degree of
neutropenia varied but diagnoses and therapy were similar except
in the report by Gurwith et al (1978) who did not quote the
diagnosis. All authors found a reduction in bacteraemia with
their regimens but results were improved by added protective
isolation. With this, GUN and FRACON + co-trimoxazole all gave
between .09 and .16 bacteraemias per patient. Neither Sleijfer
et al (1980) nor Rosenberg-Arska et al (1980) quote the degree
or duration of neutropenia, but both showed useful results in
preventing bacteraemia during remission induction of AML•
The multiple drug regimen of Guiot and Van Furth (1977)
given to 9 transplant patients seemed effective. Winston et al
(1978) gave routine parenteral amphotericin to their second group
of transplant patients having seen 16 fungaemias in the first
group, probably associated with 'SCARI', their very toxic pre¬
conditioning regimen.
Buckner et al (1978) took some care assessing compliance
with the prophylactic antimicrobial agents and showed how this
affected the incidence of bacteraemia in their transplant patients.
C ompliance Patients B acteraemias
Bacteraemias
per patient
good 12 2 .17
"average" 24 5 .21
bad 8 3 .38
Schimpff et al (1978) found that compliant patients had a
bacteraemia rate of 0.3/100 days whereas the poorly compliant
had a rate of 2.1/100 days. Compliance adds a further variable
to assessments of the antimicrobial regimens. On the basis of
infections per patient and the incidence of bacteraemia, there
is little to choose between the GUN and FRACON regimens, even
when a protected environment is included. The combination of
a protected environment with these prophylactic antibiotics
*4-
Table 8





















































(Acute leukaemia and aplas'ia)
Author Regimen
Protected Patient No. of Bacteraemias
environment numbers Bacteraemias /patient
Guiot and
Uan Furth Multiple LAF 9 1 .11
1977
Winston et GUN BN 60 48(16 fungal) CDCO•
al 1978 GUN+A(IU) BN 18 6(1 fungal) .33
Buckner et — BN 44 23 .52
al 1978 GUN plus LAF 45 10 .22
*PE used in both groups FRACON given to both groups
LAF laminar air flow
BN Barrier nursing For details of regimens see
tables 4 and 5b
is more effective but the results with co-trimoxazole are
encouraging.
Patients developing no infection
This is not recorded sufficiently frequently to make any
comparison of antimicrobial regimens per se, but the combination
of protective isolation with these prophylactic antimicrobial










18/66 (27/) 15/33 (45/)
Levi et al
197 3
8/28 (29/) 14/21 (67/)
Schimpff et al
1975
2/21 (10/) 8/24 (33/)
24/ of control patients had no infection compared with
47/ who were in protective isolation and receiving GUN (p<.05).
61/ of AML patients taking co-trimoxazole in the ward received
no additional antibiotics compared to 15/ of control patients
(Rozenberg—Arska et al 1980). This data is not reported in
other trials and is worthy of further study.
Deaths from infection
Table 9 compares the deaths from infection occurring with
each regimen, comparing control patients with those in protective
isolation and receiving prophylactic antimicrobial agents.
Overall 107 (22%) of 484 patients in the 'control' arms died of
infection compared with 61 (12%) of 527 (p<.00l) who received
prophylactic antimicrobial agents in protective isolation.
Whilst table 9 does not compare only the effects of
prophylactic antimicrobial agents in preventing death from
infection, the numbers of patients receiving the different
regimens within a protected environment does allow some compar¬
ison. The GUN reports are mainly from the early 1970's but the
proportion of protected patients dying of infection has remained
fairly constant in each study. Summating the deaths in each
group gives the following results
Table 9
COMPARISON OF ANTIMICROBIAL REGIMENS
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49 12 (24*) FRACON* 46 2 (4*)













52 9 (17*) Multiple 53 0 (0*)
Details of regimens - see tables 4 and 5b
■^protected environment (PE) in use
37
% of patients dying from infection
No. of
patients
control protected environment plus
prophylactic antimicrobials
'
GUN 336 25$ 10%




If the earliest GUN study (Bodey et al 1971) is excluded
the percentage dying of.infection while receiving GUN remains at
10%. The results of the FRACON type regimen are better than
those for GUN within the difficulties of this comparison. There
is nothing to recommend the BNNP regimen or the multiple systemic
antibiotic regimen of Rodriguez et al (1978). However none of
67 patients receiving co-trimoxazole died of infection.
Cost
Author Regimen C ost
Bodey et al 1974
Schimpff et al 1975, 1978
Storring et al 1977









The difference in cost (PHI hi S 1979) between the regimens of
5chimpff et al (1978) and Storring et al (1977) was £54 per
patient per day which would almost pay for two additional staff
nurses per patient each day. This is the most substantial
difference between any of the regimens.
Conclusions
In summary, the three most reported regimens are GUN,
FRACON/NEOCON and BNWP. BNNP is the least effective in a number
of assessments. There is little to choose between GUN and FRACON
as far as elimination of pathogens or prevention of bacteraemia.
FRACON is probably superior to GUN in reducing the number of
fever days and the days when therapeutic antibiotics were given.
GUN is no better than other regimens in preventing infections,
but FRACON is superior in preventing deaths from infection.
When a protected environment is used with antibacterial agents,
results are improved.
As GUN is not superior t-o FRACON, and costs considerably
38
more there is no reason to recommend GUN. On limited evidence,
the formulation of FRACON can be altered and the dose per day
halved without detriment (Watson and Jameson 1979). Co-trimoxazole
regimens are even cheaper and may be more effective. Until these
are evaluated, NEOCON (Watson and Jameson 1979) must be the
recommended prophylactic regimen, but urgent evaluation of
co-trimoxazole is required.
Unwanted effects of antimicrobial prophylaxis
Oral antimicrobial regimens are of little use if not
tolerated by the patients. The antimicrobial agents may be
directly toxic, may interact with chemotherapy or select a
population of antibiotic resistant organisms. Interpreting
anorexia, nausea and vomiting with these regimens is difficult
I
owing to the concurrent chemotherapy and reports of diarrhoea
and abdominal pain are much modified by the use of codeine
phosphate and similar agents.
The rotating regimen of Priesler et al (1970) was poorly
tolerated with frequent anorexia, nausea and vomiting. All
patients had mild diarrhoea as did many taking GUN (Priesler
et al 1970; Bodey et al 1974). A few patients had abdominal
cramps and severe diarrhoea. Bodey et al (1969) found GUN
as well tolerated as paromomycin, polymyxin and vancomycin.
Even so, 15% of patients do not tolerate GUN (Bodey et al 1972;
Levi et al .1973), Bodey et al ( 1969) found nausea on one third
of the days and vomiting on one day in nine. Rodriguez et al
(1978) found one-third of their patients receiving the complex
prophylactic regimen (table 7 ) had nausea and epigastric pain.
Although these effects may seem trivial, they are an additional
burden for the patient and interfere with adequate nutrition.
Some intolerance to all regimens is reported, the effects
usually being as described for GUN. Storring et al (1977)
found 10% could not tolerate FRACON, and Watson and Jameson
(1979) using half doses found an equal percentage intolerant
of NEOCON. Co-trimoxazole caused a rash in about 12% of patients
(Gurwith et al 1978). Schimpff et al (1978) found that GUN was
taken on 82% of days. Buckner et al (1978) using GUN +
polymyxin and paromomycin found that only 25% of patients took
all their antimicrobial regimen and that one patient in six
took less than 10% of the prescribed amount. This latter group
had more than twice as many severe infections as the former
group. After total body irradiation prophylactic antimicrobials
may not be tolerated for a few days (Guiot and Van Furth 1977),
and the Leiden group currently give co-trimoxazole intravenously
if the oral antibiotics are not tolerated.
There are also positively harmful effects of the antimicrob¬
ial regimens. Four of 90 patients receiving prophylactic
systemic antimicrobials including amphotericin B and colistin
developed acute renal failure with three deaths. Six of 145
receiving prophylactic clindamycin developed necrotising entero¬
colitis, of whom two died. (Rodriguez et al 1978). Keating and
Penington (1973) had one case of necrotising enterocolitis in
38 patients receiving framycetin. Gentamicin absorption from the
GVN regimen is usually insignificant although Priesler et al
(1970) found half their patients to have detectable serum levels.
One with radiation enteritis had a serum level of 0.53^/J-g/ml
and excreted 10^ of the administered gentamicin in the urine.
Levi et al (1973) found detectable serum gentamicin on a third
of occasions. Neomycin and framycetin are directly toxic to the
gut causing villous changes and mice tolerate methotrexate less
well when also receiving neomycin (Zaha^ko et al 1959), probably
because neomycin reduced the absorption of methotrexate and also
its degradation to non-toxic metabolites. Neomycin might
therefore be an unwise choice where gut toxicity is the
therapeutic limiting factor as with high dose melphalan therapy.
Another problem is resistant organisms especially when the
oral antibiotics include those usually used in a therapeutic role.
Bodey et al (1972) found 22% of bacterial isolates from their
patients receiving prophylaxis were resistant to the absorbable
antibiotics they used (tetracycline, chloramphenicol, doxycycline
and ampicillin). Klastersky et al (1974) reported that one-
third of organisms causing infection in their patients were
resistant to the oral prophylactic kanamycin and polymixin B
used and the in-vitro sensitivity to gentamicin was also greatly
decreased. In Baltimore (Schimpff et al 1973) gentamicin
resistant pseudomonads were an occasional problem but by 1978
Schimpff had to use amikacin as first line aminoglycoside
l+o
therapy in the neutropenic febrile patient. Although the GUN
regimen was not solely responsible its use outside a protected
environment must have played a part.
Interrupting prophylactic antimicrobials during neutropenia
in hospital is also unwise. Eight of 43 patients unilaterally
stopped taking GUN (Schimpff et al 1975). Of two in protective
isolation one died of infection and of six patients not in
protective isolation four died of infection, three due to a
hospital acquired pseudomonas spp. This further argues in
favour of protective isolation when prophylactic antibiotics are
being used.
For a variety of reasons all the regimens seem not to be
tolerated by 10-1552 of patients. The use of antimicrobials with
known highly toxic effects on the gut seems unwise and the use
of potentially powerful therapeutic antibiotics as routine
prophylaxis has little to commend it as a policy.
Recontamination after suppression of microbial flora
Protective, measures adopted during leukaemia remission
induction or marrow transplantation are usually withdrawn when
g
the neutrophil count is in excess of 1 x 10 /I. In SC IDjwithdrawal
of protective measures must await objective signs of a function¬
ing transplant. If acute graft-versus-host disease (GUHD) is
considered to be related to the quantity or nature of micro¬
organisms in the gut, protective measures will be indicated for
60 days, after which the incidence of GUHD is less although 30
days may be sufficient (Uossen 1980).
Recontamination is necessary only for an axenic patient.
Patients undergoing leukaemia remission induction are not axenic
and simply stopping their oral antimicrobial agents leads to
rapid alimentary recolonisation. Bodey and Rosenbaum (1974)
found half the organisms present in the stools between 3 and 17
days after stopping GUN had been present before oral antimicrob¬
ials commenced.








aerobes 202 11 2 (55%) 90
anaerobes 37 19 .(51*) 18
fungi 11 5 (45*) 6
Kliebsiella spp, ^Lactobacilli spp. , proteus spp. , citrobacter
s pp» and streptococci spp, were the most common bacteria to re¬
appear. Enterobacter, esch coli, proteus spp. and Clostridia
spp. were the most common apparently new acquisitions. One-
third of the micro-organisms which persisted during decontamin¬
ation vanished on re-emergence of the previously suppressed
flora.
This occult viable load of micro-organisms makes it
difficult and probably unnecessary to actively recontaminate
the gut. The patient has previous experience of these organisms
and should have some appropriate cellular or humoral immunity.
Their growth following withdrawal of oral antimicrobials
militates against overgrowth by new exogenous organisms and
sending the patient home directly from isolation means that
such organisms as are acquired will not be antibiotic resistant
hospital flora. If fungal overgrowth is thought possible, oral
antifungal agents should be continued.
narrow transplant recipients however take up to 12 months
to recover their immunity or longer if GVHD occurred (yitherspoon
et al 1976) and their allogeneic graft may not be able to
produce a rapid secondary response. If prophylactic
cyclosporin-fl is being given, the graft may be tolerant of new
antigens. Child sibling donors usually share a home environ¬
ment and their microbes with the patient so this tolerance may
not be a real problem.
Septrin, given after grafting for Pneumocystis prophylaxis,
suppresses stool microflora and may therefore reduce the
inoculum of a new organism to below the level required for
colonisation. However, some centres actively recontaminate
after transplantation, giving the organisms either by mouth or
per rectum.
Fresh yoghurt or subcultures of fresh yoghurt have been
used (Schwartz and Perry 1956) as have the faeces of pathogen-
free mice. Another approach is to use organisms selected for
their low pathogenicity and high antibiotic susceptibility
either from the donor's stools (Ramsoe et al 1978), or the
patient's original flora preserved in liquid nitrogen from
before decontamination. Additional anaerobes may be required
^2-
as these survive poorly in liquid nitrogen. O'Reilly et al
(1977) at Sloan-Kettering uses a mixture of diphtheroids,
neisseria spp., lactobacilli, Clostridia, bacteroides spp. (not
. ,
^
fragilis) and peptostreptococci until 10 organisms/gm are
present in the stool. 10%, of their patients become transiently
febrile with this regimen though none developed clinical
in feet ions.
The value and the ease of recontamination has been over¬
stated. For the non-axenic patient to go straight home from
isolation, stopping their oral antibiotics as they leave hospital
is the simplest policy. For axenic infants it would be wise to
establish a low-grade pathogen alimentary flora of strep, faecalis,
bacteroides spp, and lactobacilli with staph, epideridis
applied liberally to the skin before leaving isolation.
l+l
INFECTION flb A TRIGGER FOR GRAFT-VERSUS-H05T DISEASE
In addition to the benefits that a protected environment
with oral prophylactic antimicrobial agents gives in preventing
infection in patients undergoing marrow transplantation^the
recipients of an allograft are also at risk from graft-versus-
host disease (GVHD). As yet there is limited evidence in man
that GVHD is triggered by infection but a number of anecdotal
reports and impressions suggest that microbial flora have a role
in the development of this problem and animal evidence of the
relationship between GVHD and micro-organisms cannot be dismissed
lightly.
flnimal Evidence
Table 10 shows the results of Van Bekkum et al (1974) who
compared the stool microbial status of recipient CBA mice with
their survival when given 900 rads total body irradiation
followed by intravenous spleen and bone marrow cells from
..conventional H-2 non-identical 057 81 mice. The conventional
recipient mice had normal laboratory mouse flora; the germfree
(GF) mice were strictly speaking gnotobiotic, as a number of
vertically transmitted viruses exist. The "colonisation
resistant" (CR) mice had a stool anaerobic flora, the presence
of which greatly increased the number of aerobes required to
colonise their bowel (Van der lilaaji et al 1971). These CR mice
were achieved either by contaminating GF mice with flora
from a CR mouse or by decontaminating conventional mice
with 5 gms of neomycin, streptomycin and bacitracin, and 100 mg
pimaricin added to each litre of drinking water.
From table 10, it is clear that the germfree state conferred
great protection against death from GVHD, as it had been previously
shown (Wilson 1963) that without grafting only 5% of germfree and
6% of conventional mice exposed to 900 rads would survive.
Host GF" mice suffered minor GVHD but they all recovered in
similar recent experiments (Heidt et al 1979) and similar results
have been found in other rodents (Table 11). The results of
grafting CR mice are sufficiently similar (table 10 ) to those
of grafting GF mice for an intrinsic immunological difference
resulting from the GF state to be unlikely to be the explanation.
Van Dekkum et al (1974) contaminated mice chimeras which
Table
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were GF or CR derived from GF at different times after grafting
and observed GVHD. They contaminated the GF group with CR flora
for 4 days before transfer to a conventional mouse room to avoid
rapid death which sometimes follows sudden conventionalisation
of GF mice (Jones et al 1971). Table 10 shows that stable
chimeras can be contaminated and live in a normal mouse room
without developing GVHD providing this contamination occurs after
a certain date. Another group - CR derived from conventional mice
using antibiotics — were reconventionalised at 66 days with 67%
surviving the next one hundred and fifty days but dying with what
seemed to be low-grade GUHD. This result is not dissimilar to
the group in table 10 reconventionalised at day 60, This
group (CR derived from conventional) mimics human aplastic
anaemia and acute leukaemia transplant decontamination but the
axenic infant with severe combined immune deficiency could be
microbiologically analogous to the germ free mouse.
Table 11 shows a summary of the organisms used to contaminate
germfree rodents after H2 incompatible marrow transplants. No
details of the timing of the contamination were recounted but the
final results are similar to those of Van Bekkum et al (1974).
There was no evidence that congenital viruses induced GVHD,
and in addition no one particular species or class of organism
has been reported which will trigger GVHD. Likewise endotoxin
has not proved to be a trigger. Most groups of GF recipients
had high survival rates following an incompatible transplant but
even the GF state would not permit the xenogeneic transplant of
rat marrow intc mouse.
Van Bekkum et al (1977) introduced further mouse evidence
of the role of micro-organisms in gut GVHD. Germfree and
conventional C57 B1 x CBA F1 mice had fetal F1 gut implanted
subcutaneously. Total body irradiation was followed by marrow
and spleen cell transplantation from a CBA donor. Conventional
recipient mice died at 20 days of GVHD. Killing the convention¬
al mice at earlier times showed alimentary tract lesions and
also damage to the implanted F1 fetal gut. Germfree recipient
mice killed at the same time after grafting showed some lesions
of gut GVHD in their alimentary tracts but comparatively much
less damage to the F1 fetal gut implant. The derived hypothesis
was that gut microfloral antigens gained access via minor
GVHD lesions, cross-reacted with host tissue antigens and
induced a considerable secondary response in the transplanted
tissue, which then reacted with recipient tissues. Decontamina¬
tion of the gut removed these gut antigens and so in the presence
of mild GVHD, the secondary response did not occur.
Human evidence
Evidence in humans is accumulating slowly, one difficulty
being the lack of axenic humans. l\lo series of transplants in
axenic GCID infants has been reported, but GVHD has been related
to the gut decontamination status of.other transplant patients
(table 12 ). The data of Vossen ( 1980) is one of the few reports
and involves only children with aplasia. There is no doubt
from these three sources that stool microbial suppression is
advantageous in allogeneic transplantation for aplastic anaemia.
Tablel2a shows CVHD in eighteen of twenty-two recipients whose
stool micro—organisms were not suppressed, compared with one-
of sixteen who had suppression of stool microflora. The
majority of these aplastic patients had specific proof of
engra ftment.
This benefit is not seen in leukaemia patients undergoing
transplantation (table12b) even in those who received cyclosporin-
A as prophylaxis against GVHD. Their stools were no different
in content of micro-organisms (lu'atson and Dameson 1979) from
those of patients who had received methotrexate prophylaxis.
The major difference' between the pre—conditioning regimens in
aplasia and leukaemia is the use of 1000 rads total body irrad¬
iation in leukaemia. Does this induce gut changes that allow
microbial antigens access at the time of, or independent of,
minor GVHD changes in the gut, thereby sensitising the transfused
immuno-competent cells with a secondary response against tissue
antigens resulting?
If the relationship between GVHD and stool microbial
suppression is confirmed in aplasia then new impetus will be
given to antimicrobial regimens both at the time of and after
transplantation.
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HUMAN MARROL' TRANSPLANTS, GV/HD AND
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complete and sustained suppression of all faecal flora
neither enterobacteriacae nor Candida grown until
at least 30 days after grafting
2. BONE MARROW TR A IMS PL ANTflT I ON FOR INFANTS AND CHILDREN
AT Tl-'Q LONDON HOSPITALS
Introduction
lilork at two centres is reported in this thesis. Originally
the Co-operative Group for Bone Marrow Transplantation in London
decided that infants with immune deficiencies would receive their
transplant at Westminster Children's Hospital and children with
leukaemia would be transplanted at the Royal Clarsden Hospital.
Children with aplastic anaemia would be grafted at either centre
or at the Hammersmith Hospital. In the course of time, the Royal
Marsden Hospital transplant team concentrated on acute leukaemia
and subsequently on only acute myeloid leukaemia, referring
children with acute lymphoblastic leukaemia to Westminster
Children's Hospital. This latter arrangement occurred at the
same time as I moved from Westminster Children's to the Royal
Marsden Hospital and is the reason why there is no separate
chapter on the transplantation of children with acute lympho¬
blastic leukaemia.
Both the Royal Marsden Hospital and Hammersmith Hospital
had purpose build leukaemia or anaemia units. Westminster
Children's Hospital had no special facilities to compare with
the Bud Flanagan Unit at the Royal Marsden Hospital which
contained 10 single cubicles each with filtered positive
pressure air and an ante—room in which staff washed and changed.
At Westminster Children's Hospital, a general paediatric
hospital in central London, there were no specific isolation
facilities and consequently, amongst all the arrangements
required to conduct a bone marrow transplant programme, an
isolation system had to be created and techniques of anti¬
microbial prophylaxis had to be developed. It is these
problems which are now described and discussed.
So
A ) PROTECTED ENVIRONMENTS AMD PROPHYLACTIC ANTIMICROBIAL AGENTS
The Establishment, Use and g-valuation of V ickers-Trexler
isolators in"Westminster Children's Hospital
The decision to use isolators
Westminster Children's Hospital mas opened in 1908 and had
72 beds and 26 cubicles in 1975. Twelve cubicles mere specific¬
ally for infants. The 14 other cubicles, divided between three
wqrds, were not allocated to specific consultants and contained
medical or surgical patients as need dictated. These cubicles
were occupied 85—90% of the time. They had no ante—rooms so all
hand-mashing and gowning by staff was performed in narrow
corridors. The sinks had elbow—operated taps with a single
water jet hitting the plug-hole directly. The surrounding plaster
was old and defective in many areas near the sinks and the
cubicles contained numerous pipes and ducts which made them
difficult to clean. The floors were of pervious cork and glass
in the corridor windows and door made communication with confined
children difficult.
These cubicles were unsatisfactory for protecting a child
with prolonged neutropenia and upgrading programmes were
severely hampered by financial restraints. The demand for
cubicles was such that the three month stay envisaged for a
child undergoing bone marrow grafting would seriously reduce the
availability of cubicles for other children. An alternative
form of protection which supplied practical effective isolation
and at the same time required no structural alterations or
permanent site in the hospital was required and it was with
these aims that a Vickers—Trexler Mark I isolator was obtained
using charitable funds.
The \l ickers-Trexler lviark I isolator
Earlier models of patient isolator (Robertson et al 1968,
Barries and Tuffrey 1968) bore only a superficial resemblance to
the model described by Trexler et al (1975) and shown in the
cut—away diagram (fig. 1 ) on the next page.
The isolator consists of two separate polyvinyl chloride
(PVC) bags, called envelopes, which are linked by a communicating
port. The main patient envelope hanos from supporting
S\
Bed isolator showing patient in bed and two half suits in use. A nurse is
working in supply isolator on left. A = Control mechanism for regulating
pressure in isolator. B = Patient entry port. C = Air filter for pressurising
supply isolator. D = Downflow supply port. E = Air supply to half suit.
F=Unoccupied half suit.
rods joined by triclamps}and reaches the floor only on the
patient's left side. The standard NHS bed and other furniture
is outside the envelope and the mattress fits in an external
pocket on the outside of the envelope base. Foam rubber
separates and protects the PVC from the bed springs. The bedding
is inside the isolator and the way the PVC mattress pocket is
attached allows the bed to be made in a normal manner. Medical
and nursing equipment is inside the envelope , stored on shelves
and racks. The supply envelope, so-called because it has a hatch
where supplies enter, is at the foot of the bed and is also
supported on a framework (not shown above). There is a foot
operated hatch through which sterile items may enter the isol¬
ator. An exit port for removing waste is fitted i;o the patient
envelope. The envelopes are kept at a positive pressure by
HE PA filtered air supplied by a blower. The flow of filtered
air entering the isolator is controlled by a hand-valve and a
pivot system with a ball valve automatically adjusts the amount
of air actively extracted from the isolator by the same
Fig. 1 The yickers Trexler Isolator (Mark i)
thus maintaining the correct positive pressure within the
isolator.
Access to the patient is provided by three half-suits
which are part of the isolator wall and a number of sleeves
with gloves, spaced at intervals round the isolator. The half-
suits cover only the upper half of the body and have a visor of
firm clear plastic. Each has four arm sleeves with gloves. A
lightweight air waistcoat is hung round the attendant's neck
and this delivers air from a small additional blower to the
attendant. It takes 15 seconds to get into a half-suit and no
protective clothing is required.
A fuller description of the isolators and how to use them
to care for severely neutropenic or immunosuppressed children
is given in appendix I. This appendix is my tape-slide teaching
aid which was used to familiarise new medical and nursing staff
with isolator care. It is purely descriptive and is relevant
only to the techniques of paediatric isolator care.
The V/ickers—Trexler Mark I ,isolator tents were designed
for adults and were not ideal. To care adequately for children,
it was necessary to modify the design and construct some new
models. Adult-sized envelopes were inappropriate for infants,
so small animal isolators were adapted for this purpose. For
toddlers an adult-sized envelope was altered to completely
enclose a standard NHS cot. A transit isolator to allow
isolated children to be moved around the hospital or between
hospitals was also designed. Examples of these different
isolators are shown in appendix I. The supporting framework
was standardised and almost all the hardware became inter¬
changeable between the different isolators.
Isolator modifications introduced at Westminster Children's
Hospital
Modifications of our exclusion isolation system had to be
compatible with the Coppets Wood Isolation Hospital's isolators,
which are used for the containment of dangerous fevers. Thus
the improvements and modifications introduced would benefit
patients requiring either exclusion or containment isolation.
These developments were performed in conjunction with Vickers
Medical and Mr. P.C. Trexler of the Royal Veterinary College.
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Technical modifications
1. Single piece demountable and frameworks
Each end framework from which was hung the patient envelope
consisted of eight-separate rods with additional shelving or a
panel including the ports joining the patient and supply
envelopes. These rods had to be assembled and clamped together
so the ports of the supply envelope and the patient envelope were
at the same height. These rods were now welded together making
each end-frame a single unit with an adjustable position for the
joining port. This saved 3 hours each time an isolator was
assembled,
2. Foot operated side entry port
The nurses had to crouch to use the downflow hatch to
enter supplies into the isolator. The hatch cover was also
potentially contaminated on its lower side. A side—entry with
bivalve flaps opened by a foot pedal was easier for the nurses
to use and the bivalve flaps effectively sealed the port. Pass¬
ing in heavy items, e.g. sheets, was a little more difficult as
these were received horizontally at arms-length rather than
vertically. A side-entry port allowed the same isolator to be
converted for containment isolation (Fradd 1979) which was not
possible using a downflow port. A further development must be
a sloping entry port angled so that only one nurse is required
to enter supplies.
3. A separate exit, port and waste bag
This was re—introduced to allow large volumes of water to
be removed by suction and the presence of a waste bag meant
many fewer openings of the entry port. This bag needed changing
daily and this could be performed without breaking isolation.
Urgent specimens, e.g. blood samples were removed via the entry
port.
4. A dispersal system for the sterile air
Fitted to the ceiling of the patient envelope this reduced
filter flow noise and stopped draughts from the sterile air
entering the isolator.
Some minor technical modifications are still required. The
half—suit air blower should have additional silencing (p~7,5 )• The air
waist-coats should be more durable and the visor/flexible PVC
half-suit seam should be strengthened. In addition, such
alterations as are wished by those caring for patients in contain
ment isolation or responsible for their transport will have to
be incorporated into the exclusion system to maintain industrial
compatibility.
Modifications related to patient care
The size, shape, position and nature of what was required,
and the thickness of the PVC, were discussed with industry. The
prototypes were assessed, further alterations made and a number
of the ideas are now incorporated as standard on all the most
recent (Mark 3) isolators.
1. Four arm-sleeves on each half-suit
These allowed two different pairs of gloves to be available
in each half—suit. The spare sleeves made glove changing easier
and this could be done electively at a less busy time. If
surgical gloves were required e.g. to allow a venous cut-down,
they were replaced at leisure by normal gloves. For routine
work, different sizes allowed the nurses and doctors to have
gloves which fitted, important if an hour was being spent in a
half—suit or 25 gauge scalp needles were being used for children
1 1 i
whose veins were becoming increasingly difficult. Dumor size 6-f
and 8 gloves were most usually fitted.
2. X-ray tube drive-in sleeve and separate cajjette sleeve
Before this development, x-rays were taken from one side
of the isolator with the film on the other side. This meant
the patient had to sit transversely across the bed and the almost
fixed distance did not make for the usual high quality radio¬
graphs. PVC, except at a seam, did not interfere with the
picture obtained. The drive-in sleeve for the x-ray head
fitted model GEC MX4 mobile, a standard WHS portable x-ray unit.
The sleeve allowed full vertical ranging of the tube and the
length of the sleeve allowed the x-ray head to cover all but
the end foot of the bed. The x-ray head could be tilted
inside the sleeve and a panel of clear PVC allowed the aiming
light beam to be positioned correctly. The cassette sleeve
ss
was 6 foot long (183 cms) and took cassettes up to 13 x 17 inches
(35 x 43 cms). The sleeve length allowed the cassette to be
placed in any required, position.
This combination 0f tube and cassette allowed all plain
x-rays including decubitus views of the chest and abdomen.
Contrast films, e.g. confirming the position of a non—opaque
long intravenous catheter, intravenous pyelography or a barium
meal (using sterile barium) were also performed as were ultrasound
studies.
The x-ray/weighing bag in the infant (cot) isolator was
integral with the isolator and made of clear PVC. The neck was
bunched and tied when not in use to prevent the infant having
access to the bag. With a table placed below the bag and the
x-ray film between the bag and table the infant was x-rayed with
the tube shooting vertically downwards. Similarly, the infants
were weighed on scales placed under the bag.
All these techniques were performed with hospital staff
wearing their everyday clothes. Apart from hand washing there
were no sterile precautions required.
3. Refrigerator sleeve
This was designed to fit inside the Electrolux 120, a
standard ward fridge, and the sleeve fitted in_continuity with
the supply envelope. Although effective, changes are needed if
ice is required, but 6°C was readily achieved. The refrigerated
part of the sleeve held 18-24 hours supply of infant feeds, 8 tins
of coca-cola or similar drinks. The refrigerator fitted below
the work surface of the supply isolator.
4. Additional storage space, sleeves and gloves
A number of shelves and storage racks were added and add-
itonal glove sleeves were positioned round the envelope at the
most useful sites, including one to allow toys to be picked up
from the floor, Several were placed near storage areas so items
could be easily taken from a shelf without entering a half-suit.
A long sleeve at the head of the isolator allowed a telephone
hand-piece to be used. The number was dialled through a nearby
glove.
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5. Additional cones /
Flany additional cones made of thin PVC were added}through
which electric flexes, catheters or intravenous lines passed out
of the isolator. This meant that numerous leads could be left
in position. Leads for an ECG and a bell call were placed
routinely. If necessary, leads supplying filtered oxygen or a
suction facility were installed. Suction leads were left un¬
plugged so the flow of air outwards through these left no damp
dead space where organisms would proliferate. In the supply
isolator, leads for an electric kettle, toaster, cooker and fan
were routine. Ripple mattress leads were also fitted and
suitable filters were included to prevent ward air contaminating
the panels of the sterile ripple mattress.
flany of the children received intravenous feeding using
Uamin-glucose, 10% glucose and occasionally Intralipid 10% in a
rotating regimen. Although an intravenous facility was available
wholly within the isolator using two exterid'ble roof—top sleeves,
it was simpler to manage intravenous therapy from completely
outside the isolator. All drip tubing except the venous catheter
was changed daily. From the isolator, a sterile anaesthetic
extension set was passed out through a glove finger tip and
taped firmly in position. This was connected to the fresh
giving sets, filled with fluid and then connected to the venous
line. The previous extension set was then drawn out of the
isolator and discarded. The used glove finger tip was securely
taped. Every fifth day the glove used for the intravenous line
was changed.
These developments resulted in a patient care isolator which
is the most complete available. As with many specialised systems
there were a number of procedures to be learned but the
discipline required was similar to that of an operating theatre.
It was of course impossible for an isolator to operate distinct
from the nursing staff and the hospital services but the effects
of the isolator on these can only in part be separated from that
of a marrow transplant programme.
Integration of the isolators with the hospital facilities
The earliest transplants were performed using conventional
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reverse barrier techniques in the very inadequate ward cubicles
briefly described on page So . when the V ickers-Trexler isolator
became available it was deliberately decided to incorporate the
isolator both physically and for nursing purposes into the wards.
Infants were more appropriately nursed on the
infant ward and not on a ward with older children, so the isol¬
ators operated on two separate wards depending on the age of the
child (Figs. 2 and 3).
Nursing staff
When the General Nursing Council discontinued training
solely Registered sick Children's Nurses in 1975, Westminster
Children's Hospital lost thirteen student nurses per annum.
Concurrently the annual intake of qualified and student nurses
for paediatric training was reduced from fifty to thirty. This
reduction in real numbers of nursing staff caused considerable
difficulty as, it must be clearly appreciated, the nurses
caring for the bone marrow transplant children also had general
ward responsibilities. For a general medical ward of up to 23
children, the nurse establishment was 21, of whom 12 were actually
in post. For an infant ward of 16 patients, the establisment
was 25 nurses of whom 15 were in post. The numbers and grades
of staff established for and actually available are shown in
Table 13 . This situation was less than ideal so we employed
two additional staff nurses paid from charity sources, as well
as a packer to maintain the supply of sterile materials but
some packing and all at weekends was carried out by ward nurses.
For nursing care, including cooking special meals, the 16
bed (10 isolation cubicles) leukaemia unit at the Royal Harsden
Hospital has 31 established posts, all for post-graduate nurses.
There are usually 25-28 nurses in post at any one time. Although
the work is of a different nature in that unit, it is clear from
my experience that a marrow transplant patient requires two to
three times the usual nurse/patient ratio. Thus the employment
of two additional staff nurses who also worked with the ward
children ensured that the child undergoing a bone marrow trans¬
plant did not claim an unjustifiably large amount of the time of
the hospital employed nurses. All the nurses including those
specially employed came under the jurisdiction of the ward sister.
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Fig. 2 VICKERS-TREXLER ISOLATOR ON A PAEDIfiTHIC 'alflRD
Fig. 3 VICKERS-TREXLER ISOLATOR IN AN INFANT UflRD
Table 13
CHILDREN'S NEDICAL WARD






























* one isolator occupies 3 beds, i.e. reduction
of 2 beds
** 2 staff—nurses specially employed
GO
If "learners" cannot participate, on grounds that the work is
too specialised, yet the work is inappropriate for inclusion in
an intensiue-care training course}then major difficulties with
staffing levels will lie ahead.
Other Hospital Services
Bed availability
The bed isolator required 165 sq. ft. of floor space to be
easily used though 120 sq. ft. was just manageable. Three
ordinary beds had to be removed to position the isolator. The
cot isolator required 90 sq. ft. which might require the removal
of another cot. These bed closures occasionally caused local
problems.
Dieticians
They were considerably involved in translating the
nutritional nedds of each child into an acceptable and palatable
regimen (page $b ).
Physiotherapy, occupational therapy and radiography
These departments were involved but their work only slightly
affected by the isolator. The isolator was as acceptable to them
as to the nursing staff and this is discussed on page "7^ .
Electricians
A 20 amp power supply wired to the emergency generator was
required. fitting of five electrical plugs to flexes, earthing
the supply and main isolator frameworks and provision of a
plug-board on each supply isolator was their responsibility. All
the electrical equipment was routinely checked after each patient.
Fire and safety officers
The risks were probably no greater than for other patients
but no electrical apparatus was used inside the isolator when
additional oxygen was given. All electrical switches were
outside the isolator. Short circuits due to spilt water twice
occurred but only in the supply isolator as no electrical supply
is present in the patient envelope. Louj voltage circuits were
not used (except for the bell call).
Building department
No capital building was required, and no ward alterations
were made except as part of a minor programme of improvements.
The isolators were assembled by medical and nursing staff,
parents and medical students.
Porters
They were required to remove two beds and replace them
later. They also arranged the meekly transport of materials
for irradiation and the distribution of stores forwarded by the
supplies department.
Administration
They were involved in press enquiries but this was not a
specific effect of the isolators.
The nursing evidence showed that the Vickers-Trexler
isolator could be integrated into a general paediatric ward and
the child requiring a bone marrow transplant could be nursed
within this environment by nurses from the ward establishment
who also had responsibilities for nearby general paediatric
patients. The hospital services were not affected in any major
way by the use of the isolator particularly since almost all the
additional supplies and stores required were a function of the
marrow graft procedure and not items specifically necessary for
the isolator. The isolator therefore fulfilled the aim of being
a practical form of isolation which required no structural
alterations to the hospital. In that it could be dismantled and
removed to storage in about 6 working hours, or re-erected in
another part of the hospital, the isolator gave a flexibility of
bed space use not available in permanent classically-built
isolation units.
Establishment and maintenance of the protected area
If the procedures required to obtain or to maintain an
adequately protected environment are too difficult, complex or
time consuming, there is little chance of the adequacy of the
environment being maintained. Initial sterilisation of the
isolator gave a sterile environment for the patient to enter.
The techniques for producing sterile supplies and entering them
(o2.
into this protected environment (described in appendix I )
with the routine "housekeeping" of the environment constituted
the means of maintaining this environment. Major additional
efforts were required to produce adequately decontaminated food
since hospital foods as served on the wards may have an unaccept¬
able bacterial content.
Sterilisation of the isolator
The filters were sterilised by 2.5 Megarads of gamma radiation
and air at 50 cfm (1400 1/min ) passed through the filters for
5 minutes before connecting the filters to the isolator. This
air flow gave a "blow-through" sterilisation of the input
filter. Once the filters were connected the isolator itself was
sterilised. The outlet filter, in communication with the isolator,
received both the "blow-through" effect and the sterilising agent
used on the inside of the isolator.
A 2% peracetic acid spray with 30 minutes exposure was
recommended (Trexler 1978). This is highly effective against
bacteria, viruses and fungi in addition to being sporocirial.
Surfaces to be sterilised must be clean and in particular be
free from grease. Peracetic acid vapour is as effective as the
liquid preparation and so good penetration into awkward corners
can be obtained. It has disadvantages in that peracetic acid
must be made up less than four hours previously, has a very
penetrating smell and is a co-carcinogen (Bock et al 1975). The
undiluted product is also extremely toxic and needs care in its
place of storage.
Although we used peracetic acid initially, alternative
methods were sought. Gamma—radiation to 2.5 Megarads caused
discolouration of the PVC after a second passage. Milton
(sodium hypochlorite 1%) caused discolouration of the PVC after
3—4 hours immersion, presumably due to the hypochlorite radicals.
This effect was lessened if the PVC was washed after being remov¬
ed from the Milton. As 30 minutes immersion of non-metallic
items in Milton is satisfactory for sterilisation; we determined
whether a 30 minute soaking with Milton followed by washing
with sterile water could replace peracetic acid as a practical
method of sterilising the isolator envelopes. The use of either
peracetic acid or Milton required the inside of the isolator
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to be substantively dried after spraying.
Swabs were dipped in sterile saline and cultures taken
from eight different sites twelve to fifteen hours after
spraying and drying'the inside of the isolator. The person
taking the swabs had not sprayed that part of the isolator and
deliberately sampled relatively inaccessible sites. The swabs
were inoculated onto blood agar and cultured for 48 hours at
o
37 C. The results were as follows:-
COMPAR ISDN OF 2% PERACETIC ACID WITH SODIUM









s t a r i 1 e
cultures
500 mis 2% peracetic acid 10 80 80 (100?Q
750 mis sodium hypochlorite
followed by 750 mis sterile water
5 48 4 8 ( 100?O
*Half these volumes were used in the cot isolator
These results indicated that spraying with Milton, waiting
30 minutes and then washing with sterile water was an effective
way of rendering the isolator sterile. Milton was henceforth
adopted despite the extra labour of having to spray the isolator
twice, once with Milton and once with sterile water.
Routine servicing of the isolator
The PVC envelopes were cleaned inside and outside each day
and the entry and exit ports were cleaned before and after each
use. The gloves and seams were checked visually every day.
Punctures were repaired with sterile yellow PVC tape on the
inside of the isolator, or resealed with 'PVX resealant' glue.
The tightness of the triclamps was checked occasionally. Extern¬
al rough filters were washed or replaced every 2—3 months and the
internal filters on the half-suit blowers cleaned every six
months. The rough filter protecting the outlet filter was
changed twice a week. The blower motors required no maintenance.
The other electrical equipment was serviced according to
standard hospital policies. The envelopes were replaced after
about 250 days of use as were the main HEPA filters although no
specific efficiency tests were carried out.
Apart from daily cleaning which would be required in any
isolation facility there was therefore a minimal amount of
routine servicing required to maintain the adequacy of the
environment. Therefore establishment of the sterile environment
and its daily maintenance did not constitute a major problem
and confirmed the isolators to be a practical system. The
question of their efficacy was however paramount. The intention
was to provide an effective isolation system and a number of
studies comparing the environment within the occupied isolators
with their surrounding environment were carried out.
Microbial studies in the isolators
Studies were made of air within the isolators to determine
the number of colony forming units (CFU) circulating in the
isolator at rest and during activity. These results were compar
ed with similar studies in the same ward, in cubicles and in a
connecting corridor.
Air samplino studies
Studies were performed using an STA biological air-sampler
which sampled 5 cubic feet (141 L) in 5 minutes through a slit
onto a rotating blood agar plate. All air samples were obtained
through a .78 inch (2 cm) diameter plastic tube 39 inches (1 m)
long. This tubing was necessary to aspirate air from inside the
isolator.
1. To ensure that the tubing used for air aspiration did not
trap bacteria and give falsely low bacterial counts, eight
parallel studies were performed in a corridor beside a staff
changing room. In half the air entered the sampler inlet
directly and in half the tubing was attached to the sampling
inlet and the open end of the tubing held beside the sampler
inlet and pointing in the same direction as it. The blood—agar
plates were incubated at 37°C for 24 hours and the number of
colonies counted by the staff of the microbiology department.
All results are quoted in colony forming units (CFU) per cubic
foot (28 L) of air sampled. The results are shown in table 14a
The number of organisms isolated shows a mean of 28.9
(range 12—37) organisms per cu. foot of air sampled. However
there was no difference ascribed to the use of the air sampling
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tubing and in particular there was no evidence that numbers of
organisms were being trapped by this tubing and consequently
failing to reach the culture plat'es.
2. A further study was made of four plates from each group to
determine whether any group of organisms were being preferentially
trapped by the tubing. The results are shown in table 14b, and
although about 7%/of.the organisms were not immediately identif¬
iable, there was no real difference between the major groups of
identified organisms detected.
3. Studies compared the airborne bacteria in different locations.
The sunny open ward containing the isolator, a corridor leading
to the ward, cubicles where patients•were being nursed normally
or without protective isolation, were all compared to the air in
the occupied isolators (table 15a).
The number of observations in the cubicles and corridors
was somewhat small to give firm conclusions but the results lay
between the ward and the isolator results. The isolator air
had one tenth the density of airborne organisms compared to the
sunny ward containing the isolator. Activity in either setting
increased the airborne load two and a half times. Sixty one
percent of isolator air samples were sterile compared to none
in any other setting (table 15b).
4. A number of slit-sample studies" reported the number of
colonies of staph, aureus in different environments.








Cubicle 1 3 101 22 21%
War d 22 940 198 21%
Isolator 77 336 0 0%
On no occasion was staph, aureus isolated in air samples
taken from the isolators whereas 21% of the CFU found in the
open ward or the cubicles were staph, aureus. Tha proportion
of airborne staph, aureus was the same in the ward, in the
cubicles with reverse barrier nursing and in cubicles without
any protective measures, thereby confirming the inefficiency of
our cubicles as an effective barrier even in the presence of
Table 14a
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without
tubing
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WARD quiet •16 371 4.64
busy 27 1671 12.38
CORRIDOR quiet 4 36 1.78
CUBICLE quiet 8 130 3.25
(normal) busy 3 56 3.73
CUBICLE quiet 5 40 1.6
(PE) busy 3 22 1 .46
ISOLATOR quiet 35 75 .43
busy 54 278 1 .03
PE — protective isolation
Table 15b
NO. OF STERILE AIR SAFPLES





overall 89 54 (61%)
quiet 62 36 (58%)
busy 27 18 (67%)
as stringent protective measures as could be easily employed.
Other cultures
On only three occasions covering over 2000 microbiological
cultures and 1217 days of use was a species of organism found on
the patient or in the isolator which was not known to be present
on the patient before entering the isolator. One organism, strep
viridans, entered through a tear in a half-suit visor and
infected the patient. Large numbers of this organism were grown
from the mother's eyebrows and nose. The other two organisms,
both .acinetobacter spp., were found on single occasions in a
corner of different isolators and during at least 40 subsequent
days of isolation, this organism was not recultured. However, as
no phage typing or biotyping studies were carried out on
routine isolateSj additional contaminants cannot be entirely
excluded.
Discuss ion
Table 16 shows the numbers of organisms isolated per 100
cu. feet of air sampled in different isolation facilities. Ply
results of 43 and 103 colony forming units when the isolator
was respectively quiet or busy compare well with those of
Solberg et al (1 971 )," 5c'himpf f et' al (197 8) and Levine et al
(1973), but are less good than those of Lowbury et al (1971)
whose PVC isolator was unoccupied at the time of testing or Yates
and Holland (1973) whose facilities may have been unoccupied
when tested by air sampling. Bodey and Oohnson (1971) had good
results but their Life-Island air samples taken over eight hours
at the same sampling volume per minute as my studies, were taken
"through a port in the head board". The filtered air usually
enters at the head end of the Life-Island so it is possible
that much of each sample was freshly filtered air which had just
entered the Life-Island. Host of my samples were taken at the
"downstream" end of the isolator.
Not many studies quote the combination of air sampling
with different degrees of activity within the protected area
but in general activity greatly increased the airborne organisms
though by much more than the factor of 2.5 in my study.
The results show that more sterile cultures were obtained
(o<\
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NR - not reported
when my isolator was busy, but this diffErence was insignificant.
The actual percentages of sterile air samples when my isolator
was busy are very much the same as those recorded in the laminar •
air flow rooms of'Bodey and Johnson (1971), Levine et al (1973)
and Yates and Holland (1973) and Schimpff et al (1978), and are
better than the results obtained by those workers using Life-
Islands (table 16 ).
It is disappointing that there was only a ten-fold
reduction in the number of airborne bacteria in the isolator
compared to the sunny open ward. However Lowbury et al (1971)
only showed such a ten-fold improvement when little ward activity
was occurring around their unoccupied isolator. Other studies
show reductions to between 1% (Bodey and Johnson 1971) and
54^ of the ward airborne bacterial density (Levine et al 1973)
when using slit sampling as the method of assessment. Results
from units using laminar air flow units achieved greater reduct¬
ions in airborne bacteria ranging from one fiftieth (Levine et
al 1973) to one-fivehundredth (Bodey and Johnson 1971). The
small reduction (one-third), quoted by Schimpff et al (1978)
results from the low ward background contamination as their
whole hospital was HEPfl filtered. However the volumes of air
required to maintain laminar air flow are greater than those
required for a closed isolator. Schimpff et al (1978) used
approximately 80 air changes per hour and Solberg et al (1971)
used between 100 and 400 air changes per hour. The Vickers-
Trexler isolator uses only 7 air changes per hour and therefore
the load of organisms per total amount of air is very much less
in the Vickers—Trexler isolator compared to the laminar flow
units quoted in table 16,
The practical microbiological evidence is clear. The
isolator provided an effective controlled environment with one
episode in over 1200 days of use where an organism was known to
have gained access, and that was due to a technical failure.
Although the number of airborne organisms was only a tenth that
of the surrounding ward at no time was staph, aureus found in
air samples from the isolator whereas it was cultured from 2'\%
of the colony forming units found in the air of both the ward
and the cubicles, including those which were supposedly providing
protective isolation.
71
Acceptability of the isolators
The evidence shows that the isolators have provided an
effective form of isolation as used within a general paediatric
ward. The question of just how acceptable the isolators were
to the children, their relatives and to the staff is equally
important. Two persons out of over 200 found the half-suits
intolerably claustophobic but these were the only persons to
whom the isolators were quite unacceptable.
The isolator was usually in a large open sunny ward. With
thermometers inside and outside the isolator, numerous record¬
ings at 0900, 1200 and 1800 hours were obtained. The temper¬
ature in the isolator was occasionally 10° warmer than the
ambient ward temperature. However when direct sunlight struck
the isolator, a "greenhouse" effect resulted in an increment of
o
up to 50 . This effect was eliminated by drawing the appropriate
blinds. Attempts to air-condition the isolator failed because
the large surface area gave so much heat exchange. The only
solution would be to air-condition the whole ward.
Noise levels
Studies were made on a cot isolator which had a 20 cubic
foot per minute (cfm) blower and on the bed isolator with a
50 cfm blower and a 5 cfm half—suit air supply blower. These
were compared with a neonatal intensive care incubator and a
Humidaire tent in a ward.
Got isolator studies (figs. 4 and 5)
Noise levels were recorded using the dbA scale two feet
(61 cms) into the cubicle containing the isolator with the
windows of the glass balcony closed. The microphone faced into
the cubicle which was 30 yards (27m) from the London to Dover
road. The 20 cfm isolator blower was 2 feet 6 inches (76 cms)
from the microphone. In figure 5, the background lay between 49
and 57 decibels (db) depending on passing traffic. A London Transport
"7Z
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bus passing 30 yards away gave a reading of 65 db; an increment
greater than that of the 20 cfm blower. Isolator induced addit¬
ional noise to which staff outside this isolator were subjected
was less than that produced by variations in the normal back¬
ground .
Bed isolator studies (figs. 6 to 9 )
Figure 7 shows the contribution of an isolator to the noise
in a general ward which faced a quiet square in central London.
There was no difference in recorded noise whether the microphone
faced the isolator or faced into the ward, the general level of
ward noise lying between 55 and 65 db. During the children's
afternoon sleep the level fell to 44-52 db. At tea time the
noise frequently exceeded 65 db. The main 50 cfm blower did not
apparently add to this but the 5 cfm half-suit blower, without
air waistcoats attached, raised the noise level to a consistent
63 db. Re—attachment of the air waistcoats halved the increment,
and gave the normal working circumstance, a noise level of 57 db.
It was to this that staff immediately outside this isolator were
exposed, a similar figure to the ward background noise.
Noise levels inside the bed isolator were compared with
the noise levels outside the isolator (fig. 8 ). This shows
the ward background to be 48-58 db whereas in the isolator it
was a few db less. With both blowers running the level was 60
db. This is slightly more than that shown in figure 7 where the
steady level outside the isolator was 57 db, probably due to the
microphone being slightly nearer the 5 cfm blower. It did mean
that the child was subjected to 55 db continuously and 60 db
when attendants forgot to switch off the half—suit blower. Fleals
in the ward often exceeded 75—80 db as recorded at the isolator
and the effect of the blowers was noticeable only on recording
where they raised the lower noise levels from 50 db to 58 db.
Staff working in a half—suit experienced considerable noise
levels (_fig. 9 ). From a background of 50 db the air-waistcoat
receiving 1.6 cfm raised the noise level in a half—suit to 66 db.
For auscultation some staff switched off the half-suit air
supply (bearable for 3—5 minutes).
Pitch recordings were also performed (not shown). Tluch of
the noise from the 50 cfm blower was less than 100 cycles per
-7^
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second (cps) and very little was above 1600 cps. Similar studies
were performed on other hospital equipment. Fig. 10 shows the
noise level in a Vickers I'ledical 59 incubator with additional
equipment in use. Extra humidity was supplied with an air flow
of 2-15 L/min. At 5 L/min the infant was subjected to a constant
70 db. This level of noise has been described by Harris et al
(1978). Similar studies in a Humidaire tent showed that a child
received a constant 54 db.
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NOISE LEVELS IN INTENSIVE CARE INCUBATOR
(transcription)
Fig
Combining the results of these assessments of the noise
generated by the bed isolator showed that the mean background
noise beside the isolator was 56 db (range 48-64 db). The 50 cfm
blower and 5 cfm blower in normal operation gave a mean operational
level of 58 db. Background levels were 2-3 db lower in the
isolator and noise levels when in operation were 1-2 db higher
than the external recordings. Figures for the cot isolator were
similar with the infant subjected to about 58 db. Simple hearing
tests have been normal^and on infants in isolators for several
hundred days apparently normal development of hearing responses
occurred. Apart from when staff used stethoscopes in the isolator,




If at all possible the children were shown the isolator
or else large photographs of the system before admission. The
parents and child could try the half-suits but unless they so
asked they did not get inside the isolator. Similarly they
did not try the sterile foods in case such experiences produced a
negative reaction for whatever spoken or unspoken reason with
an increase in anxiety for all around. Methods of sterilising
toys, clothes and their personal possessions were discussed to
give as full a range of entertainments and diversions as possible.
Patients who had previously been in the isolator undergoing bone
marrow grafting, or their parents, were very helpful in explain¬
ing many aspects of the whole experience to other families.
Children adapted much better to the isolators 'within a
general ward than did adults (Watson et al 1977). Without doubt,
their physical condition was the greatest determinant of their
psychological well-being. Initially the children found the
isolator entertaining and they variously regarded their isolator
as a castle, a camping tent or a 'bendy House', and the attend¬
ants in the half-suits as space men or ' bonder Woman'. These
first reactions rapidly changed and after a week they accepted
the isolator for what it was and became efficient in managing
their environment. Over the next weeks they became critical of
staff techniques and knew as much of the procedures as the nurses.
A new nurse starting at this t'ime might feel threatened by her
patients' knowledge and her own lack of knowledge. This needed
tactful handling as the parents or child could reject an uncertain
member of staff, partly as an expression of their own anxieties.
After four weeks, the children became ambivalent towards
most situations, with their reactions swinging markedly from
hour to hour. At times they became very withdrawn, especially
if unwell, hiding under the sheets and rejecting their drugs and'
visitors. This reaction was initially interpreted as boredom,
but was really a product of apparently endless time, investig¬
ations and negative feelings about the future. Emotions became
very labile with often insistence on one particular staff member
to do certain tasks and rejection of all other help. These
critical and rejecting episodes were difficult for parents to
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accept as they were not part of the customary family behaviour,
and some parents felt their child was "letting them down".
Threats to leave isolation were common but never enacted.
After about 6 weeks the child's physical condition determined
their most frequent behaviour pattern. Most of the pre-teenagers
who were well, realised that only a short further time was
needed in the isolator and frequently "played to the gallery",
thoroughly enjoying the attention. Before leaving the isolator
feelings of insecurity were occasionally manifest and returning
to an environment where they were no longer the VIP gave
occasional problems. After discharge the children were somewhat
self-centred and some had difficulty relating with school friends.
The desire for tactile stimuli was noticeable for some days;
attention span was reduced and verbal activity increased. Over
six months these all returned to normal. Recurrent dreams of the
isolation period-only once occurred.
It was important .to organise parts of the child's day in
the isolator. A quiet rest period had to be provided when even
staff were discouraged from disturbing the child. Time set aside
for the school teacher indicated that the future existed to both
parents and child. Although visits from pop stars or footballers
were greatly appreciated also by other patients in the ward, too
many inquisitive visitors made the children feel they were in a
Sgoldfish bowl". Contact with other patients was encouraged and
usually enjoyed. With the isolator in a general ward, particip¬
ation with the ward school teacher and entertainments was possible.
The isolator did not. prevent the occupant shouting to his
friends in the farthest corner of the ward. Curtains and a
folding partition allowed the isolator to be screened off from
the ward if necessary.
Should death be approaching, there was the choice of
leaving the child in the isolator or removing him to allow close
family contact. Some parents felt that removal from the
isolator would indicate to the child (and themselves) that hope
was gone. Others regretted that they did not have close contact
with their child at death. There was no specific policy except
to respect the parents wishes. On balance I would prefer to
move the child to a cubicle.
Acceptability to relatives
bJith the isolator and therefore their child being in a
general ward was helpful as the parents developed relationships
with other parents and other children. Since the mean stay
in the ward isolator was 65 days, parents often developed a
surrogate role with another child. This role, in addition to
physically helping with the nursing of their own child, allowed
displacement of some tension and anxiety and meant that the
parents were not totally displaced from their traditional role.
The isolator techniques were easily taught and parental help
was actively encouraged.
Visiting the child was greatly eased by the minimal
training necessary compared with the training required to maintain
isolation successfully in a cubicle with full aseptic precautions.
The technique has to be correct every time a cubicle is entered
whereas the isolation is never broken by a visitor to the isol¬
ator tent. Brothers or sisters with a respiratory infection could
just as readily visit the patient, whereas this could not be
allowed in a cubicle. They would not however enter a half-suit
as the staff would then be at some increased risk of infection.
A parent could sit beside the isolator or in a half—suit, just
to be with their child and knit or read whereas this ..might be
less acceptable in cubicle protective isolation.
A new toy or electronic television game could be immediately
used with the child in the isolator operating it through one of
the sleeves in competition with his visiting sibling outside.
The controls of a television set were equally accessible, and
no extra audic equipment was required. Letters and postcards
were read through the PVC envelope and then sterilised and passed
into the isolator or sellotaped to the envelope.
Acceptability to staff
The major benefit was the ease of access to the patient
compared to a standard hospital cubicle. Casual conversational
visits, and quick reviews of certain problems were much more
easily performed than when the child was in a cubicle with full
reverse barrier precautions. Routine nursing observations were
made without entering a half—suit by a nurse who could look
after other patients in the same ward. Rotating intravenous
feeding regimens and intravenous drugs were given through the
intravenous line outside the isolator; thus two nurses did not
have to gown up, and senior staff checking intravenous drugs were
not hampered in their other work.
Nurses were not confined for considerable periods of
time with the children, which in protective cubicle nursing
leads to progressive inefficiency of protective clothing. The
presence of less critically ill children around the isolator
helped alleviate emotional strain for all members of staff.
Occasionally both student and staff nurses found certain duty
rotas arduous especially when the isolator patient was very
seriously ill but this was not a problem confined to isolator or
transplant patients. Changes in duty rotas and sympathetic
handling of the situation forestalled some of these problems.
The nurses trusted the isolators, and felt that much of
the responsibility for the prevention of cross—infection ha J
been alleviated for them. The actual nursing was little differ¬
ent in the isolator, although some improvisation might be
required. This did not imply any reduction in the standard of
nursing but more a planned approach to each action. The senior
ward staff found the discipline, planning and responsibility
required in isolator nursing helped some student nurses
become more methodical and foresighted about their work. Such
special emergencies as might arise with the isolator itself,
e.g. loss of inflation pressure, had procedures to be followed
but this was a matter of prior education for both nursing and
medical staff.
The medical staff concurred with the nurses' opinions and
saw the same benefits as the nurses for the patient and them¬
selves. The reliability of the isolator was a considerable
benefit and the need for no protective clothing saved time.
Several staff members present at a consultation could all
examine the patient without numbers of people breaking isolation
by entering a cubicle. Discussion needed the same sensibilities
as with any patient since sound transmission was good. Casual
social visits were very easy and talking to parents did not
require them to leave a cubicle and regown afterwards.
Hectical procedures were performed in the isolator with a
minimum of difficulty. The thickness of the gloves reduced
sensation a little, but venepuncture could still be performed
solely by palpation. Surgical procedures such as opening of
abscesses, insertion of long intravenous lines via the internal
jugular or subclavian veins were all performed. Gloves were
changed aseptically to accommodate the surgeon's requirements.
Investigations such as a barium meal, electroencephalo j
electrocardiography and ultrasound studies were all carried
out without breaking the sterile barrier. Stethoscopes with a
paediatric head were passed down a sleeve into a glove (with or
without a hand in the glove) and easily used, though the benefits
the bell were lost. Chemical sterilisation of an ophthalmoscope
would ruin the lenses, but those who learned the knack could use
the instrument from outside through a half-suit visor. Najor
resuscitation is still not possible in the isolator, but common
sense dictated the immediate policy. Specific instructions were
always in force and reviewed frequently.
There was no doubt that the isolator was acceptable to the
relatives and the members of fetaff. The access to facilities and
contact with other patients and staff mads it the least isolating
form of isolation available for children of all ages and they
accepted it well. Whilst similar arguments apply to laminar air
flow units regarding the degree of isolation from the social
environment, the lack of necessity for any protective clothing
was a major advantage for the staff and relatives.
Discussion
This is an extension of the only reported evaluation of
isolators for bene marrow transplantation on an open ward
(Watson et al 1977). It is also the only such evaluation
involving solely children being cared for in a general ward of
a general children's hospital and not in a special anaemia,
leukaemia or transplant unit with its own specialised staff.
A comparison can be drawn between the isolator and other
forms of protected environment (Table 17 ). The isolator in
common with cubicles and LAF rooms provides a barrier which is
independent of air flow. A LAF bed is totally depend ;nt on
the air flow to maintain the protected environment. Air filtered
Table 17











Physical barrier + + + - + +
Barrier










+ +1+1 - - -
Easy use of bed
for other + + + + + +
purposes
Easily removed
and reassembled — - - + + +
elsewhere
Building
modifications - + + - + —
require d
Easily kept clear - + + + + +
Barrier breached
to care for + + + + + -
patient
Protective




+ + + + + +
Good visibility
of patient
+ +1+1 + + +
Considerable
social contact
- - - + + +
Protection from
i 1 + 4.
careless visitors
+ T T
to HEPA standards is often difficult to fit to a normal hospital
cubicle but is available giving both protection against and dil¬
ution of air-borne organisms in specially constructed cubicles,
LAF units or isolators. Additional air conditioning is not
required for LAF units or the isolator but may be necessary in
cubicles depending on their nature. If not required for their
primary purpose, the beds in cubicles or LAF can be readily used
for other purposes, but should the isolation facility not be
required for some reason, only LAF units and isolators can be
removed and the space put to other uses, LAF and isolators can
be re-assembled in other sites and no building modifications are
required when using isolators or LAF-.
Normal hospital cubicles are difficult to keep clean
unlike units specially designed for protective isolation. Caring
for the patient requires the barrier to be breached in all
systems except the isolator and the LAF room where some
procedures may be performed through the wall of the room.
Staff attending to or examining the patient must take full
aseptic precautions every time in all systems except the LAF room
and the isolator. Sudden emergency access to the patient is
not quite so easy in the isolator as in other systems since a
generous slit must be made in the PVC but the ability of staff
outside the isolator to see the patient is considerably better
that when the patient is in a cubicle. LAF and isolators give
the patient much more contact with other patients and visitors
than any cubicle system but the physical barrier of the isolator
or LAF room prevents the careless visitor from breaking the
protective barrier
The isolators therefore provide an effective practical
protected environment which has a number of advantages over
other systems, particularly of the cubicle design. There are
fewer advantages over LAF but the major ones remain of a physical
barrier which is not broken by the attending staff who therefore
need no protective clothing, and only require to wash itheir
hands before attending to the patient. The objective in using
isolators was to provide practical effective isolation within
a seventy year old children's hospital which had not undergone
major modernisation and would not be able to find the construct¬
ion or staffing of a designated unit. This objective was achieved.
Use of an exclusion isolator for containment
An additional use. of the isolator presented itself when
episodes of cross-infection occurred within the infant ward.
UJhen used with positive pressure, the isolators exclude airborne
infection whereas with internal negative pressure, infection
within the isolator may be contained, protecting the attendants
from air disseminated organisms. Although the PVC envelope
prevents contact transmission, care is still required in the
disposal of infected material. These techniques with a contain¬
ment isolator were described by Trexler et al (1977). Such
containment isolators are available at designated hospitals in
the United Kingdom for patients with dangerous fevers, e.g. Lassa
or Marburg fever. These isolators have the same basic design as
those used for exclusion of micro-organisms at Westminster
Children's Hospital and all modifications made to the basic
design must maintain industrial compatibility even though the
ultimate use of each isolator is different.
l\lo opportunity had arisen for an isolator usually used for
exclusion isolation to be converted and used for containment
isolation in the same institution by staff familiar with nursing
in the exclusion mode. We had thought that such conversion and
management could be achieved and put this into practice when
presented with an appropriate situation.
Case report
D.E., aged 3 months, weighing 2.6 kg presented from the
Middle East with severe diarrhoea for 2 months. On initial
investigation, Salmonella wein was isolated from the stools on
several occasions and ultimately infection by this organism was
the final diagnosis. The child was fed intravenously for 97 days
and very slowly regraded to normal feeds via a diet of comminuted
chicken with mineral, lipid and carbohydrate supplements. Cubicle
isolation and barrier nursing was effective until 128 days after
admission when three episodes of cross—infection gmongst other
infants occurred. On each occasion a different nurse was found
to excrete 5. wein in her stools. Despite rigorous protective
measures with five nurses being allocated to look after only
this child and a short course of antibiotics to
the index case, a further infant became colonised. kJithin a
cubicle the infant was placed in a Trexler cot isolator converted
from exclusion to containment mode. l\lo further cross infection
or positive environmental cultures occurred during the 113 days
she spent in the isolator. On discharge home, ueighing 8.3 kgs,
Salmonella vein was still present in her stools.
Technical alterations
A standard cot isolator with supply envelope and framework
was converted to the containment mode. Since the patient
envelope of an exclusion mode cot isolator has its structure
maintained by positive air pressure without any supporting frame¬
work, the use of negative pressure would have caused the envelope
to collapse around the child. The envelope was therefore kept
in position by stretching uickers "Q'xymist" tent elastic cords
along the length of the cot and using the "Oxymist" pegs to
secure the patient envelope to the cords. This gave adequate
support. The p\IC envelope was protected with PV/C adhesive tape
applied where the pegs were positioned. The supply isolator had
its own framework so no additional support was required.
The air supply required alteration. In the cot isolator
filtered air enters the patient envelope via a sleeve and diffuses
out through the entry port. This could not have been satisfact¬
orily reversed so a new port was cut in the roof of the supply
canopy and through a 6" (15.25 cm) HEPA filter, air was drawn
out of the isolator to the suction side of the blower. The
patency of the usual air entry sleeve was maintained with spacers
and ward air entered this passively through an 8" (20 cm) HEPA
filter. An additional similar sized passive air entry was found
necessary to allow an adequate number of air changes per hour
within the isolator.
A standard 14" (35.5 cm) diameter side entry port was
used to enter and exit items from the isolator. The procedures
were exactly as described for Lassa fever patients by Trexler
et al (1977) and required Panduit ties and a Weller heat gun
to separate and further seal discarded infectious packages.
Gloves and glove rings were fitted from outside instead of
from inside the isolator. These modifications took 4 hours and
setting the isolator up took another hour. The ward nurses
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were familiar with the techniques required for exclusion isolation
of the marrow transplant patients. |\|o particular nursing
problems were encountered and the nurses accepted this form of
source isolation extremely favourably (Fradd 1979). The great
benefit to the ward and the nurses was that no longer did this
child require nurses specifically for her. This meant that these
nurses now worked throughout the ward though it did seem wise
to exclude nurses working with the infant from the milk kitchen.
The patient benefited in that no longer was she visited as
infrequently as possible but people could now visit her socially.
Discussion
Such cross- infection as occurred when the child was nursed
in the cubicle should not have happened and it could be argued
that the infant should have been cared for not in a general
paediatric environment, but in a proper isolation unit. Those
locally available to us could not have adequately managed the
intravenous feeding of an infant weighing 2.6 kg. The subsequent
events show that infants can be readily cared for in containment
isolation using flexible film isolators, and that an exclusion
mode isolator can be readily converted to containment by non-
industrial staff. This dual use preserves skills in the nurses
who may not be continuously employed in exclusion isolation. A
containment isolator in a general paediatric ward fulfilled its
two objectives, protection of the staff and patients and freeing
nurses for ward duties.
In addition, it. was evident how much more social contact
the infant received when she was in the isolator compared to when
she was in a cubicle with source isolation procedures.
A PATHOGEN FRLE FOOD SUPPLY
Introduction
The paediatric isolator formed an effective method of
achieving isolation within a general ward and elaborate arrange¬
ments enabled a supply of sterile equipment to be "always available.
However a major problem lay in providing food of an equally high
microbiological standard. Pathogenic bacteria frequently con¬
taminate the conventional food offered to hospital patients but
this, as a source of infection only becomes of importance when
S7
other techniques have eliminated patient-to—patient or staff-
to—patient cross—infection.
Shooter et al (1969) showed that 8% of food samples from
their hospital kitchen contained pseudomonas spp. as did one-
fifth of surface cultures taken from either the main kitchen
or the diet kitchen. Although cultures from the main water
tanks were sterile, the kitchen taps were frequently contaminated
especially if a detergent dispenser was attached. Salads and
cold foods were the foods most frequently contaminated with
pseudomonads, gsch. coli or kliebsiella spp. (shooter et al 1971)
but hot food was not entirely exempt. One—third of milk based
feeds were similarly contaminated with intestinal organisms.
While much of this food contamination is at a low level,
3
2.5% of food samples contained more than 10 organisms per gram
(Shooter et al 1971). Although the number of esch. coli required
5 6
to colonise a healthy patient is probably between 10 and 10 ,
the number required to colonise an immunosuppressed patient who
is taking oral prophylactic antimicrobial agents is not known.
Wherever the actual source of the organisms, about 25% of
patients in a general hospital ward for 3 weeks become colonised
with new pseudomonas spp. (Shooter et al 1969) and some of
these must be acquired via the normal hospital diet. This makes
the use of some form of specially prepared food essential for
patients undergoing bone marrow transplantation, especially as
the intention is to prevent the patient being colonised by all
exogenous gram negative organisms.
Although trials with neutropenic patients comparing a
normal diet with a sterile diet as the only variable have not
been reported, Priesler et al (1970) compared a "cooked" diet
with a "sterile" diet during remission induction of adult AWL.
Of their 21 patients, those taking the sterile diet had a greater
percentage of sterile stool cultures but showed no particular
clinical benefit to result from the "sterile" diet. yossen and
Van der Waaj (1972) found all their samples of a steam-sterilised
diet to be sterile compared with half the samples of a pasteur¬
ised diet and 8% of the samples of the pasteurised diet contained
large numbers of bacteria. This source contributed considerable
contamination to their ultra clean rooms.
Host decontamination regimens have included a special diet.
Usually this excluded uncooked dairy products and fresh vegetables
and was specially cooked in a separate kitchen with either an
autoclave or steam-sterilisation facility. Careful transfer
arrangements were required to take the prepared food to the
patient who used autoclaved crockery and cutlery. Establishing
a special kitchen and transfer arrangements requires both space
and capital. Fly need was to establish a pathogen—free food
supply for the children undergoing bone marrow transplantation.
Whilst exclusion of certain dietary items would have helped,
the problem remained of delivering pathogen-free food to children
in the isolators within a general ward in a hospital which had
no diet kitchen or cooking facilities outwith the normal hospital
kitchen. The small ward kitchen (120 sq. feet) was already used
for serving and washing—up the other children's meals and
storing the ward crockery and cutlery. Therefore an alternative
had to be found.
Methods
Because there was no real possibility of cooking elsewhere
and transferring the cooked foods to the isolator patient, the
nurses and children's parents cooked within the isolators. Each
isolator contained a pop-up toaster, automatic electric kettle,
mark 2 Sunbeam multicooker and a small refrigerator. Food passed
into the isolator therefore had to be of an acceptable micro¬
biological content. Infants7 feeds were made up in the isolator
and a twelve hour supply stored in the refrigerator. For the
children a more varied diet was required.
Commercially available good quality canned foods were
accepted as pathogen—free providing the can was undamaged. The
label and glue were removed, the can labelled with a felt—tip
pen and the surface of the can sterilised in Flilton for 30
minutes. The can then entered the isolator, was opened with a
sterile can-opener and cooked. Autoclaved or Long-Life milk
and sterile water was treated in the same way.
Individual packs of frozen food were delivered to the deep
freeze. This clean food was sealed in two nylon film bags with
the date and a radiosensitive marker on the inner bag and
returned to the freezer. Subsequently the frozen non-sterile
si
packs received at least 2.5 rnegarads from a Cobalt —50 source and
then returned to the hospital freezer. Bread, cereals, tea,
sugar, coffee, salt and pepper were packed in convenient amounts
and treated in a similar but non-frozen way, as were packs of
disposable plates, bowls, cups and cutlery.
Supplemental feeding was also used, particularly when mouth
ulcers or dysphagia was present. Sip feeds were sometimes
successful as were fine-bore nasogastric silicone tubes but these
were not very convenient and even when in the duodenum or jejunum
were regurgitated and had to be repassed almost daily. Intra¬
venous feeding was used for a time for almost all children. A
simple intravenous supplementary regimen administered through the
central venous line supplying 60 kalories/kg/day, with 2.1 gms
of aminoacids/kg/day proved adequate. 30 mls/kg/day of vamin-
glucose and 100 mls/kg/day of 10^ glucose with additional electo-
lytes and fluid supplied 60,kalories/kg/day without excessive
glycosaemia. For infants this was calculated on expected rather
than actual weight. This intravenous regimen was inadequate for
growth but complemented the oral intake.
Discussion
The microbiological results of this food preparation policy
were entirely satisfactory. From time to time specimens of
freshly opened irradiated food or samples from freshly opened
cans of food were cultured in broth and then on blood agar and
Maconkey agar at 37°C for 24 hours. Of twenty such specimens,
only one, a specimen of roast chicken, grew a few colonies of
bacillus spp. and the relevance and true source of this remained
in doubt. Foods were not sampled microbiologically before
radiation since this would inevitably have been a random process
and such an approach is not employed for public health surveillance
purposes (Charles 1979). Having proper techniques of preparation
of food is a more effective way of ensuring a high standard of
food hygiene. :'Since our foods were derived from many sources,
irradiation where possible was the most convenient policy.
Gamma irradiation to 2.5 Tlrad is within the guidelines of
the Ministry of Health working party on Irradiation of Food
(1964) but is a compromise dose to reduce the microbiological
content, and yet maintain palatability. Since irradiation does
lo
not destroy autolytic enzymes, irradiated food remains perishable
unless frozen at minus 20°C. Our food remained palatable for at
least a year. The use of radiation increased the variety of
foods considerably giving a choice (to be selected 2 hours before
cooking time) of 33 main dishes, nine different vegetables and
ten desserts (table 18 ). No new irradiated food was offered
to a child until the staff first tasted a sample. Some problems
encountered with this irradiation are summarised in table 19 .
There were disadvantages in this diet, mainly due to the lack of
fresh vegetables. Extra vitamins were given to ail children
either as Ketovite tablets and elixir, multivite tablets or
multivitamin infusion with additional Parentnvite A and B. All
children received at least one gram of vitamin C per day.
A fine-bore nasogastric tube had problems in addition to
vomiting of the tube. Even without an oesophageal foreign body,
oral candidiasis may spread to the oesophagus. In the presence
of a nasogastric or nasoenteric tube, staff tended to give
drugs via this route. If the oral antifungal agents were given
thus, oral candidiasis became more prevalent. Oral hygiene was
further compromised by the reduction in the mechanical effects
of drinking and so greater attention to the oral cavity by the
nurses.is required when a gastric tube is in place.
Liberal use of nutritional supplements such as Build—up,
Bengers, Caloreen and Hycal was made where possible. The most
convenient fluid food was Isokal on account of its isotonicity,
sterility and freedom from lactose. Since it is ready for use
no preparation is required and it could drip slowly straight
from the tin using the special adaptor. Infants with severe
combined immune deficiency almost invariably hod secondary
lactose intolerance so received Galactomin 17, comminuted
chicken, or Prosobee. Their oral drugs were also lactose—free.
The intravenous feeding policy varies In different centres.
Most patients in the Seattle transplant unit receive intravenous
feeding but it is only occasionally necessary at the' Royal
Plarsden Hospital. Three-quarters of their transplant patients
lose weight during their admission with a mean weight loss of
1%. Those aged 16 or less lose an average of 12.5^ of their
admission weight and the only patients of the most recent
Table 1 8

















































































PROBLEMS ENCOUNTERED IN RADIATION OF FOOD
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thirty—five transplanted there who received intravenous feeding
were two children aged 7 and 11. Eight patients of the thirty-
five were aged 16 years or less. The majority of units in Europe
transplanting children use routine intravenous feeding. Since
using routine intravenous feeding a weight loss greater than 5%
in the French transplant children is unusual (Gluckmann 1979).
A major difference between the Royal Harsden and other centres
is that cyclosporin-A not methotrexate, is used to prevent GVHD.
Little severe mouth ulceration is seen as a result, whereas in
Seattle, 80-90% of patients have severe mucositis. This mucositis
is particularly common in the patients transplanted for acute
leukaemia because of the combined effect of total body irradiation
and methotrexate.
Using these oral foods, supplemental foods and intravenous
feeding as described, the infants gained weight and older children
who did not develop acute GVHD and received intensive feeding
support lost about 5% of their body weight during the transplant.
Those without this intensive support lost 20% of their body weight.
The intention was to supply a pathogen-free palatable diet
for the children undergoing transplantation. There were no
facilities to prepare this elsewhere and bring it ready for eating
to the child and so a pre-sterilised food supply was established
with foods being cooked in the protected environment. A consid¬
erable choice of foods became available giving a widely varied
diet. The combination of these foods with additional nutritional
encouragement prevented an unacceptable weight loss.
EUALUATIUN or THREE PROPHYLACTIC ANTIMICROBIAL REg IME IMS
Introduction
The combination of oral framycetin, colistin and nystatin
(FRACON, table 20 ) has been useful in preventing infection in
patients undergoing remission induction of AWL within a protected
environment (storring et al 1977). A similar regimen (NE0C0W,
table 20 ) using half the quantity of antibiotics contained in
FRACON was described as being of equal efficacy by Watson and
Dameson (1979), but an earlier variation of FRACON, AFRAC0, was
used from 1976 for children undergoing marrow transplantation at
Westminster Children's Hospital. At first framycetin, colistin
and nystatin were commenced simultaneously but in the first three
children thus treated, Candida spp. persisted in their stools and
the stools of one child grew only Candida spp. on culture. For
the 17 subsequent children, the antifungal agent was commenced
four days before framycetin and colistin and oral amphotericin-B
replaced nystatin as the antifungal agent, thus giving the
acronym AFRfiCO. (Table 20 )• The bone marrow transplant units
at Seattle and at the Royal Marsden Hospital, London use respect¬
ively gentamicin, vancomycin and nystatin (GV/N) and NEOCON.
Both regimens include oral amphotericin although the acronyms do
not reflect this. Both units also commence the antifungal agents
48 hours before the antibiotics.
A further regimen in which there is increasing interest is
co-trimoxazole plus antifungal agents (TSN, table 20 )• Interest
in cotrimoxazole as a prophylactic agent to prevent infection in
immunosuppressed patients stemmed from Hughes et al (1977) who
reported that in addition to effectively protecting children with
leukaemia against Pneumocystis carinii, the children taking
cotrimoxazole had fewer intercurrent infections. Long term use
of sulphonamides or cotrimoxazole in patients with urinary infect¬
ions had not led to problems due to multi-antibiotic resistant
organisms and early work using co-tr imoxazole to prevent infection
during periods of severe neutropenia, showed encouraging results.
The present results of a randomised prospective trial comparing
TSN with NEOCON show that although useful, cotrimoxazole has
certain disadvantages in children and adults undergoing bone
marrow transplantation because of acute myeloid leukaemia (AML).
AFRACO, FRACON/NEOCQN and TSN as used for children under¬
going marrow transplantation can be compared to determine whether
any regimen has particular benefits within the paediatric pop¬
ulation and how the results obtained from patients aged 16
years or less compare with results obtained from adults.
Patients and regimens
The prophylactic antimicrobial regimens are detailed in
table 20 . AFRACO was given to all children undergoing bone
marrow transplantation at Westminster Children's Hospital (LJCH).
The patients'1 diagnoses included severe combined immune deficiency
(5 patients), acquired aplastic (7 patients) and Fanconi's anaemia
Table 20
ORAL PROPHYLACTIC ANTIMICROBIAL REGIMENS
FRACON Framycetin 500 ma qds
Colistin 1.6 x 10^ units qds
Nystatin 0.5 x 10^ units (tablets) qds
0.5 x 10^ units (syrup) qds
Amphotericin B lozenges 10 mg qds
AFRACO Amphotericin B 200 mg qds
Framycetin 500 mg qds
Colistin 1.6 x 106 units qds
NE0C0N Neomycin 500 mg bd
Colistin 1.6 x 10^ units bd
Nystatin 0.5 x 106 units (tablets) bd
Nystatin 0.1 x 10^ units (syrup) bd
Amphotericin B 200 mg qds
Amphotericin B lozenges 10 mg qds
TSN Trimethoprim 160 mg bd
5ulphamethoxazoIe 800 mg bd
Nystatin 0.5 x 10^ units (tablets) bd
Nystatin 0.1 x 10^ units (syrup) bd
Amphotericin B 200 mg qds
Amphotericin B lozenges 10 mg qds
All drugs given orally. Quoted doses are adult equivalents
(3 patients) and acute lymphoblastic leukaemia (2 patients).
The patients at the Royal Marsden Hospital (RMH) received FRACON,
NEOCON or TSN. All patients receiving TSN suffered^acute myeloid
leukaemia (AML) as did 11 of the 17 transplanted children receiv¬
ing FRACON/NEOCON; of the other six children, two had idiopathic
aplastic anaemia and four had acute lymphoblastic leukaemia.
Twenty-six of 28 adults received FRACON/NEOCON or TSN in the course
of their treatment for AML; the other two being transplanted
because of chronic myeloid leukaemia. All patients were cared
for in a protected environment and received specially prepared
f ood.
The patients receiving AFRACO form too heterogeneous a
group to usefully compare data relating to infection or the
incidence of fever as many received prophylactic granulocyte
transfusions. It is equally inappropriate to compare their
requirement for additional therapeutic antibiotics. However
data relating to the effects of oral AFRACO on the stool flora
may be compared with the results of giving FRACON, NEOCON or TSN
despite differing institutions and diagnoses as stool culture
methods were similar. The microbiological and clinical results
of giving NEOCON or TSN in a prospective randomised trial are
directly comparable. Patients who could not tolerate their
prophylactic regimen were excluded, but those who had their
regimen withdrawn for clinical reasons are included in the stool
microbiological results up to the time of withdrawal.
Microbiological aspects
Methods
Stools were obtained three times (UCH) or twice (RMH) each
week. They were transported to the laboratory and cultured within
four hours. A weighed gram of stool was added to 9 mis sterile
water and vigorously shaken for 5—10 seconds. A standard 1Oytvl
loop of the suspension was streaked onto blood agar plus
neomycin, MacConkey agar, and Sabouraud's medium. Following over¬
night incubation at 37°C under both aerobic and anaerobic
conditions the plates were read and such further identification
of colonies as was appropriate carried out. Previous experience
and a small repeat study showed that a one in ten dilution of
°ll
stool gave similar qualitative microbiological results to
dilutions ranging from one in a hundred to one in one hundred-
thousand. There appeared to be no additional organisms cultured •
at these higher dilutions suggesting that neither antibiotic in
the stool nor overgrowth by aerobes was exerting a major influence
on the culture results.
Organisms were considered to be suppressed in the stool if
they were not grown on culture as described above. Consistent
suppression was defined as the organism or group of organisms
not being cultured at any time during the study period. Stools
were considered bacteriologically acceptable if no enterobacter—
iaceae, pseudomonads or well recognised pathogens could be
cultured from the stool and mycologically satisfactory if no
fungi were cultured using the above techniques. Bacteria
considered acceptable included bacteroides spp., lactobacilli,
strep, faecalis and staph, albus. Entirely acceptable stools
contained neither fungi nor undesirable bacteria on culture.
Stools described as "no growth" gave no bacterial or fungal
isolates after 24 hours culture. An isolate was the culturing
of a species of micro-organism from a stool and any one stool
culture might contain several such isolates. Unacceptable
isolates were any species of enterobacteriaceae, pseudomonad,
well recognised pathogen or fungus. •
Results
Microbial suppression
Fungi were consistently suppressed in the stools of 59 (80%)
of 74 transplant patients while they occupied a protected environ¬
ment and received prophylactic oral antimicrobial agents. (tahle
21). The number who received TSN was rather si . ill to properly
compare but TSN was effective in both children and adults in
contradistinction to AFRACO and FRAC0N/NE0C0N which both suppres¬
sed fungi consistently from the stools of 65% of a heterogenous
group of transplant children, compared with 93% of adults.
The stools were consistently bacterioloqically satisfactory
in 44 (60%) of 74 transplant patients, who received AFRACO,
FRAC0N/NE0C0N or TSN. (Table 22). Sixty-one percent of adults
had consistently bacterioloqically acceptable stools compared
Table 21
CONSISTENT SUPPRESSION OF STOOL FUNGI Il\l TRANSPLANT PATIENTS
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to 58% of children. AFRACO and FRACON/NEOCON were equally
effective in the children.
It has already been shown that FRACON and NEOCON alter the
stool flora (Watson and Jameson 1979) to the same extent and
therefore these results of microbial suppression bear out the
clinical impression that it is more difficult to achieve entirely
acceptable stools in children. Despite the heterogeneity of the
AFRACO group, their results are similar to the more homogeneous
groups receiving FRACON/NEOCON or TS N.
Children undergoing transplantation for acute leukaemia are
less likely to achieve consistent entirely acceptable stools
than adults (table 23) undergoing transplantation or remission
induction, even when the same oral antimicrobial regimen is used.
Seven of the children in table 23 were in leukaemic relapse at
transplantation but three of these achieved entirely satisfactory
stools so there is no prima facie reason that this relapse group
have affected the results.
Microbial isolates from stools
The isolates from the stools of transplanted children are
shown in table 24 . The number of children receiving TSN is too
small for real comparison but there is no indication that they
have a greater proportion of undesirable isolates than those taking
AFRACO or FRACQN/NEOCON. The greatest proportion of the stools
yielding no growth in culture were in those patients receiving
AFRACO but the proportion of unacceptable isolates from the
stools of these children was similar to that from those receiving
FRACON/NEOCON. All but two of the pseudomonas isolates from the
AFRACO group were contributed by one infant. There were more
isolates of Candida from those receiving FRACON/NEOCON.
Oral dose of antimicrobial agents
The dose of oral amphotericin 8 prescribed per kg body
weight as part of the AFRACO regimen was considered in relation
to whether or not fungi could be cultured on any occasion from
the children's stools (Table 25). Of ten children who
received more than 12 mg/kg/day of oral amphotericin 8, one
showed the presence of Candida spp. on stool culture. Of, seven
children who received less than 12 mg/kg/day, Candida spp.
loo
Table 23
PATIENTS WITH LEUKAENIA (RMH)
R egimen
NE0C0N ,
FRACON 3) NE0C0N b) NE0C0N c)
Procedure Transplant Transplant Remission
induction
Patients Children Adults Adults
















p < . 05
Not significant
Table 24
isolates fropl stools of transplanted children
receiving d i f fere n t ural antil1icrobial prophylaxis regime n s
afraco fracon/neocon TSN
No. of patients 17 17 4
No. of stools 1 83 96 16
No growth 43 (24%) 11 (11%) 0 (0%)
No. of isolates of
staph, albus 29 5 0
lactobacilli 9 22 8
bacteroides 31 20 4
Clostridia 3 6 1
strep, faecalis 23 24 8
pseudomonads 14 1 0
esch coli 10 20 5
enterobacteriaceae 32 27 1
Candida spp. 10 16 0
Total isolates 171 124 26
Unacceptable isolates
(per cent)
56 (33%) 44 (35%) 5 (19%)
102,
Table 25
TRANSPLANT CHILDREN IN ISOLATION RECEIVING AFRACO






AD SCID V T I 26 YES
LS (1) SCID VTI 56 NO
LS (2) SC ID V T I 30 NO
S I SCID VTI . 50 NO
DU* SCID BN 38 NO
MR FA VTI 10.6 NO
Did AA VT I 6.1 YES
MB AA VTI 7.2 YES
LP AA VTI 12.8 NO
KG FT A VTI 1 3.2 NO
AU AA VTI 19.2 NO
AD* AA VT I 10 YES
RR* FA VTI 10 NO
CT* AA VTI 20 NO
LA AA BN 16.8 NO
PC ALL BN 8.8 YES
RS ALL BN 9.6 YES
* died 24-48 hours before transplant
VTI - Vickers Trexler Isolator BN
SCID — Severe combined immune FA
de ficiency
H L L






was cultured from the stools of six. Those children whose
stools consistently contained only acceptable bacteria received
the same amount of framycetin (B5 mg/kg/day) and slightly.less
colistin (98,000 units/kg/day compared to 114,000 units/kg/day)
compared to those whose stools were not consistently acceptable
(table 26).
Influence of protected environment
AFRAC0 was used in two environments, an isolator tent and
a normal hospital cubicle with such protective measures as
were possible including the staff wearing protective clothing and
the children receiving specially prepared food. Flore children
in the isolators had entirely acceptable stools (table 27).
The proportion of 'sterile' stools was the same in each environ¬
ment (table 27 ) but greater than the 12% of stools examined
when children were taking FRAC0N/NE0C0N in a protected cubicle
with filtered air. Patients in the isolator received mean doses
of framycetin and colistin of 92 mg/kg/day and 101,0G0 units/kg
/day respectively compared with 73 mg/kg/day and 114,000 units/
kg/day given to those in cubicles. Both groups received similar
amounts of amphotericin B (20.8 mg/kg/day and 18.3 mg/kg/day).
With such small numbers of patients and disparate diagnoses it













Isolator 1 3 7 9 6
Cubicle 4 3 2 1
STOOLS CULTURED FRON CHILDREN IN






Isolator 163 39 (24%)
Cubicle 20 4 (25%)
Table. 26
TRANSPLANT CHILDR FIN IN ISOLATION RECEIVING ftFRACO
AMOUNT OF ANTIBACTERIAL DECONTAMINATION








A 3 SCID 260 1 32 YES
LS
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SC ID 116 192 NO
(kliebsiella spp)
SI SCID 128 128 YES
DLJh* SCID 96 196 NO
(salmonella spp)
MR FA 44 84 YES
Old AA 32 30 NO
(c oliforms)
MB AA 36 36 NO
(Esch"Coli)
LP AA 96 128 YES
KG FA 64 100 YES
AU AA 64 96 YES
AD* AA 76 100 NO -
(Esch Coli)
RR* FA 52 52 YES
CT* AA 100 100 NO
(Proteus spp, Esch Coli)
LA AA 56 168 YES
PC ALL 44 44 YES
RS ALL 48 48 YES.
* died 24—48 before transplant
For abbreviations and details of isolation see table 25
I OS
Comparison between NEOCON and TSN
This prospective randomised study involved both adults and
children undergoing marrow transplantation for AML who were
allocated at random to receive NEOCON or TSN (table 20 ) as oral
antimicrobial prophylaxis within a protected environment. Five
children received NEOCON and four received TSN. Twenty-five
adults are included in this comparison between the two regimens.
The NEOCON group had a greater proportion of 'sterile'
stools, and a lesser proportion of unacceptable isolates from
their stools. (Table 28 ). There was no real difference in the
proportion of each group who achieved consistently acceptable
stools and no patients had consistently sterile stools. Candida
spp. was cultured from the stools of two patients on NEOCON and
one taking TSN. There were more isolates of .enterobacteriaceae
from the stools of those taking TSN, and more isolates of
bacteroides spp. and staph, epidermidis from those taking NEOCON.
The remainder of the isolates in both groups were predominantly
strep, faecaljs and lactobacilli. A parallel study of the same
two prophylactic antimicrobial regimens in adults and children
undergoing remission induction of AML within a protected environ¬
ment showed less difference between NEOCON and TSN (Table 29 )•
The percentage of sterile stools was similar in both groups as
was the proportion of unacceptable isolates from the stools.
More patients receiving NEOCON achieved consistently bacteriol¬
ogical ly acceptable stools but two patients taking NEOCON had
fungi present on a total of three occasions in their stools.
/
The proportion of isolates of enterobacteriaceae from the two
groups was similar with more esch. coli and pseudomonads isolated
from the TSN group. Other gram negative bacilli were cultured
from the stools of those receiving NEOCON; .kliebsiella spp.
(9 isolates), proteus spp. (5 isolates).
Even if both the transplant and remission induction stool
microbiology results are combined it is difficult to find any
significant microbiological difference between thg results of
the two regimens, except that there is a greater variety of
microorganisms cultured from any one stool of those taking TSN.
The proportion of patients (44%) achieving entirely satis factory
stools is the same in both groups.
Table 28
STOOL MICROBIOLOGY IN TRANSPLANT PATIENTS WITH AML
RECEIVING' NCOCON OR TSN
R egimen NEOCON TSN ■
Fbtient numbers 19 15
Stools cultured 103 59
No. with no growth 13 (13/) 4 (7/)
Total no. of isolates 144 99
isolates/stool 1. 39 1 .68
unacceptable isolates 29 (20/) 28 (2 8/)
No, of isolates of
Enterobacteriaceae 22 (15/) 22 (22/)
Esch. coli 13 (9/) 14 (14/)
Bacteroides spp. 21 (16/) 11 (11/)
Staph, epidermidis 10 (7/) 3 (3/)
Strep, faecalis 54 (38/) 26 (26/)
Candida spp. 4 2
Pseudomonas spp. 2 2
Lactobacilli 23 (16/) 24 (24/)
No. of patients with
consistently sterile stools 0 0
^ 25/ of stools sterile 4 (21/) 3 (20/)
consistently acceptable
stools (bacteriologically)
9 (47/) 9 (60/)
consistently acceptable
stools (mycologically)
17 cn to VI Ch->. 14 (93/)
consistently acceptable
stools (entirely)
8 (42/) 9 (60/)
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Table 29
STOOL MICROBIOLOGY IN PATIENTS UNDERGOING REMISSION INDUCTION
OF AML AND RECEIVING NEUCON OH TSN
NEOCON TSN
Patient numbers 19 16
Stools cultured 99 99
No. with no growth 9 (11%) 13 (13%)
Total no. of isolates 1 34 171
isolates/stool 1 . 35 1. 73
unacceptable isolates 29 (22%) 38 (22%)
No. of isolates of
Enterobacteriaceae 25 (19%) 31 (18%)
Esch. coli 10 (7%) 24 (14%)
Bacteroides spp. 19 (14%) 16 (9%)
Staph, epidermidis 5 (4%) 6 (4%)
Strep, faecalis 65 (49%) 63 (37%)
Candida spp. 3 0
Pseudomonads 1 6
Lactobacilli 15 (11%) 25 (15%)
No. of patients with
consistently sterile stools 0 0
more than 25% of stools
sterile
4 (21%) 4 (25%)
consistently acceptable
stools (bacteriologically)
10 (53%) 5 (31%)
consistently acceptable
stools (mycologically)
17 (89%) 16 (100%)
consistently acceptable
stools (entirely)
9 (47%) 5 (31%)
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Discussion
Priesler et al (1970) using a rotating antimicrobial
regimen cultured fungi from 49% of the stools and Bodey and
Rosenbaum (1974) cultured fungi from 81% of the stools when
patients were prescribed PPVF and from 56% of the stools when
the patients received GUN. Their patients were undergoing
remission induction of aML usually in a protected environment and
in the similar group of patients reported here, fungi were
cultured from 2% of the stools of those receiving NEOCON and
never from the stools of those receiving TSN. Transplant
recipients had higher rates of fungal isolation, respectively 5%
for AFRACD and 17% for FRAC0N/NE0C0N, but these isolations were
almost entirely confined to the children. There was r,o
difference between AFRACO and FR ACON/NE'OCON in the ability of
either regimen to give consistent elimination of fungi in
children.
. The dose of amphotericin B would seer to be important in
that 90% of those receiving 12 mg/kg/day or greater had consistent
elimination of fungi from the stools compared with 14% of those
patients who received less than 12 mg/kg/day. Adults receiving
NEOCON or TSN regimens receive 880 mg per day and should there¬
fore receive adequate if weighing less than 74 kg. If the dose
should be based on surface area then a lesser amount per kg will
suffice in an adult compared to a child of less than nine years.
Why it should be more difficult to obtain consistently
acceptable stools in children with leukaemia undergoing marrow
transplantation than similar adults is difficult to explain.
The major difference is in the incidence of fungal suppression.
If the Candida isolates (table 24 ) are disregarded the per¬
centage of unacceptable bacterial isolates is 23% in those
children transplanted using FRAC0N/NE0C0N, a figure similar to
the overall 18% of unacceptable bacterial isolates found in the
NEOCON arm of the prospective trial involving transplant
patients (table 28 ) and the 20% found in the parallel study
of those undergoing remission induction. These differences
are minor and it is the different incidence of fungal isolation
which mainly causes the - greater difficulty in obtaining
consistent acceptable stools from children.
lO^
Consistently sterile stools were not achieved in any of the
patients described here'but were achieved in 9% of those taking
Priesler's rotating regimen and 26% of those taking GUN from
Bodey and Rosenbaum (1974). Whether the stools are sterile or
not depends on many factors including whether the oral anti¬
microbial agents have been eluted from the stool prior to culture.
It would seem more important that the bacteria present are
acceptable in that if they are only low-grade pathogens the
chances of infection arising are lessened.
Guiot and Uan Furth (1977) introduced the term 'partial
antibiotic decontamination' (better named 'selective antibiotic
decontamination') to describe their objective of eliminating only
pathogens and not achieving sterile stools. This had been the
practical aim of all workers who accepted that sterility of the
stools was either very difficult to achieve or else inadvisable
on account of possible super—infection or patient symptoms.
Selective decontamination preserves the resistance to colonisation
described by Uan der Waaij et al (1971). They reported that germ-
free mice were difficult to contaminate with oral esch. coli,
pseudomonas spp. or kliebsiella spp., providing the germfree mice
had previously been contaminated with the stools of conventional
but antibiotic decontaminated mice. The more lactobacilli and
bacteroides spp. then present in the stools of the mice, the
greater was the resistance of these mice to colonisation by
enterobacteriaceae. The stool flora of patients given neomycin,
polymixin and antifungal agents also protects germfree mice
against such colonisation (Heit et al 198D).
Preservation of the stool anaerobes and strep, faecalis is
associated with less diarrhoea and fewer isolates of Candida
spp. or enterobacteriaceae. This has been associated with a
reduction in GUHD in some groups of transplant patients. (Uossen
1980). As vancomycin will remove bacteroides spp. as well
as pathogens and therefore seems inadvisable, there seems little
gain in achieving sterile stools at present, which is the
intention with GUN regimens but is neither the intention, nor
would seem possible with most other regimens. However suppression
of pathogens is a reasonable and achievable aim.
Of the randomised remission induction patients (table 29)
receiving NE0C0N47% had consistent suppression of pathogens
I to
comparer1 to 31% of those receiving TSN. Of transplanted patients,
59% receiving AFRACO, 46% of those receiving FRACON/NEOCON and
50% receiving TSN had consistent suppression of pathogens. In
the only reported transplant series Buckner et al (1978) do not
report suppression of pathogens but found 20% of their trans¬
planted patients receiving GUN had consistent suppression of all
faecal flora. These patients with satisfactory stools were all
among the 25% of patients who took and retained all their
prescribed GUN. Authors using oral non absorbable antimicrobial
prophylaxis in remission induction of AMI have reported suppression
of pathogens in 0% (BNNP, Dietrich et al 1977) 25-33% (GUN,
Bodey and Rosenbaum 1974; Levine et al 1973), and more than 90%
of patients (GUN, Schimpff et al 1975; FRACON, Storring et al
1977 ; NE0C0N, Watson and Oameson 1979). The definitions of a
pathogen vary slightly from series to series.
The difference in the proportion of patients with consistent
stool pathogen suppression oy NE0C0N (90%, reported by Watson
and Oameson 1979 and 47% in this present study) are significant
but are related to methodology. In this present study all stools
passed more than 36 hours after commencing the antibacterial agents
are considered whereas in the previous study a trend was allowed
to develop and the steady state reached constituted whether or
not the stools were acceptable.
The greatest and rarely discussed variable (compliance)
was well shown by Buckner et al (1978) who described how 73% of
their patients did not take all their GUN and that 17% of patients
took less than 10% of their prescribed antimicrobial agents. It
was not possible to determine this within the NE0C0N/ TSN study
but when using AFRACO and studying six children intensively,
a compliance ratio of about 88% was found for amphotericin and
framycetin but only 65% for colistin.
No difference was found in the guantities of framycetin and
colistin ingested per kg, body weight in those whose stools were
or were not bacteriologically acceptable. This is in keeping
with the finding that the change from FRACON to NE*0C0N which
halved the effective doses of neomycin and colistin did not
result in a great change in the stools. Indeed it is possible
that a further reduction in the amount of NE0C0N is practicable,
but vomiting one dose of a twice daily regimens means that little
prophylaxis will have occurred over a 12 hour period compared to
six hours if a dose of a four times a day regimen is vomited.
Patients in isolators receiving AFRACQ were more likely to
have entirely acceptable stools than patients in cubicles but
the numbers are too small to draw a firm conclusion. Since the
percentage of sterile stools was the same in each group and two
of the cubicle patients received inadequate amounts of ampho¬
tericin, there is no evidence that the exigencies of the
isolator contributed to the achieving of a more acceptable
stool flora.
From assessments of stool microbiology, there is little to
choose between AFRACQ and FRACON/NEOCON in creating a more
acceptable stool microbial population. FRACON and NEOCQM
give very similar results but the dose of amphotericin needs to
be at least 12 mg/kg/day. TSI\! seems to give fewer microbiolog-
ically acceptable stools though only one of 31 patients had
Candida in their stools compared with 4 of 38 who received
NEOCON, and a greater proportion of transplant recipients had
consistently acceptable stools while taking TSN. All these
regimens compare well (especially in cost) with the standard
North American regimen GVN. Children do seem to be more difficult
to achieve consistent satisfactory stools, mainly because of
fungal isolates and since fungal isolates are so infrequent
when taking TSN, the use of co—trimoxazole should achieve
useful prophylaxis.
Prevention of infection by prophylactic antimicrobial agents
The object in using prophylactic oral antimicrobial agents
is to reduce the risk of infection in the severely neutropenic
patient. FRACQN has been shown to be effective within a
protected environment (storring et al 1977) and the change to
NEOCON, also in patients undergoing remission induction of A l*l L,
did not lead to more days with fever or days when therapeutic
antibiotics were required. In addition, none of the 34 patients
receiving NEOCON died of infection (lu'atson and Dameson 1979).
TSN was studied in a randomised prospective trial to determine
whether this absorbable antimicrobial agent was more effective
than the non-absorbable NEOCON at preventing infection during
Ill,
marrow transplantation for AFIL which is associated with a much
shorter period of neutropenia than remission induction of AFIL.
Broad comparison can be made with previously published
results of the prophylactic antimicrobial regimens used in AF1L
remission induction but nothing has been published discussing
the role of absorbable prophylactic antimicrobial agents in
bone marrow transplantation. It is not possible to discuss
the AFRACO regimen in terms of infection prevention since the
17 children were a heterogeneous group without a control series.
Definitions and methods
All patients admitted for remission induction or
bone marrow transplantation because of A L who were nursed in
protective isolation were allocated at random to receive either
NEOCON or TSN (table 20 ). If patients were known to be
intolerant of co-trimoxazole before the randomisation procedure
(coin-toss), they were not randomised but received NEOCON and
were excluded from the study. If it became known after random¬
isation that they, or in the case of marrow transplant patients
their donors, were intolerant of co-trimoxazole, they were
withdrawn from the study, received NEOCON and were disregarded.
Patients were considered to be on study 24 hours after commencing
oral antibacterial agents which were in all cases commenced 48
hours after the antifungal agents. All patients were seen at
least three times per week by the same observer.
A fever day was a day when the patient's temperature was
at least 38°C on two occasions or 38.5°C or greater on one
occasion. An antibiotic day was one on which therapeutic
antibiotics were administered. Antibiotics already commenced
before entry to the trial were disregarded. An antibiotic course
was a single or a combination of antibiotics given for a
discrete period of time and altered in the light of subsequent
antibiotic sensitivity reports on any cultured organism. Circum¬
stances requiring a change of antibiotics not based on culture
or antibiotic sensitivity evidence were considered to be an
additional course of antibiotics. Bacteraemia was diagnosed only
when proven by blood culture results and blood cultures were
only performed when clinically indicated. The isolation of a
well recognised pathogen from one blood culture bottle was
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significant but less definite pathogens e.g. staph, epidermidis
required that at least two blood culture bottles contained the
organism and that a clinical response followed appropriate
therapy. Local infections required local inflammation, pain
tenderness and redness to be present and were considered proven
when an appropriate organism was cultured from the site. Local
candidiasis and viral infections were excluded from this defin¬
ition.
flost patients undergoing remission induction were in¬
patients for four days before entering the study and had received
such blood and platelet support as required by their presenting
haematological indices. Harrow transplant patients were well
and in remission and required no immediate support. Stool
characteristics were as reported by the patients. Those not
speaking adequate /nglish were excluded from the stool assessments.
Anti-diarrhoeal agents were used liberally when indicated in all
patients. Patients came off study when isolation was discontinued
which usually coincided with discharge from hospital.
Of 9 patients age 16 or less, 5 received NEOCON ana 4
received TSN. These small numbers do not make it appropriate to
present the paediatric results separately. Thirty-seven patients
undergoing marrow transplantation were randomised, 21 to receive
NEOCON and 16 to receive TSN. Two patients vomited their
NEOCON and three were similarly withdrawn from the group receiv¬
ing TSN, two because of a rash and one because of repeated
vomiting of all preparations of Septrin. An additional three
patients had TSN discontinued, two who developed intercurrent
renal failure associated with the mismatched graft syndrome
(Powles et al 1980) and one on account of haematological toxicity.
Twenty-nine patients were therefore evaluated, 19 who received
NEOCON and 10 who received TSN.
Details of the diagnoses, sex distribution, age and time on
study are shown in table 30 as are the duration and degree of
neutropenia in each group. Those receiving NEOCON spent an
g
average of 14.3 days with less than 0.5 x 10 neutrophils/1




RANDOMISED PATIENTS UNDERGOING Pi ft RR Old GRAFTING
NE0C0N TSN
Patients randomised 21 16
Patients withdrawn 2 6
Patients evaluable 19 10
















Total days cn study 609 288
Duration of neutropenia
Days with neutrophils
<0.1 x 109/1 129 (21%) 65 (23%)
g
0.1-0.5 x 10 /I 142 (23%) 67 (23%)
0.501-1.0 x 109/1 115 (19%) 42 (15%)
>1.0 x 109/1 223 (37%) 114 (40%)
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Results
Fever days and days on therapeutic antibiotics
The percentage of fever days similar in both groups
(table 31 ) but 15 of the febrile days in those receiving TSN
were contributed by one patient who had indolent GVHD. The group
receiving TSN spent tu/o days in every ten receiving additional
therapeutic antibiotics compared with the NEOCON group who
received additional antibiotics on over four days in ten. The
TSN patients had half as many courses of antibiotics per 100
days as the NEOCON group and many more patients receiving TSN
required no therapeutic antibiotics.
In feet ions
Bacteraemia occurred in five of 19 patients receiving
NEOCON and one of 10 patients taking TSN. Table 32 also shows
the organisms involved. The incidence of bacteraemia while
receiving TSN was less than half that found in patients receiving
NEOCON. Sixteen proven local infections and eleven clinical
local infections were found, three—quarters in the group taking
NEOCON (table 33 ). Two patients had more than one proven
local infection. One local infection was associated with a
bacteraemia. The distribution of sites of local infection, proven
or not, were similar in both groups with the exception of the
urinary tract where there were four times as many proven
infections per patient in those receiving NEOCON. No patient
receiving TSN had an infection due to staph, aureus and amongst
all patients only one infection was proven to be due to gram
negative bacilli. One NEOCON patient received two leukocyte
transfusions on account of pneumonia due to streptococcus
faecalis.
The data showing how many of each group had less than
three days with fever, no microbiologically proven infection
and no additional therapeutic antibiotics given are shown 'n
' '
I. ~Each circumstance shows a benefit for those
patients receiving TSN» but in each case p is greater than 0.05.
One patient taking NEOCON fell into all the above categories
compared with three who received TSN.
Table 31





Total days 609 288
Days with fever 58 9.5/ 28 9.7/
Days on therapeutic antibiotics 256 (42/) 58 (20/)
Courses of antibiotics/100 days 5.1 2.8
Patients receiving no
additional antibiotics





BACTERAEMIA IN TRANSPLANT PATIENTS
NEOCON TSN
No. of bacteraemia 5 1
Bacteraemia/100 days 0. 82 0.35
Bacteraemia/patient 0.26 0.1
Causative organism
Staph, epidermidis 2 1
Staph, aureus 1 0
Pseudomonas aeruginosa 1 0
diphtheroids 1 0
Table 33a
LOCAL INFECT IONS IN TRANSPLANT PATIENTS
Regimen NE0C0N n=(R n = io TSN
No. of local infections 21 6
No. of proven local infections 14 2
Proven local infections/1 00 days 2.29 0.7

















2 1 2 0
dental 1 1 0 0
skin and soft tissue 8 3 2 1
lower respiratory
tract
2 1 1 0
















PATIENTS 'ITH FEW INFECTIVE PROBLEMS "Taile 33 c.
Regimen NE0C0N TSN
No. of patients 19 10
Patients with <2 days
of fever
10 (53/) 7 (70/)
Patients with no
proven infection
5 (26/) 7 (70/)
Patients receiving no
therapeutic antibiotics
1 (5/) 5 (50/)
Haematological reconstitution and support
The number of transplanted nucleated stem cells/kg. recipient
body weight was similar in both groups and although those taking
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TSN required 36 rmurs longer on average to attain 0.5 x10
polymorphs/1, this difference is not significant (table 34 ).
Patients taking TSN received 10 units of blood and 56 units of
platelets per 100 days on study compared to 11.4 units of blood
and 77 units of platelets per 100 days required by those taking
NE0C0N (table 35 ).
Subjective stool changes
Patients receiving TSN reported that their stools were
loose, very loose or diarrhoeal on 27/ of days and that they
passed no stool on 41/ of days (table 36 ). They passed on aver¬
age six stools in every week. Those taking NEQC0N reported
loose, very loose or diarrhoeal stools on 41/ of days and
absolute constipation on 33/ of days. On average they passed
nine stools in each week. One of nine receiving TSN spent more
than half their days with loose, very loose or diarrhoeal stools
compared with four of sixteen receiving NE0C0N.
Reliable data on weight loss were available for 22 patients.
The results were similar with either antimicrobial regimen
(table 37 ). OveralljIB/ of patients showed a net- weight gain
between admission and discharge and despite no intravenous
feeding being used on any of these patients the mean weight loss
of those who lost weight was just over 8/ of their admission
weight. Those 16 years of age and under lost on average 11.2/
Table 34







Mean days post transplant







HAEMATOLOG ICAL SUPPORT REQUIRED
DURING BONE NARROW TRANSPLANTATION
Regimen NEOCON TSN
No. of patients 19 10
Units of blood/patient 3.6 2.95
Units of blood/100 days 11 .35 10.0
Units of platelets/patient 24.7 16.0
Units of platelets/100 days 77.2 55.5
IZO
Table 36
STOOLS IN TRANSPLANT PATIENTS
R egimen NEOCON TSN
■No. of patients evaluable 16 9
No. of days observed 355 200
No. of stools passed 455 171








very loose 30 9
diarrhoea 65 24
$ of days with loose, very
loose or diarrhoeal stool 41$ 27$







WEIGHT CHANGES DURING TRANSPLANTATION
Regimen NEOCON TSN
No. of patients evaluable 1 3 9
No. gained weight 3 1
No. maintained weight 0 0
No. lost weight
Dean weight loss
Mean weight loss as








and the adults who lost weight lost 7% of their admission weight.
Discuss ion
Two patients were withdrawn from the 21 who were randomised
to receive NEOCON. Both suffered repeated vomiting which,
although possibly aggravated by TBI and the use of cyclosporin-A
resolved when NEOCON was discontinued. This proportion (9.5%)
is similar to the 11% of 46 patients who were intolerant of
FRACON (storring et al 1977) and the 11% of 38 patients who were
intolerant of NEOCON (Watson and Jameson 1979). In the only
reported series of patients undergoing transplantation (Buckner
et al 197B), 17% of 45 patients took less than 10% of their
GUN antimicrobial regimen and clearly found GUN unacceptable.
Six patients were withdrawn from the 16 who received prophylactic
TSN. Two developed a rash, an incidence of 12.5% which compares
with the 12% incidence of rashes reported by Gurwith (1978) using
co-trimoxazole for his remission induction patients and more
generally quoted data. One had repeated vomiting of co-trimoxa¬
zole tablets, dispersable tablets and elixir. One patient had
co-trimoxazole discontinued fallowing failure of a first trans¬
plant to engraft. At that time free circulating antibodies to
trimethoprim were detected in the patient's serum (Claas 1980)
which were not present in serum stored before commencing
co-trimoxazole. These antibodies were undetectable two
months after discontinuing co-trimoxazole. No other tested
patients had these antibodies. A second graft from the same
donor was successful, and subsequent culture of the patient's
bone marrow showed this to be suppressed by the addition of
both components of co-trimoxazole to the medium. Two further
patients randomised to receive TSN received a transplant from
a one-haplotype identical donor and developed renal failure as
part of the mismatched graft syndrome (Powles et al 1981). Co-
trimoxazole was discontinued on account of the renal failure.
These six patients withdrawn from those randomised to receive
TSN constitute 37.5% of the randomised patients. Unacceptable
effects of co-trimoxazolc were directly.responsible for four
(25%) patients being withdrawn.
A rash is one of the cardinal signs of CUHD and thus
confusion could arise as to whether GUHD or co-trimoxazole was
I 2-2.
responsible for a rash. Biopsy appearances of GV/HD should leave
little doubt if GVHD is the cause of a rash but negative results
will not exclude the development of CVHD.
The evaluable patients were directly comparable in distrib¬
ution of diagnosis, sex, age and time spent on study. The
mean time spent by all the patients with a polymorph count of
g
less than 0.1 x 10 /I mas 6.7 days. This, and the mean days with
g
a polymorph count of less than 0.5 x 10 /I (13.9 days) is very
much shorter in patients transplanted because of leukaemia than
those with severe aplastic anaemia where not only is there no
early period following immunosuppression during which there are
adequate numbers of circulating granulocytes but this period
of severe neutropenia will have already persisted for some weeks.
Since the incidence of infection rises as the duration of neutro¬
penia extends (Hersh et al 1965; Bodey et al 1966) reported
transplant series combining patients with aplasia and patients
with leukaemia are not directly comparable with the results of
this trial. In addition, rejection of the transplant was until
recently common in aplastic patients, further
( o _j<n^
neutropenia 3 the aplastic patients. The pre-oraft state .
of the marrow also slightly affects the incidence of infectious
complications. Patients transplanted in leukaemic relapse at
Seattle had more infections per patient than those transplanted
in remission whether or not a protected environment with
prophylactic antimicrobial agents was employed. (Buckner et al
1978).
If the patient who had 15 days of fever due to GVHD is
excluded, those patients taking TBN had half the number of
fever days experienced by those taking PJEOCON. The median number
of fever days, one, was the same with each regimen. Fever may
be caused by circumstances other than infection, e.g. GVHD»
reaction to blood product transfusions and endotoxins from
bowel organisms. The incidence of histologically proven GVHD
was about 25% in both groups and febrile reactions to blood
products were not particularly common partly because intra¬
venous hydrocortisone and chlorpheniramine were given before
each transfusion. Access by endotoxin may be facilitated by
the changes in the gut secondary to TBI and hepatic neutral-
12-3
isation of endotoxin impaired by radiation or cyclosporin—A
induced hepatitis but these effects would have been common to
both groups. Fever was not due to leukaemia as all patients
were in remission when transplanted.
At Seattle (Buckner et al 1978) the protected patients
each spent over twice as long with a neutrophil count of less
g
than 0.1 x 10 /I as in this study and 28^. of their days (mean
12.6 days per patient) were days on which they were febrile
( ^"38.30c). The patients discussed here spent 9.5%, of their
days febrile, a mean of 2.9 days per patient. This paucity of
fever is rather surprising, given that all patients had a
general anaesthetic for insertion of.a central venous catheter
with a subcutaneous tunnel; each received about 19 separate
transfusions of blood products; underwent total body irradiation
and spent an average of 13.9 days with a neutrophil count of
g
less than 0.5 x 10 /l. In addition 8 (27%,) suffered some degree
of histologically proven GVHD whilst under study, but of the 45
patients described by Buckner 58^ suffered GVHD which was
implicated in the deaths of J\5%, of those affected.
Patients undergoing remission induction of AflL and taking
FRACOIM in a protected environment spent a mean of 28.4 days with
g ,
a neutrophil Lount of less than 0.5 x 10 /I and each had 7 days
of fever (storring et al 1977) in comparison to patients taking
NEOCON who had a similar neutropenia for 23 days and were febrile
for a mean of 5 days. (Watson and Oameson 1979). This and the
subsequent therapeutic antibiotic requirements (table 38)
emphasise the relative simplicity of this aspect of transplant¬
ation to the remission induction of AML.
Therapeutic antibiotics administered will depend somewhat
on the policies of the individual unit. Gentamicin and
carbenicillin were commenced if the patient had a fever in
excess of 38°C for four hour, or had a clinically diagnosed
infection which might or might not become microbioloqically
confirmed. Cefuroxime- was given in place of or in addition to
carbenicillin if surveillance cultures with antibiotic
sensitivities had suggested this would be useful and cloxacillin
was given in addition to gentamicin and carbenicillin to treat
cutaneous infections. Antibiotics were administered for about
Table 38
















46 34 1 8 19
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28 (72/) 23 (68/) 27 (68/) 143 (45/)
febrile days/
patient




18 (45/) 16 (47/) 18 (44/) 14 (42/)
ref 1 Storring et al (1977)
ref 2 Uatson and Dameson (1979)
ref 3 Watson et al (1981)
ref 4 This report
RI — remission induction
BC1T - bone marrow transplantation
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seven days which frequently coincided with the reappearance of
neutrophils in the peripheral blood at day 15 after transplant¬
ation since the most usual time for a fever to occur was between •
days 5 and 8 after grafting. Three patients (two NEOCON j one TSN)
were on antibiotics at entry to the trial. One of each group
commenced antibiotics because of a fever in relation to the
surgical placement of the Hickman intravenous catheter and one
was receiving penicillin because of recent mild dental sepsis.
These antibiotic's were disregarded in the calculation of the
results.
Patients receiving NEOCON (tables 31 and 38) each spent
14.3 days (42% of study days) on additional therapeutic anti¬
biotics compared a mean of 5.7 days (20%) for each of the TSN
patients, who also received half as many courses of antibiotics.
The mean duration of a course of antibiotics was similar in
both groups (8.2 and 7.2 days) showing there was no real bias
resulting from one group receiving shorter courses of antibiotics
than the other. In addition 50% of TSN patients received no
additional therapeutic antibiotics compared to 5% of the NEOCON
patients.
The comparative percentages of days on antibiotics during
remission induction of A ML is shown in table 38 . Those
undergoing transplantation receive antibiotics on fewer days
but the difference is less marked because in all these patients
less than one day of fever is sufficient to warrant about 7 days
of antibiotic therapy. There are no comparative controlled
»
data including a protected environment in both arms where the
antibiotic days are discussed. The data of Buckner et al
(1978) who reported antibiotics being administered on 52% of
days to their group transplanted in a protected environment is
not directly comparable mainly because of the considerably
longer period of severe neutropenia in their patients as a
result of including both aplastic and relapsed leukaemia patients.
They continued antibiotics until the granulocytes reached
9
0.5 x 10 /I which added 2 days to the duration of each patient's
antibiotic days.
Five bacteraemias occurred in the NEOCON group and one in
the TSN group. (Table 32). The incidence per patient or per
I l(o
100 days on trial was almost three times higher in those
receiving NE0C0N compared to those receiving TSN and overall
six of 29 patients (21%).had a bacteraemia. Buckner et al (197B)
reported 10 patients (22%) developing bacteraemia out of 45
undergoing transplantation and in this whole group eight (27%)
of 29 were patients with leukaemia. 20% of the small group with
leukaemia in remission at the time of their transplant developed
a bacteraemia compared with 21% in this Royal Marsden series.
However, Buckner et al (1978) had somewhat more stringent
criteria for bacteraemia to be diagnosed and amongst the twenty-
two microbiologically proven infections in their LAF group only
one infection was attributed to staph, epidermidis. whereas three
of the six bacteraemias in this trial were due to staph,
epidermidis. One bacteraemia was due to ^ram-negative bacilli,
pseudomonas aeruginosa.which could not be cultured from the stools
of that patient-while receiving NE0C0N although he suffered
pseudomonas infections during remission irduction four months
previously and intercurrent stool culture had grown pseudomonas
aeruginosa while he was an out—patient.
There were 27 local infections with the incidence of local
infection being twice as high in those receiving NE0C0N. (table
33a )• However the differences in the site of the local infection
between the two groups are not significant although four times
as many urinary tract infections occurred in those taking
NE0C0N. Since the components of the NE0C0N regimen are not
absorbed unlike the co—trimoxazole of the TSN regimen, it is
not surprising that TSN will exert a protective effect on the
urinary tract. Two perianal infections occurred, both in
those patients taking NEULON. storring et al (1977) reported no
anorectal infections in 45 remission induction patients taking
FRACON and Buckner et al (1978) found only one anorectal
infection in 46 transplant patients taking GUN. One concern had
been that TSN would not give sufficient reduction in bowel
organisms to prevent anorectal infections but TSN .gave consistently
acceptable stools in 9 (60%) of 15 transplant patients (more
than with NE0C0N) and gave in addition systemic protection which
may explain the lower incidence of anorectal complications and
also skin and soft tissue infections.
11"?
One patient (taking NEOCON) of the 29 received granulocyte
transfusions on account of pneumonia due to streptococcus faecalis.
Five of the 46 transplant patients reported by Buckner et al
(1978) required granulocyte transfusions compared with 50% of
those in a minimally protected environment but not taking
prophylactic antimicrobial agents.
Mo bacteraemias or proven infections were due to entero—
bacteriaceae and one (3%) due to other gram negative bacilli
despite the stools of 10 of 19 taking NE0C0N and 6 of 15 taking
TSM persistently containing these organisms. The control
transplant group reported by Buckner et al (1978) received no
oral antimicrobial agents (but had a minimally protected
environment) and had 125 proven infections of which 52 (42%)
were due to gram negative bacilli. The patients receiving GVN
within a protected environment had 22 proven infections of which
2 (9%) were due to gram negative bacilli. GUN, NE0C0M and TSM
exert considerable protective effects on the incidence of gram
negative in feet ion, but overall a greater proportion of patients
taking TSM had two or less days of fever, no proven infection
and received no therapeutic antibiotics than patients receiving
NE0C0N (page IIS ).
There was also concern regarding the haematological effects
of co-trimoxazole. One patient taking TSM had failure of graft
take associated with antibodies to co-trimoxazole and was
successfully regrafted from the same donor two weeks after stop¬
ping TSM. One patient receiving NE0C0N similarly failed to
engraft at the first attempt, a circumstance attributed to the
use of methotrexate to prevent the mis—matched graft syndrome.
Although patients receiving NE0C0N received slightly more
nucleated stem cells/kg, recipient body weight, the size of the
graft was similar in both groups and there was a delay of
about 36 hours in the mean time taken to reconstitute to 0.5
g
x 10 polymorphs/1 in those receiving TSM (table 34 ). Folic
acid supplements were not given. Platelet counts were more
variable and affected by exogenous transfusion and the use of
cyclosporin—A but the haematological support required for the
two groups showed that less support was required for those
receiving TSN. (Table 35). The lower incidence of infection
is the probable explanation for this difference.
One patient taking NEUCON died of the mismatched graft
syndrome. No patients died of infection and the death rate of
3.5%, on study compares well with the 9% death rate by day 50
(excluding resistant leukaemia) reported by Buckner et al (1978).
Of the patients transplanted from a matched sibling entering
this study the 50 day survival was 95%.
Patients taking TSN reported less bowel upset than those
receiving NE0C0N. They passed fewer stools and a greater
proportion of stools were either normal, firm or soft in texture.
Although patients were given anti-diarrhoeal agents ad libitum
there was considerably more fluidity of the stools in those
receiving NE0C0N. It is surprising that on 35-40% of days there
was absolute constipation and bulk laxatives were also freely
used, to avoid the dangers of a hard constipated stool causing
mucosal abrasion in passage. No specific assessment of patient
compliance with the NE0C0N or TSN regimens was performed but
75% of the quarter who were fully compliant with the GUN regimen
of Buckner et al (1978) achieved their aim of "complete
suppression of all faecal flora". In other words 37 of 46
patients (8Q%) did not achieve this. The aim as far as the
stool microbiology was concerned in this study was achieved in
17 (50%) of 34 patients.
The weight loss (mean 8%) is remarkably little and although
many factors will interfere with food absorption after a transplant
the major difference between this series of patients and others
is that cyclosporin-A was used to prevent GUHD, not methotrexate,
and consequently all the major oral problems associated with the
combination of methotrexate and TBI were avoided.
Compared to NLUCON, patients taking TSN have fewer febrile
days, less need for additional therapeutic antibiotics, fewer
bacteraemias and fewer local infections both microbiologically
proven and clinically observed. Despite their reconstitution
after grafting being slightly slower, they required less support
with exogenous blood products. They had fewer and more normal
stools which were microbiologically similar to those obtained
from patients taking NE0C0N. They lost less weight and were
discharged sooner after their transplant. It would seem that,
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if tolerated by the patients and acceptable to the medical staff
when taking a whole view of the patient's condition, that TSN
is a useful regimen in patients undergoing marrow transplant¬
ation.. However if 12% of patients develop rashes and 6% of
patients have entirely unacceptable haematological toxicity,
TSN will not be an ab initio useful regimen but a useful
replacement for other regimens which are not tolerated by
individual patients.
SURFACE AND ORIFICE DE C 0 NT ATI I NAT ION,
Although the major endogenous source of infection in
neutropenic patients is usually considered to be the gastro¬
intestinal tract, other sites may harbour pathogens which gain
access when oral ulceration or mucosal damage is present. Oral
antimicrobial agents are primarily given to reduce the alimentary
flora which they do to a greater or lesser extent. The non¬
absorbable preparations have a limited effect on the micro¬
organisms in other sites but the effect ot absorbable preparations
e.g. co—trimoxazole has not yet been reported.
Bodey and Rosenbaum (1974) reported very extensive micro¬
biology results from 91 adults with leukaemia and indicated the
non—alimentary sites most likely to harbour pathogens and
therefore most worthy of further decontaminating measures, (tabla
39 ). A number of regimens have been used to (decontaminate
these sites. The most extensive was that of Bodey and Rosenbaum
(1974) and the least extensive recently quoted, that of Watson
and Jameson (1979) (table 40 ). Both regimens applied to
leukaemia patients undergoing remission induction but the regimen
of Watson and Jameson (1979) was also used for marrow transplant
recipients. A relatively complex regimen was used at
Westminster Children's Hospital and its value is worth comparing
to the simple regimen used at the Royal Marsden Hospital.
Patients and regimens
All children undergoing marrow grafting in isolator tents
at Westminster Children's Hospital were subjected to a rigorous
programme of surface and orifice decontamination. Those trans¬
planted at'the Royal Rarsden Hospital on account of AML received
no specific decontamination of their surfaces and orifices but
I 2>o
Table 39







Skin 564 265 47
Throat 360 162 45
Ear 210 30 14
Nose 202 45 22
Vagina 95 62 65
(39/ if Esch. coli
excluded)
Bodey and Rosenbaum 1974
Table 40
COMPARISON OF EXTENSIVE AND SIMPLE SURFACE DECONTAMINATION
Boduy and Rosenbaum 1974
Watson and
Oameson (1979)





polymyxin B 5 mg/ml
nose
throat suck amphotericin




































a daily shower or bed-bath using 'Baby Soap'. The ^oyal
Plarsden regimen is shown in table 40 in which the oral anti¬
fungal agents formed part of the prophylactic antimicrobial
regimens discussed previously. The regimen used at Westminster
Children's Hospital is shown in table 41 .
The Hibiscrub bath consisted of Hibiscrub applied to the
skin, allowed to almost dry and then washed off. Hibiscrub was
not used after total body irradiation in either centre, the
effects of the detergent being too drying. For these patients,
Dohnson's baby soap was used. Chlorhexidine douches to the
vagina and nightly instillation of chlorhexidine obstetric cream
proved irritating. Half-strength Savlon twice daily was accept¬
able. All these procedures could be performed by the patient,
but nursing supervision gave more efficient care and better
microbiological results.
Microbiolocical surveillance ■
At Westminster the sites routinely sampled were scalp,
hairline, ears, nose and throat, mouth, axillae, umbilicus,
groins, foreskin, urine, vagina and rectum if a stool was not
available. For the first three weeks swabs from each site
were cultured three times each week and subsequently once per
week, with half the sites being sampled on Monday and half on
Thursday. SwaDs to be taken from dry areas were first moistened
with peptone water. All swabs were taken before the morning
bath about 3 hours after the 6 a.m. spray of the orifices,
and cultured for 24 hours on blood agar /lacrConkey agar and
Sabouraucts medium within 4 hours of sampling. At the Royal
Marsden Hospital, swabs similarly moistened were taken once each
week from the nose, throat, axillae, toes and vagina. Culture
conditions were as described above.
Results
Compliance with the procedures
Eight children in isolators at Westminster were studied
during a total of 794 days. The data were derived from nursing
administration records and may be underestimates. Table 42
shows how often each procedure was recorded as having been
carried out. The mean compliance was 76^. The low figure of
Table 41
DECONTAMINATION OF SURFACES AMD ORIFICES










(4% chlorhexidine in detergent) bath daily
(1.5% chlorhexidine in 15% cetrimide) hair
washes alternate days -
(0 .1% chlorhexidine with 0.5% neomycin) to
the nares q.d.s.
(0.02% aqueous) mouth washes q.d.s.
(0.02% aqueous) spray to external auditory
canal, throat and foreskin q.d.s.
(1% chlorhexidine) dental gel applied to
gums b.d.
twice daily to vagina
Table 42








\iibiscrub bath 441 322 7 3%
Savlon hair
wash
166 1.30 7 8%
Naseptin 1987 1578 79%
Chlorhexidine
'mouthwash






685 400 5 8%
Overall
compliance
7 34 2 5607 76%
I 33>
6B% for the dental gel reflected the children's distaste for this.
All these procedures took staff time, were a nuisance and
sometimes unpleasant for the children, therefore must be
justified microbiologically.
Microbiological results
Table 43 shows the number of sterile cultures from
transplanted children in isolator tents and in barrier nursing
cubicles. Microorganisms were cultured from 26% of swabs taken
from the patients' surfaces in both environments. 75^ of the
organisms isolated were staph, epidermidis or diphtheroid spp.
The orifices were less well decontaminated (table 44 ) although
patients in the isolators had a greater percentage of sterile
cultures, 46^? compared to 9%0 in the cubicles (p <.01).
Table 45 shows the number of sterile cultures in the
isolators from infants with severe combined immune deficiency
(SCID) and from children wich aplastic anaemia or Fanconi's
anaemia (AA). The percentage of sterile surface cultures was
the same in both groups but more orifice cultures were sterile
in the infants (p >0.1). The proportion of sterile stools was
the same. The volume of Hibiscrub bath used was similar per
unit area of skin. The relative sterility of orifices was
greater, so perhaps the greater volume of chlorhexidine spray
per unit area contributed to the better score of the infants.
There was a sex difference in the results of the decontam¬
ination (table 46 ). Combining the results for SCID and
aplastic anaemia showed that males achieved better decontamination
(p <(.01). Table 43 showed that the surfaces of each group had
a similar percentage of sterile cultures and that more orifice
specimens from the infants were sterile. Since the infant group
consisted of 4 females and 2 males this would have skewed the
results to favour the female group. In fact, considerably more
sterile specimens were found in males than in females (table 46 ).
Why the scalp, hair, axillae, nose and throats of females are
more difficult to decontaminate than those sites in the male
is difficult to explain, but since only 31^ of vaginal swabs
were sterile this site could well have been acting as a
reservoir.
The results from the Royal Marsden Hospital with surveill-
Table 43
SURFACE DECONTAMINATION
n = 16 n = 4












217 1 82 84% 31 25 81%
ears 308 219 71% 29 14 4 8%
axillae 308 242 7 9% 29 26 90%
groins 302 196 6 5% 26 21 81%
umbilicus 73 57 -o CD
eyes 47 33 70%




















nose 203 113 56% 30 5 16%
throat 199 79 4 0% 30 3 10%
mouth 108 37 34% 31 2 6%
vagina 83 33 4 0% 16 0 0%
foreskin 40 27 6 8% -
total 633 289 46% 1 07 10 9%
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Table 45a
SURFACE DECONTAMINATION IN ISOLATORS












54 44 81% 158 1 33 84%
ears 90 61 6 8% 207 143 6 9%
axillae 94 80 85% 199 156 CD
groins 86 63 7 3% 202 123 61%
umbilicus 33 27 82% 39 28 72%
total 357 275 77% 805 583 72%
Table 45b
ORIFICE DECONTAMINATION IN ISOLATORS











nose 60 39 6 5% 144 53 37%
throat 57 29 51% 119 34 29%
mouth 35 20 57% 80 16 20%
vagina 38 19 5 0% 45 7 16%
foreskin 15 1 2 80% 24 14 5 8%
total 205 119 5 8% 412 124 30%
j stools 60 1 8 30% 94 24 2 6%
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Table 46
SEX AND THE NUMBER OF STERTLE CULTURES
IN THE ISOLATORS
site













115 109 95%0 97 68 70%
axillae 1 38 128 95% 155 108 7 0%
groins 1 35 98 7 5% 153 88 58%
nose 84 55 65% 91 37
throat 80 35 44/o 96 29 30^
stools 61 15 25% 93 27 29%
overall 613 440 72% • 685 357 52%
ir?
ance of five sites in nine children with AP1L in remission under¬
going transplantation are not directly comparable with the
results for Westminster Children's Hospital. However, 67^ of
isolates were staph, epidermidis or diphtheroid spp. (table 47 )}
and staph, aureus, enterbacteriaceae and Candida spn. amounted
to a total of 10% of isolates. 'Normal flora' were a mixed
group of normal upper respiratory tract commensals and what
might be considered innocuous flora accounted for over 80Jo of
all isolates. Apart from all five isolates of Candida spp.
being in those who received TSN there was no difference between
those receiving TSN and those receiving NEOCON.
Patients in the isolators receiving extensive and time
consuming decontamination procedures were studied to determine
if the microbial load had been markedly reduced by the regimen
in table 41. Reduction in the microbial growth was assessed
using this scoring scheme:
0 = no growth
1 = scanty growth (+)
2 = moderate growth (+)
3 = heavy growth (++ or +++)
(multiple organisms were counted separately).
The first 13 patients in the isolator achieved the reduction
in average score shown in table 48 . The surfaces were
reduced from a moderate growth to a very scanty growth and the
orifices from a fairly heavy growth to an almost moderate growth.
Stools remained more than moderately full of viable organisms.
Females were more contaminated than males on admission but the
same general degree of decontamination was achieved in both
males and females. Males had more sterile specimens than
females (table 46), so the non-sterile specimens from males
were considerably more contaminated with organisms than the
equivalent specimens from female children.
Discuss ion
The reduction in microbial load is very disappointing
for the amount of effort entailed in administering the complicated
regimen in table 41 and the low prevalence of pathogens as
shown by these surveillance cultures makes the institution of
any more radical cleansing regimen prooably unrewarding. Other
138
Table 47






No. of cultures 62 101
No. sterile 11 (13%) 9 (9%)
No. of isolates 80 125
Isolates of
Staph, aureus 0 5
Enterobacteriaceae 3 8
Candida sp. 0 5
Staph, epidermidis 71 56
"Normal flora" 0 28
Diphtheroid s 3 6
Table 48














throat 2.77 1 .74
mouth 2.57 2.02
vagina 2.88 2.15
mean 2.46 1 .51





authors have attempted extensive decontamination of particular
areas of the patient but without great success.
Bodey and Rosenbaum (1974) found 47% of skin organisms
to be potential pathogens. The perianal area, groin and chest
were the most contaminated; the back, abdomen, neck and scalp
the least contaminated. Despite their skin cleansing regimen
(tables 40 and 49 ) one—third of patients had persisting skin
pathogens and 40% had persisting skin fungi. Despite topical
antibiotics pathogens persisted in the groins in 25% of
patients. Phisohex (3% hexachlorophane) was the best skin
decontaminant of the three they used.
Their regimen resulted in 75% of skin cultures showing no
aerobes and 50% of skin fungal cultures being-sterile. Levitan
and Perry (1957), Levine et al (1973) and Klastersky et al (1974)
all found 70% of skin aerobic cultures were sterile with no
antibiotics being used, only a daily hexachlorophane bath. This
degree of skin sterility was achieved in the isolator children
studied but not in the AWL children whose cultured sites, the
axillae and toe clefts, are much more likely to be contaminated
than flat open areas of skin such as the back or abdomen.
Almost every study has shown the difficulty of decontaminating
the oral cavity. About half the organisms isolated by Bodey and
Rosenbaum (1974) were potential pathogens, mostly streptococci
and though usually a two-log decrease was achieved, a quarter of
the patients had persisting pathogens. The complexity of the
oral regimens varied from that of Bodey and Rosenbaum (table 40 )
to that of Schimpff et al (1975) who used nothing additional to
GUN which by itself gave a "reduced" oral flora. Buckner et al
(1978) reported that of 12 patients who took all their GUN only
2 (17%) had continuous suppression of oral and nasal microbes.
No study gives any consideration to the mechanical and dilutional
role of repeated mouthwashes, which I believe to be very important.
The ears and nose are relatively harmless in micro¬
biological content with the exception of nasal staph, aureus
carried by 20% of the population (Bagshawe et al 1978). If
presentjthis should be suppressed as transfer to other sites is
common. Two of the nine AWL children had nasal staph, aureus and
one of these was the only AWL transplant patient of 29 in the
Table 49
SKIM CULTURE RESULTS WITH DIFFERENT




































NEOCON/TSN study to develop a staph, aureus bacteraemia. Neomycin
nystatin, polymixin and vancomycin ointment will eliminate 80%
of aerobes from the nose, the same proportion as with much
simpler methods e.g. Naseptin (0,5% neomycin in 0.1% chlorhexidine)
cream.
The male genital mucosa is rarely a problem (except for
herpes virus) and can be treated in the same way as the skin but
the vagina harbours potential pathogens, usually the same as those
in the stool. Measures adopted include chlorhexidine 1% obstet¬
ric cream, acetic acid 0.25% douches and multiple antibiotic
gels inserted twice daily (Table 40 ). Some apparent decon¬
tamination will result, but irritation may often be caused.
Normal washing and hygiene remain very important and the
use of expensive, potentially sensitising, sticky antibiotic
gels is probably unnecessary, potentially harmful and their
value has never been proved. The vagina? almost the most
contaminated area (table 48 ),proved the most difficult to
decontaminate in the Westminster children and in the Royal
Marsden children this same area had almost twice as many isolates
per swab than any other site sampled.
Our ability to suppress the micro—organisms of the body
surface and orifices using the AFRACO gut regimen and a
complicated series of skin and orifice decontamination techniques
has not been very effective. However, body surfaces achieved
greater sterility than body orifices. Infants with combined
immune deficiency were easier to decontaminate than older children
with aplastic anaemia. Females were more contaminated than
males on admission but both achieved the same degree of residual
bacterial growth following extensive decontamination. A
complicated surface and orifice decontamination programme gave
microbiological results that do not justify the time and effort
even within a stringently protected environment. It is
probably worthwhile suppressing nasal staph, aureus providing
the protected environment is such that new acquisition will not
occur. There is no reason to believe that sampling more sites more
frequently will give more useful information.
B ) THE CLINICAL BONE nflf^R O'-jJ TRANSPLANTATION OF THIRTY-ONE INFANTS
AND CHILDREN ~ ~ '
Management of Children undergoing
bone marrow transplantation
There are two aspects to this; the discussions necessary
with the child, the family and the staff both before and during
the transplant and the practical day to day medical programme
throughout the hospital stay.
The necessary discussions
Unless an incompatible transplant is envisaged, tissue
typing and mixed lymphocyte culture (fiLC) will indicate whether
the option of grafting is available. The question of whether or
not to graft, and when, and with which donor can then be
discussed. Though medical staff may recommend a marrow transplant,
it must be the parents final decision whether or not to accept
this advice.
The present results of conventional therapy and of grafting
must be fully discussed, with frank admission of that which is
not known. At least two separate discussions with the parents
and hopefully the grandparents are necessary. Grandparents are
a little removed from the situation and when kept informed may
provide a useful shoulder for the parents despite family mobility
reducing their role in recent years. The family need a concise,
honest account of the procedure, and of the natural history of
the illness stressing the difficulties, dangers and problems of
each course of action. Such unwanted effects as hair loss and
sterility, must be included in the discussion. I encourage
parents tp take notes during the discussion so they have inform¬
ation to fully discuss at home and on which to base further
questions during a subsequent discussion. The difficulties of
this discussion are least when the child's initial illness has
been treated by those proposing to do the transplant. Convers¬
ations with the parents alone are necessary and a talk with the
child and with the donor without the parents present will allow
exploration of such fantasies as the children have about the
procedure.
If either parent refuses to agree then careful thought
must be given before proceeding with the transplant. Separated
or divorced parents should both be involved in the discussions
and granting of permission. Should the parents so wish, they
should speak to other parents and children who have had trans¬
plants. If a second opinion is requested then every effort
must be made to obtain this from an appropriate specialist in
another centre.
Talking to the child
Explaining the procedure to the child has proved
remarkably easy. The concept of new blood or a new bone marrow
is readily understood by children of a comprehending age. The
two things which usually worry the children most are that they
will lose their hair and that they will require repeated blood
tests. The value of the long intravenous Hickman line allowing
blood to be both given and taken is readily appreciated. It is
particularly important to explain how the preconditioning will
create a space for the new marrow and that the transplant is
given through the intravenous line so holes do not have to be
drilled in the bones to put the new transplant in place.
Explanation of the isolation facility is necessary and a visit
to this is almost mandatory. It is important that the degree
of isolation has already been decided on(so that questions of
the nature "Can mummy come in and talk to me?" can be answered
positively at that time.
Five to six weeks, the usual in-patient stay, is an
eternity to a young child so it is unwise to be specific about
the duration of stay and confine the information to "until you
are better". An elective transplant should not coincide with
Christmas or a birthday if at 3ll possible.
I do not consider it productive to describe all the
possible complications to the child but the likely and 'simple'
ones for which there is a good treatment may be mentioned,
providing the treatment for these will be understood. The
predictable and transient side-effects can all be described and
a series of time goals set. A leisurely hour or two divided
between several visits and involving casual but interested
conversation about school, sport, friends and other interests
is never wasted and will often reveal previously unexposed fears
and misconceptions which can be corrected.
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The parents during the transplant
Parents resident in the hospital may be a long way from home
with socio-economic problems and guilty feelings about their
lack of attention to their other children. Chronic anxiety
and nightmares give way to periods of depression and elation.
These spells do not coincide in each parent so each does not
get the required response from the other. They may feel displaced
from their traditional role by a technology with which they only
slowly come to terms. After about two weeks they play an
increasingly constructive role with apparently less labile
emotions, taking a more active part in the ward and helping more
with their child. Although it is helpful to have the parents
actively involved they must also be sure to get away from the
hospital from time to time. They become friendlier and more
informal with the staff but may still be occasionally hostile and
impatient, particularly if the transplant is not proceeding
unevent fully.
It is be' parents, together, get information from
only one or two people. Some ask everyone's opinion about every
aspect and, because they hear only part of half-factual replies,
an ideal situation for misunderstandings easily arise".
However often one parent will want, to talk separately from the
other and this must be appreciated. As always, it is infinitely
easier to tell the truth, but with an optimistic air. Even
when the child is well, the predictable physical effects of
various treatments should be stressed.
The staff during the transplant
An emotional load also falls on the staff. The same
nurse should not always look after the same patient but if this
is unavoidable careful watch needs to be kept for signs of
nervous fatigue. Whilst no—one wishes staff uncaring for
their patients, at the same time they must be able to stand back
emotionally from the situation. The children need caring staff,
*
not more parents. Some transplant units have daily meetings
where staff can ventilate their feelings but this public forum
does not suit everyone. A resident hospital chaplain may be of
inestimable help to both the staff and also the parents whether
or not of a religious persuasion.
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A short time should be available each day when those
responsible for the transplant programme are available to any
one of the many different disciplines involved. Twice weekly
more formal meetings of no more than one hour at which any
involved person can be present are also helpful. These allow
the non-medical staff to be kept informed of the patients'
progress and why certain decisions are being taken. Meetings
like these also allow relevant staff to participate in the
reaching of decisions and the staff can be kept informed of
previous patients' progress now they are at home. Every three
months a meeting should be given over to.the nurses to air their
complaints and frustrations. Taking nurses or ancillary
professional staff to outside meetings is good for morale and
encouraging the writing of articles makes then crystallise
their thoughts and attitudes.
The childhood donor
The child donor should be off school for 5 days before
the transplant, and longer if susceptible to prevalent measles
or chickenpox. The donor should be kept away from the common
cold, not so much because of the risk of virus transmission in
the transplant but to avoid the addition of any unnecessary
risk to the- donor who usually has a general anaesthesia for the
marrow harvest. Spinal anaesthesia would be less than ideal in
a young child. The donor should be assessed for fitness at an
early stage in the proceedings by a physician independent of the
transplant team}and should have a blood count, liver function
tests and urinalysis. Routine chest x-ray and electrocardiogram
are unnecessary. Both parents should give their permission as
should the donor if able to understand the procedure. The
legal aspects of this permission have never been tested in the
courts of the United Kingdom but this will happen, probably
with a donor in the care of a local authority. Harm to the
donor has not yet been reported, and the situation is quite
different from that of a living kidney donor whose donated
organ is not self-replacing. A pregnant donor should not be
used.
It is usual to venesect 5—10 mls/kg from the donor a week
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before the transplant. Some protocols require the white cells
so obtained to be given to the patient and the red cells to be
available for return to the donor after the marrow extraction.
This venesection may stimulate the donor marrow and give a more
cellular yield. The return of the autologous red cells will
reduce the transient hypovolaemia following marrow harvest and
avoids using allogeneic blood. The donor is usually discharged
the next day and should be given iron supplements for six weeks.
Post—graft donor leukaphoreses (occasionally recommended) will
put a severe strain on a young donor, but may be possible on a
1spin-and-return' basis.
The day to day medical programme
A check list of investigations is essential as the
programme is too complicated to be readily remembered each
day. A routine list also ensures comparability of follow-up,
allowing post transplant patterns to be identified. The list,
which combines routine and research procedures, requires regular
review. Infants and toddlers will need a modified programme,
and some investigations are only applicable to certain diagnoses.
Pre-trans plant
Pre—transplant investigations (table 50) fall into a
number of sections and do not include investigations into the
nature of the disease. Those with asterisks also apply to the
donor. From table 50 a number of points should be noted.
Hepatic activation of cyclophosphamide may be compromised
by previous medication and since occult hepatitis is most common
among young children both donor and recipient may be at risk.
The metabolism and clearance of drugs will be affected by poor
renal function and good glomerular function is necessary during
the diuresis required with cyclophosphamide preconditioning.
Serum amylase and CPK levels rise after cyclophosphamide or TBI
to levels of 5000 units and 400 units respectively but both
should be normal by 3—4 days later. If the cerebrospinal fluid
is abnormal or the marrow contains more than 5% blasts, the
transplant should probably be postponed.
Surveillance cultures with antibiotic sensitivities are
















Creatinine and creatinine clearance
• Creatine phosphokinase (CPk)
*store 20 mis serum and 20 mis plasma
Microbiology
Surveillance cultures
Stool culture and ?preservation of certain cultures
Microscopy of urine for inclusion bodies and viruses
*Antibody titres Hepatitis A and B Toxoplasma
Immunology
*T and B lymphocyte sub-populations
*T lymphocyte function (PHA, MLC, Candida responses)
■^Immunoglobulins
*Specific antibody responses (Tetanus, Salk Polio, isohaemagglutinins)
*Salivary IgA and free secretory piece
*Schick test
^Delayed hypersensitivity to SK-SD, PpD» Mumps, Candida











C' Table 50 (contd.)
Histocompatibility laboratory
*Tissue typing of family
*lvlixed lymphocyte cultures against family (flLC)
*Cross-matching against donor
*-Red cell isoenzymes and genotyping
* G and K allotyping
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another hospital. Antibiograms to choose an appropriate
decontamination regimen are used in some centres but are of little
practical value (EORTC 1980). In-vitro preservation of stool flora
gives the option of full autologous recant amination. Specific
antibody titres indicate whether certain infections have definitely
occurred in both the donor and recipient. A rise in a donor's
antibody titre a few days after the graft increases the chances
of having transferred that organism during the transplant. The
viruses thought important which may be transferred during the
transplant are cytomegalovirus and EB virus but recipient
antibodies should provide a degree of protection. There is
little point in seeking CMV or EBV antibody negative blood
product donors, -if the recipient or donor were antibody positive
before the graft.
The immunological investigations are most relevant to
transplants for immune deficiency where a number of other
research investigations may be appropriate. Donors, possible
heterozygotes, should have the same investigations. The
documentation of simple immunological recovery in non-immuno¬
deficiency diseases is interesting but at present does not have
great practical value. However transplant regimens change and
the monitoriny of immunological recovery using increasingly
sophisticated immunological tools may be valuable in understanding
immunological ontogeny and the early prediction of graft—versus—
host disease.
The histocompatibility investigations relate to finding the
donor and documenting engraftment. Red cell grouping, erythro¬
cyte isoenzyme and genotyping studies will prove red cell engraft¬
ment and K and G allotvpino may reveal the source of subsequent
m m * '
immunoglobulin production. Chromosome banding studies may
document engraftment when other markers are not available. Storage
of lymphocytes is important in an aplastic patient. Should the
graft fail to take and the patient thereafter have severe
leukopenia, there will be no way of matching an alternative
donor unless lymphocytes are stored. Those stored may not be
effective responders in the MLC but should stimulate adequately
in predicting GVHD.
Depending on the urgency of the transplant, radiologically
opaque sinuses should be treated before immunosuppression. This .
is more important (and more difficult) in aplastic patients than
IS"I
leukaemia patients. lu'rist and hand x-rays are included both for
morphological and future auxometric studies. Hormonal studies
may be thoughfuorthuhile. Respiratory function tests provide a
base line and serial repetition may identify those who will
develop interstitial pneumonitis although almost all patients
with acute myeloid leukaemia have impaired lung function pre—
transplant (Barrett and Depledge 1981). Sequential electo-
cardiography is necessary during 4 day cyclophosphamide
conditioning but will not indicate anthracycline toxicity in the
leukaemic children.
Pneumococcal immunisation (Pneumovax), though unproven in
this country, is effective in preventing pneumococcal septicaemia
in children with sickle cell disease (ftmmann et al 1977).
Pneumococcal infections are common in transplant recipients
(Winston et al 1979) so despite an impaired response, pneumococcal
immunisation should probably be given. Any child receiving
total nodal irradiation (which includes the spleen) should be
immunised and all transplant recipients remain on prophylactic
penicillin until one year after the transplant.
Sperm storage may be applicable to a small number of children
undergoing transplantation. Leukaemic males are subfertile even
before anti-leukaemic chemotherapy and so storage of adequate
sperm may be difficult. Cyclophosphamide preconditioning before
transplantation for severe aplasia may not lead to sterility
but the possibility of sperm cwopreservation should be
considered. This whole matter needs handling with tact.
A number of other departments in the hospital need to be involved.
Social services Physiotherapists
Dental department iilaro teacher
UJigmaker Chaplain
Dieticians Psychiatrist
A specific person in each department is informed about
the child and the family. They should meet the parents and child
to identify any specific help required and by liaising with
the referring hospital and local authority integrate such help
as is. required, both during the admission and when the child
returns home.
If possible, dental problems should be resolved before
IS-2.
the trarspiant and the continuing interest of a paediatric
dentist leads to a high standard of mouth hygiene. The
dieticians' role has been previously discussed. A resident
hospital chaplain, available at all times, provides excellent
support for parents and staff whether or not they have religious
beliefs. For more formal support and discussion the psychiatric
department is available. Though some parents find this helpful,
many have preconceived ideas of the role of the psychiatrist.
However, there is great value in psychiatric advice when the
staff are uncertain how to handle a particular circumstance.
The in-patient programme
My present in-patient programme for marrow transplantation
at the Royal Mars den Hospital is shown in table 51 . This is
for children with AWL, but would be the same in principle for
those with ALL, or aplastic anaemia. The transplant is given
the day after the irradiation for purely local reasons. All
children are transplanted in single cubicles with positive pressure
filtered air. For children with aplasia the preparation would
be somewhat different. Usually four days of cyclophosphamide,
2
(1,5 gms/m /day) are given but more complicated regimens may also
be used.
The isolators used at Westminster Children's Hospital will
require the initial timetable to be different but the differences
are trivial. With isolators the programme would start four days
earlier with .decontamination. If microbiological surveillance
cultures on days -10 and -8 were satisfactory when read on day
—7 the child would have the theatre procedures on day -5 and
enter the isolator on return from theatre. If there were reasons
for delay, the child could enter one isolator until decontamin¬
ation was acceptable, go to theatre from there, and return to a
second isolator. TBI can be and has been performed in a transit
isolator for one child already extremely well decontaminated
and in an isolator. More usually a child with leukaemia would
enter the isolator on return from TBI.
High dose cyclophosphamide may cause haemorrhagic cystitis,
myocardial failure and fluid retention.. A good urine flow is
essential and adults with leukaemia will have urinary catheters
inserted. Their neutrophil counts are normal, unlike the aplastic
\ST>
Table 51




f'lon -9 Admission. CXR, ECG, Radiotherapy
planning, Lung function tests
Tues -8 Start antifungal agents. Stool + all screening
swabs
Wed -7 Urinary catheter. Hickman line, Bone marrow
+ L.P. + i/T Cytosine 40 mg/m^, chromosomes and
markers .
Thurs —6 Leukaphoresis. Start antibacterial agents








Venesect 1 pint from DONOR. F8C, U&E, LETS,
Amylase
2 2
Cyclophosphamide 1.8 gms/m + phenobarb 60 mg/m
+ chlorpromazine 25 mg
ECG © 6 hrs.. FBC, U&E
2 2
Cyclophosphamide 1.8 gms/m + phenobarb 60 mg/m
+ chlorpromazine 25 mg
ECG pre-cyclo FBC, U&E
Premed © 2200 hrs phenobarb. 60 mg/m +
dexamethasone 8 mg po Screening swabs and
Stool FBC U&E
Tues -1 0700 Phenobarbitone 60 mg/m IV + dexamethasone
8 mg IV TBI
Start Cyclosporin 6.25 mg/kg bd IM
We d Bone marrow transplant
IS it-
patients in whom a transient bacteraemia is much more serious.
Catheterising a child is an unwarranted interference. An
appropriate diuresis programme is detailed below
DIURESIS WITH HIGH DOSE CYCLOPHOSPHAMIDE
Start 1 hour before cyclophosphamide
Rate 250 mis/m"/hour for 5 hours
200 mls/m / hour for 4 hours
2
100 mls/m /hour for 15 hours
2
3550 mls/m /day over 24 hours
fluids Dextrose/Saline 500 mis alternating with
N/2 saline 500 mis
Additions At least 10 mmols K+/500 mis fluid
Drugs
2
Frusemide 20 mg/m at 1 hour and 6 hours
2
Promethazine 35 mg/m before and 4 hourly prn
Check Sodium and potassium daily and after 8 hours
during courses one and two, ECG before cyclo¬
phosphamide and after 6 hours during each course
2
This supplies about 180 mmols of sod.ium/m and at least
75 mmols of potassium per square metre. Twice this amount of
potassium may be necessary. If gentamicin and carbenicillin
are being administered concurrently with cyclophosphamide,
normal saline and even more potassium will be required. Chlor-
2
promazine 10 mg/m will also be required if there is vomiting.
The intention is that the child should sleep for the first
8-10 hours. R p! xh-lkj' cov'fv!' % n- ,5c,c af-jt is required
to prevent intracranial haemorrhage in the event of vomiting.
In aplasia^he transplant is given 36 hours after the last
dose of cyclophosphamide.
Doses are quoted per metre squared and not per kilogram.
2
A certain dose/kg will be the same amount /m for a nine year
old but if given /kg to a two year old will only tae 75/5 of dose/
2
m and an infant of 3.5 kg would only receive 40^ of the equiv-
2
alent dose/m . Teenagers will be relatively overdosed if based
on mg per kg.
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One aplastic child had been intermittently septicaemic,
with profuse diarrhoea and normal plasma biochemistry. She
died suddenly the day before her transplant and was the only
patient with a drop in the electrocardiogram voltage (table 52 ).
This change was only in the limb leads and no other patient
showed more than 10% reduction in ECG voltage. No autopsy was
allowed so there was no specific evidence that cyclophosphamide
caused her death, but should this voltage drop occur, the regimen
of cyclophosphamide will need adjusting.
Table 52
Average voltage/standard









chest leads 6.6 6.1 NE 6.1 6.3 6.5 5.4
limb leads 11.4 NE 11.8 12.5 12 12.7 7.4
NE - not evaluable
Investigations after grafting
Routine investigations after the graft are shown in table
53, An additional marrow examination on day 21 is justified if
there is no peripheral reconstitution. If this aspirate is 'empty'
immediate regrafting using the same donor but with either no or
different preconditioning is indicated. By the time this is
organised slow reconstitution may have appeared. Should a second
graft fail and leave' the patient profoundly aplastic}either stop
treatment or use the stored lymphocytes in an attempt to find
another donor. The outlook in this situation is grave.
Methotrexate is given post-graft as GVHD prophylaxis unless
cyclosporin-A has been commenced pregraft. The usual intravenous
2 2
regimen is 15 mg/m on day 1, followed by 10 mg/m on days 3, 6,
11 and weekly thereafter to day 102. UJith poor marrow recovery,
omit the day 18 dose. If hepatic or renal function is impaired,
2
give folinic acid (3 mg/m ) 12 and 24 hours after each dose.
Blood products must be irradiated to 1500 rads and chronic
granulocytic leukaemia (CGL) cells to 5000 rads for one year
after the transplant. This radiation does not impair neutrophil
function (Van der fleer 1980) but will prevent stem cells in the
POST GRAFT INVESTIGATIONS FOR IN-PATIENTS
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change cyclosporin A
to 6,25 mg/kg bd po
At discharge VIGG 750 mg
start Septrin tabs T bd
Folic acid 5 mg daily
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transfusion being able to proliferate and establish an incompatible
clone with the risk of GVHD.
for infants with SCID the programme in table 53 must be
curtailed. They do not usually require preconditioning and so
avoid all the related investigations. However, they often require
intravenous feeding with appropriate surveillance. Laboratory
micro-methods should allow adequate monitoring with about 25 mis
of blood per week. Even so this is 9% of the blood volume of a
4 kg infant so irradiated transfusions will be required every
4 weeks.
ftfter discharge home
An out-patient follow-up programme is shown in table 54 .
This combines research and routine investigations and must be
reconsidered from time to time. As 60 mis of blood are requested
te be,
some weeks it needs^reviewed for younger children with considerable
inter—laboratory liaison to ensure parts of each specimen are not
wasted.
Haemopoiesis and evidence of engraftment clearly need to be
documented and close watch kept on renal and hepatic function.
Immunological reconstitution in leukaemic and aplastic
patients has been well studied but the use of cyclosporin—A
adds a new dimension. The virology studies are part of an on¬
going investigation.
On leaving protective isolation en route directly for
home^children should receive 10 mg/kg of varicella immune globulin
(V/IG) and 5 mg/kg every two weeks until 14 weeks after grafting.
Acyclovir does not make this precaution obsolete. They should
receive Septrin for 6 months as prophylaxis against Pneumocystis
carinii. Penicillin-V should be given from when Septrin is
stopped until 1 year after grafting. Oral antifungal agents
may be required for three months.
They and their parents need instruction about avoiding
infection hazards. This is best done verbally but also with
a sheet of simple guidelines, (table 55 )most "of which are
commonsense. They must realise the dangers of measles and
chickenpox. Avoiding direct sunlight only applies to those who
have had irradiation. Just how necessary all these precautions
are is difficult to prove and it is likely they can be somewhat
158
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Table 55
PRECAUTIONS TO TAKE AFTER ft BONE MARROUJ GRAFT
Risk of'infection at home will be reduced to a minimum by
the following procedures, which you should follow for five months
after going home.
a) If anybody in the family has a cold^they should keep away
from you.
b) Pets should not be allowed to lick you, and you should get
no new pets.
c) Visitors should avoid touching you, and should not come if
they have a cold, influenza, diarrhoea or a boil.
d) Members of the family at school or work should stay away if
there is an epidemic of chickenpox or measles. If you come
in contact with one of these infectious diseases get in
touch with us immediately.
There is no need to feel tied to the house; fresh air is
beneficial, but stick to the following rules:—
i) Don't go into crowded shops or cinemas, cafes and discos,
ii) Go into the countryside rather than the town for excursions
but avoid direct sunlight if possible during the first
three months,
iii) Avoid crowded public transport.
Food
Eat freshly cooked foods and only salads which are freshly
picked, home grown and well washed. Avoid take-away foods.
You may discontinue these precautions after five months.
3GIU
\ &>o
reduced. Children will return to school 4-5 months after their
transplant, or after stopping cyclosporin-^.
Infants transplanted for SCID have greater immune suppression
for much longer. Consequently they need protection and a high
standard of family hygiene for a year. a considerable level of
medical awareness is required even later as they contract the
common infections of childhood. Routine \J IG is not necessary
unless other children in the family constitute a risk but should
other children be likely to bring chickenpox or measles home,
appropriate immunoglobulin must be given. All killed immunis¬
ations should be given including Salk polio and pertussis, but
should they be exposed to pertussis under the age of five,
erythromycin prophylaxis should be employed.
The programme and schedules described do not cover all
aspects of a transplant, but they have proved effective in my
experience.
IM
SEVERE COMB I NED IMMUNE DEFICIENCY IN IMFflNTS
The condition now termed severe combined immune deficiency
(SCID) was previously called Swiss-type agammaglobulinaemia,
a term derived from the descriptions of congenital agammaglobulin¬
aemia by Bruton (1952) and "familial essential lymphocyto-
phthisis" by Glanzmann and Riniker (1950). SCID is probably
more common than is realised, but whether it accounts for ~\0%
of the post-neonatal mortality as suggested by Rosen (1972) is
doubtful. If so, over 300 British infants each year would be
affected. Berry and Thompson (1968) found 14 of 1000 consecutive
autopsies at Great Ormond Street Hospital to satisfy their
diagnostic criteria for SCID of which half had been recognised
as immune deficient during life. This, given the nature of
in—patient population at that hospital, would suggest around
50 new cases occur each year in the United Kingdom.
By 1979 ten infants with SCID had been admitted to Westminster
Children's Hospital for bone marrow transplantation or other
appropriate therapy. In addition a seven year old male in Texas
Children's Hospital Houston, Texas has also been in my care, giving
an experience of eleven children and infants with SCID.
Pre-transplant studies
Initial presentation
Table 56 shows why the infants with SCID first presented
to hospital. Candidiasis and respiratory infections were the
most common presentations which is similar to the presentations
in the report by Hitzig et al (1968) who found that B9% of
these children had pneumonia; B5% diarrhoea; 79% candidiasis and
57%> had cutaneous sepsis. Lung disease or diarrhoea were the
most common problems in sixty-nine infants who ultimately
received marrow transplants (Bortin and Rimm 1977), so the
combination of respiratory infection, diarrhoea and candidiasis
are important diagnostic pointers.
The mean age at first presentation was 13 weeks (range 3—18
weeks) and there were 4 females and 7 males. It was not
possible to know in most cases whether the inheritance was sex-
linked, autosomal recessive or sporadic. Traditionally there
are supposed to be three times as many male infants with SCID
IkZ
Table 56 (a)
REASONS FOR INITIAL REFERRAL ( EXCLUDING DU*)
Respiratory infection 6 0%
Candidiasis 6 0%
Diarrhoea 30%
Failure to thrive 30%
Other sepsis 2 0%
*"DV - germfree delivery in Houston, Texas
Table 56 (b)




LS F 3 Respiratory infection, esch. coli
septicaemia
PL M 5 Diarrhoea, respiratory infection
HN F 9 Oral candidiasis
SI M 1 3 Oral candidiasis, respiratory
infection
MP M 1 3 Oral candidiasis, respiratory
infection
GS M 14 Respiratory infection, failure to
thrive, candidiasis
TD F 15 Diarrhoea, skin sepsis, failure to
thrive
AO M 16 Oral candidiasis
DF F 1 8 Oral Candida, respiratory infection,
diarrhoea
Oldh M 1 8 Failure to thrive
DV* M at birth none
*axenic delivery in Houston, Texas
Its
compared to female infants and this was so in the series of
69 infants reported by Bortin and Rimm (1977).
Time to diagnosis
Table 57 shows the time elapsed between
first presentation and full diagnosis. The mean interval
to full diagnosis (at a mean age of 21 weeks) was 8 weeks. Only
1 (10^) had not developed considerable diarrhoea and two infants
(at the time undiagnosed) had been mistakenly admitted to
infectious disease hospitals because their diarrhoea was such
that a severe bowel infection was suspected. The infant in
Houston, maintained in a gnotnbiotic.environment, did not
develop diarrhoea and thrived. This interval of 8 weeks to
full diagnosis could be improved on but only to the extent of
a week or two, unless profound lymphopenia was recoanised on
the initial admission. This finding, like many of the immuno¬
logical featureSjis very variable despite the ultimate similarity
of the clinical picture. Half the infants required a third
hospital admission before diagnosis and only one was diagnosed
on his first admission to hospital.
Immunological studies
Lymphocyte numbers
The International Bone Marrow Transplant Registry data
(Bortin and Rimm 1977) described 69 infants with SCID who
received haemopoietic tissue transplants. Lymphocyte counts
were subnormal in 96% and half the infants had less than
9
1x10 lymphocytes per litre. Table 58 shows the lymphocyte
and lymphocyte sub-population numbers in ten infants at transfer
to Westminster Children's Hospital. fill lymphocyte counts
g
were subnormal and B0% had less than 1x10 lymphocytes per
g
litre. T lymphocyte numbers were very low (mean 0.01 x 10 /I)
and could not be increased with in-vitro thymosin, the usual
finding in SCID. Of 15 cases of SCID reported by Lewis et al
g
(1977), half had less than 1 x 10 lymphocytes/litre with a
9 9
mean of 0.09 x 10 /litre (range 0-0.38 x 10 /I). Lewis et al
(1977) found B lymphocyte numbers to be more variable and were
sometimes normal, as in 62/> of the Westminster Children.
In eight infants adequate data was obtained from the
1
Table 57
SEVERE COMBINED IMMUNE DEFICIENCY


















LS* 3 7 2 4 continued
diarrhoea
(rotavirus)
PL 5 1 8 3 1 3 Diarrhoea,
respiratory
infect ions
HN 9 20 2 11 Diarrhoea,
pneumonia x2




l¥IP 1 3 20 2 7 Diarrhoea,
candidiasis
GS 14 1 8 1 4 Diarrhoea,
candidiasis
TD 1 5 17 2 2 Diarrhoea,
skin sepsis









3Wh 1 8 24 3 6 Diarrhoea,
respiratory
infections
DV** at birth 2 - 2 None
* previous child died of infection at less than 6 months of age












x 109/1 as % of
leukoc ytes
TO 16 4 0.6 15%
LS 16 12 0.24 2%
GS 1 8 4.5 0.23 4%
MP 22 ■ 4.8 1.6 50%
□Ulh 25 7.8 1 15%
HN 25 9.6 0.29 5%
DF 37 5.3 0.53 10%
S I 37 6.2 0.5 8%
AO 50 4.5 0.16 4%
PL 70 6 0.8 1 5%
DM 26 4.8 . .7 35%
Lymphocyte subpopulation numbers







Patient patient NR patient NR
TD NA NA
LS 0.019 0.07-0.3 0.116 0.1-1.0
GS 0 0.2
MP NA - NA
OWh 0 0.12
HN 0.014 0.08-0.7 0.015
DF 0.005 0.01
S I 0.025 0.18-1 0.405 >
A3 0.028 0.01




— normal range for age
— not available
SRBCR - sheep red blood cell rosettes
Ig - immunoglobulin
referring hospital. (Table 59 ). All but one initial lympho¬
cyte counts were low, the number on first presentation being less
g
than 1.5 x 10 /I in five of eight infants. In all the infants
9
presenting with more than 1.5 x 10 lymphocytes/litre, the
lymphocyte count progressively fell. Moreover, T and B lymphocyte
numbers were not always low from first testing and also showed
this progressive decline although only two of the results in
Table 59 were obtained at less than 10 weeks of age. Long term
gnotobiotic infants with SCID have been described (Teller 1973;
Williamson 1977). All three maintained their initial low
(toWes-go.).
lymphocyte counts throughout the first year of life ^These data
patient ER UR DM Normal Range
Lymphocyte count
x 109/1 at
birth 1.0 1.4 1.5 3.0-10.0
4 weeks 2.0 2.6 3.8
2.7-8.5
13 weeks 1.8 2.0 2.0
22 weeks 1.3 2.2 2.0
36 weeks 1.0 1.7 2.0 2.8-7.7
52 weeks 1 . 8 2.0 2.3
probable autosomal autosomal sex-
inheritance recessive recessive linked
with the data from the eight infants do not suggest any particular
pattern of involution of lymphocyte counts with different patterns
of inheritance, although involution of non-maternal derived
immunity occurs in the immune deficiency associated with adenosine
deaminase (ADA) deficiency (Polmar 1977). Normal or only slightly
reduced lymphocyte or lymphocyte sub—populations do not exclude
the diagnosis of SCID, and lymphocyte function studies are more
reliable.
Lymphocyte function studies
T lymphocyte function was severely depressed in all
patients as assessed by the uptake of tritiated thymidine in
response to phytohaemagglutinin (PHA), allogeneic cells and
Candida immunogen (table 50 ). In addition no skin tests for
delayed hypersensitivity were positive, and in the two children
who had biopsy of a lymph node, the node was vestigial.
Bortin and Rimm (1977) reported that none of 47 infants had
I L>1
Table 59


















3UJ h 13 4.0
22 1.2
25 1.0
















AO 4 5 1.0 0.19 0.03
49 0.94 0.15 NA
50 0.16 0.03 0.01
51 0.33 0.1 0.04
56 1.20 0.23 0.05












Lymphocytes MR 5-15 weeks 2.7-8.5 x 10^/1
15—40 weeks 2.8—7.7 x 1 09/l
T lymphocytes NR 5-26 weeks 0.08—0.7 x 109/1
26-52 weeks 0.18-1.0 x 109/1
g






Cell mediated immunity at presentation to WCH
Increments (cpm)








TD 16 209 0 0 DNCB neg.
LS 16 2400 1600 110 No DHS









HN 25 0 250 450
DF 37 240 2 20
S I 37 severely severely severely Heaf neg. ^
No DHS1reduced" reduced" reduced*
AO 50 100 220 480






. 7000+ 7000+ 2000+
infected with Candida DHS — delayed hypersensitivity
2
given BCG at birth
* assessed elsewhere
\(,°\
a positive delayed hypersensitivity skin test on 138 test
occasions. In-vitro proliferative responses expressed as the
mean uptake of thymidine compared to control were as follows






allogeneic cells 6%a 6.7%
Candida immunogen 6% 7.5%
The Westminster results very much parallel the larger
reported series, variation in response to different stimuli being
attributed to patients having different residual activity in
their T lymphocytes or to the allogeneic stimulating cells
supplying unknown essential metabolites to the test lymphocytes.
Either way, the results in both series show severe impairment.
Except in comparison with the International Registry series
above, I have chosen to report the increments shown by the test
lymphocytes over the background. If the background count is
unusually high a stimulation index expressing the ratio of
response obtained from the test lymphocytes divided by the
background response will be disproportionately low. In addition
the tests were performed in -both autologous and AB plasma. AB
plasma avoids the effects of free inhibitors in the patient's
plasma but would not affect lymphocytes with inhibitors already
surface bound. There was no difference between the results
obtained in autologous or AB plasma so the results quoted are
those obtained in autologous plasma.
Heterogeneity was more evident in B lymphocyte furxvion.
The number of lymphocytes bearing surface immunoglobulin was
normal in four of eight infants (table 61). Immunoglobulin
(ig) G levels were usually very low and reflected maternally
derived immunoglobulin or re placement therapy. IgA levels were
usually minimal and the only immunoglobulin present in any
quantity was the IgM present in four of eleven patients. (Table
61). However only one had any competent Igfl in that he has an
anti-B isohaemagglutinin titre of 1/4 at 6 months of age (table
62). This would usually be detectable at 8 weeks of age. Despite




Humoral immunity at presentation to UCH
A ge
weeks






TO 16 ND 1 .4 <.01 .08 ND
LS 16 0.12 1 .4* <.01 < .05 34
GS 1 8 0.35 0.25 <.01 .09 ND
MP 22 ND 0.55 .03 .05 350
DUh 25 0.12 0.25 .06 .4 ND
HN 25 0.02 1 .2* < .01 .1 <10
DE 37 0.01 0.5 < .01 < .1 1 8
S I 37 0.41 1.7* <.02 .5 4
AD 50 0.01 0.15 < .01 < .05 47
PL 70 0.8 1 .4* .27 .37 NA
DV** 26 NA 1.2' < .01 .22 NA
Normal
range
1 6i-52 0.1-1.0 2-1 0 0.1-0.9 0 . 2 — 2.0 <35
* on replacement therapy ** gnotobiotic









A ntib odies Complement
TD 16 0 No anti-A or Anti-B 2





Clq 35/ of normal
G5 1 8 0 No anti-A or anti-B No germinal centres
in lymph node
MP 22 A No anti-B
No salivary IgA
2
JUJh 25 A Anti-B 1/4 3
bJidal negative
ND
HN 25 A No anti-B
No salivary IgA
2
DE 37 A No anti-S ^
Ul i d a 1 negative
2
SI 37 B No anti-A 2
Clq 54/ of normal





PL 70 0 No anti-A or B NA
DV** 26 A No anti-B 2
Clq 30/ of normal
NA not available ** gnotobiotic
1
received diphtheria/tetanus immunisation previously
2
C„ C, were normal3 4
3
infected with salmonella spp.
ND not done
in
the infant with salmonella typhi septicaemia had salmonella
antibodies. Two infants who received diphtheria and tetanus
toxoids could neither neutralise intradermal diphtheria toxin
nor produce anti-tetanus antibodies unlike many normal infants
aged 4 weeks (Smith and Eitzman 1964). In the Registry report
(Bortin and Rimm 1977) 96% of infants had sub-normal IgG levels,
91% subnormal IgA levels and 80/ subnormal Igd levels. A few
had isohaemagglutinins but the titres were less than 1/4. Twenty-
three of 29 infants produced no antibody in response to any
immunisation and those who did produce a four-fold antibody
titre rise did this to only one of the administered antigens.
Complement and C^ levels were normal whenever tested
but Clq levels were subnormal in the three infants assessed. No
salivary immunoglobulin was found in the two infants assessed
and both had free secretory piece present in their saliva. These
findings have been reported in many cases of SCID and each has
become normal after a successful transplant, as have chemotactic
defects (Pahwa et al 1978),
Sequential studies of immunoglobulin levels on four patients
showed the expected decline in IgG levels (table 63 ). IgA
levels varied in P.L. who received maternal plasma as did IgM
levels in both P.L. and S.I. Despite P.L. having almost normal
IgM levels for seven months, not once was he shown to have
competent antibody.
Laboratory diagnosis of SCID
This heterogeneity does not give much diagnostic confusion
in SCID but more difficulty may be experienced with milder cases.
If in doubt then repeat of the most important investigations
after two weeks will almost certainly resolve the problem. The
history, family history and examination accompanied by the
following investigations should make the diagnosis clear (table
64 ) .
Specific radiolooical abnormalities in SCID
Classically the thymus is absent in SCID. However this
absence is not always real as the thymic shadow frequently
appears about three months after a successful marrow transplant.
In these cases, the thymus must have remained vestigial and
P3
Table 63
SEQUENTIAL Imr-:UNOGLOBUL IN LEVELS
Patient age in Immunoglobulins gms/1
weeks G A
LS 3 4.2 <0.1 < 0.1
5 4 < 0.1 < 0.1
15 1 .4* < 0.1 < 0.1
A3 49 0.1 < 0.1 < 0.1
50 0.15 < 0.1 <0.1
56 2. 6* <0.1 < 0.1
S I 22 2 0.2 0.4
24 0.2 0.05 0.41
28 1.5* 0.05 1 .4
37 1.7 0.05 0.5
PL 14 0. 86 0.05 0.18
1 8 0.7* 0.05 < 0.1
22 1.0 0.2 < 0.1
26 0.8 0.23 0.35
30 0.5 0.1 0.26
40 0.9 0.1 0.41
48 0. 86 0.05 0.42
57 1.4 • 0.27 0.37










2-4 3.5-12 <0.1-0.2 0.1-0.3
4-6 3.5-12 < 0.1-0.2 0.1-0.5
6-12 2-7.5 0.1-0.5 0.1-0.7
12-26 2-8 0.1-0.7 0.2-1.4
26-39 2.5—8. 5 0.2-0.85 0.4-1.8
39-52 3-10 0.3-0.9 0.5-2.0
52-104 3-1 3 0.4-1.3 0.5-2.0
n<t
Table 64
INVESTI GAT ION OF POSSIBLE SCID
Basic
Lymphocyte numbers
* T lymphocyte numbers
B lymphocyte numbers
* Immunoglobulins G, A and M
Isohaemagglutinin titres
* DH5 to mumps, Candida, trichophyton, SK-SD
* Transformation to PHA, allogeneic cells and Candida immunogen
Chest X-ray (PA and lateral)
* normal results in these tests mould be against the diagnosis.
Additional
Salivary, IgA (present after age 18 weeks)
Complement Clq
Response to immunisation with diphtheria and tetanus toxoid
Adenosine Deaminase, nucleoside phosphorylase, co-carboxylase
and transcobalamin II levels
Other
Antibody generation by autologous B cells
Chemotactic studies
Lymph node biopsy
Thymic biopsy (Borzy et al 1979)
DNBC, KLH skin testing
Skin grafting from third party
Platelet function studies
I "75
failed to populate until it was presented with competent lympho¬
cytes. Any infant subjected to major stress may lose the
thymic shadow on chest x-ray in 72 hours - thus the absence of
a thymus on chest x-ray of a sick infant does not always indicate
SCID. When the stress is past, the thymus shpdow will re—appear.
Radiological changes associated with ADA deficient SCID
have been described by Meuwissen et al (1975). There is splaying
and cupping of the costochondral junctions and sclerotic lines
in the iliac apophyses. Wide vertebral disc spaces with increased
height of the vertebrae and short stubby ilia with widening of
the metaphyses were also described by Alexander and Dunbar (1967).
The absence of a zone of proliferating cells at the metaphyseal/
epiphyseal border seems to be characteristic of SCID with
adenosine deaminase deficiency and is unlike the abnormalities
in the chondrodysplasia with immunodeficiency syndromes (Lederbaum
et al 1976).
Apart from absence of thymic shadow, none of these cases
has demonstrated any of the other radiological abnormalities,
even those associated with adenosine deaminase deficiency.
Fietabolic disorders associated with immune deficiency
Five metabolic disorders have been associated with primary
immunodeficiency. These are- deficiency of the enzymes adenosine
deaminase (ADA), nucleotide phosphorylase, 5—nuclaotidase, biotin
cocarboxylase and absence of transcobalamin II,.- ADA deficiency
affects 16% of infants with SCID (Bortin and Rimm 1977) and was
the first enzyme deficiency to be associated with immunodeficiency.
(Giblett et al 1972).
ADA catalyses the conversion of adenosine to inosine and
hence to eliminat ion via hypoxanthine. It also catalyses the
conversion of the corresponding deoxynucleosides to the same
final pathway. (Fig. 11 ). Inactive forms of the enzyme may
exist (Hirschhorn et al 1976) and a labile enzyme inhibitor has
been suggested to explain why lysed erythrocytes from some patients
and obligate heterozygotes have normal activity after prolonged
storage (Trotta et al 1976). Rare cases of deficiency of ADA
without immune deficiency have been reported (Denkins et al




ADENOSINE DEAMINASE IN PURINE METABOLISM








































The histopathology of the thymus differs in ADA deficient
SCID. In conventional SCID a primitive embryonal epithelium
without Hassvtll's corpuscles is hsually found but in ADA def¬
iciency the central epithelium is differentiated, Hass.JLl's
corpuscles are present and the blood vessels are relatively large,
suggesting that involution has occurred. (Polmar 1977).
In patient L.S., the only one with ADA deficiency, family
studies confirmed her parents as heterozygotes in that they both
had reduced enzyme activity. Lymphocyte-ADA levels were not
studied pre-graft on account of the infant's severe lymphopenia.
ADENOSINE DEAMINASE ACTIVITY IN FAMILY OF PATIENT L.S.
Red cells Fibroblasts






results quoted inytmols/mg protein/hour
ADA replacement therapy in L.S.
During the search for a donor, three separate exchange
transfusions using irradiated nitrogen frozen erythrocytes
supplied on each occasion an ADA activity of 65y^mols/mg
haemoglobin/hour. The technique used two simultaneous butterfly
needles (23g) over half an hour to remove sufficient blood to
give about 25 mls/kg of ADA containing red cells, with a post¬
transfusion haemoglobin of 14 gms/dl. This was a messy
inconvenient procedure using peripheral veins but the central
venous feediny line was nut be be compromised by the passage oi
blood.










1 0 0 2400 9300
15 0 1500
17 32
19 26 daily thymosin
for 14 days
70 140
21 24 2900 60
n&
The number of lymphocytes and T lymphocytes remained unchanged.
The level of ADA in the infant's erythrocytes (1.6% of normal)
was much less than that of the children treated successfully
by Polmar et al (1976) and is similar to the levels of those who
responded poorly (Schrnalsteig et al 1 978). In-vitro addition
of ADA to the infant's lymphocytes produced no response. Within
two weeks of the first red cell transfusion, the patient of
Polmar et al (1976) had a normal lymphocyte count and normal in-
vitro responses to PHA, Concanavalin—A, pokeueed mitogen., and
allogeneic cells. Subsequent transfusions produced less effect
but normal plasma followed by red cell transfusj.on restored the
effect. Rubenstein et al (1979) reported an 18 month old child
who responded to frozen red cells when thymosin was also given,
whereas his 6 week old affected sibling responded to only red
cells. A sixfold increase in PHA increments was seen at two
weeks without change in cell counts^ so it is possible that
L.S. was responding to red cell infusions. In the meantime
an unrelated donor who was HLA-A,B,C compatible and PILC unreactive
was found. ADA replacement therapy was discontinued and bone
marrow grafting performed.
Purine studies following transplantation
CI ills et al ( 1976) stated that adenine was the characteristic
urinary metabolite in the A DA deficient SCID and that urine
examination would screen satisfactorily for ADA deficiency.
Using urinary isotachophoresis, Dr. Anne Simmonds of Guy's
Hospital demonstrated that adenine was not in:. ' ^ present in
the urine of that Texas patient but was a degradation product
of adenosine and deoxy—adenosine. (Simmonds et al 1978). In—
vitro studies (Polmar et al 1977; Simmonds et al 1978)
demonstrated that both adenosine and deoxyadenosine are toxic
to dividing cells. The concentration of adenosine require to
inhibit lymphocyte proliferation was 100 times greater than that
of deoxyadenosine (1y<umol/l) and this level of deoxyadenosine
was close to that finally demonstrated in the patient reported
by Rills et al. It therefore seemed most likely that deoxyaden¬
osine rather than adenosine was the toxic factor present and this
was confirmed in my patient L.S. (table 65 ) before treatment.
Successful transplantation was associated with loss of deoxy—
m
Table 65
URINARY PURINES IN L.S.
pre days po st transplant




1.71 1 .06 1 .32 CO• 1 .21 .89 0.04-0.94
urinary
adenine
UD UD UD UD UD UD UD
urinary
deoxyadenosine
.19 UD UD .006 .001 UD UD
results quoted as mmols/mmol creatinine
UD - undetectable
Table 66
ERYTHROCYTE NUCLEOTIDE LEVELS IN L.S.
ATP A DP AMP dATP dADP dAflP
pre treatment 760 1 35 30 750 116 15




+65 1020 214 52 not detected
+ 84 1 1 33 1 33 16 not detected
+ 1 00 1 340 1 37 15 not detecte d
+ 200 1260 1 31 10 not detected









^fiiols/ml packed red cells
ME - not evaluable
ISO
adenosine from the urine.
Erythrocyte nucleotides were also studied (table 66).
Large amounts of different deoxy-nucleotides were present in the
erythrocytes before therapy and these could not be detected
after successful marrow transplantation. The presence of the
deoxy compounds in a similar ratio to that of the oxy compounds
was a new observation and this infant was the first in whom
deoxy AMP had been detected.
Erythrocyte ADA activity was raised after the transplant
and it is possible that this was responsible for elimination
of the toxic nuc !e.osides. Erythrocyte ADA activity after
grafting could only have arisen from- transfusions or the transplant,
but there is only one reported case of red cell engraftment in
SCID (Rubenstein et al 1971). Erythrocyte ADA levels (fig. 12)
show no tendency to a .steady level as should occur in a stable
chimera and in particular show a steady decline between days 50
and 100 after grafting during which no transfusions were given.
It seems most unlikely that a red cell graft occurred and in
particular erythrocyte genotypinc and iso—enzyme studies on days
100 and 200 showed no factors which could not have been parentally
derived. There was therefore no specific evidence of a red
cell graft, and all red cell ADA activity must have been derived
from transfusions. ~
Lymphocyte ADA activity was studied only after transplant¬
ation (table 67). It is likely that this lymphocyte activity
was the result of engraftment although no C or Q banding was
performed and tissue heterogeneity of ADA activity has been
described. Lymphocytes are implanted in successful transplants
and ADA deficient infante given red cell exchange transfusions
do not alter their lymphocyte ADA levels (polmar 1979). The
decline in lymphocyte ADA activity to 10% of the minimum of the
control values was not associated with impairment of T lymphocyte
responses but B lymphocyte function progressively fell from day
120. Ultimately T lymphocyte function also declined and the
graft failed.
ERYTHROCYTE ADA LEVELS Fig. 1 2
-25 0 50 100 150 200 250
Days post graft
RED CELL ADA ACTIVITY (L.S.)
mls/kg 32 26 24 34 23 14 25 11 31













expressed at % of lower limit of control
MARROW TRANSPLANT,ATIDM FOR SEVERE COMBINED IMMUNE DEFICIENCY
As soon as the diagnosis of SCID has been made, arrangements
for tissue typing of the infant and immediate family should proceed
as quickly as possible. In the United Kingdom there is an even
chance of an older living sibling but only a 7B% chance that this
sibling will be fully compatible, i.e. one infant in eight should
have a compatible sibling. If the parents were previously related,
appear to share one haplotype or are apparently homozygous at any
HLA locus then uncles and aunts should also be tested. Haplotypic
identity outwith the immediate family is only such as can be
defined by in-vitro testing and cannot imply full MHC identity.
Several successful HLA-A,B incompatible but D compatible transplants
have been reported (O'Reilly et al 1978), and if no HLA compatible
relative is found, it is still worth performing mixed lymphocyte
cultures between the infant and the immediate family in addition
to seeking an unrelated but compatible volunteer and before
indulging in immunological modification of the parents.
Transplant details
One bone marrow graft six patients
Two bone marrow grafts one patient
Fetal liver graft one patient
Graft from blood transfusion one patient
Died pre-graft one patient
Still in isolation awaiting
transplant, now age nine one patient
(Houston, Texas )
Of rruj 11 infants, four had no compatible family or unrelated
volunteer donor and therefore did not receive a bone marrow trans¬
plant. The infant accidentally grafted by a washed red cell
transfusion at the referring hospital died of acute GVHD. This has
been reported on several occasions previously and is a well
recognised hazard of severe cellular immunoincompetence. Of the
seven infants who received bone marrow transplants (table 68) two
(iBfo) had a compatible sibling and two had a compatible father.
A compatible unrelated volunteer was found for one infant and
two had an aunt with one locus mismatched. All donor/recipient
pairs seemed compatible in MLC as indicated by an increment of
less than 500 cpm over the unstimulated background, despite
two of the seven infants having a known HLA-A, or B mismatch with
their donor.
The technique of marrow harvest has been described by
183.
Table 68
TRANSPLANTS FOR SCID.DONORS AMD RECIPIENTS
Age
(weeks )
Donor vs patient (m)
Patient Sex Donor Age
c « p • m « increrne nt
stimulation
index
T.D. F 30 Brother 4 1 86/332 0 0.56
L . S . (1 ) F 21 Unrelated 30 400/372 28 1 .08
L . S . ( 2 ) F 58 Unrelated 30 73/421 0 0.17
G • S • L! 19 Step¬
sister
7 6 9/68 1 1.01
M. P. M 26 Father 24 95/52 43 1 . 83
H.N. F 29 Maternal
Aunt
14 545/1 56 389 3.49
D. F. F 37 Paternal
p.unt
24 219/135 74 1.62




Barrett and Humble (1975). The packed marrow was usually given
with frusemide through a platelet giving set, the infusion
being completed within 6 hours of marrow harvest. Trypan blue
exclusion showed greater than 95% viability of the infused









TD 1 3 0.68 X 10s
LS (1) 60 3.2 X 108
L5 (2) 200 13 X 1 0 8
OS 40 5.5 X 108
MP 40 .3.01 X 108
HN 100 10 X 108





mean 90 6.31 X 1 0 8
The mean graft of 6.3 x 10® nucleated cells/kg recipient body
weight is higher than necessary. No immunological disadvantage
is known to result from this in 5CID but the amounts required to
8
graft an infant with 5CID are much smaller than the 3x10
nucleated cells/kg recommended in aplastic anaemia. (storb et
al 1978). No preconditioning was used although this is occasion¬
ally necessary to overcome "non—lymphoid cellular resistance"
(O'Reilly et al 1977).
Five transplants showed evidence of engraftment including
two infants who died at 7 and 37 days after grafting. Three
infants died at days 13, 18 and 23 with no evidence of graft-
take. Prophylaxis against GVHD was given on five occasions,
either using methotrexate in the Seattle schedule (storb et al
1972) or cyclosporin—A (Powles et al 1980). To date other
special techniques to avoid GVHD in grafting for SCID have
either been unsuccessful or have not resulted in full immune
reconstitution. Definite GVHD occurred in two of four infants
who survived in excess of 20 days and was fatal in the one in
whom the most vigorous reaction was predicted by the in-vitro
assessment (patient HN table 68 ).
1
Recovery after graftina
This was seen both clinically and on laboratory investigation
The first sign is an improvement in the diarrhoea, usually at
about 10 days and the infant becomes less miserable. Subsequently
weight is gained, infected sites heal, areas with candidiasis
show a local reaction and slowly lymph nodes become palpable and
tonsils visible. Delayed hypersensitivity challenge sites may
become positive. A thymic shadow may appear on chest x-ray
after three months. The peripheral blood may show a reticulo-
cytosis during the second week, followed by a slowly rising
lymphocyte count though it usually remains subnormal.
Early deaths
In this series of eight marrow transplants in seven infants,
five died within 37 days of a marrow graft (table 69 ). Three
showed no evidence of graft-take. S.I. died of BCG disease
derived from a neonatal immunisation despite 10 days of treatment
with streptomycin, rifampicin and isoniazid. He received
cyclosporin-A and methotrexate as prophylaxis against GVHD.
D.F. died of overwhelming pseudomonas aeruginosa infection at
day 13. LS (2) probably died of Pneumocystis carinii pneumonia.
An earlier severe neutropenia was attributed to co-trirnoxazole
which she had received as prophylaxis against Pneumocystis. She
also received cyclosporin—A and methotrexate as prophylaxis
against GVHD. The events following her first graft are discussed
in this chapter.
Two infants who' died had evidence of engraftment (table 69 ).
G.S. developed an acute duodenal ulcer with a major concealed
haemorrhage. H.N. had a skin rash, biopsy of which showed mild
GVHD. She developed two-to—one heart block on day +32 which
rapidly progressed and despite transvenous pacing she died 5
days later of myocardial failure. No viruses were found and
antibody studies were unhelpful. Lymphocytes wore found inside
the sarcolemmal sheaths as well as in the other tissues mentioned.
She had normal numbers of T and B lymphocytes by day 27 with
normal immunoglobulin levels when she died (Table 70 ).
i &(o
Table 69



















ls2 + 23 Pneumonitis
?pneumocystis
None (no autopsy)



































NR 2.8-13.6 0.180-1.0 0.1-1.0
NR - normal range
Immunoglobulins (gms/1)
G A ri
Pregraft 1.2 ND 0.1
Days post graft
+ 14 1.9 0.1 0.1
+ 20 2.0 0.2 0.1
+ 30 2.6 0.3 0.2
+ 36 4.2 0.7 0.4
NR 2.5-8.5 0.2-0.8 CO•-sT•O
i
NR - normal range NO — not detected
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Prolonged engraftment
Three infants reconstituted completely, two of whom remain
well seven and eight years later. The other infant
showed reconstitution but the graft did not persist beyond day
230.
1) TD received a transplant from her compatible brother aged
4 years. (Fig. 13 and 14)., She has been fully reported
(Yamamura et al 1972). Mastoiditis the day after grafting was
followed by rapid clinical improvement, cessation of diarrhoea
and weight gain within the first month. Immune reconstitution
was rapid although in—vitro T lymphocyte function remained
impaired for many months. Details of this reconstitution are
shown in tables 71 and 72 • Return of salivary immuno¬
globulin A was delayed until 6 months after the graft,
coinciding with improvement in her chronic cough.
She has had three episodes of pneumonia in different areas
in the past 6 years and had a fairly severe attack of chickenpox.
Otherwise her progress has been unremarkable and she attends
a normal school. Her lymphocytes remain XY on karyotype assay,
but her polymorphs retain nuclear clubs.
2) MP received marrow from his compatible father. The two
photographs (fig. 15 and 1.6 ) show MP before his transplant
and about 12 months later with his donor. Table 73 shows his
lymphocyte reconstitution and normal immunoglobulin levels by
5 weeks. He had a severe hepatitis due to GVHD between days 50
and 500. This was reflected in some depression of his immuno¬
globulins at that time. Qualitative antibody was present when
tested at 811 days. He had pneumonia at 880 days from which he
made a full recovery. Figure 17 shows his response to PHA,
allogeneic cells and Candida immunogen expressed as the increment
in cpm over background. The depressed results at 650 days bore
no relation to his excellent health. Mixed lymphocyte cultures
between the child and his father were completely unreactive at









(gms/1) A ntib odies
A M
Pre graft 0.6 1 .4 .01 .08 no isohaemagglutinins
days post graft
+ 7 0. 88
21 2.10 7.0 0.08 0.2
60 2.31 8.2 0.04 0.12
120 2.43 3.9 0.04 1.9
150 1 .27 4.5 0.03 2.5
1 80 0.72 6.8 0.05 2.4
210 1 .40 5.5 0.7 0.56 E coli antibodies present






T.D. CELL MEDIATED WIUNE RECONST ITUT ION
pre graft
PHA MLR
6/o of control 2/ of control
days post graft
-
+ 30 8/ of control
+60 63/ of control 60/ of control
+ 120 42/ of control
+ 140 50/ of control
+ 334 weeks 170/ of control 700/ of control
n i
PATIENT 1*1.P, Fig. 15
PREGRAFT
ONE YEAR POST GRAFT with donor Fig. 16
tu
Table 73
IMMUNE RECONST ITUT ION M. P .
Immunoglobulins
Lymphocytes • G A
x 109/1 gms/1
pre graft 1 .22 ' 0.55 0.03 <0.05
days post graft
+ 9 1 .06
14 0.96
21 1 .79
31 2.25 5.1 1 .01 1 . 85
44 9.2 1.45 1.15
55 3.72
1 P3 2.9 0.11 1 .08
661 1.68 5.9 0.3 0.7
81 1 3.74 6 0.7 0.9
+ 137 weeks 5.6 0.4 0.7
j







Lymphocytes 2.5—6.2 x 10
Isohaemagglutinins
tetanus and polio antibodies
present at day 811 ■
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PATIENT H.P. Fig. 17
RECOVERY OF T LYMPHOCYTE FUNCTION















3) received her transplant from an unrelated female
volunteer who was HLA-A,B,C compatible and RLC unreactive on two
separate occasions. Cyclosporin-A and methotrexate were given
as prophylaxis against GVHD. Her reconstitution (tables 74
and 75 , figure 18 ) may have been slowed by the GVHD
prophylaxis regimen. No Gm or allotypic immunoglobulin marker
which was present in the donor and not present in either parent
was identified. Chromosome bdnding was not done, so absolute
proof of engraftrnent is lacking.
Table 74 shows lymphocyte repopulation and immunoglobulin
levels after tier transplant; table 75 the qualitative antibody
and clinical delayed hypersensitivity tests; and figure 18
the increments following stimulation of her T lymphocytes by
PHA, pooled allogeneic cells and Candida immunogen.
Reconstitution of lymphocyte numbers was never very
impressive. T lymphocyte numbers became normal at 70 days
but 8 lymphocyte numbers did not increase. Immunoglobulin levels
were normal by day 50. IgE levels were grossly elevated as
immunological reconstitution occurred, probably due to T
lymphocyte dysregulation. c1q levels became normal. Unusually
the Igfl isohaemagglutinins showed a higher anti-B than anti-A
titre (table 75 ). Competent antibody was present by day 7u
as indicated by isohaemagglutinins and the ability of her serum
to neutralise her endemic pseudomonas. None of the pseudomonas
inhibition studies were performed while she was receiving systemic
antibiotics. Schick tests were unreactive i.e. normal}after
2 doses of diphtheria toxoid and cutaneous delayed hyper¬
sensitivity to Candida was present at day 120. In—vitro
T lymphocyte responses to PHA, allogeneic cells and Candida
immunogen are shown in fig. 18 ,
By day 100 after grafting from this unrelated donor there
was considerable T lymphocyte function and delayed hyper¬
sensitivity to Candida was present with normal quantitative and
qualitative immunoglobulin levels. This immune function did
not persist. Immunoglobulin levels and isohaemagglutinins
fell from day 130 but Schick testing remained unreactive and
cutaneous delayed hypersensitivity persisted. T cell function
suddenly declined and the infant lost weight, developing
diarrhoea and chest infections. The graft failed completely by
115
Table 74a







pregraft 0.37 (n=8) 0.026 (n=4) 0.268 (n=2)
days post
graft
+ 35 0. 30 0.08 0.12
+ 50 CO•O 0.02 0.07
+ 70 0.69 0. 35 0.05
+ 1 00 2.4 1 .98 0.07
+ 1 30 0.48 0.19 0
+ 170 • 0.70 0.39 0.06
+ 200 0. 36 0.15 0.03
+ 225 0.4 6 0.24
+ 235 1.1 0.76 0
NR 2.8-7.65 0 • —i CD 1 • o 0.1-1.0
Table 74b
L .5 . If-inUNOHLOBUL IN AMO C ORI PL EH ENT RECOMST ITUT ION
* Immunoglobulins
gms/1 I .U. C 1 q
/ of
normal
G A M E
1
pregraft 1 .4 .02 ND 34 35/
days post
graft
+ 35 2.1 0.2 1.5 1700
+ 50 8.5 1.1 3.0 2900
+70 10.2 0.8 1 .4 260
+ 100 12.1 0.5 0.8
+ 130 8.6 0.5 0.4 200 1 05/
+ 170 5.6 0.5 0.3 170
+ 200 5.6 0.5 0.3 200
+ 225 5.0 0.5 0.3
+ 235 4.8 0.4 0.3
NR 3-10 0.3-0.9 0.5-2 30 10 0/
NO - not detected NR normal range
m
Table 75
US. QUALITATIVE ft MT TODDY TESTS POST GRAFT




















0 0 none MD negative x 2
+ 50 1 /B
+7 0 1/2 1/64 1 /64
+ 120 1/2 1/32 7mm
4-17 0 1/4 1/8 12 mm
+ 190 1/2 1/4 1/64 no reaction 10 mm
+ 220 1/2 1 /1 6 no reaction 7 mm
+ 235 0 1 / 8





PATIENT L.S. Fig. 18
RECOVERY OF T LYMPHOCYTE FUNCTION



















Classical rejection had not occurred as the donor was still
compatible (table 68). There was no evidence of immune
suppression caused by GVHD. Dietary deficiency seemed most
unlikely as did a gross metabolic cause. D0uld the micro-
environment have been inimical to the unrelated stem cells which
were perhaps unable to co-operate with those of the recipient?
A few unrelated grafts have been successful so non—family
stem cells can proliferate in an unrelated recipient, Reconstit-
ution with fresh yoghurt between days 140-150 and her removal
from isolation did not seem associated with immune decline.
Plasma inhibitors were present on day 149 when her plasma
suppressed normal third party sheep red cell rosettes by a
factor of three. Her own sheep red cell rosetting J lymphocytes
increased from 0.39 to 0.48 /I with in-vitro thymosin at that
time so her plasma inhibitor was not excess thymic hormone.
Because no thymus had appeared on chest x-ray one possibility
was that she had outgrown her own supply of thymosin but the
administration.of parenteral thymosin (1 mg/kg/day) for two
weeks was without effect. The infused erythroblasts could have
given an undetected passive red cell graft supplying ADA which
would persist only for the 120 day life span of erythrocytes.
If subsequent top—up transfusions were insufficient to supply
enough ADA* a toxic suppression of graft would have ensued.
However deoxyadenosine did not reappear in the urine nor did
deoxynucleosides reappear in the red cells, which is against such
a toxic suppression of the graft. Whether reticulo-endothelial
cells, monocytes and macrophages are engrafted in SCID is not
known and it may be that there was imbalance at this level in
the marrow stroma. Recent evidence suggests that monocyte
grafts may not be permanent (Kersey 1980) so only a
transient marrow stroma improvement is possible in this patient,
but there is no real explanation of the failure of this
transplant.
There is no doubt that two of these seven children have
prolonged effective transplants and that these two children are
leading a normal life. Only one of the seven had a compatible
sibling, a situation that usually gives a 65/C success rate^and
m
two had a compatible parent, a circumstance giving about a 40%
chance of success (Bortin and Rimm 1977). Other less well
matched grafts have success rates of 5—20%. No other therapy
has any real success in treating SCID although occasional claims
are made for fetal tissue grafts. Red cell transfusions to supply
ADA in those with coincident ADA deficiency may be effective
but this usually requires very- early diagnosis and institut¬
ion of transfusion therapy. Until other enzyme deficiencies
are identified and enzyme therapy is more effective, marrow
transplantation remains the treatment of choice.
MANAGEMENT OF INFANTS 'jJITH SCID
Once the infant is diagnosed as having SCID, the tissue
types and mixed lymphocyte culture (MLC) responses of all
appropriate family members should be ascertained as soon as
possible. Tissue typing should be available within a few days
as the tests take one day to perform and specimens can travel by
overnight post. An HLA identical sibling has a 98% chance of
being acceptable as a donor. The I'lLC takes 6 days and is not as
widely available as tissue typing. The earlier the infant is
assessed and appropriate isolation and decontamination established
the better, sr the child should be transferred as soon as possible
to a referral centre where the marrow graft may be carried out.
Delay in referring the infant is engendered by the improvement
that occurs in hospital with appropriate antibiotics, dietary
changes and fluid therapy. A lack of realisation that, once
deteriorating, these- infants die rapidly and that grafting
becomes more difficult, coupled with an understandable reluct¬
ance to send the family many miles from home all contribute
to the delay.
The referral centre can organise appropriate further
investigations with appropriate blood replacement and family
studies can be performed at the same time as the MLC. Precise
definition of the nature of the SCID in their infant in
association with the family studies may give information import¬
ant in the genetic counselling of the parents which can be
undertaken either at the referral centre or more locally. In
addition, having met the staff and seen the centre, the parents
may feel less anxious about subsequent infants requiring a
2-CrO
"germfree" delivery or early neonatal assessment at the same
centre. After seeing and assessing the child fully, the staff
are in a position to discuss the infant's problems and the
therapeutic options with the parents.
Isolation and decontamination
The infant should be nursed in protective isolation. A
clean cubicle with sterile linen and attendants wearing
protective clothing and taking proper barrier nursing precautions
are necessary. This does not preclude the trained parent.
During the first few days, microbiological assessments and
decontamination take place and if a plastic isolator is to be
used, this can be discussed with parents who then familiarise
themselves with its use, so they can continue to play a full
part in the care of their infant. Transfer to the isolator
would occur when decontamination is satisfactorily established,
usually around the same time as the IILC results become available.
The benefits of the isolators were already discussed on page 81.
Infants have shown no long term emotional or physical
problems as a result of isolation although only six isolated for
more than one year have been reported. They tended to be
placid and thrir maturational development was ahead of their
learned development but all showed quick catch—up after release
from isolation.
I would not recommend using an isolator however until a
therapeutic programme has been decided upon as it is not as
easy to remove a well though immunoincompetent infant from an
isolator as might be imagined.
NEOCON (table 20 ) would be appropriate as antimicrobial
decontamination but with increased antifungal agents. Soptrin
should be avoided until ADA deficiency has been excluded as
profound neutropenia is associated with these two circumstances
coinciding (EBflT 1980),
The question of bacterial contamination and GVHD (page ^-3> )
remains open in SCID. Swabs in transport medium from the scalp,
ears, nose, throat, axillae, umbilicus, groins, vagina and toe
clefts as well as specimens of sputum, urine and stool should be
taken before decontamination is commenced. Viral cultures
should be sent from the throat^and sputum, nasopharyngeal
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aspirate, stool and urine also examined for viruses by electron
microscopy or direct immunofluorescence as appropriate. Further
microbiological surveillance should follow that outlined in table
50 with additional viral studies on account of the defect
in cell mediated immunity.
Humoral replacement therapy




NHI 150 2-6 1
Plasma cn 1
* •ps 0.5-3.0 0.5-2
Triple strength plasma 1 5-4 2 1.5-9 1.5-6
The normal synthetic rate of IgG of 34 mg/kg/day would
require 0.23 mls/kg/day of NHI (150 mg/ml) by the intramuscular
route. If the usual dose of 50 mg/kg/week of NHI is given to a
4 kg infant, the volume is an acceptable 1.3 mis but this replace¬
ment is only 20% of what would be synthesised normally in an
older child and the standard dose of 25 mg/kg/week is a mere
10%. NHI supplies little IgA or igM. To supply IgG in amounts
comparable to the normal synthetic rate would require 1.4 mls/kg
of NHI by the intramuscular route each week, 45 mis of plasma/kg/
week or 14 mls/kg/week of triple strength plasma.
The true amounts required to maintain a satisfactory level
would be greater as catabolism of IgG increases at higher serum
levels. In addition the infant is hypercatabolic owing to
infection and impaired nutrition. The sodium content and
volume of plasma are other problems. It is not surprising that
it is most unusual to achieve serum levels in excess of 2.5 gms/1
of IgG with 50 mg/kg/week of intramuscular NHI. High dose
intravenous NHI (Ochs et al 1980) and the comparable subcutaneous
preparation (Berger et al 1980) should be evaluated and the
indwelling subcutaneous needle should not lead to an increased
risk of infection. Specific high-titre herpes simplex, varicella
or pseudomonas immunoglobulin may have a limited value. Immuno¬
globulin replacement therapy has not a great role in treating
already present infection but may help phagocytosis although
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plasma would probably do this better. The low Clq in many SCID
patients does not make a great in-vivo difference as the
alternate pathway of complement activation is probably intact.
Infections
The majority of bacterial infections are due to common
pathogens, predominantly gram-negative bacilli but pneumococci
cause some morbidity and if present are an indication for
continuous penicillin. Staph, aureus is not a major problem
but fungal infections are common. Topical antifungal agents
are necessary and the newer absorbable antifungal agents such
as ketoconazole which also has some immunostimulatory action
need evaluation. However, an infecting organism must not be
considered eliminated until there is reconstitution of immunity.
If a live immunisation has been given to the infant it must be
assumed that the organism is still present and appropriate
therapy instituted if possible. One infant who received 8CG at
birth died of systemic BCG disease after C months, the diagnosis
being delayed by gentarnicin partially suppressing the organism.
Diagnosis of infection must be by culture, antigen detection,
or microscopy. Specific antibody is not formed but vacuolation
of peripheral lymphocytes (best observed in a cytocentrifuge
preparation) occurs with some viral infections.
Interstitial pneumonitis may or may not be due to
Pneumocystis carinii. Lung aspiration using a 21—gauge needle
has slight dangers but may be useful. • Open lung biopsy is a
major undertaking. If due to Pneumocystis, response to high
dose co—trimoxazole usually occurs within 48 hours. Unfortunately
some patients with Pneumocystis do not respond, some cases are
due to bacteria and some are viral in origin. Failure to
respond after 48 hours of high dose Septrin should be fallowed
by lung aspiration with gram and giemsa staining and both
bacterial and viral culture of the aspirate. Electron microscopy
may also be useful, as may direct immunofluorescent studies for
viral antigen on cells present in lung or nasopharyngeal
aspirates.
Candida spp. in properly taken urine specimens or in a
suprapubic aspirate makes the use of systemic antifungal agents
likely but there is not an automatic necessity to continue
these daily for six weeks. Some units give amphotericin B for
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two days each week, and are prepared to commence this on the
slightest supposition of non-superficial Candida infection.
With any suggestion of herpes or cytomegalovirus infection^
acyclovir should be used. Interferon or irradiated parental
lymphocytes may be useful in other viral infections. However
any remedies can only be of any practical value if cure of the
basic problem is under way.
Prophylactic septrin may have disadvantages as two of six
SCID infants in this series developed severe neutropenia. In
the ADA deficient infant this was definitely caused by co-
trimoxazole, and this is now recognised as a relatively common
circumstance in infants with ADA deficiency (EBMT 1980). Folinic
acid might have protected the marrow but would it also protect
Pneumocystis carinii? Exposure to Pneumocystis before the age
of one year is likely as 6 of 14 normal children between seven
and twelve months of age had antibody to the organism (Meuwissen
et al 1977).
Supportive care
Nursing care of these infants must be meticulous and
paediatric nurses are the only ones appropriate. There is no
place for these children in a general transplant unit as the
nursing problems are too specialised (Birtwhistle 1977). Skilled
physiotherapy is probably more important than antibiotics in
keeping the lung fields clear (Young 1978).
Adequate oral intake of nutrition is unusual and diarrhoea
with malabsorption reduces the energy supply further. Supple¬
mental intravenous feeding is usually required. Central
catheters, inserted with full sterile precautions should be
used for intravenous feeding but infants are too small to allow
silastic 'Hickman' catheters to be used. The standard size
are suitable for intravenous feeding, as well as giving and
taking blood. There is a need for an infant catheter which can
be used in this way without the narrow diameter leading to
blocking of the lumen.
Taking blood specimens needs to be properly organised.
Micro or semi-micro laboratory facilities are essential and
it is necessary to speak personally with laboratory staff to
ensure that "inadequate samples" are in fact adequate.
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Communication is required whereby one laboratory will pass
the remainder of a sample on to another. Quantities quoted in
general hospital pathology services handbooks are impossibly
large.
Blood products must be irradiated to 1500 rads before
transfusion (except for the transplant). This prevents stem
cells in the transfusion proliferating and mounting a GVH
reaction. Washing of red cells is useless and though nitrogen
freezing may be effective, radiation is more certain.
The family
The care of the infant includes care of the family. From;
the pleasure of a new baby the parents over a few weeks
realise that the infant is unwell and seek medical advice on
a number of occasions. Not surprisingly they are at first
reassured and the candidiasis is treated. The infant's
respiratory affliction is treated and the loose stools ascribed
to antibiotics or the respiratory affliction. By 3 months the
infant is failing to thrive, miserable and has skin rashes.
Finally the diagnosis is made and the family face the unlikely
possibility of cure. There is guilt about not having taken the
infant back earlier to the doctor and "insisted on him doing
something", accompanied by anger at the diagnosis having been
delayed. Much of this passes once the rarity and the implications
of the diagnosis are explained.
For transplantation, the infant plus mother often have to
move many miles from, home with loss of the support of family
and friends. Flother will be in continual close contact with
her sick child for many weeks and may feel guilty if she leaves
him. Other children at home wil-1 suffer from mother's absence
and father may not be able to take unlimited time away from work.
The "therapeutic community" of the resident parents'
accommodation may not be entirely helpful. Great stress will
be placed on the marriage and parents should very definitely
not spend unlimited time at the transplant centre, but be
encouraged to be together at home whenever possible. No matter
the outcome of the transplant, the family itself has a future




The genetics of SCID will have been explained to the
parents as best as possible and the implications of a further
pregnancy will have been discussed at length. In the light of
this, many parents will elect to have further children and
therefore a germfree delivery will have to be considered, even
if only to be discarded as a possible option. Techniques to
obtain germfree animals have been available since the first
germfree delivery of a goat in 1913. The first delivery of an
axenic human infant was in 1967 (Alpert et al 1969) and the
first such delivery performed on account of possible immune
deficiency was reported by Barnes et al (1968).
It is essential to think clearly about the implications of
a germfree delivery performed on account of potential immune
deficiency in the infant. fin affected axenic infant maintained
in a germfree environment but without a curative treatment
programme is a difficult moral problem for every member of the
medical and nursing staff. To discontinue germfree care in
this situation is not as easy as it seems. Prior discussions
and decisions made by the parents may no longer be valid. Texas
Children's Hospital, Houston' are now, in their eighth year of
caring for a child with SCID who has no bone marrow donor and
remains very well both physically and psychologically in a
plastic isolator. filthough his team felt that "presented with
a similar circumstance, our team would assume a similar role
in the care of another child" and that "sterile delivery may
assume more importance in the future" (flalinak et al 1973), it
is noteworthy that they have performed no similar deliveries
in the past eight years.
Germfree delivery is only appropriate when other
alternatives have been considered, if only to be rejected. If
the combined immune deficiency is of sex-linked inheritance,
then sexing of the fetus and abortion of the males is possible
however distasteful. With associated AOfi or other enzyme
deficiency, amniocentesis followed by fibroblast culture and
determination of enzyme activity may be able to distinguish
between affected and unaffected infants. Variation of ADA
activity in different tissues and the difficulty of distinguishing
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the affected from the carrier infant complicates the results.
Immunological assessment by fetal blood sampling will be possible
in the future.
Given that the parents wish the infant delivered, the final
benefits of a germfree delivery are speculative. However, an
affected infant will return infected by three months and should
a transplant be possible, it would seem sensible to have the
child in good condition and proceed as soon as possible. Germfree
delivery implies having the facilities to continue this standard
of isolation subsequent to the delivery. To suggest that an
affected infant remain in an isolator while the parents have
another child who might be a'marrow donor is more than
mischievous.
Any form of germfree delivery involves separation of the
infant from its parents. This is not a real problem as the
family have already lost a child with immune deficiency and although
there is a better than even chance that the new infant will
be normal, it is likely that some degree of mourning for the
new baby has already occurred before the birth. I do not
believe that the week necessary for the initial tests will
blight the parents' relationship with the new infant. The
infant needs cared for and parents who are familiar with
isolation nursing techniques' can perform the care. This can be
taught before labour commences and if the previous infant was
cared for in the same hospital, the staff and routines will
be familiar to both parents. nother can also see and touch the
baby transiently between delivery and isolation without a host
of pathogens being transferred to the child.
Three deliveries
The choice lies between caesarian section and vaginal
delivery. Caesarian section can be pre-arranged and the
incision and delivery made through the drape in a closed
sterile surgical isolator. The newborn is then passed through
into a connecting sterile cot isolator thus maintaining a truly
germfree state. Despite this, I am not in favour of caesarian
section. Apart from the inherent dangers of the operation there
are two major disadvantages. Statistics favour the child being
unaffected by 5CID and if active resuscitation of the infant is
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required, this is still impractical within an isolator. Barnes
et al (1968) reported how they had difficulty intubating in
their isolator and despite improved models of isolator this is
too great a price to pay.
Delivery by the vaginal route results in greater exposure
to the environment but adequate local decontamination can be
achieved using iodinated compounds (e.g. Betadine) which also
have anti-viral activity. fln appropriately secured plastic
sheet should prevent faeces soiling the child. There is little
point in giving mother oral non-absorbable antibiotics and if
the birth canal is adequately decontaminated such antibiotics
should not be necessary for the child. Vaginal delivery allows
such resuscitation as necessary in optimal conditions and
mother to touch and see the infant before he is confined in a
controlled environment.
Three such deliveries were undertaken using techniques
described in appendix 2 , Our obstetric unit was in the
main Westminster Hospital, 800 yards from the Children's Hospital.
There were no paediatric staff continuously in the obstetric unit
and thus the staff responsible for the infant had to be summoned
at the appropriate time. A senior paediatric registrar and a
nurse were sufficient, the required equipment being already
prepared and in place.
A specially cleaned, fumigated and sealed Vickers 59
incubator was used because the humidity port exactly fitted
a Flicrof low 0.3/x- LF 40 air filter. Filtered air from a
5 cfm mains/battery blower gave about 20 air changes/hour, which
could be increased if the incubator ports were opened.
Because this air flow will cool the infant, the room and
therefore the air, must be at the required incubator temperature.
The infants were delivered vaginally without surgical
interference but with the topical application of copi^ous amounts
of local Betadine. They were received onto a sterile sheet in
which they were wrapped and dried. Wo resuscitation was requir¬
ed but the infants were observed for a minute on a Resuscitaire
trolley covered in sterile drapes, shown to the parents and
then placed in the prepared incubator. The incubator, still with
positive pressure filtered air, was transferred by ambulance
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to Westminster Children's Hospital. The infants remained in
this incubator in a specially cleaned cubicle until immuno¬
logical tests were reported. fill attending staff wore masks,
gowns, gloves, hats and overshoes and all supplies used were
sterile.
Surface and orifice decontamination using Hibiscrub (4%
chlorhexidine in detergent) topically and oral sprays of
0,02$% aqueous chlorhexidine were used from age 2 hours, but
no antibiotics administered. The infants were fed 5% dextrose
initially followed by Gold-cap SWA. When the mother's milk
came in, this was pasteurised and given within two hours of
collection.
Placental blood, collected by cannulating the 'umbilical'
vein was used for the initial investigations. Two infants
were normal and one was affected by SCID. Although there was
no obvious family donor for this infant a therapeutic programme
had been previously discussed, that of attempting to induce
tolerance in father and render his lymphocytes unresponsive to
the non-shared HLA loci of the c-hi 1 d. Since there had been
encouraging experimental results with this technique, the
infant was transferred to an isolator tent age 4 weeks. The
outcome is awaited. The infants who were normal were transferred
to a conventional environment or home depending on circumstances,
Results
Table 76 shows the microbiological results of these
delivery techniques. The infants acquired staph, epidermidis
readily but faecal organisms, strep, faecalis and anaerobes,
appeared after the third day. Infant AO was contaminated with
faeces at delivery, but it is li-kely that the peptostreptococci
were acquired in the birth canal. The presence of the other
organisms indicates some deficiency in our cubicle/incubator
protective care. The pasteurised breast milk (given from day 3)
may have been a source of organisms. Should the maintenance of
a totally axenic state in SCID be vital, then caesarian section
with a sterile surgical isolator will have to be reconsidered.
Table 77 shows the cord blood results from the three
infants. DF and fiQ were normal infants; AN suffered severe
ZD0)
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DF 3 hr s 8 8 -
28 hrs 5 3 staph, epidermidis
(light growth)
76 hrs 1 1 2 staph, epidermidis
(light growth)
1
8 days 9 0 staph, epidermidis
(light growth)
diphtheroids )
coliforms ) . ,'
in stool
strep. faecalis)
AQ 2 hrs 3 3
24 hr s 4 3 Clostridia spp. ) . .'
in stool
peptostrefDtococci)
AN 4 hrs 1 2 12 _










CORD BLOOD RESULTS ER OH THREE INFANTS
DELIVERED UITH BARRIER PRECAUTIONS
DF AO AN** Normal ranges
g
Lymphocytes x 10 /I 9.06 9.15 1 .26 2.3-9.0
□
T lymphocytes x10 /I 0.91 3.3 0.34 0.6-4.0
B lymphocytes x 10^/1 4.70 • 2.75 0.3 3 0.22-2.5
*increments oyer
control (c.p .m . )
to PH.A 50,000 ND 0 more than 9000
allogeneic cells 9, 800 ND 0 more than 9000
Immunoglobulins
(gms/1)
G 5.2 8.6 4 .4 7.5-18
A 0.5 <0.05 0.2 <0.1







* results in autologous plasma; results mere similar in
AB plasma
** increments following in—uitro SK—SD, and Ccncanavalin—A
were also very low
ND — not done
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combined immune deficiency. The T lymphocyte function uas the
most useful investigation in making or refuting the early diagn¬
osis of SCID.
Summa ry
fl simple form of decontaminated vaginal delivery was used
in three instances where the unborn infant was at risk of having
combined immune deficiency. The delivery was effected
satisfactorily by the vaginal route but the use of a specially
cleaned incubator with sterile positive pressure air, sterile
supplier and attendants wearing protective clothing did not
prevent the infants becoming colonised during the first 7 days
by which time the immune status of the infant had been ascertained.
However no■antimicrobial agents were given to either mother or
infant and pasteurised breast milk was given to the infants.
More stringent measures need to be adopted if the axenic state
is thought to confer additional benefit, but this will increase
the likelihood of having to maintain an affected child in a
gnotobiotic environment without a therapeutic programme. All
these measures will be unnecessary for three-quarters of at-risk
infants will be unaffected by SCID.
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SEVERE APLASTIC ft MA Ed IA IN TEN CHILDREN
Introduction
Severe aplastic anaemia is characterised by marked
peripheral blood pancytopenia and bone marrow hypoplasia. There
is anaemia, a reticulocyte count of less than 1% or less than
10 x 1 09 reticulocytes/1itre, a platelet count of less than
20 x 109/1 and more than 60^ of the bone marrow cells are of the
non-myeloid series. Excluded from the definition are selective
cytopenias such as pure thrombocytopenia or the erythropenia
of Diamond and Blackfan (1938), the hereditary anaemias such
as that originally described and reviewed by Fanconi (1967),
paroxysmal nocturnal haemoglobinuria, myelophthisic conditions
such as osteopetrosis and the effects of cytotoxic drugs or
systemic illness.
Incidence and aetiology
In 1978 the Registrar General recorded 255 deaths from
aplastic anaemia in England and Dales, of whom 17 were children.
About 0% of cases are known to be drug-induced, this being either
a direct toxic effect or an idiosyncratic response by a
susceptible bone marrow. A further 8% of cases follow a
hepatitis, the severity of which is unrelated to the ensuing
aplasia. dost such patients are aged less than twenty years and
almost all such aplasias are severe. Opinions differ as to
whether the aplasia is a direct consequence of the viral
infection or the result of an immunological process engendered
by the virus.
The cause of 75% of severe aplasias is unknown. There is
evidence to favour abnormalities of the marrow, the marrow bed
and the lymphoid system. dice with hereditary aplasia and an
abnormal marrow stroma cannot be reconstituted by marrow
grafting yet their apparently ineffective marrow will effectively
populate the marrow cavities of mice with hereditary stem ceil
defects (dcCullough et al 1965). Rat femur, irradiated locally
to 4000 rads will only transiently support the ingrowth of new
marrow (Knospe and Crosby 1971). Osteopetrosis can be cured by
spleen and marrow transplantation in mice (walker 1975) and}at
least tsmporarily)in humans (Coccia et al 1980) indicating
a close relationship between bone marrow stem cells and the
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osteoclast component of bone. The occasional failure of a
human syngeneic marrow graft in aplasia may be attributed to
an abnormal marrow bed, acquired as a result of unknown toxic
processes which may still be operative at the time of grafting.
fin immunological cause is suggested by the increased
lymphoid component of most aplastic marrow. A failed syngeneic
marrow transplant may engraft at a second attempt when immuno¬
suppression is used (Royal flarsden Hospital 1977). Occasionally
autologous reconstitution is seen following immunosuppression
(Baran et al 1976). In-vitro cultures of aplastic marrow give
granulocyte colony or cluster formation in soft agar only when
marrow lymphocytes are removed from the preparation (flscensao
et al 1976) and these same aplastic marrow lymphocytes will
inhibit colony formation by cultured normal marrow. This effect
is particularly evident with added T lymphocytes bearing gamma
Fc receptors, so called suppressor cells. (Bacigalupo 1980).
The immunological imbalance associated with GVHD (in which excess
suppressor cells are often present) has also given rise to
aplasia (Park et al 1973; O'Reilly et al 1976).
Natural history
The natural history of aplastic anaemia is variable but
table 78 summarises a. number of reports of patients with
aplasia. The best prognosis quoted is 50% survival to 15 months
from diagnosis. If less severe cases have been included, or if
some received steroids and/or androgens and if these are helpful,
then survival data here Is optimistic. If these data are accepted
at face value, the survival rate of the quoted series reported
since 1968 (excepting Camitta et al who only reported post¬
hepatitis aplasia) is 35% overall at best and 30% for children.
A more likely outcome in severe aplasia is 20% or less alive at
1 year (Feig 1978; Gluckman et al 1980).
Some patients with severe aplasia will survive when given
only supportive care. Attempts to identify those most likely
to survive have given rise to a number of prognostic formulae,
based on the initial presentation data. Table 79 shows
five prognostic formulae, and table 80 compares the results of
four formulae when applied to the Westminster Children's Hospital
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Wolff et al 1957 334 2 5%
children
66% died
(30% lost to follow up)
Shahidi and 1959 40 children 90% died
Diamond
Nora and 1969 37 children 7 8% died
Fernbach
Heyn et al 1969 33 children 48% died
(39% dead in 3 months)
Li et al * 1972 58 children 70% died
Lewis 1965 50 70% died
(50% dead in 15 months)
Vincent and 1967 43 63% died within 1 year
De Gruchy
Davis and 1972 25 80% died
R ub in*
Camitta et al 1974 80 87% died
(hepatitis aplasia)
Lynch et 1975 99 43% dead by 4 months
al
Tso et al 1977 129 62% died by 1 year
(47% by 6 months)
Mir and 1 9 BO 147 71% died
Geary
* the majority received androgens
215
Table 79
PROGNOSTIC FORMULAE IN APLASTIC ANAEMIA
Author Date Formula indicating bad prognosis
Lewis 1965 platelets <20, 000/yu. 1;
neutrophils <100/^1
Camitta et al 1976 platelets <20,000/^1;
neutrophils < 500/^1;




1976 reticulocytes <10,000/ l(corrected)
("lathe and
Schwarzenberg
1977 low lymphocyte count; low number of
CPU - C
Lynch et al 1975 C= -0.01796 B (8-onset with bleeding,
if yes = 0, if no = 1)
+0.01272 A (S-sex; female =1, male = 2)
—0.00000 0FV (months between onset
and clinic visit)
-0.00359 R (R=corrected initial
reticulocyte count per cent)
-0.000002 N (N=initial neutrophil count/
cumm )
-0.00018 P (P=initial platelet
count in thousands/cumm)
4-0. 00046 NM (NM=percent of non-myeloid
cells in initial marrow)
If C > 0.035 the prognosis is
probably poor)
Conversion to SI units
g
10,000/cumm = 10,000,^1 =10x10 /I
Z\ (o
Table BO
FORMULAE USING DATA ON FIRST PRESENTATION
Patient Lewis Camitta L ohrmann Lynch Final Outcome
Old G G G G Grafted — well
CT 7 G* X X Died of infection
MB 7 X G X Grafted, no take, died
of infection
PM (adult) G G* X G* Grafted, died of
in fection
AD ? 7* X G* No response to ALG died
pre—gra ft
LP G G G G Grafted. Died of
haemorrhage
SH 7 X X X Died of haemorrhage
AU 7 7 X X Gra fted — well
LA 7 ? G X Grafted. No take. Died
of haemorrhage
G = relatively good prognosis
? = uncertain
X = relatively poor prognosis
* when recalculated, using data on admission to
Westminster Fiospitals; these patients were now
of poor prognosis
in
patients witty aplastic anaemia. In five of nine patients the
formulae disagreed, the formula of Lohrmann et al (1976) being
the most dissimilar. However what is more unsatisfactory is that
when the prognosis was recalculated using the data at admission
to the Westminster Hospitals, three of nine patients had changed
their prognosis, all from a relatively good to relatively poor
prognosis. The patients are a selected group in that those doing
well would have been less likely to have been referred. No
patient changed to the good prognosis group. The Lohrmann
prognosis did not change; the others changed to agree with Lohrmann.
It seems unlikely that a good prognosis should become poor
during a hoped-for spontaneous recovery. Lynch et al (1976)
found Q% of those surviving 6 months had been originally in the
bad prognosis group, but in our hands, Lohrmann's formula seemed
the most reliable.
Treatment
Apart from bone marrow transplantation, treatment with steroids
or immunosuppression is available. Androgens are said to take
3 months to produce an effect and marrow improvement may be an
epiphenomenon. Matched patient trials of androgens in aplasia
have shown no significant benefit (Lynch et al 1976) yet there
are certain patients who do benefit from androgens and relapse
when they are discontinued. The mode of action is unknown although
androgens increase erythropcietin production in the isolated
perfused dog kidney (Paulo et al 1974). However, there is no
evidence that aplastic anaemia is associated with deficiency
of or insensitivity to erythropoietin. Of the androgens
available norethandrolone 0.5-1 mg/kg/day is perhaps the most
effective (Speck et al 1980). There is a definite incidence of
hepatotoxicity (Tso et al 1977) and many patients develop abnormal
bromsulphalein excretion or liver enzymes (Sanchez-Medal et al
1969; Cornso et al 1971). Lithium carbonate may increase
the peripheral polymorph count (Barrett et al 1977) and marrow
granulocyte colonies but does not affect the platelet count.
Although lithium has no real place in the management of aplasiaj
it may accelerate marrow recovery after grafting and thereby
slightly reduce the period of severe neutropenia.
XI
Immunosuppression has given responses in aplasia. Apart
from cyclophosphamide used as pre-transplant conditioning,
the two most used immunosuppressants have been steroids and
anti-lymphocyte" globulin (ALG). Rarmont (1979), using methyl-
prednisolone 20 mg/kg/day for 21 days, reported a 46% complete
remission rate in 26 patients with severe aplasia. He reported
no difficulty withdrawing the steroids and those patients with
compatible donors who did not respond were transplanted. narrow
cultures from the responding patients showed only clusters
whereas cultures after successful- grafting gave normal colonies.
5peck et al (1977) gave ALG with or without a one haplotype
identical marrow transplant. Overall survival in both groups
was 55/o at 1 year with 41% showing sustained haematological
improvement. No graft took so there was no GVHD, but 70% of the
patients developed serum sickness following the equine globulin.
Combinations of equine and rabbit ALG have given a similar
response rate. (Bacigalupo 1980).
Harrow grafting is the curative treatment of choice.
Transplantation from a compatible sibling before the patient
has received any transfusions has given an impressive 75% two
year survival (storb et al 1980). This can be compared with
Seattle, Los Angeles and the European transplant series (table
81 ) where an overall survival of 43% is quoted with 30% of
patients suffering GVHD. Unfortunately u n trans fuse d aplastic
patients are not common. If the value of cyclosporin-A in
preventing GVHD in allogeneic transplantation for acute leukaemia
(Powles et al 1980) is confirmed in aplastic anaemia, then a
major hurdle will have been overcome.
Despite circulating stem cells being sufficient to graft
dogs and rodents and give GVHD in infants with SCID, the
numbers of stem cells and nature of the human haemopoietic system
make this an inadequate graft for a patient with aplasia. A
syngeneic graft using leukaphoresis from peripheral blood
failed but a marrow graft which supplied twice as many stem cells
succeeded (Hershko et al 1979). The intravenous route is the
most convenient although intra-peritoneal, intra—arterial and
intramedullary routes have been used. Different handling
techniques of donor marrow (Barrett et al 1979) confer no
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advantage providing the donor marrow is given as soon as possible
after harvesting.
The marrow donor is usually an HLA identical, FILC unreactive
sibling, although occasionally a parent is suitable. Unlike
heart or kidney grafts, ABO compatibility between donor and
recipient does not affect the results. An ABO mismatch usually
requires the recipient to be plasma exchanged before and possibly
after the graft. Sufficient plasmaphereses are required before
the transplant, to reduce the haemolysin titre to 1/4 or less.
Donor type red cells are then infused carefully to "mop-up"
remaining antibody and the patient transplanted. Occasionally
Witansky substance may be used. Following graft—take some ABO
incompatibility and a minor haemolytic state may persist for some
weeks but this is rarely more than a minor clinical problem and
the patient's blood group and iso-haemagglutinins become those
of the donor by the third month.
Preconditioning for transplantation
Immunosuppression is required for all but syngeneic grafts
which are virtually out-patient procedures with only the
recipient's other problems governing the management. The
traditional protocol is derived from matched littermate dog data.
Day -6 Donor buffy-coat
-5 Cyclophosphamide 50 mg/kg
—4 Cyclophosphamide 50 mq/kg
—3 Cyclophosphamide 50 mg/kg
-2 Cyclophosphamide 50 mg/kg
-1
0 Graft
Donor buffy coat is not essential but is given to stimulate
host reactive cells which when dividing in response to this stimulus
will be destroyed by cyclophosphamide. This regimen has proved
reasonably effective in patients who have received only a few
transfusions. However, blood products from family members or
transfusions from more than 10 random donors will sensitise the
recipient. The four day cyclophosphamide regimen is then less
effective and greater immunosuppression is required, especially
if the patient is refractory to random donor platelets as manifest
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by a platelet increment of less than 20 x 10^/1 one hour after
11
infusing 10 platelets/sq. m. body surface area.
To reduce the high rejection rate in patients sensitised to
their donors, regimens including procarbazine., ALG, TBI and
cyclophosphamide were used and although with TBI graft rejection
was much less common, many more patients died from infection and
GVHD (Gale 1978). For patients both sensitised to their donors
and refractory to random platelets, the addition on days 1 to 5
after grafting of donor huffy coat to the standard four day
cyclophosphamide preconditioning regimen reduced the
rejection rate from 81% to 37% and increased the survival from
25% to 63% of patients without any increase in GVHD (feig 1978),
The intention is to supply additional stem cells to those
obtained by marrow harvest but the presence of this large amount
of donor antigen and competent granulocytes during the recovery
phase may be of relevance.
Total nodal irradiation (including the spleen) with lung
shielding attempts to avoid the radiation effects of TBI on
the lungs. Early results were promising and graft rejection was
much reduced. Kersey (1980) recently reported 20 aplastic
children, all of whom had received multiple transfusions, who
were successfully engrafted with matched sibling marrow^ using
4 days of cyclophosphamide followed by 900 rads total nodal
irradiation. 7 of the 20 developed GVHD with 3 deaths, so the
problem of GVHD remains. It may be that 900 rads is excessive
and less or more limited radiotherapy will prove effective, but
this should not affect the incidence of GVHD.
Failure to engraft
Rejection of the transplant is associated with a transplant
of less than 3 x 10^ nucleated stem cells/kg recipient body
weight, and prior sensitisation of the recipient to the donor
(Storb et al 1978). Attempts to predict this latter circumstance
using the FILC, the relative response index (RRl) of recipient
to donor compared to pooled random lymphocytes have not shown
any one test to be superior (storb et al 1977). Lymphocytotoxins
in the recipient pre-graft may correlate with failure of
engraftment (Gale et al 1978) but others (Gluckmann 1978)
believe these are only significant if they persist after the
2.2.1
transplant.
However, all these predictors of graft rejection are
becoming less relevant as with the use of total nodal
irradiation, busulphan and cyclophosphamide, and more extensive
preconditioning before the transplant, graft rejection is becoming
less common. With adequate preconditioning graft-take is almost
assured but the preconditioning itself must not give unacceptable
side effects.
Graft-versus-host disease
Prophylaxis against GUHD is usually given and until the
advent of cyclosporin-A, methotrexate was used. In dogs this
is highly effective (storb et al 1970) but there are no controlled
human studies. No studies of prophylactic cyclosporin~A in the
grafting of aplasia have been reported. Other measures such as
incubation of the marrow with ALG or steroids to deplete the
infused marrow of T and pre-T lymphocytes are presently under
trial as is the use of monoclonal antibody.
Results of marrow transplantation
Some results of transplantation in aplastic anaemia are
shown in table 81 . Only a few patients had Fanconi's anaemia
which presents it s own special problems. Bortin (1976) presented
results reported from 17 centres participating in the International
Registry. Storb et al (1978) showed no change in the
percentage surviving between 1974 and 1978. The best results are
in the only paediatric series (lohnson et al 1976), and these
are as good as the results from those who have received no
transfusions before grafting. Of 30 patients grafted within
48 hours of receiving their first transfusion of blood products,
15% have survived two years (storb et al 1980). However there
does, seem to be a high incidence (36^) of chronic GUHD (Gluckmann
1980). The European groups (Gluckmann et al 1978; Barrett 1979)
have more problems with graft rejection than workers in the
United States, and overall in Europe 1971—1979 (Gluckmann et al
1980) only 40^ survived more than 1 year. Approximately 5% of
all patients died early after transplantation. Infection alone
killed 15%, and infection accompanied by GUHD killed a further
27% of those successfully grafted. GUHD was implicated in 7"\%
ZZZ.
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22 19 (86$) 3 (16$) 16 (73$)
Gale et al
1 97 B
20 16 (80$) 8 (50$) 7 (35$)
Storb et al
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25 11 (44$) 8 (72$) 9 (36$)
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162 105 (65$) 69 (66$) 69 (42$)
* includes results of Storb et al (1974) and Johnston et
al (1976)
** includes Gluckmann et al (1978) and Barrett (1979)
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of the post transplant deaths. Infection was the major cause
of death in those whose grafts were rejected. Few patients who
survive 150 days after the graft die, but 10% long term survivors
are disadvantaged by chronic GVH (storb et al 1976) a figure
which shows signs of rising.
In table 82 , where possible, children are separated from
each series. In each report and in the recent report of 162
European patients (Gluckmann et al 1980) patients age less than
seventeen do better as regards graft take, incidence of GVHD,
and survival. From the natural history (table 78 ) a better
survival compared to adults is not a feature of childhood
aplasia and both facts give encouragement to the policy of early
transplantation in severe aplastic anaemia in childhood.
Fanconi's hypoplastic anaemia
Children suffering Fanconi's syndrome are usually short and
have cafe-au-lait patches, skeletal and renal abnormalities, and
characteristically progressive pancytopenia first presenting as
bleeding in middle childhood. Over the ensuing years neutropenia
and anaemia develop and transfusions are increasingly required.
Chromosome breaks, gaps and endo-reduplications increase with
time. Plost patients die of haemorrhagic problems but 25%
develop acute myeloid leukaemia. However there is a spectrum
of severity and it may be that the mesenchyme is more affected
than other tissues in some patients.
Deficiency of superoxide dismutase allowing free superoxide
radicals to persist .has been identified in a number of cases and
in—vitro culture of Fanconi cells with this enzyme reduces the
number of chromosome abberations observed (Nordenson 1977)
whereas the addition of very dilute activated cyclophosphamide
to cultures of Fanconi cells causes an increased number of
chromosome abnormalities (Berger et al 1980). This must be a
partial explanation for the severe mucositis that arises follow¬
ing bone marrow transplantation in that the basic defect in
*DNA repair is intensified by alkylating agents.
With an almost inevitable natural history, a marrow
transplant is appropriate but there are difficulties additional
to those of grafting in severe aplasia. Timing of the graft is
difficult as subjection of the child to a possibly lethal
Table 82
MARROW GRAFTS FOR SEVERE APLASIA
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88 55 (62%) 26 (47%) 34 (39%)
Barrett
1979
1 0 4 (40%) 4 (100%) 3 (30%)
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procedure when the child seems well has to be balanced against
probable increasing sensitisation to blood products and
progressive chromosomal abnormalities. Although washed nitrogen
frozen red cells will reduce HLA sensitisation, platelet
transfusions undo any such benefit. Since no rejection of a
sibling transplant has been reported in a Fanconi patient
sensitisation may not be a great problem. However a one
haplotype identical parental marrow was recently rejected at
Westminster. The children are particularly prone to mucosal
complications of cyclophosphamide preconditioning and methotrexate
GVHD prophylaxis, developing severe mucositis and haemorrhagic
cystitis. To use irradiation would be disastrous. They are
also at particular risk of severe GVHD, with a 80% mortality
rate in those who develop GVHD.
There have been attempts to obviate these complications.
Half-dose preconditioning with folinic acid rescue after each
dose of methotrexate did not minimise the severe mucositis and
three of five patients developed fatal acute GVHD (Gluckmann et
al 1980). If there is a progressive cell mediated immune defect
(Pedersen et al 1977) then it might be helpful to wait for this
state and transplant with minimal preconditioning. Whether
grafting early or late will make any difference to the incidence
of malignancy remains to be seen, but at least one patient
remains well 5 years after his graft (Barrett et ai 1977)
Table 83 shows the results of transplantation for Fanconi's
anaemia, with an apparent overall success rate of 29^, but
probably many other grafts have been performed but not reported.
CLINICAL MARROW TRANSPC A NTAT 1ON fOR SEVERE APLASIA
Seven children with idiopathic aplastic anaemia and 3
with Fanconi's anaemia were prepared for bone marrow transplant¬
ation at Westminster Children's Hospital. Three children died
24 hours before grafting; three showed no evidence of graft—take
and subsequently died and four had established grafts, one of
whom died of acute GVHD. Three of the seven transplanted., remain
well at least 24 months later. Details of these transplants are
shown in table 84 . The general management and organisation
of these transplants is discussed from page . Typical
clinical courses following transplantation for aplasia are
Table 83
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MARROW GRAFTS IN FA NC DIM I 'S ANAEMIA
Centre Patients Alive Dead GVHD
Cause of death
GVHD infection
Paris 5 1 3 5 4
Seattle 4 1 3 2 2 1
Westminster 3 1 2 1 1 1
Others 2 1 1 2 1
14 4 9 10 8 2
zin
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CT 4 M - - Died pregraft (infection)








No take; died of
in feet ion
Bill 16 F 9 Sister Proven graft; mild
chronic GVHD resolved;
now well
AD 15 F — Died pregraft
?cyclophosphamide
myocarditis





No take; died of
haemorrhage
LA 4 F 4 Half-
brother
No take; died of
haemorrhage
AU 13 M 2.7 Sister Proven graft - well
Fanconi's anaemia





MR 14 M 6 Brother Proven graft - well
RR 14 M - - Died pregraft - infection
KG 9 F 4 Sister Died of acute GV/HD
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shown in figures 19 to 27 .
Successful engraftment
1) Patient AU
He presented with two months of bruising and one month of
tiredness and pallor. He had a haemoglobin of 4.2 gms/dl, leuko-
9 9
cytes 2.3 x 10 /l, polymorphs 0.6 x 10 /I and platelets of
9 4
14 x 10 /1. His corrected reticulocyte count was 0.4 x 10 /1.
Despite his presenting haemoglobin and platelet count, he
received no transfusions until nine days before commencing
cyclophosphamide preconditioning. Washed nitrogen frozen red
cells supplied by the Army Medical Centre, Aldershot, were used
to minimise exogenous antigenic stimulation. Allogeneic
platelets were given three days before cyclophosphamide. His
HLA , MLC compatible sister donated marrow and 26 days after
grafting female polymorphs appeared in the peripheral blood
(Fig. 19 ). He showed a lymphocyte peak on day 8, a feature of
female to male grafts (Barrett 1978). Norethandolone 0.5 mg/kg/
day was given as his engraftment was rather slow. He discontinued
isolation and was discharged home on day 65. He has since
remained well and retains a female karyotype in both marrow and
peripheral bluod chromosome preparations. Further details of
his reconstitution are discussed later.
Figure 20 shows his clinical prooress, the least complicated
of any of the patients. He never developed any rash and bilirubin
and alkaline phosphatase levels remained normal. Alanine
aminotransferase (ALT) levels were raised between days 15 and
40 days. The sudden rise around day 50 was attributed to
norethandrolone, which was discontinued. Fever during the
leucocyte nadir between days 6 and 11 was microbiologically
unexplained but that between days 42 and 47 was caused by a
cryophilic kliebsiella spp., probably acquired from the blood
transfusion on day 42. On only three days did he have more
than two stools a day.
His relatively smooth course was due to a number of
factors; the rapidity of the referral; the courage of the
referring paediatrician in not transfusing him; and his initial
g
lack of infection with a polymorph count of 0.6 x 10 /l.
Prophylacticleukaphoreses given from days 5 to 11 were probably
Z2°l
PATIENT fl.U.
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unnecessary despite their apparent value in the hands of
Buckner et al (1978) and may have been the cause of the early
fever. The cryophilic bacteraemia was avoidable but he produced
g
8x10 polymorphs/1 in response to this 46 days after grafting.
2) Patient DW
3.W. presented with one month of epistaxis and tiredness.
Despite her presentation data indicating a good prognosis she
deteriorated over 5 months with progressive neutropenia, oral
and vulval ulceration, skin petechiae and subconjunctival
haemorrhages.
Since by referral she had received blood products from
31 donors she was regarded as highly sensitised, f\nti—lymphocyte
globulin (ALG) with 6 days of cyclophosphamide preconoitioning
were given before she received bone marrow from her HLA, MLC
compatible sister. Her haematological recovery is shown in
figure 21 . A chimeric state was never positively proved as
the only red cell genotyping difference uus the presence of
S- in the doner. However, she developed biopsy proven GVHD.
Her clinical course was stormy (Figure 22 ). A sternal
rash developed immediately after the transplant without specific
evidence of fat embolism. A further generalised maculopapular
rash developed^sparing the palms and soles}associated with
abdominal distension, a high fever and confusion but without
positive evidence of bacterial or viral infection. Skin biopsy
showed grade 2 GVHD with ballooning of the cells at the dermal/
epidermal junction, selective cell pyknosis and separation of
the epidermis from the dermis (fig. 23 ). Additional ALG
and methotrexate was given. Although the fever may have already
been responding all other features diminished. On day 16 when
fever, confusion and the rash recurred, ALG was repeated with
2
immediate response. Since ALG is given with 40 mg/m of methyl-
prednisolone the cause of the response may be questioned.
About day 31 she deve loped prolonged diarrhoea with elevated
liver enzymes and serum amylase, with 10 days later more fever,
confusion and two-grand mal convulsions. This constellation
of signs and symptoms did not respond to ALG and was
ultimately shown to be due to cytomegalovirus (CMV) which was
isolated from only her leucocytes. This cytomegalovirus infection
PATIENT J.UI.
HAEMATOLOGICAL PROGRESS Fig. 21
BMT
PATIENT J.W.
CLINICAL PR OCR ESS Fig. 22




is further discussed from page 1.1-5 . Subsequently she had two
episodes of pneumococcal pneumonia and one pneumococcal septicaemia
between days 90 and 122.
Seven months after grafting she completed a five mile
sponsored walk but three months later she showed the skin changes
of mild chronic GVHD (fig. 24 ). Her skin was taut and stretched
over her face and hands, with thickening and telangiectasia over
her shoulders, back, thighs and arms. She had contractures of
the fincers and bilateral shortening of the achilles tendons,
sufficient to severely restrict mobility. She had no dermal
calcification nor radiological evidence of gut involvement.
Skin biopsy showed a marked increase- in collagen with lymphocyte
infiltration. Because the skin biopsy sites took a month to
heal, the place of surgical achilles tenotomy was uncertain
but this was successfully performed eight months later. Biopsies
confirmed the clinical improvement in her skin despite no
specific treatment and now, three years after her graft her
skin is virtually normal and she works as a typist. The effects
of chronic GVHD on her immunological reconstitution can be seen
on page 1-WS.
3) Patient KG
K.G. aged 9, had Fanconi's anaemia. She died of severe
acute GVHD, 42 days after receiving marrow from her HLfi, FiLC
compatible sister. Her pregraft transfusion requirements were
two units of blood every eight weeks for the previous 18 months
and she had received platelets on one occasion. Prednisolone
and oxymethalone had given only undesirable effects. Her
9 9
polymorph count remained around 0.5 x 10 /I and she had 20 x 10
platelets/1 with repeated spontaneous petechiae.. Conventional
cyclophosphamide preconditioning and grafting was followed by
six infusions of donor buffy coat in the first week. A standard
methotrexate regimen but with folinic acid rescue was given as
prophylaxis against GVHD.
Her clinical progress is shown in figure 25 . As the GVHD
progressed she developed marrow failure, and considerable
support measures were required. She developed profuse diarrhoea
from the fifth day, presumably due to the cyclophosphamide or
methotrexate as she had no other signs of GVHD until the fifteenth
2 2, if
day when a rash and raised liver enzymes were noted. She devel¬
oped severe oral ulceration. Her rash desquamated and her fever
and liver enzymes returned towards normal which gave false
reassurance as on day 22 her palms and soles developed a
maculopapular rash typical in distribution of GV/HD and confirmed
by skin biopsy. ALG, methylprednisolone and cyclosporin-A were
given without effect and she died in progressive coma with
hepatic and renal failure and progressive marrow aplasia. It is
difficult to know the exact cause of death in acute GVHD but
this sequence of clinical events is typical.
4) Patient MR
MR, age 15, has already been fully reported (Beard et al
1973; Barrett et al 1977). He had Fanconi's anaemia and was
successfully transplanted from his compatible 9 year old brother
using a modified PAPACY (Procarbazine, ALG, and cyclophosphamide)
regimen. At that time there was one previous report of a
successful graft in Fanconi's anaemia (stnrb et al 1974). His
major intercurrent problem was nutritional as he had severe
dysphagia due to a lesser curve stomach ulcer. Severe
disseminating ophthalmic zoster at 130 days and orbital cellulitis
arising from a staphylococcal maxillary sinusitis at 145 days
(fig. 26) complicated his post graft convalescence. Moderate
cystitis presenting as frequency and' strangury after 8 months
required a number of bladder dilatations over the next two
years before it resolved. He remains well and working as a
painter four years after his graft.
Unsuccessful grafts
One unsuccessful aplastic graft provides an example of
the difficulties encountered.
MB presented following a domiciliary psychiatric visit
requested on account of severe depression. She had a haemoglobin
9 9
of 1.5 gms/dl, platelets of 10 x 10 /I and 0,4 x 10 polymorphs/1.
Over 6 weeks there had been no response to prednisolone,
oxymethalone and lithium carbonate. By the time she was grafted
from her compatible brother, she had received blood products from
35 donors.
• Her clinical progress is shown in figure 27 . She was
23S
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febrile before the first transplant and apart from the 10 days
when she received ALG and methyl prednisolone, this state
persisted. There was no evidence of engraftment. She had a
pseudomonas bacteraemia at day 12 and further bacteraemias 20
and 46 days later. These were related to prolonged severe
neutropenia and to the start of severe diarrhoea. She also
sero-converted to CHV, and excreted polyoma virus. Since the
transplant had been unsuccessful, efforts were made to discern
whether she had rejected the graft and whether the donor was still
compatible. However her haematological indices were so depressed
there were insufficient lymphocytes available to repeat the
mixed lymphocyte cultures. Occasional rashes appeared, liver
function deteriorated, intravenous feeding was required, blood
product requirements escalated and severe diarrhoea continued
with spreading perianal infection.
This patient's course shows the difficulties of transplant¬
ation in aplastic anaemia when the first graft does not lead to
reconstitution. Continued neutropenia leads to infection which
is unresponsive to antibiotics. Nutrition becomes difficult to
maintain. Leukaphbreses and platelet support become increasingly
required and less effective. HLA matched support becomes necessary
and in the absence of any expectation of spontaneous recovery,
team morale rapidly declines. Further less cellular transplants
with risk and disruption to the donor may be attempted, but if
the first graft fails, the chances of,a successful second
allogeneic graft in aplastic anaemia are slim (storb et al 1978).
To embark on this degree of continuous support and grafting in
hope rather than expectation is not a desirable policy for a
transplant team or the family involved.
RECONSTITUTION AND SUPPORT REQUIRED AFTER GRAFTING
Haemopoietic reconstitution
Table 85 shows the haemopoietic reconstitution of the
9
successful transplants. The mean time from grafting to 1 x 10
polymorphs/1 was 34 days and the mean time until a sustained
9
count of 40 x 10 platelets was 27 days. For children grafted
because of A hi L at the Royal Marsden Hospital using cyclos por in-A
and not methotrexate as GVHD prophylaxis the corresponding
zss
Table 85
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MR 30 34 50 29
OU 30 1 8 90 30
AU 42 29 33 30
A plasia
(mean )
34 27 58 30
AML
(mean)
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Table 86















MR 43 6 0.14 14 0.33
□ UJ 85 11
' 0.13 4 . 0.05
AU 65 ■ 2 0.03 3 0.05





59 5.5 0.1 8.3 0.19








42 3 0.07 4 0.10
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figures were 23 days and 28 days respectively. Both methotrexate
and the relative 'space' created in the marrow by cyclophosphamide
as compared to total body irradiation must contribute to this
difference.
Table 86 indicates the blood products which may be
required in the care of aplastic children undergoing marrow
grafting. The amount of support per day required for those with
unsuccessful transplants is considerable. Compared to those
who engrafted promptly, the unsuccessful transplant recipients
required 50% more units of blood and twice as many platelet
packs per day. In addition they were in hospital nearly three
times as long. The number of white cell donations were not
comparable as these were given prophytactically to some children.
The eleven most recent children transplanted for ANL required
half the quantity of blood and half the number of platelet
packs per day as even the successful aplastic grafts. This
serves to illustrate that even successful grafting for aplasia
is a more intensive procedure than grafting for AML as the
procedures for each now stand..
Immunological recovery after grafting
Aside from the question of immunological imbalance being
the cause of acute GVHD, the immunological recovery after a
transplant has two major facets. Is the patient prone to
infections and do they have chronic GVHD? Immunological
incompetence certainly follows acute CVHD (ditherspoon et al
1978) and chronic GVHD is associated with depression of both
cell mediated and humoral immunity. In must patients these
immunological deficits will be manifest as infections and
table 87 shows the microbiologically proven infections suffered
by three children successfully grafted for aplastic anaemia
or Fanconi's anaemia. No proven infection occurred later than
145 days after grafting and all patients recovered.
2_i+0
Table 87
INFECTIONS AFTER SUCCESSFUL GRAFTING
(Aplasia and Fanconi's anaemia)






















These patients had serial studies of their immune
reconstitution performed.
Lymphocyte sub-populations (table 88 )
There is a steady increase in the number of T lymphocytes
during the first 24 weeks by which time almost normal levels
were achieved. Thereafter the numbers fluctuated. The high
number in 3.Li. were associated with chronic GVHD between weeks
38 and 78}and CHV infection. Her B lymphocyte numbers show a
similar rising pattern. The other two patients had normal
numbers of B lymphocytes by the twelfth week after grafting.
3.W. had normal numbers of Tyuu and T y lymphocytes, (supposedly
"helper" and "suppressor" lymphocytes) at 65 weeks. In chronic
GVHD, the suppressor (T y ) lymphocytes are said to be elevated
(Reinherz et al 1979) and though"she did not show this by the
surface marker technique used, her lymphocytes suppressed normal
lymphocyte transformation to pokeweed mitogen by 96%, indicating
a profound functional suppressor activity.
Table gg shows the effect of different concentrations of
thymosin fraction 5 on the peripheral blood lymphocytes of H.R.
60 days after his transplant. There is an increase to normal
in the number of rosetting cells with increasing concentrations
of thymosin. Further in—vitro lymphocyte studies using thymosin











MR AU uw MR AU Oil)
pre-graft 1.1 0.58 0.72 0.18 0.12 0.21
4 0.04 0.09 0.28 0.04 0.09
6 0.11 0.17 0.08 NE
9 0.31 0.23 1.16 ■ NE 0.15 0.30
12 0.43 1.53 0.15 0.09
1 8 0.60 0.22 2.24 0.38 0.20 0.03
24 0.14 0.32 1 .70 0.54 0.10 0.18
30 0. 30 0.60 3.40 0 ,74 0.4 5 3.30
45 0.53 1.16 2.80 0.50 0. 35 2.00





0.47-1 .8 x 105 /i 0.1-1 .0 x 109/1
NE - not evaluable
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as / of lymphocyte count
0 0.216 2 8/
0.01yivg/ml 0. 353 46/
3 3/a. g /rn 1 0.399 52/
3 33yi*~g /ml 0.453 59/
1 m g /m 1 0.607 79/
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the maximum increment induced with thymosin of T lymphocytes
on day 60 accounts for the number of previously null lymphocytes
(Table go ). No such increment can be demonstrated on day 130
(3 days before he developed shingles) suggesting that a maximum
recruitment had occurred and the increment on day 210 is normal
(Byrom 1978). AU, untroubled by infection, showed a normal
increment on day + 70. A majority of J y's null lymphocytes
could have the surface characteristics of T cells induced despite
having considerable numbers of T lymphocytes. This reflects
the considerable immune dysregulation present in chronic GVHD
especially with coincident CWV infection. None of the patients
had more than a small number of monocytes, the presence of which
would render the separation of lymphocytes from total leucocytes
much more difficult.
A marked deficit in T lymphocytes accompanied by an excess
of pre-T lymphocytes might constitute an indication for thymosin
therapy but there is no evidence that giving thymosin or fetal
thymus transplants after allogeneic transplantation hastens the
reconstitution of immunity or prevents GVHD or the immune
dysregulation associated with GVHD (Atkinson 1980).
T lymphocyte function
Figure 28 shows the increments obtained in-vitro with
lymphocytes from M.R. in response to PHA, allogeneic cells and
Candida immunogen. Responses before the graft were extremely
low and progressive deficiency of cell mediated immunity has
been reported in Fanconi's anaemia (pedersen et al 1977). After
the graft there was a marked increase in response to PHA and
allogeneic cells and finally to Candida immunogen. The responses
at day 150 were diminished proba'bly due to recent varicella/
zoster and staphylococcal orbital cellulitis. In—vitro Candida
killing at, that time was reduced but staphylococcal killing was
normal.
A.U. (fig. 29 ) showed normal in-vitro T lymphocyte
function by day 41 after grafting but cutaneous delayed hyper¬
sensitivity to Candida was not detected until 3 months later,
probably reflecting local monocyte function or T lymphocyte/
monocyte interaction. No circulating inhibitors of T lymphocyte
responses to Candida were identified.
Table go







lymphocytes x 10 /l
max increment
total B T null post thymosin induced
MR + 60 0.77 0.15 0.22 0.40 0.61 0.39
+ 130 1 .06 0.38 0.60 0.09 0.60 0
+ 210 0.75 0.14 0.27 0. 34 0. 33 0.60
AU -20 1 .77 0.12 0.58 1 .06 0.78 0.20
+70 0.56 0.15 0.22 0.19 0.25 0.03
DW + 106 5.33 0.04 2.24 3.05 5.00 2.76
+ 171 7.38 0.18 1 .70 5.50 3.94 2.24
Normal increment 0-0.4
g
Normal range T lymphocytes 0.47-1.8 x 10 /I
g
B lymphocytes 0.1—1.0 x 10 /I
(Byrom 1978)
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□ .UJ. showed good recovery of in-vitro T lymphocyte function
by day 130 (fig. 30 ) with subsequent depression during chronic
GVHD with CMV. There was also a massive, elevation of immuno¬
globulin G levels. T lymphocyte responses at this time were
increased up to thirty fold in normal plasma compared to her
autologous plasma indicating that her plasma caused considerable
inhibition of these responses.
Immunoglobulin levels (table 91 )
M.R. had two transient depressions of immunoglobulin (ig)
G, one in the first month after his graft and one at three months.
The levels were virtually normal at 18 weeks before he suffered
disseminating zoster and orbital cellulitis. fl.U. ehowed no
real abnormality of his immunoglobulin levels at any time
following his transplant. 3.W. showed a massive increase in
IgG associated with very high CTIV antibody levels and chronic
GVHD. This was a normal polyclonal antibody and no free chains
were present in the urine. hone of these children showed any
significant abnormality of IgA or Igfl. The lowest isohaemagglutinin
titre was in 3.W. at week 37 with an anti—3 titre of 1/8, virtually
the same as her pregraft titre of 1/16. A.U. showed a three
tube depression of his pre—graft anti—B titre during week 6
but this recovered by week 24. All complement (c^, C ) studies3 4
were normal.
Discussion
These three patients had almost normal T and B lymphocyte
numbers by 12 weeks after their grafts. There was good evidence
of thymosin induction of J lymphocytes in all patients and of
suppressor activity in the one patient with chronic GVHD. In—vitro
responses to PHA were normal by 11 weeks in two but not until
one year in one patient. Responses to allogeneic cells were
normal in all three by 18 weeks and rt.,ponses to Candida
irnmunogen normal by 18 weeks in two patients and one at one year.
Immunoglobulin levels were normal in two by 8 weeks and in one
by 18 weeks. These three patients had all but normal immuno¬
logical studies by 18 weeks (126 days) after grafting although
the patient who developed chronic GVHD showed subsequent severe
immune disturbance at that time. Two suffered intercurrent
IN—VITRO T LYMPHOCYTE FUNCTION
















IMMUNOGLOBULINS (cms/1) AFTER GRAFTING
(Aplasia and Fanconi's anaemia)




IgG IgA IgM IgG IgA IgM IgG IgA IgM
pre-
graf t
9.4 0.8 0.25 7 0.7 1.1 5.8 0.8 0.9
0 8.6 1.0 0.4 .
2 3 0.4 0.4
4 4.3 0.5 0.3 7 0.5 0.4
8 5.8 0.4 0.2 8.2 0.5 0.7 3.7 0.3 0.4
14 2.6 0.25 0.3
1 8 7 0.6 0.3 6.0 0.3 0.4 13.6 0.1 0.4
28 16 1 .4 1.1 26 0.6 1.0
38 7.2 0.3 0.6 45 0.5 1.0
45 45 0.5 1.0
67 6.2 0.4 • 0.8 33 0.5 1 .4
77 10.4 2.3 0.8 28 0.4 1 .6
110 24 0.4 1.3







severe infections but none later than 145 days after grafting.
Gale et al (1978) found in a mixed group of grafted aplastic
and leukaemia patients that T and B lymphocyte numbers were
normal by 7 weeks as was the response to allogeneic cells. PHA
responsiveness was depressed in one—third until one year. No
particular depression of immunoglobulins was found. Elfenbein
et al (1976) reported a very mixed group of transplant patients
in Baltimore with similar results but found isohaemagglutinin
levels depressed for a year and great variation in the return
of delayed hypersensitivity. The Seattle data (storb et al
1976) suggested that T and B lymphocyte numbers, immunoglobulins
G and M, and complement levels were restored by three months,
in-vitro T lymphocyte function by five months, but immunoglobulin
A levels, antibody responses to <j)X 174, isohaemagglutinins and
cutaneous delayed hypersensitivity tests took more than one
year to return to normal. No particular difference in the
return of immunity after successful grafting has been associated
with different preconditioning regimens, and methotrexate post-
graft regimens probably have little intrinsic effect. Witherspoon
et al (1978) showed that GVHD had considerable effect on immune
reconstitution and was associated with impairment of immunity
even if no longer present. Fatal infections are most unusual
in the absence of GVHD in British patients who have returned
home after bone marrow grafting. The vast majority of patients
without GVHD who survive four months after a marrow transplant
(no matter the primary diagnosis) have no real problem with
infection.
1-4-1
MflRR Oli.1 TRfi N8PLA MT T I ON OF ELEVEN CHILDREN
UITH ACUTE MYELOID LEUKAEMIA
Iritroduct ion
Chemotherapy with or without cranial irradiation is the
initial treatment for acute leukaemia. Induction of remission
is followed by maintenance of remission which may or may not
include episodes of pseudo-reinduction, intensive chemotherapy
or immunotherapy. The results of this conventional therapy
determine the place of such alternative measures as allogeneic
marrow grafting.
Acute lymphoblastic leukaemia (ALL) in childhood of the
common type (c ALL) will almost always remit with chemotherapy
and this initial remission is maintained in about 45% of patients
until treatment is stopped between two and three years later
(George et al 1979). About 55% of children with CALL therefore
will have recurrent disease and of these very few become long
term survivors, the median survival being 8-9 months after
first relapse. (Kung et al 1978). T-cell leukaemia and more
especially those who present with a high white cell count have
a worse prognosis from the outset resulting in about 5—10%
of males and perhaps 25% of females being long-term survivors
following conventional therapy. Conventional treatment of B
cell leukaemia is highly ineffective and the results of treating
null cell leukaemia, though poor, are more variable as a
proportion with null cell disease probably have one of the other
forms without exhibiting the cell surface characteristics.
Conventional therapy appears to cure a proportion of children
with ALL but a substantial number will need an alternative
therapy if a cure is souyht.
Chemotherapy is much less effective in curing acute
myeloid leukaemia (AML). Most series report 5-15% long term
survivors but the median survival of the 70% who obtain a
first remission is 16 months (powles et al 1980). Once relapse
occurs the median survival is three months. Although these data
relate predominantly to adults, there is little evidence that
childhood AML behaves in any different manner, although recent
results with chemotherapy and immunotherapy may be a little
more encouraging (M R C AML 1981).
The evidence very much suggests that a majority of
children with AF1L in remission, high count CALL, relapsed common
ALL and possibly T cell ALL will die within eighteen months.
Despite the dangers of marrow transplantation it is reasonable
to consider these children as candidates for matched allogeneic
marrow grafting if a cure is being sought. The state of the
art is not yet such that incompletely compatible grafts can be
easily recommended although this is a coming option.
The results of marrow transplantation
The early results of bone marrow transplantation in acute
leukaemia are reflected in the variety of preconditioning
regimens used at different centres (table 92 )> all with poor
survival rates. Of 206 patients in these series, 21 were
'actuarial' survivors, a rate of 10% overall. In general the
regimens with the least recurrent leukbemia (SCARI; CY-TBI-8CNU)
had many early deaths from complications of the preconditioning
regimen, or GVHD. Thomas et al (1977) reported 100 transplant
recipients with a minimum follow—up of one year. Seventeen
were alive, three of whom had chronic GVHD and four who had
recurrent leukaemia. Gale (1979) from 1969-1975 had similar
results with 1 8% survivors more than two years after grafting
compared with no survivors in his coincident chemotherapy series.
Many patients in these series had leukaemia resistant to
conventional therapy so results of 17—18^ long term survivors
were remarkable in that any long term • survival was achieved.
The massive cytoreductive therapy (table 92 ) gave major
complications and yet still the leukaemia returned in many
patients. Patients in remission who had already achieved a
2—3 log decrease in the amount of leukaemic tissue might show
better results and interest turned to performing elective
transplants in remission. Buckner (1979) reported 89 patients
with acute leukaemia transplanted in 1976 and 1977. Those
transplanted in relapse had a one year survival of 18^ (a figure
similar to their units earlier results quoted by Thomas et al
1977) whereas those transplanted in remission (less than 5%
leukaemic blasts in the marrow and a normal CSF) had a one
year survival of 55^. All patients received the same
preconditioning, cyclophosphamide and TBI, plus marrow from
2.51
Table 92
SURVIVAL RftTF-S WITH DIFFERENT PRECONDITIONING R E G I PI E N 5





TB I 10 1 10
CY 34 0 0
CY-TBI 43 6 14
CY-TBI-DNR 29 3 10
CY-TBI-BCNU 1 8 3 17
CY-TBI-Ara-C 9 2 22
BACT 10 0 0
SCAR I 30 4 13
DAFT 23 2 1 1
(Gale 1979)




BACT ) acronyms describing regimens involving irradiation,
SCARI ) anthracvclines, nitrogen mustards, cyclophosphamide.
DAFT ) cytosine arabinoside and 6-thioguanine
asi
a matched sibling.
This same advantage is shown in the results of Thomas et
al (1979) who reported patients with j^LL transplanted at least
15 months j \ Of 22 patients transplanted in second or
subsequent remission, eleven were alive compared with only four
of 26 transplanted in relapse. In AFIL, Thomas et al (1979)
reported that twelve of 19 patients transplanted in first
remission were alive at least one year later and a mean of more
than 17 months after achieving complete remission. Powles et
al (1980) properly and cautiously describing the follow-up after
grafting as 'continued duration of first remission' reported
that 18 of 22 patients grafted because of AML continued in
remission compared to nine of 28 who had not received a transplant.
The median duration of remission of their patients receiving
conventional maintenance therapy was 52 weeks and that of the
transplanted patients had not been reached but was in excess of
45 weeks.
Grafting in remission gives better survival than grafting
in relapse and it seems likely from the results of Thomas et al
(1979) and further follow—up of the patients of Powles et al
( 1980) that grafting in APIL gives both longer survival and
longer duration of first remission than conventional therapy.
UJith ALL in second or subsequent remission, the results quoted
are encouraging compared with conventional therapy but longer
follow-up is required to assess the ultimate benefit. Disease-
free survival is certainly prolonged.
The additional dangers of marrow grafting
Infection
There are dangers intrinsic to marrow grafting over and
above those in conventional therapy. Infection during the
period of severe neutropenia and during immune reconstitution,
GVHD, interstitial pneumonitis and a presumed risk of second
tumours have to be added to the chance of recurrent leukaemia.
The risk of dying from infection during the transplant procedure
or the succeeding three months is small although fevers and
systemic antibiotic therapy are common as are septicaemia
and major local infections. The incidence of these problems
£53
is considerably reduced by the use of a protected environment
and prophylactic antimicrobial agents (Buckner et al 1978) although
these protective measures made no difference to the incidence
of GVHD, interstitial pneumonitis or ultimate survival. Of 89
leukaemia patients transplanted in Seattle, four died of
pyogenic infection shortly after grafting (Buckner 1979) as did
two of thirty-three in Duarte, California (Blume et al 1980);
three (of fungaemia) of fourteen in Los Angeles (Gale et al 1976)
and none of twenty-two (Powles et al 1980) in London. The high
figure from Los Angeles reflects the very toxic programme then
being used.
Interstitial pneumonitis
Interstitial pneumonitis is associated with infection,
GVHD, radiation and the allogeneic graft but the precise
association between these factors remains difficult. In addition
some leukaemia remission induction regimens contain drugs known
to be toxic to the lung parenchyma and methotrexate is often given
after grafting as prophylaxis against GVHD. Centres in the USA
have a greater incidence of interstitial pneumonia than centres
in Europe, but whether this reflects genetic, environmental or
therapeutic differences is unclear. The median onset is about
52 days after grafting with a few days of fever and cough
followed by progressive dyspnoea, hypoxia and relatively
unimpressive chest signs compared with the diffuse infiltrate on
chest x-ray. The aetiology and outcome of the interstitial
pneumonitis seen in 89 leukaemia transplant patients in
Seattle are shown in table 93 (Buckner 1979). 60?; of patients
died, the highest death rate being associated with CEIV infection.
In the United Kingdom, Powles et al (1980) reported one
fatal case out of 22 AML transplant patients, but on the West
Coast of the USA the incidence is 40—50?g of patients transplanted
for acute leukaemia and 10-30?' of patients transplanted for
acute aplasia. Although aplastics did not receive TBI many
received additional immunosuppression in the form of ALG.given
on account of GVHD. If GVHD was sufficient to require ALG,
the incidence of interstitial pneumonitis rose from 27?o to
78?£ of patients (Neiman et al 1977 ), and patients transplanted
in relapse are more likely to suffer interstitial pneumonitis
1SI+
Table 93
AETIOLOGY AND OUTCOME OF INTERSTITIAL PNEUMONITIS IN 89






Cytomegalovirus 12 (34%) 10 83
Pneumocystis 5 2 40
Herpes simplex 1 1 100
Idiopathic 17 (50%) 8 47
Total 35 21 60
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than those grafted in remission (507b compared to 32%) (Buckner
1979). Leukaemic patients receiving syngeneic grafts had an
incidence of Q% (Neiman et al 1976) so postgraft methotrexate or
the actual allogeneic graft must play a part. The latter is
perhaps supported by the 50% incidence of overwhelming pulmonary
oedema following incompatible bone marrow transplants for AML
seen at the Royal Flarsden Hospital when cyclosporin-A not
methotrexate was used as GVHD prophylaxis (Powles 1981).
There are no references to an aplastic patient receiving syngeneic
marrow who developed interstitial pneumonitis.
Graft-versus-host disease
In an earlier series of 100 transplants (Thomas et al 1977),
acute Gl/HD affected 80/' of patients, was moderate or severe in
64% of these and was implicated in the death of 37% of the
transplanted patients. The fatalities due to acute GVHD
increased if donors were less than fully HLA, MLC compatible but
a donor of the opposite sex to the patienv did not increase the
risk. (Bortiu and Rimm 1978). The incidence of GVHD was
unaffected by whether the patient was in relapse or remission at
the time of grafting but the incidence of recurrence of leukaemia
was reduced in those surviving moderate to severe CVHD. This
was no real benefit as the number dying as a consequence of
GVHD compensated for any gain achieved. Syngeneic grafts
avoid the GVHD mortality but have a higher incidence of recurrent
leukaemia and syngeneic recipients were at an overall advantage,
with around 30-35% long term survivors (similar to those with
grade I GVHD) compared to the overall 18% survival of those
transplanted in relapse, but there may have been some patient
selection.
The death rate from acute GVHD in first remission AML patients
has fallen to about 8% recently (Atkinson 1980). This was
coincident with Powles et al (1980) reporting the prophylactic
use of cyclosporin-A until at least three months after grafting;
a policy resulting in an acute GVHD death rate of 5% (compared
to 20% previously), Seattle does not as yet use cyclosporin-A
so an open question remains on the specific value of cyclosporin-A
in the matched allogeneic sibling graft performed early in first
remission of AML. Controlled trials (versus methotrexate)
2Sk
should resolve at least part of this question.
Chronic CVHD remains a problem. Table 94 shows that in
recent publications 13 of 73 survivors (11%) have chronic GVHD
and an incidence of may prevail. This has been usually
mild or confined to one system only. Powles et al (1980)
reported the lowest incidence but the shortest follow-up and their
median follow-up after stopping prophylactic cyclosporin-A was
5 weeks. Fifteen percent of their reported patients who have
been observed for more than a year after their transplant have
now developed chronic GVHD.
Recurrent leukaemia and tumours
This is not really an additional risk specific to grafting
but is an important sequela. It is almost always of the original
type and only eight reports exist of leukaemia being proved to
be of the donor karyotype. Followed up for between 15—35 months
(Thomas et al 1979) 10 patients relapsed of 22 ALL patients
transplanted in second or subsequent remission compared with 15
relapses in 20 patients transplanted in relapse. The chance
is therefore considerable. A history of, or active CMS disease^
doubled the likelihood of recurrent leukaemia. While this
incidence of recurrent leukaemia is not encouraging there is no
doubt that the projected survival of 50^ at 2 years after graft¬
ing is better than would be expected from the natural history of
ALL in second or subsequent remission.
The group with ALL transplanted in second or subsequent
remission included 13 children below the age of 10 of whom 7
are alive without leukaemia, a mean of over 2 years later.
Three of these seven were in their third or fourth remission and
two had active CNS disease at the time of grafting. A further
two children are alive but in relapse. The latest time of relapse
was 55 weeks post graft for those transplanted in relapse and
40 weeks for those transplanted in remission. Remembering that
chemotherapy nearly always fails to maintain a second remission,
transplantation would seem to have a valuable role in half the
children, and the difference between the results for children and
adults is becoming increasingly apparent, both in transplantation
for ALL and A IT L .
151
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AML Acute myeloid leukaemia




With AML transplanted in first remission Thomas et al
(1979) reported one relapse in 19 patients which occurred in
the 24th week after grafting. Twelve patients have survived
longer than this, their mean survival after grafting being
greater than 1D0 weeks. Powles et al (1980) report 3 relapses
at a mean of 52 weeks post graft in 20 allogeneic transplants
for AFIL, although there is doubt in one patient about the
original diagnosis of AML. If that patient had ALL then his
lymphoblastic relapse at 93 weeks after grafting is an ominous
portent. Thirteen patients (65^5) have survived disease-free
for a mean of 74 weeks, including 14 weeks between complete
remission and transplantation, whereas of their control group
of 28 patients, 8 (28%) have survived disease-free for a mean
of 61 weeks from complete remission. The reported numbers of
children are too small to draw any useful conclusion but there
is no evidence they behave any differently. So also in AP1L it
would seem that transplantation has a useful role to play bsth
as regards survival and disease-free survival.
Should the patient relapse after grafting, their marrow
is of course that of the donor and so very toxic chemotherapy
can be given followed by more donor marrow to curtail the period
until marrow recovery — a ' pseudo—syngeneic rescue'. Whether or
not there will be an increased incidence of second tumours in
survivors following a transplant for acute leukaemia is
impossible to say. Control data from ALL patients surviving
after second remission or APHL patients is too scanty and the
adults transplanted and surviving when cyclosporin—A prophylaxis
was used have not been followed long enough. Second tumours in
aplastic patients successfully transplanted with cyclophosphamide
are rare but the use of TBI in patients who have already
suffered a haematological malignancy must increase the risk.
However it is clear that at least during a five year follow-up
in Seattle that second tumours are extremely rare.
The results of matched sibling marrow transplants are
sufficiently encouraging for such marrow transplantation in
remission to be indicated in AML, B cell ALL, boys with high
risk ALL in first remission and in all children with ALL in
second remission.
Z5°l
CLINICAL HARROW TRA NSPLA NTAT ION FOR CHILDHOOD AF1L
In the past 18 months eleven patients, aged 16 years or less
with A ML have received bone marrow transplants at the Royal
flarsden Hospital. All were in remission at the time of grafting,
this having been achieved with either the MRC protocol or other
combinations of anthracycline, cytosine arabinoside, 6-thioguanine
and steroids. Three children were in second remission, the others
in initial remission. All received some form of maintenance
therapy between remission and grafting. One (A.B.) had extradural
cord compression at presentation and three had infection of d
nature and course requiring white cell support during their
remission induction regimen. Table 95 shows the FAB diagnosis;
the problems encountered during remission induction and the time
taken to achieve a first complete remission.
Donor compatibility data and crafting details are shown in
table 96 . Seven children received grafts from an HLA, F1LC
compatible sibling, one from a phenotypically HLA identical MLC
unreactive father and three from their one haplotvpe identical
8
FiLC reactive father. The mean graft size was 3.44 x 10 nucleated
stem cells per kg. recipient body weight. G.C. required a second
graft after the first graft was suppressed by cytosine arabinoside
given for suspected progressive multifocal leukoencephalopathy.
The interval between achieving full remission and marrow grafting
is shown and the mean interval between diagnosis and transplant¬
ation was 33 weeks.
All received the same pretransplant conditioning;
cyclophosphamide 1.8 gms/m^ on days minus four and minus three,
with 1000 rads TBI on day minus one and cyclosporin-A 12.5 mg/kg
per day also starting on day minus one as prophylaxis against
GVHD. The four children who received paternal marrow also
received methotrexate GVHD prophylaxis. All were nursed in a
protected environment and received either NEQCON or TSN as
antimicrobial prophylaxis.
Their problems after grafting while still in-patients are
summarised in table 97 . Nine of the eleven children became
febrile and received systemic antibiotics. Six developed skin
rashes of which five were histologically proven to be GVHD, and
four of these five had received partially matched transplants
2(aO
Table 95
PATIENTS AGED SIXTEEN YEARS OR LESS
TRANSPLANTED FOR ACUTE MYELOID LEUKAEMIA












C.C. F 14 M4 None 48





S.L. M 11 sub-acute
M 5
None 116





G.C. F 6 M4 None 40
• CD • M 16 M 2 Extradural cord
compress ion
44
L.S-F. F 15 M4 None 46
T.T. F 14 M6 ■ None 1 86
A . F. M 14 . M2 Pneumonia 60





S • A . M 14 M 2 None 1 37
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Table 96
COMPATIBILITY AND TRANSPLANT DATA
Patient Donor
HL A
















C .C . Brother yes yes . 3.0 44
E.H. 9 rother Yes yes 3.7 296
S.L. Father A and B
only
no 3.5 77
3.G . Sister yes yes 3.4 76




• CD • Sister y es yes 3.1 75
L.S-F. Brother yes yes 3.3 44






L.F. Brother yes yes 3.3 530













E.H. 21 days Sacteraemia (staph, aureus) 5%
S .L . 43 days Diarrhoea
bacteraemia (staph, albus)




si • 30 days Convulsions
cytomegalovirus excrection
none
G.C . 83 days Diarrhoea
rash - GVHD grade 2
convulsions and brain damage
marrow suppression by cytosine
intravenous feeding for 60 days
15% (3 kg)
A.B. 19 days None
I
none
L.S-F. 24 days None 1 .6%
T.T. 26 days Rash
severe mucositis
GVHD - grade 3
8% (4 kg)









L.F. 30 days Urinary infection 7% 4.2 kg




from their father (table 96 ). One of the seven children who
received a matched allogeneic graft developed GVHD. All ultimately
responded to high dose methyl prednisolone. Two children had
marked diarrhoea following TBI, without any qualitative micro¬
biological difference being detected in their stools compared with
those of the other patients. These two children lost more than
10% of their body weight and received intravenous and supplemental
feeding. Four children had no net weight loss by discharge.
Two children had proven bacteraemias and three had urinary tract
infections. une excreted cytomegalovirus in association with a
convulsion and two with neurological complications shed BK polyoma
virus in the urine. One who developed chickenpox 4 days after
his transplant was treated with acyclovir and showed no untoward
effects. One boy showed marked psychological withdrawal during
isolation, despite full parental access and did not return to
normal until 4 weeks after discharge home.
Problems after discharge and their timing are shown in table
98. Five patients had flattening of their affect, nausea,
vomiting and weight loss with tiredness and debility which
improved from about the tenth week. These symptoms were due to
the after-effects of a major hospital procedure and an in—patient
stay in a comined cubicle for almost six weeks combined with
the known side effects of cyclosporin—A and the late effects of
radiation. Almost all children have shown some degree of tremor
or clumsiness while taking cyclosporin—A and it is becoming
increasingly possible that cyclosporin-A contributed to-the
serious neurological problems seen. However, blood levels of
cyclosporin-A can only now be measured and the excessive levels
found retrospectively in these two children will be avoided in
future. Two children developed skin GVHD after discharge which
responded rapidly to doubling of the dose of cyclosporin-A.
Infections have been a minor problem. Two developed oral herpes
simplex lesions and two suffered shingles. The patient with
the longest follow-up showed some increased pigmentation especially
in sites of previous trauma but this tendency seems to be most
marked in those of Mediterranean descent. One patient relapsed
at 6 months and is now dead.






























S.L. 49+ to 11
20
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Herpes simplex of lip
very well,
at school



























T.T. 22 + 8
10+ GV/HD (grade i)
very well,
at school








L.F. 1 2+ None Very well.
S .A . 8+ None v. mild
GV/HD
us
immunological problem and nou has chronic GVHD. Her first graft
was severely compromised by cytosine arabinoside given to treat
possible multifocal 1eukoencephalopathy. A second graft from
the same donor gave prompt haematological reconstitution.
However, from that time her immunoglobulin G levels declined as
her lymphocyte count recovered. IgA and IgM levels remained
virtually normal and no immunoglobulin abnormalities have been
observed in any of the other patients transplanted for leukaemia
unless they also had E\/HD. She had a very high number of activated
suppressor T lymphocytes, the sex of which has yet to be
determined. 'Her" lymphocytes suppressed the production of IgG
by normal lymphocytes in response to. pokeweed mitogen by 95%.
Her father has had no infective problems and has normal immuno¬
globulin levels. However, his lymphocytes show a mildly suppressive
action on normal immunoglobulin production, though he has no
excess of activated suppressor T lymphocytes. In the absence of
any other explanation, it would seem likely that a suppressor clone,
present but under control in father, has been grafted but without
whatever controlling influence exists in father. Stopping her
cyclosporin-A did not alter the situation.
Six of seven alive more than twenty-two weeks after their
transplant arc at school and leading a normal life.
Haematological recovery and support
The mean stay in hospital for these children was 8 days
before the graft and 34 days after the graft, slightly longer
than the overall mean of 38.5 days quoted by Kay et al (1980).
None required white cell transfusions (table gg ) but on average
each child required 3 units of blood (range 2-6) and 14 units
(4 packs) of platelets (range 8—24 units). These requirements
per day are half those of successfully grafted aplastic children.
Reconstitution after transplantation was rapid and was
proved by chromosome assay in the seven patients with a donor
q
of the opposite sex. The mean time to regain 0.5 x 10 and
g
1.0 x 10 polymorphs/I was 19.5 and 23 days respectively, and
g
in excess of 40 x 10^/1 platelets was maintained from a mean
of 28 days (range 3—83 days). The mean time spent with less
g
than 0.5 x 10 polymorphs/1 was 15.5 days. Previous children
with leukaemia receiving allografts at the Royal Flarsden Hospital
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Table 99
SUPPORT REQUIRED AND POST GRAET RECONSTITL1T ION
Patie nt
Units of
Days from graft to
polymorphs platelets
40X109/1blood platelets 0.5x1 09,/l 1.0x109/l
CC 4 1 2 16 20 14
EH 3 8 12 22 1 3
SL 2 20 26 28 34
3G 2 20 21 22 3
GC 3 20 15 1 8 83
AB 3 8 15 23 16
LSE 2 8 19 22 20
TT 4 16 19 21 17
AE 6 8 20 21 55
LE 2 16 26 30 1 8
SA 2 24 25 27 32
3Jol
who survived more than 100 days with methotrexate as GUHD
g
prophylaxis reached 0.5 x 10 polymorphs/1 at a mean of 15 days,
g
1.0 x 10 polymorphs/1 at day 18 and had sustained platelet
g
counts in excess of 40 x 10 /I by day 22. Both rates of
reconstitution are faster than that of aplastic children
receiving methotrexate post graft. The children with AFIL who
received co—trimoxazole as antibacterial prophylaxis were at no
particular disadvantage in speed of reconstitution.
Metabolic effects of preconditioning and grafting
2
The immediate effect of 3.5 gms/m of cyclophosphamide and
1000 rads TBI on these children was mainly a biochemichal one.
Other short-term effects on the skin and the brain are those
well-recognised after radiation. Long term, growth as well as
endocrine effects deserve study.
Plasma amylase may reach 7000 I.U. on the day after
radiation (mean 4250 I.U.) but rapidly falls and should be normal
by the fourth day after transplantation. Iso-enzyme studies
have confirmed the salivary glands as the origin of this amylase.
No glyosuria was seen purely as a result of grafting. Plasma
urate levels during marrow grafting have been normal despite
no patient receiving allopurinol during preconditioning, even
in those adult patients who were technically in relapse at the
time of preconditioning.
The only child with elevated alanine aminotransaminase (ALT)
levels pre-graft also had atypical lymphocytes and subsequently
excreted cytomegalov.irus. Even so, her ALT level fell following
preconditioning but rose later in association with CMU excretion.
Two-thirds of children showed a trivial increase ( < 20 I.U.)
in ALT during their transplant. ■ Some rise in bilirubin occurred
in most patients. In four this exceeded 35/vjtioIs/I ; one had a
urinary infection three had moderate GUHD with one child
also receiving I.U. feeding. Alkaline phosphatase levels were
not usually disturbed. All measurements were normal in nine
patients but two developed unexplained levels in excess of 500
I.U., which subsequently fell. No other patient had a level in
excess of 200 I.U. Half the patients received vitamin K on
account of a prolongation of their prothrombin time by four or
more seconds. All patients had a low serum albumin and two
Zi,Z
with diarrhoea had a marked reduction, Both received supplemental
plasma. within the limits of the dye-binding method used
most measurements were in excess of 25 gms/1. Earlier
experience suggested that two-thirds of those with a serum
albumin of less than 25 gms/1 diedjSO any patient with less than
25 gms/1 of albumin received exogenous replacement. If the
more reliable immunological methods of measuring albumin are
used^a lower level will be found.
All children had reduced calcium and phosphate levels,
usually from day 5 through to day 15 or 20. In all the
patients the low serum albumin contributed to the reduction in
plasma calcium, but even correcting .for the low serum albumin
still showed a 5-10/ reduction in plasma calcium. Mo child
showed tetany or paraesthesiae and additional calcium did not
assist the two who had convulsions. Magnesium levels when
measured varied with the calcium. There was no connection between
the 10/ fall in serum phosphate and evidence of renal tubular
leaks of urate, bicarbonate or glucose. No studies of
parathyroid gland function following TBI have been reported.
Sodium and potassium levels were complicated by the use of
gentamicin with carbenicillin or ticarcillin, a fall in both
electrolyte levels showing within 48 hours of commencing these
antibiotics. withdrawing these antibacterial agents led to a
return to normal over 48 hours. Levels of blood urea and
creatinine were frequently low and it was only in those with
diarrhoea that urea levels rose as a measure of dehydration
until about the third week when most patients showed some
sustained rise in blood urea. This was almost certainly due to
cyclosporin—A, and blood level measurements of cyclosporin—A
have now reduced the incidence of this compliestion.
There are few specific metabolic upsets associated with bone
marrow grafting in acute leukaemia. The most consistent and
specific is elevation of serum amylase during the first three
days. All other changes of note may be attributed to a combin¬
ation of problems. The early use of albumin, plasma and
electrolyte supplements is useful along with sufficient fluid
2
to maintain a urine output of 1 litre/m /day.
Results of transplantation in childhood AML
Six other children with AML grafted in remission at the
Royal Marsden Hospital can be added to these eleven and the
seventeen compared with the children suffering aML who have also
been treated at the Royal Plarsden Hospital but with conventional
maintenance therapy. This group spans a greater age range and
includes children treated from 1973. Therefore the conventionally
treated patients do not represent optimal present day chemotherapy,
partly due to improvements in the range of drugs and support
available, but also because of a reluctance to subject particularly
young children to intense therapy which was most unlikely to
result in a cure. However, if children aged less than six years
are excluded from those receiving conventional maintenance the
age difference between the groups is reduced. Of these seventeen
who received conventional maintenance therapy three are alive,
one of whom is presently in relapse. Fourteen of the seventeen
transplanted are alive, one of whom is in remission following
relapse (table 100). The present mean survival from diagnosis
for the conventionally treated children is 79 weeks compared with
91 weeks for those transplanted. The mean duration of first
rem ission for those treated conventionally was 45 weeks and
for those transplanted in first remission is at present 71
weeks. Thirteen of the fourteen transplanted in first remission
were grafted before the 45 week mean duration of first remission
in the conventionally treated group and currently ten of those
thirteen are alive with the mean duration of first remission
of this whole group being 62 weeks and the mean survival being
84 weeks. Therefore even the group transplanted before they
were likely to relapse have shown an increased duration of first
remission and a prolonged survival. At no point are the results
of grafting in remission worse than conventional therapy.
The medians are similar to the mean results though 2—3
weeks less and with thirteen of the seventeen transplanted
alive and in continued remission from before the time of their
transplant, both figures should continue to increase, whereas
only two of the original seventeen treated conventionally are
alive in continued remission. Fourteen (82%) of seventeen
children transplanted because of AML are alive a mean of 75 weeks
Table 100
CONVENTIONAL THERAPY VERSUS TR ft K c' PLfl NT AT I ON

















10 3 (1) 79 45
Transplanted
n = 17
12.5 14 (1) 91 + 71 +
( ) = relapsed
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and a median of 74 weeks from obtaining complete remission. These
results are more remarkable when it is considered that four of
the transplant donors were not matched siblings. Of the
thirteen patients receiving matched sibling grafts in this series,
ten (77/b) are alive a mean of 81 weeks after first complete
remission was achieved.
One patient died of GVHD thirty-four days after his
transplant, an acute GVHD death rate of 6%. One of eight alive
more than a year after their transplant has chronic GVHD. Three
patients have relapsed, two of whom are dead, the other in
remission. One relapse at 82 weeks after grafting showed ALl
and since the original diagnostic marrow was never made available
and no marker or cytochemical examinations were made of the
original marrowj it is quite possible that he never had AT1L but
he is included in the series. The mean time to relapse (three
patients) after grafting was 57 weeks but the inclusion of the
patient who relapsed at 82 weeks makes discussing the risk of
relapse at certain times difficult. Excluding this patient,
the latest time relapse has been reported following an allogeneic
graft for A ML is 65 weeks, a point now passed by 6 of the 14
sruviving children.
Although these are early results, they are very encouraging
especially as the quality of survival for all but two of the
fourteen evaluable within my personal experience (table 98 ) is
excellent. The two children with neurological problems may not
show any improvement but this problem is not one usually
following marrow transplantation and with the advent of cyclosporin-A
serum assays direct toxic effects should be avoided in future#
The question of cyclosporin—A affecting the handling of virus
infections may be a contributing factor.
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VIRAL INFECTIONS IN B DM E MARROW TRfi IMS PL A MT RECIPIENTS
CYTOMEGALOV IRU5
Introduction
The reports of Neiman et al (1977) and Winston et al
(1979) describe the role of CMV in 140 patients who received
marrow transplants on the west Coast of America. Of Neiman's
80 patients with aplasia or acute leukaemia, 43 developed
interstitial pneumonitis of whom 28 died. 47% of pneumonitis
cases also had 0MV and of these 80% died, compered with 50%
of thosa with interstitial pneumonitis but no evidence of CMV.
CMV associated interstitial pneumonitis killed 20% of the
patients successfully grafted in Seattle and 10% of those
successfully grafted in Los Angeles, Combining the results from
London (Barrett 1979) and Paris (Gluckmann et al 1978) there
were 27 successfully grafted aplastics, of whom three (11%) died
with CMV. CMV therefore exerts a considerable influence on
the outcome of marrow transplantation.
To diagnose CMV infection the most useful specimens are
urine, throat washings, leukocytes and serum. Sputum and
bronchial washings or brushings are less useful. The most
useful techniques are culture, microscopy for intra-nuclear
inclusions and serology. Lung biopsy allows identification of
other pathogens but is a highly invasive procedure. Monitoring
every 2 weeks, Neiman et al (1977) found 46% of their transplant
patients to shed CMV from some site (including at postmortem),
the latest timing of- the first isolate being 130 days (median
53 days). Fourteen of fifteen patients who had a four-fold
rise in antibody titre had cMV isolated in culture. Sero¬
conversion may be affected by the transplant preconditioning
but is anyway a later event than the infection even if early
antibodies are sought. Culture also takes time so the search
for intra—nuclear inclusions or the presence of circulating
atypical lymphocytes is important, particularly as new
therapeutic possibilities develop. Antibody studies are
useless in the immune deficiency syndromes, but detection of
CMV antigen, free or cell bound may be possible in the future.
Isolation of CMV or seroconversion does not always herald
significant disease. CMV was isolated but no pneumonia developed
in 2 5% of those transplanted for acute leukaemia and 35% of
patients transplanted because of severe aplasia. Eleven percent
had CMV present in the lungs at autopsy without there being
any indication of pneumonia in life. However 58% of leukaemia
transplant patients and 83% of aplastics who developed lethal
pneumonia shed CMV (Neiman et al 1977). Of 25 shedders (45% of
leukaemia patients),15 (50%) died of pneumonia as did 41% of the
12 aplastic shedders who constituted the same proportion of the
aplastic population. Half those who shed CMV from any site
after grafting in Seattle or Los Angeles died from pneumonitis.
In both series failure to seroconvert following shedding
CMV was of serious portent. All those who failed to seroconvert
when CMV was the sole organism obtained at lung biopsy died
compared with 20% of those who seroconverted (Neiman et al 1977).
Sixty-three percent of Los Angeles transplant patients with
interstitial pneumonitis but no CHV/ seroconversion died compared
to 18% of those who seroconverted (Winston et al 1979). Sero¬
conversion is the single most important question in the event
of CMV being isolated from a marrow transplant recipient.
About 54% of the adult indigenous population of London
have CMV antibodies (Stern and Elok 1965). in 82 potential
bone marrow donors 49% had CMV antibodies but of another 22
potential donors with tissue type HLA BW15, 73% had CMV antibodies
(p <.01) (Pereira et al 1979). The incidence of antibody
presence is therefore different withih an apparently homogeneous
population, perhaps as a variable expression of antibody
response. If the marrow donor is an HLA identical sibling,
any such HLA linked variability of expression will be constant.
Presence of antibody is taken to indicate immunity though
neither this, nor the converse may be entirely true. Patients
with CMV antibodies before transplantation have three times the
incidence of CMV shedding after their transplant compared to those
who have no complement fixing antibody before the transplant
(Neiman et al 1977) but Winston et al (1979) found no such
difference although they did not perform routine viral surveillance
cultures. Neiman et al (1977) isolated CMV slightly more often
from the recipient of marrow when the donor was CMV antibody
positive. No group has reported the incidence when marrow
from CMV positive donors was given to CMV negative recipients.
Fewer children (22%) shed CMV after grafting than adults (63^).
Children are more likely to lack CMV antibody and to receive
marrow from a negative sibling. Patients who require white
cell support have a slightly higher incidence of CMV isolation
(44^) compared with those who do not receive additional white
cells (34$&). It would seem reasonable that if the recipient
and donor are CMV negative, blood products from CT'll/ negative
donors should be used.
There are no differences in the incidence of CMV infection
that have been associated with sex or the use of steroids in
conventional doses. Whether high dose methylprednisolone used
in GVHD will affect the incidence remains to be seen but Gl/HD
itself is associated with an increase from 34/' to 57% in the
incidence of CMV shedding, (Neiman et al 1977). Although the
incidence of virus excretion is increased with the use of ALG,
patients with grade I GVHD who did not receive ALG had a similar
incidence of CMV excretion to those with grade II GVHD or greater.
The incidence of CMV shedding is the same in those transplanted
for acute leukaemia or aplasia but there is a difference in
the incidence of interstitial pneumonitis, though not the death
rate. One poor prognostic feature, apart from failure to sera—
convert, was the isolation of CMV from peripheral white cells.
All five patients of Neiman et al (1977) who had positive
cultures from buffy coat died of pneumonitis, which is in contra¬
distinction to the London experience where of four patients
whose white cells contained CMV, none developed pneumonitis or
died.
Adenine arabinoside (Ara—a) had no prophylactic value
(Kraemer et al 1978) and the patients so treated had more
interstitial pneumonitis and CMV isolation than the controls.
Both Ara-A and interferon have marrow toxicity unlike acyclovir
(Selby et al 1980). Unfortunately the in-vitro sensitivity
of CMV to acyclovir is much less than herpes simplex and
nephrotoxicity seems a likely accompaniment of blood levels
adequate to treat CMV. Vaccines have given serological conversion
without late virus shedding in normal volunteers (Elek and
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Stern 1974; Plotkin et al 1976). However, it would not be wise
to give those live DNA viral vaccines to leukaemia patients or
their donors pre—graft. Aplastic patients are usually ill and
require a transplant - as soon as possible without waiting for
CRV antibody responses to a vaccine, Whether killed CHV vaccines
can give a useful result in these patients is not known but early
work has not been encouraging. Normal human immunoglobulin has
some CFIV antibody and hyperimmune preparations may be available
but its efficacy has never been proved. In the event of active
infection, irradiated parental lymphocytes, interferon or
immunological modification with thymosin might prove useful.
Despite its disadvantages the present therapy is probably Ara-A
until the place of acyclovir is resolved.
Clinical studies
CRV was not identified in any of the infants with SCID.
Details of the CRV status of twenty leukaemia and aplasia transplant
children are shown in table 101 .
Five of the twenty had CRV antibody pre-transplant and of
these, two shed CFIV after grafting and both seroconverted. Of
five children without pre-existing antibody who received a graft
from a CFIV positive donor, none shed virus but two seroconverted.
Of the ten without antibody -who received marrow from a CflV
negative donor, one shed virus and seroconverted and a further
two seroconverted. Both the shedder and one seroconverter
received, multiple transfusions from random donors and the
other patient seroconverted 80 days after going home so the
infection could just have arisen unrelated to the transplant.
Of the seven patients (35^) who had evidence of active
CRV infection two had no apparent problems (table 102 )• Two
rejected their grafts, one following GVHD and two others
developed GVHD. Two had convulsions but showed a complete
recovery. Only one (O.U.) had a constellation of symptoms
suggestive of CFIV infection.
She received a bone marrow graft from her histocompatible
11 year old sister. Cyclophosphamide and ALG was used as
preconditioning, and she was nursed in a Vickers—Trexler
isolator. Eleven days after grafting she developed fever,
diarrhoea, elevated hepatic enzymes and a morbilliform rash.
ZKo
Table 101





























KG <8 <8 No No < 6
LP <8 <e Yes ( 36) No 64
LA 32 < 8 7 No
MR 48 < 8 No No < 8
MB <8 + Yes (60) No 64
PC 64 < 8 Yes ( 32) Yc.s (110)
leukocytes
1024
RS* < 8 + Yes (18) No 1024
GC <8 32 No No < 8





EH 8 8 No No 8
SL 4. 8 8 ' No No < 8
CC < 8 < 8 Yes (120) No 64
AB < 8 8 No No < 8
LS-E 32 64 No Mo 16
TT <8 <C 8 No No < 8
AE <8 < 8 No No < 8
LE < 8 < 8 No No <8




PROBLEMS IN TRANSPLANT RECIPIENTS





DW . Symptomatic convulsions, chronic GVHD
LP Asymptomatic acute GVHD, rejection
MB ?asymptomatic rejection of transplant
PC Asymptomatic acute GVHD




Skin biopsy showed GVHD for which she was given equine ALG.
Clinical improvement but slow haematoloqical recovery followed,
requiring multiple transfusions with fresh blood products.
forty-five days after grafting, her pyrexia recurred, with
mental confusion, jaundice and severe diarrhoea, but without
pneumonitis. There was elevation of CMV antibody titres (table
101 ) and circulating atypical lymphocytes were present.
Peripheral blood leukocytes cultured in human embryonic lung
tissue were the only source from which virus could be grown.
She received adenine arabinoside 15 mg/kg/day which had
to be discontinued on the eighth day because of haematolocical
suppression. Daily cultures showed no virus growth on the eighth
day of chemotherapy.
Six months later, she developed fever and mild jaundice.
Her CNV IgG antibody titre was 1 in 32,000 and the serum IgG
was 45 g/1. Attempts to demonstrate the virus by electron
microscopy of the urine and cultures from the oropharynx and of
urine, stools and white cells were unrewarded. Her symptoms
resolved with eventual recovery.
It is most likely that she acquired her infection from
fresh blood products, as many of these were positive on retro¬
spective testing for CMV antibody; neither she nor her marrow
donor had serological evidence of previous CM\l infection. Her
susceptibility to infection may have been increased by her GVHD
or its treatment with ALG. Although the value of adenine
arabinoside in CPIV infections is not proven, it produced rapid
clinical improvement without irreversible marrow toxicity. The
recurrence of symptoms, with a markedly raised antibody titre,
suggested that the virus was not eradicated by adenine arabinosid
even though it was not demonstrable in tissue culture.
CMV seroconversion and culture
The mean time between grafting and seroconversion was 50
days (range16-120 days). Antibody titres were assayed using
complement fixation techniques. In a new infection, the CMV
specific immunoglobulin (lg)M response should occur earlier
than the IgG response and therefore be of diagnostic help.
Table 103 shows that virus specific IgPI did not rise early in
four tested patients, two with presumed new infection and two
Xl°\
with presumed reactivation of CflV.
Table 103





Timing of rise in







Three patients shed CMV after grafting (see below )?the
mean time from grafting to CUV isolation being 61 days (range
21-110 days). Two developed GVHD and one may do when cyclosporin-A
is withdrawn. All produced antibody responses and none suffered
interstitial pneumonitis. Two children had pre-existing antibody
and these isolations were probably reactivations rather than
newly acquired infections. In all three it was only leukocytes
which first provided culture evidence of CP1V but two children
had atypical peripheral blood lymphocytes in the 24 hours prior
to the culture positive leukocytes being collected.
RELATIONSHIP BETWEEN SEROCONVERSION
AND SHEDDING OF CMV
Patient Timing post graft of seroconversion(day)
Days when
CF!V shed
3D 16 5 3-6 0
PC 32 110
3G 39 21-38
In retrospect two showed seroconversion before CFIV shedding
was detected and one shed CFIV at the same time as the antibody
titre rose (Table 101 ). The urine did not show intra¬
epithelial cell inclusions nor virus on culture except




Although the numbers of patients with CMV infection here are
small, some results are unlike those of some of the larger
reported series (Neiman et al 1977; Winston et al 1979) where
half those who shed CMV died as did all patients from whose
peripheral leukocytes CMV could be cultured. One-third of
the children who developed GVHD showed evidence of CMV infection,
a similar proportion to those evaluable who did not develop
GVHD. Fifteen per cent of children shed CMV after grafting and
two of the three had a clinical illness with this. Pre-existing
antibody made later CMV shedding more likely; seroconversion per
se was not associated with identifiable clinical infection nor
was marrow from a CMV antibody positive marrow graft into a
CMV antibody negative recipient usually associated with
identifiable problems although 40% of recipients seroconverted.
Peripheral blood leukocytes were the most fertile source when
culturing for CMV. Circulating atypical lymphocytes were likely
to be associated with CFIV and these gave an early suspicion of
CMV infection but other methods such as direct immunofluorescence
Vs t>e
to identify CMV components on cell surfaces meed^developed.
The use of specific IgM antibody detection was disappointing as
a means to identify infection at an early stage.
Polyoma viruses
Introduction
Human papova viruses are usually associated with human
warts but in 1971 two new strains, BK end DC, polyoma virus
were identified. (Gardner et al 1971; Padgett et al 1971). The
DC strain may oe associated with progressive multifocal leuko-
encephalopathy (PML). BK virus has yet to have any specific
disease associated, but may be associated with ureteric damage
after renal grafting (Coleman et al 1978) and it has been
isolated from a cerebral tumour in an immunodeficient child
(Takemoto and Rartin 1976). Most isolates of BK virus have been
from asymptomatic subjects. 5% of pregnant women excrete papova
virus, usually BK though occasionally DC, in their urine
(Gardner et al 1978) and excretion is particularly common if
ALG is used as immunosuppression after renal transplantation
as i
(Lecatsas et al 1973). At least 70/ of adults have antibodies
against these two viruses (Gardner 1973) and it is likely that
just as other DNA viruses (CMV, herpes simplex and varicella/
zoster, EB virus) become latent, papova viruses are latent in
patients and donors. Because BK virus has been cultured from
human lymphocytes^Lecatsas et al 1976) there is the possibility
of transferring a primary infection in a bone marrow transplant.
Bust as CMV and herpes simplex may reactivate following immuno¬
suppression, the techniques involved in marrow grafting may also
activate papova viruses giving problems not previously encountered.
A recent report (O'Reilly 1980) suggested that up to one-third
of marrow transplant recipients shed.BK virus and that this
was associated with a rise in hepatic enzymes.
Clinical studies
Papova virus was found in the urine of a girl with GVHD and
neurological symptoms 37 days after transplantation (Fig. 31 ).
She was also infected with CMV but there was no confusion on
electron microscopy (Henry et al 1977) and immunofluorescence
confirmed the strain of papova virus. Since 1977 the urine of
all transplant in-patient children was studied each week by
electron microscopy to determine whether papova virus excretion
uuas a common observation.
Five of eight children transplanted on account of aplasia
shed BK virus in their urine (Table 104). No DC excretion was
detected. All who had GVHD excreted BK virus and all who
excreted BK virus ha.d received ALG. Equine or rabbit ALG was
the only common factor but was given with 20-40 mg of methyl—
2
prednisolone. No high dose (500 mg/m ) methylprednisolone was
given. Three of eleven children transplanted on account of AML
excreted BK virus. Two of the three received high dose steroids
and all eleven received cyclosporin-A. None received ALG. BK
virus excretion is thus not entirely an ALG effect but the
result of immunosuppression in an appropriate subject and
there was no regular temporal relationship to the use of either
ALG or steroids.
The three children with AML were the only three patients
with urinary shedding of BK virus out of 48 leukaemia transplant
Figure 31




CHILDREN WITH' BK VIRUS URINARY EXCRETION
Patient Diagnosis Therapy used GVHD
BK
viruria
□Ui AA CY, ALG,
steroids
BMT, ALG , Y es Yes
MB AA CY, BMT
CY, ALG, Steroids, BMT
probable Yes
LP AA CY, BMT
CY, ALG, Steroids, BMT
Yes Yes
AD A A ALG, steroids - Y es
KG FA CY, BMT, CSA
ALG, Steroids
Yes Yes
CC A ML CSA , CY, TBI, BMT No Yes
GC AML CSA , CY,
Steroids
TBI, BMT Y es Yes
AF AML CSA, CY,
Steroids





patients, including eleven less than 17 years old. Unlike those
in the report by O'Reilly (1980), no particular change in liver
function was seen. All were monitored weekly until discharge^a
mean of 35 days after grafting,
BK antibodies
All aplastic children except one 3 year old had antibodies
against BK virus (table 105) and thus had evidence of previous
infection. The precise prevalence of antibodies in early
childhood is not known but most children aged over four years
have antibody (Gardner 1978). Any relationship between aplasia
and BK antibodies seems unlikely. Those children transplanted
on account of aplasia who developed GVHD had the highest pre-
graft titre. The child who died of acute GVHD and the one who
developed chronic GVHD both had pregraft titres of 1/10240., It
is possible that different antibody titres would identify those
liable to develop GVHD although the antibody titres did not predict
those who would shed BK virus (table 106 ),
It is important to realise that BK virus in the urine
is common after grafting and consequently care must be taken that
this virus is not confused with CMV. 'Atypical' lymphocytes were
not present in the blood of those excreting BK virus. Rapid
specific identification of BK by immunofluorescence should be made
in the event of a neurological problem when the morphologically
identical 3C virus may be present. As the present recommended
treatment for DC leukoencephalopathy is cytosine arabinoside
(Bauer et al 1973; B.uckman and Wiltshaw 1976), a drug
suppressive to the emerging marrow, unnecessary treatment would
be unwise, yet early treatment in the event of a true 3C
infection is probably essential.
Herpes Virus Infections
Introduction
Herpes simplex virus (HSV) and varicella-zoster virus (VZ)
have received less attention than cytomegalovirus. However,
primary infection with either virus is more likely in childhood
than in adults and, in particular VZ virus must be considered
seriously. Topical idoxuridine is irrelevant to systemic
disease and the value of cytosine or adenine arabinoside has
Table 105







DliJ 13 10240 Yes
KG 12 10240 Yes
LP 11 5120 Yes
FIR 15 1 2 BO No
AU 14 1280 No
MB - 14 640 No
LA 4 320 No
GRAFTED






BK VIRUS URINARY EXCRETORS AND BK VIRUS ANTIBODY TITRES
(Transplanted aplastic children)
E xcretors Not excretors
DU* 10240 AU 12 BO
MB* 640 LA 320
LP* 5120
KG* 10240
* received ALG with steroid cover
excretion status of one child was not ascertained
2.2, fc>
remained controversial. Both drugs are myelotoxic and mould be
used reluctantly in the early period after a bone marrow trans¬
plant. The new antiherpes virus agent, acyclovir, is not myelo¬
toxic (Selby et al 1979) and it s probable efficacy makes it
appropriate in the treatment of certain herpesvirus infections
after bone marrow transplantation.
Herpes simplex
HSV can be cultured from mouth swabs taken from five per
cent of adults with respiratory tract infections, and about
25^ of the adult population have a past history of mucocutaneous
cold sores. Forty per cent of adult febrile renal transplant
recipients receiving' immunosuppression excrete HSU in mouth
swabs (Stalder 1978) and 26% of bone marrow transplant
recipients in Seattle excreted HSV, almost all within the first
30 days after grafting (Neiman et al 1977). Twenty-five per
cent of patients transplanted for AML at the Royal Marsden
Hospital develop clinical HSU infections by 30 days compared
with one in eight patients undergoing remission induction of AML.
HSU mainly causes discomfort and interference with nutrition but
generalised HSU caused two of 28 deaths from- pneumonitis in 80
Seattle transplant recipients compared to 16 similar deaths due
to CFIV (Neiman et al 1977). .
This incidence of CM V associated deaths led to an unsuccessful
trial of intermittent prophylactic adenine arabinoside in a dose
of 5 mg/kg/day (Kraemer et al 1978). Those treated had twice as
many HSU isolations and more interstitial pneumonitis than the
untreated group and the only case of clinical UZ infection
occurred in the treated group. One—third of treated patients
showed a drop of more than 26% in their white count.
Treatment with acyclovir
Ten of 40 transplant recipients have received acyclovir on
11 occasions on account of HSU lesions (table 107 ). All
episodes were oro-facial and all virologically proven were due
to HSU type I. Two patients whose lesions were extending despite
thrice daily topical idoxuridine (IDU) healed in 4 days, and
nine episodes {Q2%) were much improved on the third day. One
(B I7!, 2) was a treatment failure, but her mouth lesions could have
5.81
Table 107
H OR PES S IMPLEX INFECTIONS











MR 3 5 mg tds chin crusted by day 3
mouth healed by 7 days
PO 3 7.5 mg bd pain improved by day 2
lip crusted by day 3
1
BM 2 5 mg tds mouth healed by day 4
2
BM 4 10 mg tds no effect until Flagyl
given on day 4
RR* 2 5 mg tds mouth healed in 4 days
BT 2 5 mg daily chin crusted by day 3
mouth much improved by
day 3
GB 2 5 mg daily mouth healed by day 3
CC* 12 5 mg daily lip crusted by day 3
A I 7 5 mg tds mouth healed by day 4 |
03 2 5 mg tds pain improved by day 3
mouth healed by day 6
LS-F 4 5 mg tds pain much improved on
day 2. healed by day
6
*lesions were extending in the
presence of IDU
been due to neutropenia with anaerobic infection because they
responded as the neutrophil count rose and oral metronidazole
was given. Isolation of HSU from the mouth does not necessarily
mean that it is the cause of oral ulceration, but it is
compelling that it must be playing a part even in the presence
of neutropenic mucositis.
Varicella-Zoster
Varicella/Zoster (VZ) infections are common and 44$ of
marrow transplant recipients in Seattle suffered clinical VZ,
half during the first six months after grafting. (Atkinson et
al 1979) One of 40 patients had a second attack.
There was no particular association with age or sex of the
recipient, the original diagnosis or the nature of the transplant
preconditioning regimen and unlike other infections there was
no association with GVHD. The only association was with an
absent cutaneous response to DNCB indicating depressed cell
mediated immunity. Gallagher and Reriden (1979) found an
absence of in-vitro cellular responses to VZ virus in patients
with prolonged zoster. The in—vivo presence of VZ antibody
was irrelevant.
Two of eighty marrow transplant patients have died of
VZ at the Royal Rarsden Hosp.ital and one of 40 transplant
recipients at Westminster Hospital. None received prophylactic
varicella immune globulin (VIG) but all transplant patients now
receive this every fortnight from discharge until 14 weeks after
transplantation.
Ten of twenty-nine transplant recipients surviving within
the past year to between 2 and 15 months after grafting have
developed VZ infection. In eight patients zoster was localised
to one or two dermatomes (table 108 ). One patient with
disseminated zoster had suffered three episodes of pneumococcal
pneumonia, suggesting that immune reconstitution was incomplete.
Two of the nine patients had no associated pain. Three were
receiving VIG at the time of their eruption and six of the
nine developed zoster within the first six months after grafting.
Half were also still receiving cyclosporin-A.
All nine received acyclovir. One (S.L.) was a treatment
failure. He continued to produce new lesions within the same
3.81
Table 108
ZOSTER IN WARROW TRANSPLANT RECIPIENTS
Localised
Name











SL1 5 5 mg tds 1 day new lesions in same
dermatome for 7 days
AW1 .3.6 4 mg daily 1 day pain improved by day 2
no nciii lesions
cc* 5.5 8 mg bd 5 days new lesions day 1 only
sc 9.3 5 mg tds 1 day pain gone by day 2
new lesions day 1 only
1
NP 2.5 4 mg daily 2 days no new lesions
itch gone at 36 hours
SB 5.7 5 mg tds 3 days no new lesions
pain gone by day 2
PN1 2.8 5 mg tds 5 days no new lesions
pain relief
BM 5.2 10 mg daily 4 days no new lesions
much improved on day 4
Disseminated





dermatome and also required reduction in the dose of acyclovir
because of azotaemia. He was the only patient also receiving
steroids because of a haemolytic anaemia. Those of the remaining
eight patients who produced new lesions did so only during the
first 10 hours after starting acyclovir. None has had a second
episode of zoster. Pain relief was also achieved but owing to
the free use of analgesics, this effect was not entirely due
to the acyclovir. Complications developed in three patients,
one due to extravascular leakage of acyclovir which has a pH
of 11 and two patients showed a transient rise in blood urea
that could not be otherwise attributed. This may be due to
acyclovir precipitating in the renal tubules when there is
renal clearance of the plasma peak following bolus injection.
Giving similar or higher doses of acyclovir over 1 hour as an
infusion has recently eliminated this problem. Five patients
received acyclovir while their graft was taking and no
disturbance of the normal pattern of graft-take was seen.
Conclusions
In marrow graft patients acyclovir would appear to be
beneficial and not myelotoxic. Since the natural history of
both VZ and HFV infections is so variable, it remains uncertain
that acyclovir shortened the" natural, history of these infections
or was the cause of the response seen in G7% of VZ and 82^ of
HSV infections. Firm conclusions await a controlled trial, as
other anti-viral agents were greeted with early enthusiasm.
However one disseminating zoster and two HSV infections which
were extending despite IDU#were rapidly controlled. In a
wider uncontrolled report of 92 patients treated with acyclovir
(Watson 1981) 10% of patients were considered to have shown no
response to therapy.
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MARROW GRfl FT IMG IN CHILDHOOD - THE PRESENT NEED FOR FACILITIES
The relevance of marrow transplantation is limited only by
the graftable constituents of the transplant, Engraftment of
erythrocytes, leukocytes and platelets can be ensured }so conditions
involving any quantitative or qualitative defect of the stem
cells or their progeny may be amenable to bone marrow trans plant¬
ation, Grafting of competent cells may be appropriate in those
inborn errors of metabolism expressed in the circulating
haemopoietic cells until other methods of enzyme replacement are
developed. GVHD, the unacceptable effects of present precondition¬
ing regimens at certain ages and the dangers of infection do not
limit the relevance of grafting, but' limit its application.
In the more experimental fields the natural history of
each condition must be weighed against the immediate outcome of
a failure to achieve engraftment. This does not necessarily mean
death as unless TBI has been used, autologous reconstitution
may occur and this can probably be ensured by previously storing
the child's..'marrow and reinfusing it if enoraftment fails. In
addition, the family attitudes will also affect the decision to
attempt a transplant, some parents much preferring that a
radical cure was sought, especially if they already have
experience of the disease. However in the diseases where there
is a considerable body of experience to draw on, i.e. SCID,
severe aplasia and acute leukaemia especially in second or
subsequent remission, such theoretical considerations do not
apply and the statistical facts of their child's particular
circumstances can be discussed with the parents, with the caveat
that no-one can know how their particular child will fare.
A major limiting factor at present is the need fcr a dcnor
compatible at the major histocompatibility loci. Such a sibling
is available for less than 25^ of possible patients. About 15%
of patients engrafting after receiving an MHC identical sibling
marrow died of GVHD before the advent of cyclosporin—A, yet
attempts to develop more stringent matching criteria would
further reduce the number of patients with a donor. However,
encouraging results are emerging in the use of cyclosporin—A
in preventing death from acute GVHD and in addition alternative
techniques such as stripping the infused marrow of T and pre—T
2.^ 2_
lymphocytes by pre-incubating the marrow with steroids, lectins
or monoclonal antibodies are developing and need evaluation.
GVHD prophylaxis with combined cyclosporin-A and
methotrexate has prevented fatal GVHD in children (and adults)
receiving- a marrow transplant from a donor who only shared one
haplotype with the recipient. Almost all children who are
candidates for a transplant will have an available parent who
must share one haplotype with their child and so we may shortly
see not only a continuing reduction in the risk of fatal GVHD
following matched sibling transplants but also a tripling in
the numder of children who have possible donors. I therefore
foresee a wider practical availability of marrow transplantation
for children of almost all ages, until that is, new approaches,
both scientific and social, replace marrow grafting as a
therapeutic option.
The indications for bone marrow transplantation can be
divided into those in which the technique is of proven value
and those in which it would be experimental but may be useful.
Table 109 shows the inborn errors that may be considered in
this manner and their likely incidence in the United Kingdom
each year. Table 110 shows acquired haematological and neoplastic
diseases with the incidence derived from the 0PC5 report of 1978.
Although the total of 470 children each year (tables 109 and 110)
includes 140 children (table 109) in whom the procedure would be
experimental, it nevertheless includes 330 children in the
groups where proven success has occurred and of these no less
than 213 children have diagnoses sufficiently common that
comparison between those grafted and those treated conventionally
shows that those grafted are definitely not at a disadvantage
compared to those treated conventionally although a longer
follow—up of the transplanted children is required to evaluate
the long term gain.
The number of deaths in table 110 are taken from the
mortality data reported by the Office of population, Census and
Survey (1978). Seventy percent of children with ANLL will
achieve a first remission but "\0% of these will probably be less
than three years of age and therefore one might be disinclined
to use TBI. A similar reduction due to age will apply to the
213
Table 109
EXPECTED ANNUAL INCIDENCE OF CHILDREN WITH INBORN ERRORS






1. Severe combined immunodeficiency (SCID) 35
2. Pure T-cell deficiency 5
3. Wiskott-Aldrich syndrome 10
4. Errors intrinsic to phagocytes 50 50
5. B-cell deficiencies 10
6. Stem-cell aplasia " 2




Metabolic errors EXPRESSED IN LEUCOCYTES
1. Mucopolysaccharidoses )
2. Lipidoses ' )
3. Urea cycle enzyme deficiencies )
, 70
4. Haple-syrup urine disease )
5. Glycogen storage disease due to *
branching enzyme deficiency






partly Stanbury et al (1979)
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Other lymphoid malignancies 84 19
Other diseases of the blood 42 16
Total 213
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90% of children who achieve an adequate second remission in ALL
and an additional 10^- may not be suitable for TBI because they
had received prophylactic cranial irradiation within the previous
few months. Perhaps half of these could be transplanted in a
third remission. Half of those with 'other lymphoid malignancies'
had Hodgkin's disease and of those with lymphosarcoma perhaps
half (less the youngest ten percent) could be eligible. Deaths
from other diseases of the blood accounted for 42 children in
1978, of whom at least the twenty who suffered aplastic anaemia,
agranulocytosis or thrombocytopenia could in theory have been
transplanted, but 20c% (at least) would not have been in sufficiently
good clinical condition for this to be feasible.
Of the 330 children (tables 109 and 110) with diagnoses for
which successful marrow grafting has occurred, statistically one
in four of these children should have a compatible sibling donor.
Particularly in the case of infants, this sibling may not yet
have been born which reduces the changes of about 60 children
having a matched sibling donor to one in eight. Although a few
children will have a compatible non-sibling family donor, it is
likely that of the 330 children per annum in whom transplantation
could be indicated, only 70-80 each year would be in a position
to receive a matched sibling bone marrow transplant. This
figure of course will change if the more recent ALL treatment
regimens (UKALL 8) prove more effective in giving long term
disease-free survival than the earlier regimens. The present
short-fall of about 250 children, almost all of whom will have
a one-haplotype identical parent available as a donor, demonstrates
how the demand for facilities will change if methods to prevent
GVHD following a one-haplotype marrow transplant are successful.
Even if in—vitro treatment of autologous marrow in leukaemia
proves effective, there will remain the demand for marrow
transplant facilities.
Combining the immune deficient infants, the patients with
severe aplastic anaemia and the children with ANLL in first
remission and acute lymphatic malignancy in second or subsequent
remission (tables 109 and 110), the total of between 70 and 80
children each year who have a matched allogeneic sibling out of
a total population of 55 million will mean that one marrow
transplant in childhood should be expected each year per 730,000
total population, and if one-haplotype identity is acceptable,
one childhood allogeneic marrou graft per 180,000 total
population may be envisaged.
The almost certainly underestimated data of adult deaths
from acute leukaemia and aplastic anaemia (0PCS 1978) under the
age of 50 years suggests that about 90 adults in the United
Kingdom per annum will be candidates for grafting and have a
matched sibling. Overall in the United Kingdom therefore we
should expect about 150 matched sibling allografts each year
i.e. 1 per 340,000 of the total population, a figure which takes
no account of 1autografting' techniques, pseudo—syngeneic second
transplants or of patients coming to the United Kingdom under
the terms of our membership of the European Economic Community.
Adult patients with AML in remission spend a mean of 38.4
days as in-patients while receiving their transplant (Kay et al
1980). Patients transplanted on account of severe aplasia will
require slightly longer in hospital purely as a result of their
graft as reconstitution is less fast. similar data for children
is shown in table 111 which indicates that to support the
present requirement for matched allografting, in theory 21 beds
would have to be in continuous use throughout the United Kingdom
It is more likely that 30 designated beds would be required and
these should be in six separate units, each with between four
and six beds and each receiving from a population of between
seven and ten million. No centre should then experience less
than twenty transplants each year. However the small number of
infants will definitely not fit into such a scheme and it is
doubtful if even older children should be in an adult marrow
transplant unit providing the facilities and skill required for
them to have a successful outcome exist in a Children's Hospital
It is readily apparent how these requirments would escalate
if donors other than matched siblings prove acceptable.
The additional cost of such a matched sibling allograft
programme will not in fact be great as these patients are
requiring care anyway and numerous unauantifiable factors come
into play, including future earnings, tax paying ability and
reduced future medical costs in an inflationary economy. Even
Table 111
DAYS IN HOSPITAL EftCH YE,n.R FOR PATIENTS





































TOTAL 165 • 73 95
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so trans plantation of leukaemia patients costs about twice the
average bed day for each hospital (Kay et al 1980). Similar
care for children transplanted for acute aplasia cost 2.7 times
the average bed day cost at Westminster Children's Hospital and
infants with SCID cost 1.8 times the average bed day. On this
basis, a matched sibling transplant programme will cost about
2.16 times the average bed day, a total of £1.6 million per
annum for the 165 patients in table 111, an average of £10,000
each.
As far as we can tel^at least 60% of the leukaemia
patients transplanted in remission have such a prolonged disease-
free survival, they may well be cured. Survival rates for the
transplanted aplastic patients and the infants with severe
combined immune deficiency are not worse than 40% and 60%a
respectively. On this basis, the cost of a successful outcome
using matched allogeneic siblings in childhood transplantation
can be derived. In acute leukaemia it will be £14,000; in severe
aplastic anaemia £39,000 and in severe combined immune deficiency
each successful outcome will cost £27,500.
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APPENDIX ONE
TAPE/SLIDE FOR THE OPERATION OE V ICKER5-TREXLER ISOLATORS
WESTFlINST ER CHILDREN'S HOSPITAL
There have been a few minor changes since this tape slide
was made so not everything in the isolator you will be using
upstairs is exactly the same as described here. However, the
differences are only minor ones. Slide one.
This first slide shows a cut—away drawing of an isolator
tent, inside which you can see a patient and her bedding. The
PVC envelope is kept in place by metal rods, and the. tent kept
at a positive pressure by a motor which blows air into the
isolator. If any holes occur in the PVC, air will pass from
inside to outside of the isolator, not the other way round.
The alphabetical letters indicate various parts of the
isolator equipment:
A) shows the control rod. This connects the PVC envelope to
a valve. The degree of inflation of the isolator is thus
automatically controlled. B) indicates the port connecting
the patient envelope where two nurses are working, to the
supply envelope where one nurse is working. When the two
envelopes are separated, the patient enters the isolator through
this port. c) shows part of the unit which filters the air
in-coming from the blower. This filter will remove particles
down to a size of 0. and will thus trap bacteria and dust
particles. Although viruses are smaller than this, they are
usually adherent to dust particles and will also be trapped.
0) indicates a hatch, through which items may be introduced or
removed from the isolator whilst it is in use. The newer
isolators have better designs of hatch, but the principles
remain the same. E) shows the air supply for one of the nurses
working in the isolator. She is in a half-suit which is also
shown as F). These half-suits are large invaginations of PVC
which have a firm, clear visor. staff may work so to speak
'in the tent' yet still remain outside. The air supply E) is
necessary, and flows to an air—waistcoat which is hung round
the neck, ensuring a supply of air to the face, chest and
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arms of the person working in the half-suit.
The second slide shows a diagramatic view, with the
patient inside the isolator. The PVC is marked in red and
the solid structural parts are black. The mattress is cross-
hatched. A standard 6 foot (182 cm) NHS bed is outside the
PVC, and the mattress is tucked in a pocket in the bottom of
the envelope. This pocket allows normal bed—making with
tucking in of sheets and blankets. There are filters where
air enters the isolator and also where air comes out. The
filter on the air exit is necessary because if somebody working
in a half—suit steps backwards, some suction will result and
ward air could be drawn into the isolator. The filter ensures
that any air drawn back is sterile. The PVC of the bed envelope
and the supply envelope is firmly joined to the main port by
sticky tape and an elastic band. The base of the supply
isolator is attached to the bed to avoid accidental separation
of the isolators.
The third slide shows a bed isolator in operation. You
can see a patient in the isolator, a nurse working in the supply
isolator, and part of the air filter system in the top corner
of the tent. The blower, control valve and air flow guage are
also shown. The blower will give a maximum flow of about 50
cubic feet (1400 litres) per minute with the filters in place.
The fourth slide shows the cot isolator. This isolator
is based on exactly the same principles but is smaller and there
are no half-suits. Instead, there are eight sleeves with gloves
set in the wall of the isolator. This is a standard NHS 4'5"
(137 cm) cot, with the adjustable back swung upwards out of the
way. The supply isolator at the far end is exactly the same as
for the bed isolator.
The fifth slide shows a transit isolator. This is placed
on a trolley and has no firm structural support; it is kept
inflated by a small battery or mains operated blower. Ue use
this isolator for transferring a child from one hospital to
another and have given radiotherapy to a child in this type of
isolator. The child can be transferred from the bed isolator
to the transit isolator without breaking isolation. Isolators
are in use in many other countries and the next slide, slide six,
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shows an isolator in the Hopital des Enfants Malades in Paris.
The principles are very much the same. For this infant there
is a sleeping area on the right and a play area on the left.
The seventh slide shows part of an isolator in Texas
Children's Hospital, Houston. This boy who is now nine years
old has been in a sterile environment since birth and has a
bespoke perspex isolator with living, sleeping and playing areas.
There are sleeves in the walls through which the doctors, nurses
and parents attend to the child's needs.
The eighth slide shows one aspect of the preparation of
items for sterilisation. As everything which enters the
isolator must be sterile, gamma irradiation, autoclaving or
chemical disinfection is used as appropriate. The isolator
itself if sterilised with Milton. This slide shows the heat-
sealer for nylon or plastic bags. Items for autoclaving are
packed in autoclave bags. Doth these methods require the
object to be double-wrapped. The reason for this will become
clear when we describe the procedure for entering items into
the tent. (slide 9) Some strange things happen during the
sterilisation process — some glass goes black when irradiated,
and so the child must get used to having red tomato ketchup
coming out of a black bottle. The little packet in the foreground
was blackcurrant syrup, which lost all colour when irradiated
to 2.5 megarads. (slide 10) Some plastics change their colour,
and some become brittle after repeated irradiation.
The next few slides show some aspects of the isolator
itself. Slide 11 shows a pre-filter protecting the main exit
filter. This pre—filter is changed every three or four days
because it becomes clocoed with fibres released during badmaking.
If the main exit filter was not protected in this way, then it
would soon become blocked and reduce the airflow.
Slide 12 shows an oxygen monitor. Sterile oxygen is
available in the isolator. The sensor in the centre right of
the slide has been sterilised and the lead passed out through
the tent wall and firmly taped in place, thus continuous
oxygen monitoring is available. Do not use electrical equipment
inside the isolator when nivino oxygen.
Slide 13 shows the electric plug board, with several
electric flexes coming out of the isolator. The flexes
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(without plugs) have been irradiated and passed aseptically
into the isolator. The flex is pulled out of the isolator
through a small cone to the required distance, and firmly
taped in place. The flex cannot be allowed to return inside,
as it is obviously now unsterile. A plug is then attached and
the electric equipment used normally. The other item in this
slide is a sleeve set in the wall. (slide 14) This sleeve
fits inside the refrigerator. Thus items which are in the
isolator may be passed, still within the sterile area, 'into'
the refrigerator and so sterile cold drinks are available.
Slide 15 shows a glove—sleeve low on the wall of the
isolator so toys may be picked up from the floor without the
nurse having to enter a half suit. The isolators usually have
3 half-suits and 9 glove-sleeves.
Slide 16 shows some of the electrical equipment inside the
isolator. There is a toaster, an automatic kettle, and a fan
which can blow either hot or cold. There is also a small cooker
in which meals may be heated. The bread on top of the toaster
has been irradiated and is sterile.
Before entering items, the nurses turn a hand valve so as
to give the maximum air flow, put on masks, and wash their
hands with Hibiscrub (Chlorhexidine) . (slide 17) The area
around the entry port is cleaned with Hycolin. The port is
opened, and, because of the positive air pressure within the
isolator, a flow of sterile air emerges. (Slide 18) In this flow,
the outer wrapping of a pack is torn open, and the item still
enclosed in the inner wrap is then grasped (slide 19) either
with a hand or (slide 20) with Cheatles forceps and lifted into
the isolator by the nurse working in the supply isolator glove-
sleeves. The hatch is then closed. Glass can be surface-
sterilised using Hilton, (slide 21) Following total immersion
in Hilton for 30 minutes the Hilton tank is presented below the
entry port and in the air-flow when the port is opened (slide 22)
the nurse working in the supply isolator can reach through with
Cheatles forceps and lift the item into the isolator. The hatch
cover is then closed. After two or three objects have been
entered, there is a pause to allow the pressure in the isolator
to build up again. Ethanol is kept readily available in the
isolator in case contamination occurs. The new Hark 3 isolators
have a side entry hatch but the principle remains the same.
Slide 23 shows a diagramatic view of how rubbish is removed
from the tent. A bag is fitted over the exit port from the
inside of the isolator and held in place with an elastic band.
Uhen the bag is full and once again from inside the tent, a
new bag is fitted over the old bag. The elastic band has
already been moved so that it holds only the new bag. The bag
full of rubbish can then be carefully eased off from outside the
tent (slide 24). This means the bag has been changed without
breaking isolation. Large quantities of water, such as bath
water, are removed from the tent by a Matburn sucker (slide 25).
A small hole is made in the exit port bag with scissors from
outside the tent. Sterile rubber tubing is passed out of the
isolator through this hole and the bath water is then aspirated
using the flat burn sucker with two two—litre jars in series.
(Slide 26) After aspiration, the rubber tubing is pulled right
out of the tent and the hole sealed using a pair of forceps^
The forceps are removed before the rubbish bag is finally thrown
away. Objects can also be dropped out of the entry port, to be
caught by a waiting hand.
Slide 27 shows a different system, in use with the cot
isolator. There is no exit port bag-, but an exit shute, which
is tied at top and bottom. The top tie is undone and rubbish
passed into the shute. The top tie is then tightened and the
bottom tie undone. The waste then falls out, but if the patient
also has a communicable infection, then the bottom tie can be
opened into an appropriate receptacle which will reduce the
risk of cross—infection to the rest of the ward.
The next slide shows an infant being weighed in the large
plastic bag set in the side of the cot isolator. The baby is
inside the isolator, but the scales are outside. In a similar
way, this bag can be used for x-raying if the x-ray plate is
placed on a table. The infant lies over the x-ray plate and
the x-ray tube can then shoot vertically downwards.
Slide 29 shows a drug being checked and drawn up inside
the cot isolator. The ward sister who is checking the drug
is wearing her normal clothes and is standing right beside
the isolator. Slide 30 shows a tube-feed inside the isolator.
Almost all the equipment we use in the isolator is standard
National Health Service issue.
The next five slides show how to enter one of the half-suits
First you remove any sharp badges or rings, then wash your hands.
The air waistcoat (slide 31) is slipped over your head and the
velcro strap secured round your waist. Your arms are placed
inside retaining loops. This waistcoat will blow air over your
face and arms. (Slide 32) You crouch down and fit the head piece
over your head. (slide 33) You then shuffle forwards "into"
the isolator. In this slide you can see the clear visor. You
place your arms into the sleeves of the half-suit. There are
four sleeves on each half—suit, with usually two gloves of size
6^ and two of size 8. This allows for different hand sizes.
(Slide 34) You stand up and give yourself a 'shake' to rearrange
the plastic in the most comfortable manner, (slide 35), and you
are now able to help the patient in the isolator. All the
procedures are easily taught to the most junior nurse and also
to the parents.
The next series of slides show aspects of the patients and
their relatives. (Slide 35) If the patient is well enough, then
it is an exce1lent idea for him to clean the isolator himself
each day. In this slide Martin is giving his isolator its daily
clean. You can see he is wearing his normal everyday clothes,
which have been sterilised in the autoclave. In the next slide
(slide 37) he is playing draughts with one of the nurses, who is
sitting on a chair while wearing one of the half-suits. The
draughts set has been gamma irradiated and is inside the isolator
In slide 38 Martin is using a sterile wrapped movie-camera
inside the isolator, so we outside the isolator will be able to
'see ourselves as others see us'. slide 39 shows Martin playing
cards with his father. Slide 40 shows a different use for the
glove—sleeves. In the same way that we use them by reaching in,
the patient can reverse the sleeve so that he can reach out of
the isolator, to adjust a television, radio or use a tape
recorder. Slide 41 shows that school work can be continued.
The final slide, slide 42, shows a baby being held by its
mother. Mother is sitting outside the cot isolator using the
sleeves, and cradling the baby in her arms. She is not
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wearing a gown, cap, mask or suchlike which are usual in reverse
barrier nursing. In other words, mother is appearing to her
baby as she would do normally and the infant can see all her
expressions and hear her voice. In addition there is transmission
of body contour and warmth through the plastic.
Although there is little doubt that this is extreme
isolation in bacteriological terms, this form of isolation does
not isolate the patient from the environment in the way that
cubicle nursing may do. For long periods of isolation our
nurses prefer the isolator tent and feel less separated from
the patient than when they are using cubicles for reverse barrier
nursing. They like the reliability of the isolator and are
convinced that the children benefit from being in an isolator
within an ordinary open ward rather than being shut away in a
cubicle.
lu'e are very grateful for the dedicated nursing of all
our bone marrow transplant patients by the nursing staff of
Westminster Children's Hospital, London, and we also are grateful
to the Elizabeth and Andrew Bostic fund, a Registered Charity,
which paid most of the specialised costs involved. Many
further details of our isolator practice, including sterile foods
available, techniques for sterilisation of equipment and how to
manage the isolators from day to day- are available in the




"GERM FR EE" DELIVERY OF INFANT WITH POSSIBLE 5CID
Delivery At Westminster Hospital by vaginal route with vaginal
decontamination using Betadine. Infant to be passed in sterile
drapes to paediatricians. As feu people present as possible, all
wearing gowns, masks, gloves, overshoes and hats. Room and
"furniture" to have been freshly cleaned with hycolin.
Resuscitation Such immediate measures as required will be
given. The Resuscitaire uill be covered with sterile drapes.
Sterile LF32 filters uill be available for oxygen or air lines.
Procedures uill involve as sterile methods as practical.
Transfer to Westminster Children's Hospital In normal double
humidity Vickers 59 incubator. This uill have been cleaned by
Nathan ward staff using hycolin in spiritjlined uith sterile drapes
and sealed. Positive pressure air uill be provided by a 5 cfm
blouer uith twin bleeds and sterile microflou LF 40 filter.
Transfer uill be by emergency ambulance and pressure maintained
using either cylinder air supply uith LE 32 filter or battery
operated 2 cfm blouer. Staff uill observe appropriate sterile
precautions.
At Westminster children's Hospital Transfer to fresh 'sterile'
incubator in Nathan ward within a specially cleaned cubicle uith
properly closing door and windows. The child uill be bathed and
observed. Positive pressure air flou to continue. Cubicle
reverse barrier nursing techniques to be followed.
Use of isolator Transfer uill be effected electively after results
of markers are known, and usual nursing care instituted. Use normal
patient entry technique.
PI icrobiology
Mother 1. pre-delivery swabs for bacteriology, mycology,
(Stewarts medium) and viruses (Hanks solution) from
vagina and stool to be sent.
2. post delivery HVS for bacteriology and mycology
Child 1. swabs from external auditory meati, vagina, mouth





2. swabs from ears, nose, mouth, axillae, groins, vagina,
throat and umbilicus at 12-24 hours of age.
thereafter swabs from all usual sites two times/
week until stable, thereafter as per schedule.
Vitamin K to be given at Ix'CH.
Surface and orifice decontamination will commence
at +2 hours but no gut decontamination
Initially 5% dextrose (sterile) then pasteurised
breast milk (if available).
Otherwise SMfi, or similar (prepacked, surface
sterilised) and sterile teat.
Immunological assessment T and B markers (15 mis in no-beads
lithium heparin) must be sent as soon as possible, perhaps from
cord blood depending on time and day of delivery. Results
(provisional) available in 4 hours, and firm results in 24-36 hours.
Immunoglobulins (3 mis clotted). Full blood count (urgent
lymphocyte count).
If abnormal: HL-A typing and family FiLR's to be set up#when
repeat tests at 48-72 hrs.
If normal: repeat at 48-72 hours. If these are normal, use
fresh breast milk.
When showing an acceptable bacterial content,
discontinue barrier techniques.
An incubator will be ready from 35 weeks gestation. An isolator
is available. Cord blood must be saved in preservative free
heparin (Nathan ward or Haematology Dept.) and put in non-frozen
part of fridge. Use cannula attached to placental end of




HOUJ 11N STILL ALIVE
by
A .U . (age 13)
I opened the door. It was 10 a.m. Dad had got me up to
go to the doctor's. I felt it was all a waste of time, after all
the bruises and being bumped on my birthday in Duly and looking
pale. He finally decided it was the doctor's for me. I waited
about ten minutes and then went in. He said that I lookoa pale.
My dad explained and the doctor said to go up to Queen Mary's
Hospital. be went outside and waited for a bus. It was about
forty minutes before one came and even then it was a little
walk up to Queen Mary's in Roehampton. When I got there we had
a little wait in the Out-Patient's Department. In the check-up
room I had about four blood tests and then the doctor decided I
should stay in 'H ' ward. I was wheeled tu it and was put in a
bed and turned the T.V. on. After about 25 minutes I was
transferred in to a little room. This little room was just the
same as a mini—house really. It had a T.V., a sink, a bed and
a couple of chairs. I got into bed: just to add to my hopeless
attitude the T.V. started to. go haywire, while the T.V. was
going mad I fell asleep, slowly, but I fell asleep.
At about 5 p.m. my mum, dad, sister, brother-in-law, all
came to see me. Before coming into my room they all put hats on,
long aprons that went down to their knees and a mask. I thought,
"This is odd". My mum and dad were first in. They looked a bit
downhearted. "Hello love!" said my mum. My dad gripped my
hand tight.
I'iUJhen will I be coming out of here?" I asked.
"In about three weeks," said my dad looking a bit lost.
After about half-an-hour my mum and dad went out. Sue and
Graham waved and then some doctors came along. I looked away,
fearing something. I don't know why. I looked back to see
the doctors talking to my mum and dad. Mum turned away, put her
head in her hands and got upset. When the doctors had gone away,
my mum put her head in the door and said, "Bye, Andrew!" All
my hope of getting out of the hospital tomorrow had gone and
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when I saw mum walking down the corridor, starting to cry, I
thought three weeks was a long way off and would I come out
al ive?
I woke up the next day and started to read some comics that
I had found in the drawers. After about half-an-hour some doctors
came. The head doctor was a bit strict with me and I was really
scared. He asked me if I had sniffed any glue, gas or paint.
I said "No." . Then he said I was being transferred to Westminster
Children's Hospital, When my dad came I told him what they had
said.
"Don't worry. tie minster's a world famous hospital."
"But I was just getting used to- this hospital."
fly Uncle Pinky (his nickname) came in the morning. He
explained that Westminster was near Stamford Bridge where he lived
and he would be able to come and see me and bring Shoot, a comic.
At about three o'clock they wheeled me to an ambulance and I
was driven to the hospital. The cubicle there was much like the
other room I had been in. I settled down just before four. I
had to have a bone-marrow test. I had to have a half—inch
needle put into my waist. The needle was pushed in the bone at
the waist. It was very painful. After about thirty minutes
pushing and pulling he pulled out the needle and there was blood
all over the place. He squirted the" blood into some little
containers. I couldn't move for about an hour because the
needle had sent all the bone numb and it hurt. The night wore on
and I fell asleep. About two days later I was excited because
my brother peter was coming over from Vancouver, Canada. The day
he came was Friday and we played cards all day using counters for
poker. After the weekend I had more blood tests to be matched
with Ena's blood from her bone marrow. They were successful and
my mum cried for joy. The doctors said I would be going in a
plastic bubble on Thursday and on Thursday morning I would be
having an operation to have a tube put in my neck.
Wednesday night, Susan, one of the nurses came in and asked
if anything was worrying me. I said the tube was worrying me.
She said,
"No need to worry. You'll be given an antispectic through
a needle."
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In the morning two nurses came and injected me with a needle.
It would make me go to sleep. I was still awake but drowsy and
before I knew it I was being wheeled along to the theatre. I was
sick about twice on the way. The needle pricked into my neck.
The pain was terrible but it eased off and went numb. I heard
scissors cutting into my neck. I started to cry. I gripped
Susan's hand tight. About thirty minutes later it was oyer. It
was sewn up and a plaster was put over it. Later I was wheeled
to the bubble and put through it by a hatch. The bubble isolates
you from germs. It doesn't have all that living space. Inside
there is a bed, a drawer and an unusual kitchen. The kitchen
is very small and is at the end. There is a stove and a little
thing to keep food in. There are suits moulded into the bubble
so people can come inside but stay outside,
I was woken up the next day by Kathy, a nurse, I had to
take a load of tablets - they were horrible. Then I was washed
with hibiscrub. Hibiscrub was a kind of soapy water and it made
my skin go all dry, I could hardly move because my neck was
hurting. All the nurses said I would get used to the tube. All
the food that was passed in had to be sterilised. It took all
the vitamins out of the food so I had vitamin tablets but mostly
I had tablets to fight infection. The blood tests became more
frequent and I only had three weeks to live but at the time I
didn't know.
The next week was important because Ena was giving her bone
marrow to me. Ena went down for an operation to have some out.
A needle was put into my hand and two bags of blood were
transplanted into my bloodstream. The marrow slowly began to
work but the trouble was it was very slow.
About three weeks later the thing I had been dreading
happened — my hair began to fall out due to a drug. finally it
was all gone but began growing back. I joked a lot with Jan,
Susan, Aly, Cathy, Claire, Sister flayers and all the doctors.
It kept up my spirits. They checked my heart rate every day
and my blood. I didn't have much to do in the bubble except
play board games and cards. fie and Peter, Graham used to organise
little football tournaments that was the only thing. There was
another thing I liked that was wrestling with the nurses. The
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physiotherapist also kept me occupied with exercises — it was
hard work. After two months in the bubble I started getting
into tempers. They kept telling me I would be out soon but the
weeks wore on. I felt condemned by Pod.
"What have I done wrongj" I cried and cried. School work
was getting me down. If I couldn't do it I would throw it into
the bin. On some occasions I would pick up the scissors and try
to kill myself.
Eventually though, my blood amount shot up and I would be
coming out soon but I didn't know when. Dr. Watson phoned up
Arsenal and asked them if they would come and see me. My sister
Sue said that my tube would be comin.g out. When it did come out
it was very painful and when it was out I felt like a free bird.
I kept my stitches as souvenirs. The doctors meeting to decide
when I would be coming out. My tempers and impatience grew more
and more and I upset everybody.
Saturday morning I was excited as Arsenal were going to
come and see me on Monday. The screens were pulled round for my
wash and through them I could see all the nurses, relations and
doctors. Suddenly I knew. My sister smiled and Dr. Watson
came in and said,
"How wouxd you like to go home to—day?"
I was so speechless all I could say was, "Okay!"
The bubble hatch was undone and I clambered out. fit first
it was funny and walking about I kept wobbling. I was not
allowed any cake because it was from a bakery and not sterilised.
My mum and dad seized me and hugged me tight. All the cameras
flashed and lit up the place. I was crying, so were my mum and
dad. I thought of Peter not being here - it was a pity. After
the celebrations we went down to the car, the first fresh air
for three months. The car was all decorated in ribbons and
writing. It was great walking about. At last I was like
everybody else. When we got home the dog did not recognise me
and then I looked at the door and it had
"Welcome home Andrew!" on it.
I was very happy. I was home, and my dream had come true.
Transcript of unsolicited school essay by patient A.U. with
acquired severe aplastic anaemia. He remains well with donor
karyotype in his marrow 28 months after grafting.
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AFRACO Amphotericin, framycetin and colistin
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ALG Anti-lymphocyte globulin
ALL Acute lymphoblastic leukaemia
AFIL Acute myeloid leukaemia
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DC Strain of polyoma virus
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PML Progressive multifocal leukoeneephalopathy
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SCID Severe combined immune deficiency
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SRBCR Sheep red blood cell rosettes
T lymphocyte Thymus—derived lymphocyte
TBI Total body irradiation
TSN Trimethoprim, sulphamethoxazole and nystatin
VIG Varicella immune globulin
VT I Vickers-Trexler isolator
Ml Varicella zoster
LJCH Westminster Children's Hospital
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Evaluation of Vickers-Trexler isolator in children
undergoing bone marrow transplantation
J. G. WATSON, T. R. ROGERS, S. SELWYN, AND R. G. SMITH
From Westminster Children's Hospital and Department of Bacteriology, Westminster Medical School,
London
summary Four children, 5 months to 15 years of age, underwent bone marrow transplantation
in Vickers-Trexler isolator tents. Two grafts were elective. During 170 days of isolation no clinical
infections due to exogenous micro-organisms developed despite severe immunodeficiency. The
decontamination regimen and sterile procedures used, as well as the microbiological results, are
described. This form of isolation in paediatric practice was found to be highly acceptable to both
patients and staff.
Isolators have been used for many years to maintain
'germ-free' or gnotobiotic animal colonies (Gordon
and Pesti, 1971) and mor? recently in the protection
of adult leukaemia patients undergoing intensive
treatment (Trexler et al., 1975). They have also been
of value in the provision of a sterile environment for
newborn babies with suspected immunological
deficiency. We have used isolators for bone marrow
transplantation in 4 children who were extremely
susceptible to infection either due to the nature of
their disease or as a result of pregraft immuno¬
suppression. Two children had severe combined
immune deficiency disease (SC1D), one had chronic
granulomatous disease (CGD), and onehadFanconi's
hypoplastic anaemia. The marrow grafting pro¬
cedures used have been described previously (Humble
and Barrett, 1975).
The susceptibility to infection in these conditions
depends on the degree to which cellular and humoral
immunity are impaired. For example, polymorpho¬
nuclear leucocytes and monocytes in patients with
CGD have greatly impaired ability to kill Staphylo¬
coccus aureus, Serratia, Aerobacter, and Candida
species, and thus predispose to infection with these
organisms (Oh et al., 1969; Rodey et al., 1969).
Previous therapy and the duration of the disease or
its complications will also markedly influence the
bacterial flora present. Even after marrow transplan¬
tation there is an increased susceptibility to infection
during the first 3 weeks due to granulocytopenia and
for at least the first 3 months because of immuno-
incompetence (Johnson et al., 1976).
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Isolation and decontamination procedures
In association with Mr. P. C. Trexler of the Royal
Veterinary College (University of London) we have
adapted isolators for paediatric use. The basic
structure and management of the bed isolator (Fig. 1),
including the supply of positive pressure sterile air
using a 1415 1/min blower and high efficiency particle
arrester (HEPA) filters, is very much as described
previously (Trexler et al., 1975). The infant isolator
(Fig. 2) is made of the same transparent polyvinyl
chloride (0T-0-2 mm thickness). It consists of a
sausage, 137x91 cm, which has four sleeves down
each side—instead of half suits—and additional
facilities for weighing and taking x-rays. The storage
isolator and its manner of connection to both infant
and bed versions are very similar. The infant isolator
can be stored complete and sterile and is ready for
use within 24 hours. The larger version is ready for
use in 48 hours. Both isolators can be erected over
standard hospital cuis or beds in a normal ward and
removed for storage when not required.
The pregraft decontamination regimens adopted
were similar in all cases. The patients were initially
nursed under reverse barrier conditions in a cubicle.
All persons entering the cubicle wore hats, masks,
gowns, gloves, and overshoes. All laundry was
sterile. Good quality prepacked food was used and
samples tested were found to be sterile on all
occasions. All surfaces in the cubicle, including
equipment, were disinfected with 1 -5% Hycolin in
spirit. The patients had daily baths after applying
4% chlorhexidine in detergent (Hibiscrub) to the
skin; they also received thrice daily sprays of chlor-
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Fig. 1 Large isolator
seen in a normal
paediatric ward.
hexidine (0-02% aqueous solution) to the nose,
throat, ears, and foreskin and, on alternate days, the
hair was washed with Savlon. Chlorhexidine obstetric
cream was applied nightly to the vagina. Corsodyl
(chlorhexidine) dental gel was applied to the gums
and Naseptin to the nose twice daily.
Bowel decontamination in the nonelective cases
was started in the cubicle, while in the elective cases
it began in the isolator. Each patient received a
combination of oral antibiotics according to the
'Fracon' regimen devised by Trexler et at. (1975).
Administration of nystatin was started 4 days before
framycetin and colistin and the doses of all anti¬
biotics were modified according to age. Two items
were changed due to patient preference. As a result
of our experience with previous cases, Case 2 (Table)
received proportionately lower doses of colistin to
lessen the risk of gastric intolerance. The full de¬
contamination regimen was continued until 72 hours
before the planned removal of the patient from the
isolator.
Once the microbial population at the various sites
had reached minimal levels, the patient entered the
isolator wearing only a sterile gown, which was shed
on entry. Decontamination of the total body surface,
bowel, and orifices was continued using sterile
solutions and sterile drugs. All articles entering the
isolator were sterilized as appropriate, by heat,
gamma irradiation, or chemical means (Milton
hypochlorite 1 in 80). Food was sterilized by gamma
irradiation in commerically prepared packs. Samples
for bacteriological culture were taken thrice weekly
from nose, throat, mouth, urine, and vagina.
Axillae, groins, hairline, ears, and any skin spots
were sampled twice-weekly using swabs moistened
with water for dry areas. Swabs from the tent were
examined regularly. All specimens were cultured
aerobically and anaerobically. The delay between
sampling and culturing specimens rarely exceeded
2 hours.
In both the elective grafts a transit isolator was
used after a 'sterile' bowel had been achieved. The
patients were transferred to a small transit isolator
for 12 hours while the original isolator was emptied,
resterilized, and restocked. Case 1, because of his
hyperplastic marrow, received radiotherapy to areas
of the iliac crests to create a 'space' for the new
marrow. For this he was transferred by van to an
associated hospital in the transit isolator and, on
return, re-entered the tent, strict isolation having
been maintained throughout. The 2 patients with
SCID (Cases 3 and 4) did not receive immuno¬
suppressive therapy before bone marrow grafting.
Results
During 15 months we have had 242 days of
experience in treating patients—including one adult
—in the two sizes of isolator. The Table summarizes
clinical data, including the occurrence of leucopenia
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Fig. 2 General view of cot isolator in use.
and fever in the 4 children. The elective transplants
(Cases 1, 2) were approached cautiously in view of
the high risks associated with vigorous immuno¬
suppression. In Case 1, despite routine Hibiscrub
and Naseptin at home, swabs from the nose and a
sternal sinus yielded Staph, aureus in large numbers.
In addition, he had aspergillosis of the spine and had
been pyrexial for several months before admission.
CGD results in a hyperplastic bone marrow and the
immunosuppression used while in the isolator
reduced the neutrophil count to <0-5xl0°/l
(500/mm3) for 6 days. On 2 of these days the neutro¬
phil count was <0 1 x 10°/1 with a total white cell
count of 0-5xl09/l (500/mm3). Using the general
measures outlined above, combined with clotrima¬
zole and amphotericin B for the aspergillosis, no
further infection occurred. However, Candida
albicans appeared in the stools 10 days after the
disappearance of bacteria. He remained in the tent
for a total of 31 days.
Case 2 received a graft because of his increasing
blood transfusion requirements, spontaneous
bruising, and infective episodes. He had no unusual
organisms on entry into the tent. His stools became
sterile 4 days after full implementation of the
decontamination procedures, and remained microbe-
free over the next 62 days. Though he was co¬
operative and capable of washing himself, decon¬
tamination was more effective when the nurses
washed him. His white cell count stayed below
0-5x 109/1 (500/mm3) for 14 days and his neutrophil
count below 0-lxl0°/l (100/mm3) for 10 days and
<0-5xl09/l (500/mm3) for a further 11 days.
Throughout his 72 days of isolation he remained
free of infection.
The two infants (Cases 3,4), unlike the older
children, required no immunosuppressive therapy
and consequently neutropenia did not occur. The
one patient (Case 3) who died of infection was
heavily colonized by pathogens on admission.
Pseudomonas aeruginosa was isolated from blood
cultures and several other sites, and Salmonella
typhimurium was isolated from stool cultures.
Despite the decontamination regimen and ampicillin,
carbenicillin, and gentamicin therapy the stools and
blood cultures continued to yield salmonella and
pseudomonas. A high fever, evident throughout the
Table Summary of clinical and haematological data on patients while in isolator
Duration (days) of No. of days Superadded
Case no. Age (yrs) Diagnosis No. of days with fever clinical Clinical outcome
and sex in isolator Lymphopenia* Neutropeniat (> 37 °C) infectionsX
1 7, M CGD 31 9 6 26 ~ Survived, with evidence of
graft function for 3 m
2 15, M Fanconi's
anaemia
72 25 21 Survived; haematological
function remains normal
15 months after graft
3 5/12, F SCID 14 10 — 14 — Died due to pseudomonas
pneumonia and septicaemia
4 6/12, F SCID 53 13 — 5 Lobar Died due to graft-versus-host
pneumonia disease
♦Lymphocytes <0-5 X 109/1; {neutrophils <0-5x 109/1; {infections arising after entry into the isolator.
CGD — chronic granulomatous disease; SCID = severe combined immune deficiency disease.
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interval between admission and entry into the
isolator, persisted. She died 14 days after isolation
due to pseudomonas pneumonia and septicaemia.
Case 4 had been in the isolator for a total of 53
days during which time small numbers of Strep,
pneumoniae and viridans streptococci were isolated
from the oropharynx, and Staph, epidermidis from
the skin, mouth, and vagina. All of these were
present before entry. The second isolation of Strep,
pneumoniae on the 13th day after entry into the
tent coincided with the development of lobar
pneumonia. Penicillin therapy led to rapid resolution
of the pneumonia, and the pneumococcus was
eliminated.
Case 4 died of myocarditis due to graft-versus-
host reaction 36 days after marrow transplantation.
There was good evidence of immunological re-
constitution. No viruses were identified by electron
microscopy or isolated by culture, either before or
after death and antibody studies were unhelpful.
In 3 of the patients, sterile stool cultures were
achieved by the end of the first week of bowel
decontamination. Subsequent stool cultures from
-these patients while in the isolator yielded no growth
of organisms in 76% of the specimens. Stool cultures
from the fourth patient, as already stated, continued
to grow the pseudomonas and salmonella organisms
present on admission.
The proportion of sterile c ultures from the various
other sites were as follows: axillae 92%, hairline
85%, groins 59%, ears 68%, nose 50%, throat 71 %,
mouth 50%, urine 87%, and vagina 91%. The
majority of the positive cultures consisted of Staph,
epidermidis while scanty faecal organisms occurred
in one-fifth of the specimens.
Discussion
Although tedious for patients and staff alike, strict
protective isolation is a necessity in children with
severe immunosuppression. Infection occurring in
these patients after transplantation could have put
impossible demands for granulocytes and platelets
on the leucopheresis unit in addition to increasing
the severity of any graft-versus-host disease (Thomas
et al, 1975).
The acceptability of the Trexler form of isolator is
not in doubt. The 2 children who were old enough
to be fully aware of their surroundings accepted their
terms of 31 and 72 days' isolation well. Case 1
regarded the isolator as a castle to keep germs at
bay. Despite numerous games, school work, and
even a cine camera inside the isolator, boredom was
a major problem. This was less so with Case 2 whose
isolator was placed in an open ward and he was very
much more part of the ward activities. It was some¬
times difficult to provide a sufficiently varied sterile
diet but a small refrigerator in the supply compart¬
ment of the isolator provided useful cold drinks.
Just how well the 2 infants accepted isolation is
more difficult to assess. Case 4, judging by normal
responses to the approach of staff and normal
developmental progress while in the isolator,
showed neither sensory nor emotional deprivation.
Tests of vision and hearing while in the isolator
gave normal results.
Parents also found the isolator acceptable in
contrast to strict room isolation where they must
either carry out rigorous aseptic rituals or be denied
physical contact and close proximity. Though
the plastic film did provide a physical barrier,
parents were aware that they looked like parents to
their child as they did not have to wear masks and
hats. They also realized that the plastic barrier was
not really different from the barrier of a gown as
regards transmission of body warmth and contour,
and that handling the child, whether in an isolator or
in a cubicle, would require them to wear gloves. The
parents were taught the isolator routines and helped
considerably. They felt it easy to come and go, and
for other relative: to do the same, unhindered by
elaborate procedures. Communication through the
plastic was very easy and no special aids were
required.
For members of staff the isolator is regarded
almost unanimously as a boon. Entry into a half-suit
takes about 30 seconds and less than 15 seconds are
needed to apply a pair of glove sleeves. Against this
must be set the time taken to put on sterile clothing
and the cost of numerous sets of these items. Some
procedures do require novel adaptation, for example,
auscultation with a stethoscope head passed down
the sleeve into the gloved hand, but most procedures
can be carried out normally (Fig. 3). The benefits of
being able to approach and talk to the patient with¬
out formalities, such as gowning, are great, and allow
much more contact between patient and staff than is
usually possible during isolation.
With regard to prolonged isolation, the tent is
greatly preferred to a cubicle by our nurses because,
despite the need for some additional planning, the
continuous maintenance of asepsis is easier and
more certain.
Strict protective isolation has been shown to be
superior to conventional room isolation in reducing
the incidence of severe infections among adult
leukaemia patients who were receiving intensive
chemotherapy (Levine et al., 1973, 1975). Dooren
and his colleagues (de Koning et al., 1969; Vossen
et al., 1973) have used a laminar flow system for
isolation of patients undergoing bone marrow
transplantation. They achieved good results in
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Fig. 3 Manipulation of nasogastric feed through glove
sleeves in cot isolator.
preventing cross-infection over long periods of time.
However, this form of isolation fails to provide a
complete physical barrier between the patient and
his environment and 2 of the 5 Leiden patients were
colonized by exogenous micro-organisms.
In a recent comprehensive review (Thomas et al.,
1975), infection is reported to be the 'usual proximate
cause of death' during and after transplantation.
The authors report that almost all of their marrow
transplants were carried out using 'simple mask
reverse isolation'. In an earlier series (Solberg et al.,
1971), 41 infections occurred in 11 patients after
transplantation. Infection with exogenous organisms
was encountered most frequently in patients occupy¬
ing conventional isolation rooms.
Except for the persistence of pathogenic bacteria
in one patient, the decontamination procedures
successfully suppressed to minimal levels the pre¬
existing bacterial populations at the various sites.
Recording, as we do, the most scanty cultures of
commensal organisms tends to create a false im¬
pression of inadequacy in the decontamination
procedures. However, we recognize the impossibility
of maintaining true sterility of body surfaces that
have previously been heavily colonized by commen¬
sals or potential pathogens. This is in contrast to
the situation where babies are delivered aseptically
and then maintained in completely germ-free condi¬
tions. But a full 'inventory' of even the most minimal
numbers of organisms is necessary to forewarn
against the hazard of subsequent overgrowth by such
organisms.
The antibiotic combination used effectively sup¬
pressed the intestinal flora despite the fact that none
of these agents individually is usually regarded as
being active against the predominant Bacteroides
group and other anaerobes of the bowel. This may
be explained partly by the fact that these drugs
achieve very high concentrations in the bowel from
which they are not absorbed systemically and, in
addition, an unsuitable milieu for anaerobes may
result once the aerobic flora has been eradicated.
At the end of the period of decontamination and
isolation patients can be discharged immediately
from hospital to minimize the risks of recolonization
by hospital pathogens. The alternative course which
we have followed is to recolonize (or 'reconven-
tionalize') the bowel with the donor's mixed flora
after screening it for suitability.
An adult patient who recently underwent marrow
transplantation at our hospital remained free of
exogenous infection during 72 days' stay in the
bed isolator despite a total white cell count of
<0-lXl0°/l (100/mm3) for 6 weeks. Throughout
this time C. albicans was isolated from several
mucosal sites and persisted despite systemic anti¬
fungal therapy. The patient eventually died of
systemic candidiasis. This, and our additional
experience with Case 1, has prompted us to ad¬
minister nystatin or amphotericin B 4 days before
colistin and framycetin in the decontamination of
subsequent patients.
Because of its high acceptability from a micro¬
biological, staff, and patient point of view, we
recommend that this form of isolation be used more
widely and thus undergo further evaluation.
We are grateful to Dr. K. Hugh-Jones for allowing
us to report on his patients; to the nursing staff for
their co-operation; to the technical staff of the
Department of Bacteriology; and to the Andrew
Bostic Fund for financial assistance.
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PROGRESS WITH TENT ISOLATORS
James Graham Watson
Westminster Medical School and Children's Hospital, London,
United Kingdom
A description of the way in which we care for transplant
patients in a modified Vickers-Trexler isolator.
The flexible film isolators are situated in general
paediatric wards and the patients are cared for by medical
and nursing staff who have responsibility for other general
paediatric patients. The isolator canopy is hung from light
metal poles and the canopy kept at an automatic positive
pressure using 1415 L/min blower. The ingoing air is passed
through 0.3 y HEPA filters. The bed is outside the canopy
but all bedding, medical and nursing equipment is inside.
Access to the patient is via built-in flexible plastic
half-suits with clear visors to give en undistorted view.
Each half-suit has an additional air supply to aid the
person working therein. Different sizes of isolator allow
appropriate care for the infant, the toddler and the older
child ana also allow aseptic transport of the patient to
other hospital departments.
The isolator is sterilised with peracetic acid ini¬
tially and thereafter anything entering the isolator must
be sterilised, either by gamma radiation to 2.5 Megarads,
steam autoclaving or hypochlorite disinfection. There is an
entry port through which items can enter the isolator asep-
tically against a positive pressure air flow, and an exit
port, closed by a bag, through which rubbish may be removed,
the technique allowing isolation never to be broken.
Frozen food is sterilised by gamma radiation or else
good quality tinned food is very carefully surface disin¬
fected. There is a choice of 23 main dishes and 16 desserts.
A cooker, kettle, toaster and a refrigerator sleeve inside
the isolator allow a wide variety of foods. Most children
receive total parenteral feeding for some time but this is
outside the isolator and directed through a plastic cone
into a central venous line.
Procedures such as lumbar puncture, electrocardio¬
graphy, electroencephalography, ultrasound studies and even
a barium meal have all been carried out inside the isolator.
No electronic communication aids are required and
other children in the ward can play games with the tent
occupant. Glove sleeves, if reversed, are used by the child
to adjust television or radio sets. A telephone sleeve is
provided. Parents are actively encouraged to help with
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caring for their child.
There is no doubt that the nurses and medical staff
feel less isolated from the patient with this form of iso¬
lation compared with cubicle isolation and to have the
isolator in a ward with other children is helpful to both
the isolated patient, his parents and the attending staff.
Over 782 days of exclusion isolator experience with
12 patients, including 487 days with neutrophils less than
500/cu mm and 270 days with neutrophils less than 100/cu
mm, there has been only one episode of bacterial contamina¬
tion which was due to a tear in the visor of a half-suit.
Although patients have contracted bacterial infection
whilst in the isolator these have, with this one exception,
been due to organisms which were known to have entered the
isolator tent with the patient despite extensive decon¬
tamination .
We have recently used an infant isolator to contain a
patient with severe salmonellosis who was a danger to other
patients. To convert the isolator from exclusion mode to
containment took about 3 hours and the nurses found no dif¬
ficulty in readapting their techniques.
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Westminster Children's Hospital, Vincent Square, London, SW1, United Kingdom
j
Vickcrs-Trexler Isolators in Childhood Bone Marrow Transplantation
We have used Vickers-Trexler flexible film isolators for thirteen bone marrow transplant
children in the past 3 years. Prior to isolator entry there is an extensive surface and orifice
decontamination regime based mainly on Chlorhexidine preparations. Oral amphotericin,
started 4 days before colomycin and framycetin is used to decontaminate the gut. These
regimes are continued in the isolator where all equipment and almost all food and drugs have
been sterilised with either 2.5 Megarads of gamma radiation, steam autoclave or filtered
through 0.22 iimillepore filters.
The bed isolators are very similar to those already described1 A modification to the mat¬
tress pocket of the patient envelope allows a cot to be placed within the isolator. This is used
for toddlers. A smaller isolator with glove sleeves instead of half suits is used for infants and a
slightly larger version is used as a transit isolator to take decontaminated patients to other
hospital departments without breaking sterility. Any hardware is compatible with all the iso¬
lators.
We have introduced a number of modifications to the original envelope design. Many more
glove sleeves give better access to all parts of the isolator and additional cones allow perma¬
nent leads for electrocardiology, electroencephalography, oxygen supply (filtered) and con¬
centration monitoring and a ripple mattress. Intravenous feeding is given from outside the
isolator through a cone with the tubing being changed everyday. A full electricity supply is
available inside, controlled from an external plug board. A sleeve continuous with the
envelope fits inside a refrigerator so sterile drinks and drugs can be kept cold if required. Each
half suit has four arms allowing doctors and- nurses to use different sizes of gloves. A large
pocket and long sleeve allows many types of x-rays to be taken including a barium meal.
On one occasion we have converted our exclusion isolator to the containment mode and
successfully prevented any cross-infection in a general ward when nursing a baby with severe
salmonellosis over 120 days. The conversion took about 5 hours and no difficulties were
experienced by the nurses who were used to exclusion mode nursing.
Air sampling studies confirm the efficiency of the isolator in the general ward, compared to
the ward and a reverse barrier nursing cubicle.
Thirteen transplant children have now spent 823 days in the isolators and on only one oc-
I casion has an organism been known to have gained access to the isolator. This was through a
tear in half suit visor, the design of which is now different. These 823 days of isolation include
535 days with a granulocyte count of less than 500/cu mm and 285 days with less than 100
i cu/mm. Most children have become infected in the isolator but with the exception above, it
has always been with an organism known to have entered with the patient or caused septi-
1 caemia previously in the patient.
We firmly believe that the isolator tent system provides a practical and reliable method of
nursing the severely immunocomprised patient within a general paediatric ward. The capital
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costs are low; the space used is very flexible and the nurses much prefer the isolator to the less
reliable aseptic rituals of the cubicle.
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letters to the Editor
v-rtBlOTlC PROPHYLAXIS FOR PATIENTS INK PROTECTIVE ISOLATION
. ]d October, 1977, you published a paper' from ihe
'Mart-den, Hammersmith, and St Mary's Hospitals on
with acute non-lvmphoblastic leuka-mia nursed in pro-paucnts'
•c isolation and given the oral non-absorbable antibiotics
*eCU\-ceiin, colistin, and nystatin (fracon), together with
._ 'an£i mucosal antiseptic preparations (mainly chlor-
^"dine compounds), or none of these. The patients on aniibi-
pcophvlaxis had significantly fewer infections, fewer
from infection, fewer pyrexia! episodes, and less sys-
"^njc antibiotic therapy than did the patients who, though'
rniiarly nursed in protective isolation, did not receive this
^mce the beginning of 1978 the regimen originally de-
"bed has been altered to halve the number of tablets taken
io reduce greatly the topical antiseptics, whilst maintain-
adequate suppression of microbial flora. Oral neomycin has
placed framycetin, thereby halving the cost of each dose,
pbr only topical antiseptic used routinely is twice daily chlor-
j^idine" obstetric cream (1%) to the vagina and vulva. Chlor-
Vxidine mouthwashes (0 02% aqueous) are used only if neces-
ury
From Jan. 1, 1978, to April 1, 1979, this new regimen has
bc-cn used on 38 occasions, all patients having acute non-lym-
j-boblastic leukarmia, newly diagnosed or in first relapse. The
^Tniparison between the previous regimen and the neomycin,
colislin, nystatin (neocok) regimen is shown in the accom-
panving table. Patients intolerant of the regimen were not in-
1183
is no evidence that oral cyclosporin A given as prophylaxis
against graft-versus-host disease makes any difference to the
stool bacterial flora.
On the grounds of patient comfort and economy the Royal
Afarsden Hospital leuka:mia unit now suggests that the follow¬
ing regimen along with protective isolation gives practical
decontamination for patients with acute non-lymphoblasticleukarmia:
Neomycin sulphate 500 mg
Colistin sulphate 1 5x10' units
Nystatin 0 5 x 10fc units.
Nystatin 0 1 > 10fc units,
Chlorhcxidine obstetric cream (1^ :
twice daily
Amphotericin B lozenges (10 mg sucked four times a day
Lrukarmia Unit,
Royal Marsden Hospital. J- GRAHAM NX ATSON
Suiion, Surrey SM2 5IT BERYL JaMF SON
one tablet twice daily
one tablet twice daily
one tablet twice daily
> as syrup twice daily
to vagina and vulva
comparison of fracon and neocon regimens
faiienis intolerant of regimen
faucnis studied
Ittal patieni-davs on study
flm pvrexial (>38 °C)
oe svsicmic antibiotics





















Aided in these studies. Despite chemotherapy policies being if
Anything more anti -leukemic, it would seem that there is
t*.g!iUy less severe neutropenia, although the lime with less
--us 500 neutrophils/u] is the same. The differences in fever
and days of systemic antibiotic therapy are insignificant,
no patient has died ofinfection in the present series.Stools were judged satisfactory in 91Sf of patients studied,patients had unsatisfactory stools. 1 patient's stools were-osidered unsatisfactory since pseudomonas was grown onoccasion from the stool and the other two were unsatisfac-
*> IE that Escherichia coli could not be eliminated. 4 patientsexcluded from the study as they could not tolerate even--"reduced amount of gut antibiotics."
14 acute non-lymphoblastic leukemic patients
' _ crated the nfocon regimen underw ent marrow trans-
| with cyclophosphamide and total body irradiation.
"
. Pa,'ents received the same regimen and protective isola-« - - vuuii. OJJU i IHCklJVl. 15U10
4-J? . ^ ^a-'s during which time they had 55 (14%) days.-cxia and 139 (36Sr) days of svstemic antibiotics. There
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CLINICAL RESULTS OF BONE MARROW
TRANSPLANTATION IN SCID AND OTHER
IMMUNODEFICIENCY STATES
I.M. ANDERSON, A.J. BARRETT, N. BYROM, N. FOROOZANFAR, C. GABRIEL,
K. HENRY, J.R. HOBBS, K. HUGH-JONES, J.G. HUMBLE, D.C.O. JAMES, A. MAWLE.
S. SELWYN, G. WATSON, M. YAMAMURA
Westminster Hospitals, London, S.W.1 (England)
The five infants diagnosed as SCID conformed to the
original Swiss-type description, all having severe lym¬
phopenia (180-600/mm3) and virtually absent SRBC ro¬
settes, FHA, Candida and MLR responses. Three of the
5 had lymphocytes behaving as poor stimulating cells in
the MLR, which makes matching difficult. ADA, NP and
transcobalamin deficiencies were excluded in all 5. All 5
also showed absence of Iga, with normal free secretory
piece in their saliva, and <2 per cent of peripheral
blood lymphocytes bearing Ig. Four were carefully exa-
,-mined with reliable fluorescent anti-lgD and none was
detected. IgM levels before plasma therapy were all
below 9 mg/dl and isohaemagglutinins were all absent.
Patient 3 did however show an IgE level of 350 iu/ml.
with 80 IgE-bearing cells/mm3, supporting a hypothesis1
that IgE is the most primitive of the immunoglobulins.
GVHD occurred in patients 3 and 5 as predicted by
the Si's; donor vs Recipient of 1.83 and 3.5 respectively
(>1.6 criterion ascertained using a well standardised
MLR2). In patient 3 this was anticipated and modified
by a single dose (8 mg/kg) of horse ATG on day 7 bet¬
ween methotrexate on days 6 and 8. This appeared to
abort the acute GVHD, but a chronic obstructive jaun¬
dice with soft xanthomatosis did follow, cleared by oral
choestyramine therapy. The T-cell reconstitution was
delayed tili 9/12 post-graft, with an overshoot of the
B-cells presumably due to lack of T-suppressor-cells.
This patient is reported elsewhere (3,4).
The- other long-term survivor, patient 1, is reported
elsewhere (5). In the two early deaths (patients 2, 4)
post-mortem microscopy showed early population of
otherwise empty lymphoid tissues by mature-looking im-
muno-blasts, some containing IgM and IgG. It was also
interesting to observe that Ills secretory IgA appeared
early in saliva in the other 3 patients (yet obviously deri¬
ved from bone marrow precursors that normally release
7S IgA (6) and serum IgA was the last immunoglobulin
to appear, up to one year post-graft.
Patients 6-10 all had good MLR responses (indeed,
7 and 10 had results above our normal range) sc we
believed there was less risk of GVHD, and indeed none
suffered that complication. Because of their severe
symptomatic immune deficiency, we were loth to sup¬
press their compensating T-cells, and only prepared
patient 7 and 10 who were to receive unrelated marrow.
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Summary of bone marrow transplant data for S.C.I.D. as at 10 march 1977.
— 24 — SYMPOSIUM
Pathologie-Biologie
Janvier 1978
Westminster hospitals bone marrow transplant team.










































No None 2 069 Alive and well
Full immunocompe-
tence
Nil 5.5 Yes (8 histology+) M
(chromosomes)











No Grade III (*) 1 539 Fully immunocom¬
petent
Alive and well




Not evaluable No Not up to
day 14
14 Pre-existing infec¬
tion : Ps. pyocya-
neus septicaemia
Nil 11 Yes (6) GVHD Not evaluable Not evaluable No Grade III (*)
only on day 36





Westminster hospitals bone marrow transplant team.
Summary of bone marrow transplant data for other immunodeficiency states as at 10.3.77.
































None None None No No blocking
antibodies
detected







None None None No High levels
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M No No No 900 Alive and well
Nil 1.7 No — No Possibly
(S.I. 2.1
at 3/12)
No 714 Died of chronic
bronchiectasis
Nil 1.9 No - No No No 1 083 Alive and well
ICRF 250 mg x
3 days
CY 30 mg/kg x 1 +
800 topelvis onby









No 774 Temporarily much
improved. Paraple¬
gia recovered. Alive
Patient 6 had the type I defect already described (7), •
with normal thymidine uptake against PHA, Candida,
MLR and PPD but with total absence of MIF production.
This had not responded to iron therapy or transfer factor
and the details of the intended lymphocyte graft are
already published (8).
It was clinically successful, but Candida lesions and
MIF deficiency reappeared some six years later, unres¬
ponsive to miconazole, possibly compatible with the
expected life of committed donor cells. MLR in each
direction was still compatible 1.1/1.1 but the lesions have
cleared for 6/12 on levamisole treatment, which could
have stimulated marginal residual immunity.
Patient 7 is reported elsewhere (S), and patient 10
showed marked clinical improvement before his graft
diminished at 3/12 with the appearance of a positive
MLR. He had a paraplegia due to spinal aspergillosis,
which showed marked improvement so he is now wal¬
king normally.
Patients 8 and 9 were not doing well on gamma¬
globulin injections and showed marked clinical impro¬
vement for 6/12 post-graft, with reduction of bronchiecta-
tic sputum and symptoms and of their pre-existinc
splenomegaly. Patient 8 slowly relapsed and eventually
died of her advancing bronchiectasis. Patient 9 has
been well-controlled for two years but his chest symp¬
toms are now beginning to relapse. Studies of the in¬
teractions of T- and B-lymphocytes between donor and
patients failed to show T-cell suppression of immuno¬
globulin synthesis, but postgraft there has been no real
evidence of normal antibody production in either reci¬
pient. Evidence of graft rejection is only borderline in
patient 8, with none in patient 9.
These five grafts for other immunodeficiency diseases
are encouraging in that no harm was done to any of
them, long-lasting good to two and worthwhile transient
good to the other three.
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CLINICAL RESULTS OF BONE MARROW
TRANSPLANTATION IN APLASIA
Report of Westminster Hospital Bone Marrow Transplant Team.
A J. BARRETT, N. BYROM, A. EVANS, K. HENRY, J.R. HOBBS, K. HUGH-JONES,
J.G. HUMBLE, D.C.O. JAMES, A. MAWLE, S. PEREIRA, S. RETSAS, T. ROGERS,
J.G. WATSON, M. YAMAMURA
Westminster Hospitals, London, S.W.1 (England)
Our early experience with bone marrow transplanta¬
tion for aplasia was very discouraging. Patients were
referred late, infected and after many transfusions. We
matched two patients with related donors, and another
five patients with unrelated donors, finding no significant
increase in well standardised (1) mixed lymphocyte reac¬
tions set up in each direction. These seven patients all
died within 1-6 days of such donors having been verified
and the real test of having attempted the actual graft
could not be made.
We were therefore encouraged by the report of Lohr-
mann et al. (2) and the other work reported at this mee¬
ting, which suggests that an early decision can be made
as to which patients have the worst prognosis. It is now
clear that every transfusion increases the risks of sensi¬
tising patients with less subsequent chance of successful
grafts [less than 15 = 86% survive ; greater than 50 =
32% survive (3)].
The first three of the six patients who underwent bone
marrow transplantation were similarly transfered as emer¬
gencies, already infected.- The first two patients were
nursed by reverse barrier technique, and both died of infec¬
tion in about one month. Patients 3-6 underwent deconta¬
mination and were managed in Vickers.
Trexler isolators, and as can be seen no gram-negat'rve
septacaemia occured. It is of interest that the unrelated
grafts to patients 2 and 3 were not followed by graft-
versus-host disease, nor was an unrelated graft to a
seventh patient (still to be assessed) who has shown
bone marrow recovery.
Patients 1 and 3 both showed acute graft-versus-host
disease, even Ihough they were transplanted from HL-A
identical sisters, although this was suggested by the
S.I.I.8 in Patient 3 which shows a significant difference
by the method used (1). They were both treated with
anti-lymphocyte globulin and indeed in both cases the
graft-versus-host disease and the graft were lost. Sub¬
sequent assays (4) showed that the batches of horse
ALG used were in fact, suppressor on colony forming
cell units, and it is possible that early use of ALG ahro-
gated potential grafts.
Patients 4 [reported elsewehere (5)] and 5 have both
suffered extensive vital infection following full prepara¬
tion and a course of ATG. The subsequent recovery of
their T-cell function has been extremely slow, taking in
Case 4 almost a year to come to the lower limits of
normal.
Of the nine bone marrow attempted in the six patients,
no less than four clearly showed no evidence of engraft-
ment, and this emphasises the need in some way to be
able to assess the soil in which the grafts are to be
planted. With reliable tests, plasma factors (6) could bo
reduced by extensive plasma exchange or immune lym¬
phocytes by ATG.
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BONE-MARROW TRANSPLANT FROM AN
UNRELATED DONOR FOR CHRONIC
GRANULOMATOUS DISEASE
The Westminster Hospitals Bone-Marrow
Transplant Team*
Summary A boy with chronic granulomatous dis¬
ease received a bone-marrow graft from
a fully compatible unrelated donor, in association with
a modified immunosuppressant regimen. He showed
considerable clinical improvement with definite evidence
of engraftment, and he has enjoyed a noimal life for
over 3 years.
Introduction
In chronic granulomatous disease (c.g.d.) intracellu¬
lar killing of microorganisms is impaired,1 and invading
organisms can be transported alive around the body so
that "cold" granulomatous abscesses (due to the lack of
heating from phagocyte activation) can form in regional
lymph-nodes, liver, bones, and elsewhere. Furthermore,
organisms of low-grade virulence, non-pathogenic in
normal individuals, can become pathogenic. Even with
*'I'he team included: Dr N. Foroozonfar, Prof. J. R. Hobbs, Dr K
Hugh-Jones, Prof. J. G. Humble, Dr D. C. O. James, Dr S. Selwyn,
Dr J. G. Watson, and Mr M. Yamamura, MSc.
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modern antimicrobial chemotherapy, few affected
children live to adulthood, and a third die before the age
of 7.2 At the present time, bone-marrow transplantation
offers the only possible cure for this disease.
Bone-marrow Transplantation
No HLA-compatible family donors were available,
and volunteer unrelated donors were chosen through the
Westminster Hospital Bone Marrow Donor Panel by
HLA matching and subsequent mixed-lymphocyte reac¬
tions (m.l.r.).3 The methods of donor handling and
obtaining marrow have been previously described.4
Donor cells in the host circulation were identified by a
positive nitroblue-tetrazolium (n.b.t.) test and (because
the donor was female) by nuclear clubs in the neutro¬
phils. The patient was isolated with reverse-barrier nurs¬
ing. This was maintained while the polymorph-count
was below 2-5x10'/l. No prophylaxis for graft-versus-
host reaction was given.
Laboratory Methods
In the n.b.t. test,5 ingestion of yeast and the actual numbers
of positive (blue) cells were checked by microscopy, since this
allows clear recognition of the Lyon effect in carriers of the
commonest variety of c.g.d.1 The capacity of phagocyte-rich
leucocytes to kill organisms was measured by the candida-kill-
ing test.6
Standardised m.l.r.3 were carried out in one direction at a
time, especially post-graft, to detect any developing reaction of
the recipient against the donor.
Case-history
The patient was born in 1971, the second son of unrelated
parents. The diagnosis of c.g.d. was suggested by the clinical
history and confirmed by numerous zero n.b.t. scores and by
candida-killing-test results of less than 6% both in his own and
in normal plasma. His elder brother had also had c.g.d. and
had died of Klebsiella septicaemia at the age of 2 yr. His
mother has recurrent minor infections, and her stimulated
n.b.t. score was 50%, confirming the Lyon effect and the
X-linked inheritance of the patient's c.g.d. At 9 mo feedevel-
oped a submental abscess which was drained but healed slowly.
In his first 18 mo he had repeated skin sepsis and ten respira¬
tory infections requiring antibiotics. In March, 1973, at age 20
mo, he was admitted to the Westminster Children's Hospital
with a temperature of 39-5°C, septic lesions on his legs and
buttocks, and severe lymphadenopathy due to exudative tonsil¬
litis. Treatment with ampicillin and cloxacillin started before
admission was continued until the initial throat-swab yielded
a penicillin-sensitive group-G hemolytic streptococcus and
blood-cultures grew ampicillin-resistant Escherichia coli.
Bacilli were identified in his peripheral-blood polymorphs.
Urine and chest X-ray were normal. Treatment was changed
to benzylpenicillin and chloramphenicol—a combination justi¬
fiable only in special circumstances. Within 48 h he improved
and was discharged 10 days later. From age 9 to 20 mo tests
revealed elevation of plasma-C3 (2-0-3-5 g/1, normal <1-7
g/1), total white-cell count (18—31 xl09/l), neutrophil-count
(9-27 xl09/l), monocyte-count (7-6-12 x 108/1), serum-IgG
(16—23 g/1), and serum-IgA (1-7-2-9 g/1). He showed good re¬
sponses to oral poliomyelitis vaccination and tetanus-toxoid in¬
jection, and his T lymphocytes gave strong (normal) reactions
against phytohxmaggiutinin, Candida immunogen, and foreign
cells. The overall picture was of striking compensatory activity
of his B and T lymphocytes. His phagocytes behaved normally
in exercise and chemotaxis tests.
Because of his susceptibility to infection, and in view of the
death of his brother from septicaemia, bone-marrow transplan¬
tation was considered. The parents fully understood the situ¬
ation and the risks involved. 7 unrelated donors were found
identical to the patient in ABO and rhesus blood-groups and
in HLA antigens (A and B loci). Mixed-lymphocyte cultures in
each direction showed 1 to be fully compatible (identical at the
D locus) with the recipient (see table). In the year following
the graft another 4 HLA-identical donors were found, 1 of
whom was identical with the recipient at the D locus.
In April, 1973, he was admitted for marrow grafting, after
further respiratory infection with otitis media and new septic
skin lesions. He was given cholorhexidine baths and oral peni¬
cillin and was nursed under reverse-barrier conditions. He
received 780 mg cyclophosphamide (60 mg/kg) intravenously
4 days before infusion of 5-5 x 109 nucleated marrow cells
from the female donor. The peripheral-leucocyte count fell to
0-5 x 109/1 9 days after grafting. 12 days after the graft, occa¬
sional neutrophils with nuclear clubs (i.e., female cells) were
seen and were found to be n.b.t.-positive. 42 days after the
graft, 5% of the polymorphs were n.b.t.-positive, and 90 days
after the graft, 12% (480/mm3) were n.b.t.-positive. At this
time Candida killing showed a significant rise to 13%. Since
then the total leucocyte-count has remained nearly always in
the normal range. Plasma-C3 and serum-Ig have also
remained within normal limits. Since the graft the patient has
shown striking clinical improvement, and he now goes to a
normal nursery school. In over 3 yr he has had only two
(largely precautionary) admissions to hospital with respiratory
infections. Under reverse-barrier nursing these responded
promptly to antibiotics. He has also had occasional septic
spots. When he is well the stimulated n.b.t. score is around
1-5 x 10V1, but it increases to 4—16 x 108/1 during a mild in¬
fection. Repeat m.l.r. between patient and donor at 4 wk, 3
mo, and 1 yr after the graft showed no evidence of sensitisation
of patient to donor cells (see table).
In chromosome studies of two phytohaemagglutinin-stimu-
lated peripheral-blood samples the female karyotype was not
seen in any of the 1Q0 mitoses examined. Before the graft
<0-2% of the polymorphonuclear neutrophils (p.m.n.) showed
possible "female" nuclear clubs. 12 days after the graft,
characteristic clubs were found in 1-5% of the p.m.n. and this
compatibility data
Transformation indices
(>1-62 is significant at the 2-5% level)







to graft Recipient-»blocked donor Donor-»blocked recipient
Recipient O, Rh positive 1,7,1,8 550
Before 1-3 M
4 wk after 10 10
Donor O, Rh positive 1,7,1,8 230
3 mo after 0-9 11
1 yr after M 10
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After the graft, neutrophils showing female clubs (arrowed in A)
were found in the blood. These cells were N.B.T-positive, un¬
like the recipient's neutrophils (B).
rose at 3 mo to 2-5%. From 9 mo to 2 yr they persisted at
1-3—1-9% of the p.m.n. while the patient was well. By observ¬
ing p.m.n. ingesting yeast and fixing some at the earliest stage
of bluing to an n.b.t.-positive state, it has been possible to
show female clubs and n.b.t. positivity in the same cells (see
figure). During the third year after the graft these cells seem
somewhat scantier, and it may be that the engrafted stem-cells
giving rise to p.m.n. have no selective survival value in the
bone-marrow itself and may finally be simply displaced by the
vast majority ofc.g.d. stem-cells.
However, since the patient shows no evidence of immunolo¬
gical rejection of the donor (or of a subsequent potential
donor), it should be possible to "top up" with good stem-cells
if the need arises.
Discussion
The clinical history of these two brothers and the
laboratory and family data are diagnostic of X-linked
c.g.d. The severity of infections in the first boy sug¬
gested that the disease in this family had a bad prog¬
nosis.
In c.g.D., since the phagocytes cannot kill many
organisms, it is important to use bactericidal antibiotics.
It is also preferable to use those that can penetrate cells
to kill ingested organisms, which would otherwise have
a safe carriage around the body. Ezer and Soothill7
advocate the use of rifampicin in c.g.d. Chlorampheni¬
col is likewise useful, despite its small risk of agranulocy¬
tosis. This drug, although only bacteriostatic, penetrates
cells very well, unlike the fs-lactam antibiotics and
aminoglycosides. It is indicated in patients with severe
grant-negative infections, since septicaemia can strike
very swiftly, as it did in both brothers. Antibiotics
should, however, be used only in short intensive courses,
to minimise the risk of resistant bacteria and fungi
emerging.
In infective crises leucocytes from healthy donors and
also from patients with chronic granulocytic leukaemia
(c.g.l.) have been used. Since polymorphonuclear leuco¬
cytes are short-lived phagocytes, such treatment has to
be repeated often during severe infection'. A leucapher-
esis unit with a cell separator ensures adequate supplies
of leucocytes. Healthy donors can, after exercise and in¬
travenous hydrocortisone, provide white blood-cells
which usually function better than those from patients
with chronic myeloid leuka;mia. Such donations must be
irradiated with 1500r before being given to an immuno-
suppressed patient, to prevent any graft-versus-host
tendency or acquisition of c.g.l. Repeated use of such
transfusions is likely to sensitise the recipient to HLA,
so they should be reserved for life-threatening crises.
Despite all these supportive measures, the patient's
elder brother died before a graft could be attempted, so
it was decided to proceed with a bone-marrow graft in
the second child, who rapidly became infected when not
on antibiotics. The objective of a bone-marrow graft is
to provide a lasting source of healthy phagocytes from
the stem-cells of a healthy donor. Pre-graft administra¬
tion of a modest dose of cyclophosphamide to the patient
was to make room for the graft in his bone-marrow,
which was always more active than normal (total leuco¬
cytes 18-31 x 109/1). It would also have encouraged
engraftment by inhibiting, to some extent, the host's
reaction, but we felt it necessary to err on the side of un-
dersuppression because reverse-barrier nursing was our
only means of preventing infection at that time. In our
patients with c.g.d., other immune reactions usually
show a compensatory increase, so that their serum-
immunoglobulin levels are continually raised, and their
m.l.r. against foreign cells are usually very high. For
these reasons, the risk of a graft-versus-host reaction
seems smaller than, for example, in infants with severe
combined immunodeficiency.
Evidence ofEngraftment
Chromosome evidence has net been obtained, but Dr
M. Berenbaum has calculated that the course of cyclo¬
phosphamide would have killed only 1-3% of the leuco¬
cyte precursors. This is in accord with the numbers of
n.b.t.-positive polymorphs which also show nuclear
clubs characteristic of female cells. Over 300 spon¬
taneous bone-marrow mitoses would have to be exam¬
ined to exclude the presence of female chromoc;mes,
and we are not prepared to subject the patient t: un¬
necessary marrow biopsies. Among T lymphocytes,
which have a much slower turnover and are less sensi¬
tive to cyclophosphamide, female cells are probably even
mor«- difficult to detect.
It is possible that the initial clinical improvement
could have been due to a "spring-clean" action of the in¬
fused norma! cells, but n.b.t.-positive polymorphs could
be expected to disappear within 48 h. Reutilisation of
messenger r.n.a. and the "missing enzyme" could pro¬
long n.b.t.-positivity, but this would not be expected to
last 3 yr.
The evidence for engraftment therefore rests on the
direct demonstration on many occasions of n.b.t.-posit¬
ive polymorphs (never seen before the graft although
sought many times) with the acquisition of typical
female nuclear clubs and with clear failure to detect any
m.l.r. against the donor on three occasions after the
graft. To this can be added the clinical improvement
maintained now for over 3 yr, with normalisation of the
total leucocyte-count and C3 and Ig levels, all of which
were persistently raised before the graft.
Certainly the procedure has been worth while. We
have learned that in a crowded marrow (where abnor¬
mal phagocytes respond just as well as normal ones to
chemotactic and other stimuli) it is important to "make
room" for the intended graft, and this is now our prac¬
tice. With the guidance of Dr K. A. Newton, it has been
possible to irradiate a large part of the iliac bones with¬
out involving important growing areas. In conclusion,
over 3 yr of observation have shown that unrelated
bone-marrow, found by HLA typing and mixed-lympho¬
cyte reactions, can be transplanted successfully, and that
1-5 x 10V1 healthy phagocytes can produce good
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disease. We are encouraged to continue the search for
unrelated donors when no matched family donor can be
found. •
We gratefully acknowledge the expert nursing care of this patient
by Sister Lockyer and the staff of Muriel Leslie Gamage Ward, West¬
minster Children's Hospital. We are also indebted to the Fane Trust
and the Lawson Trust, without whose help this work could never have
been done. We are grateful to many colleagues in the British National
Blood Transfusion Service and overseas who helped in the search for
the donor.
.
Requests for reprints should be addressed to J. R. H., Department
of Chemical Pathology, Page Street Wing, Westminster Medical
School, 17 Page Street, London SW1P 2AR.
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STUDIES OF CYTOMEGALOVIRUS IN DONORS AND RECIPIENTS
R.S. Pereira, T. Rogers and J.G. Watson
Westminster Hospital Marrow Transplant Team, London,
United Kingdom
SUMMARY
Screening of HLA-matched donor panels for CMV antibody status has re¬
vealed groups with higher than expected numbers of antibody carriers;
this is tentatively linked in this population with HLA-BW15. A case of
systemic CMV infection due to transfusion following marrow transplanta¬
tion is described, with details of successful treatment with adenine
arabinoside.
In the course of screening several 'panels' of volunteer,
HLA-matched but otherwise unrelated donors in connection
with a marrow transplant programme, it was noted that 2
panels, both sharing the tissue type HLA-BW15, had higher
than average numbers of individuals (9/10 and 3/4) with
antibodies to CMV. On further tescing of donors possessing
this tissue type, CMV antibodies were found in 16 out of
22 (73%). The donor population was drawn from healthy adults
in the Greater London area, and the frequency of CMV anti¬
body for all the donors so far tested was 49%, which is
comparable to the 54% reported for an age-matched population
examined in London in an earlier survey (see Table 1) (1).
The 22 donors (mean age 35.3 years) with the tissue
type HLA-BW15 (16 of whom were CMV antibody-positive) were
compared with the 60 donors (mean age 34.1 years) possessing
other tissue types (24 of whom were CMV antibody-positive),
in a Fisher exact probability test, one-tailed since the
direction of the difference was predicted in advance. The
analysis indicated a low probability (P = 0.009) that the
different frequencies of CMV antibody were due to chance
alone.
The findings suggest that normal donors with tissue
type HLA-BW15 either have greater susceptibility to CMV in¬
fection or respond more readily with antibody production
than does the general population. A similar association in
the mouse between CMV susceptibility and the murine major
histocompatibility complex has recently been reported (2).
Thus, in some transplant cases it may be difficult to
provide CMV-free donations from unrelated donor panels. Two
of our recent cases with this 'susceptible' tissue type
have been infected post-graft by transfusion of fresh
180
X
TABLE 1. HLA-BW15 and cytomegalovirus antibody
CMV antibodies
+ - % positive
H
P
HLA-BW15 (22) 16 6 73 <0.01
Other HLA (60) 24 36 40 N.S.
All donors (82) 40 42 49 N.S.
Stern and ElekKX(199) 108 91 54 N.S.
KFisher exact probability test (one-tailed).
KXSee References (1).
(irradiated) blood products. One was asymptomatic; the
other had a severe clinical syndrome with systemic CMV in¬
fection and graft-versus-host disease. The latter case was
treated successfully with adenine arabinoside (Vidarasine)
and will be described in more detail.
A 15-year-old female with severe idiopathic aplastic
anaemia received a bone marrow graft from her histocompat-
ible 11-year-old sister. She was managed in strict protec¬
tive isolation. Eleven days post-graft, she developed fever,
diarrhoea, elevated hepatic enzymes and a haemorrhagic mor¬
billiform rash. Skin biopsy showed evidence of graft-
versus-host disease for which she was given antilymphocyte
globulin. This was followed by clinical improvement but
slow haematological recovery.
Forty-five days after grafting, pyrexia recurred, with
mental confusion, jaundice and severe diarrhoea, but no
evidence of interstitial pneumonia. There was a significant
elevation of serum antibody to CMV. However, despite strong
clinical suspicion of CMV infection, no chemotherapy was
administered until virus was isolated from culture of her
peripheral blood white cells in human embryonic lung tissue
(see Fig. 1).
She was given a course of adenine arabinoside in a
dose of 15 mg/kg/day which was discontinued on the 8th day
due to suppression of the total leucocyte count and reticu¬
locyte count. The chemotherapy resulted in cessation of
virus growth after the last day of treatment, and subse¬
quently the white cell count recovered to satisfactory
levels. Eight months post-graft she was re-admitted to hos¬
pital with fever and mild jaundice. The CMV IgG antibody
titre, which had been progressively rising, was now 1:32,000,
with virus-specific IgM antibodies present. However, at¬
tempts at demonstrating the virus by electron microscopy of
the urine and cultures of urine, stools, white cells and
from the oropharynx proved unrewarding. She was managed





Adenine arabinoside is a relatively new antiviral
agent. Although early trials have indicated that it may be
effective in the treatment of human CMV infections (3),
doubt has recently been cast on its efficacy in such cases
(4). Its successful rise in our patient, in producing clini¬
cal recovery, suggests that it may be valuable even during
the emergence of a marrow graft. Although there was undoubt¬
ed myelosuppression, the graft was not ablated and recov¬
ery occurred following cessation of therapy. The recurrence
of symptoms, with a markedly raised antibody titre, suggests
that, despite the chemotherapy, virus was not eradicated
even though it was not demonstrated in tissue culture. It
is most likely that she acquired her infection from fresh
blood products, as many of these were positive on retro¬
spective screening for CMV antibody; neither the patient
nor the marrow donor had serological evidence of previous
CMV infection. Her susceptibility to infection may have
been further increased by the antilymphocyte globulin given
post-graft.
In view of this hazard, we would advocate the exclusive
use of CMV-negative donors of blood and blood products in
susceptible cases, although this may be difficult, as sug¬
gested above. The similarity in clinical presentation be¬
tween graft-versus-host disease and systemic CMV infection,
and the possibility of their simultaneous occurrence,
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emphasise the importance of screening for both conditions
concurrently, especially as their respective management is
quite different. The use of adenine arabinoside has pro¬
duced encouraging results in this single case, but it is
recommended that haematological monitoring during adminis¬
tration be performed daily and the drug be discontinued at
the first sign of marrow suppression; the graft should
ideally be well established rather than in an early emer¬
gent phase. Nevertheless, the frequency and morbidity of
I cytomegalovirus infection in marrow graft cases justifies
stringent measures for avoidance of infection; where these
'
measures fail, the problems of chemotherapy are not in¬
superable.
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LITHIUM THERAPY IN APLASTIC AN,Y.MIA
Sir,—Some patients treated with lithium for psychiatric
disorders develop a polymorph leucocytosis.1"' Since lithium
stimulates human granulocyte colony growth in vitro' it
seemed worthwhile investigating the use of lithium to stimu¬
late granulopoiesis in patients with aplastic anaemia. We des¬
cribe here the results in two patients.
A 27-year-old Libyan male developed aplastic amemia after
hepatitis. He had shown no sustained response to oxymetha-
lone, and a course of antilymphocyte globulin in November,
1975, did not produce a complete remission. In January, 1976,
his main problems were monthly blood-transfusions, occa¬
sional gingival infections requiring antibiotic treatment, and a
fistula-in-ano following an ischiorectal abscess. He was receiv¬
ing prednisolone 7-5 mg/day but no other systemic agents dur¬
ing the trial of lithium carbonate. Before the lithium therapy
his blood count showed a haemoglobin of 6 g/dl, 0-1% reticulo¬
cytes, 2-3xlO*/l leucocytes, 0-25xl0*/l neutrophils, and
10-80xl0'/l platelets. Lithium was given three times per day
to achieve serum-lithium levels of 1 mmol/1. In the first 2
weeks reticulocytes rose to 3-5%, platelets to 125xlO*/l, and
neutrophils to 0-5-0 8xl0*/l. After 4 weeks of treatment, the
beneficial effects disappeared, and no further improvement ■ as
noted. The bone-marrow aspirate remained extremely hypocel-
lular. Transfusion requirements did not alter.
A 13-year-old boy was diagnosed as having Fanconi type
aplastic ansemia at the age of 6. Until 1976 be had been main¬
tained on oxymethalone, 50 mg twice daily and did not require
transfusions. In May, 1976, he had increasing anaemia, recur¬
rent epistaxes, purpura, and mouth ulcers. His hemoglobin
was 6 g/dl, l-4xl0*/l leucocytes, 0-3xl0'/l neutrophils and
10-20xl0'/l platelets. He was put on lithium carbonate, 750
mg/day and prednisolone 15 mg/day, which has since been
progressively reduced to 7-5 mg on alternate days. The pur¬
pura stopped abruptly, the platelet-count rose to 80xl0*/l,
reticulocytes to 3-5%, and, associated with a rise in neutro¬
phils, the mouth ulcers healed. The rise in platelets and reticu¬
locytes was not maintained, but the neutrophil-count rose to
normal over 4 weeks. 5 months later his blood-count showed
a hemoglobin of 6 g/dl, 1-2% reticulocytes, 5xl0v/I leuco¬
cytes, 3xl0v/l neutrophils, 2xl0v/l lymphocytes, and
10-30x10*/! platelets. There has been no serious bleeding or
infection. He is at present maintained on lithium carbonate
250 mg three times a day.
Neither patient experienced any side-effects from lithium
except polyuria and initial fatigue. Both patients showed simi¬
lar initial hatmatological changes, but only the second patien
showed a sustained rise of neutrophils to normal levels. It is
possible that lithium carbonate is effective in stimulating
granulopoiesis in patients with neutropenia who have sufficient
reserve of granulocyte stem cells to respond. These preliminary
results suggest that lithium therapy could be useful in some
patients with neutropenia secondary to aplastic ansemia.
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